<SEC-DOCUMENT>0001193125-25-213583.txt : 20250923
<SEC-HEADER>0001193125-25-213583.hdr.sgml : 20250923
<ACCEPTANCE-DATETIME>20250923171338
ACCESSION NUMBER:		0001193125-25-213583
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250917
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250923
DATE AS OF CHANGE:		20250923

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XOMA Royalty Corp
		CENTRAL INDEX KEY:			0000791908
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				522154066
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39801
		FILM NUMBER:		251334537

	BUSINESS ADDRESS:	
		STREET 1:		2200 POWELL STREET
		STREET 2:		SUITE 310
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		510-204-7239

	MAIL ADDRESS:	
		STREET 1:		2200 POWELL STREET
		STREET 2:		SUITE 310
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA Corp
		DATE OF NAME CHANGE:	20120119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA LTD /DE/
		DATE OF NAME CHANGE:	19990107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XOMA CORP /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d48493d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xoma="http://www.xoma.com/20250917" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2025-09-17_to_2025-09-17">XOMA Royalty Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-332">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-09-17_to_2025-09-17">0000791908</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="xoma-20250917.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-09-17_to_2025-09-17"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-17</xbrli:startDate> <xbrli:endDate>2025-09-17</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-17</xbrli:startDate> <xbrli:endDate>2025-09-17</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xoma:M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-17</xbrli:startDate> <xbrli:endDate>2025-09-17</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000791908</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xoma:DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-17</xbrli:startDate> <xbrli:endDate>2025-09-17</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-367">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt:datemonthdayyearen" id="ixv-368">September&#160;17, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">XOMA ROYALTY CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:stateprovnameen" id="ixv-369">Nevada</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-370">001-39801</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-371">52-2154066</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-372">2200 Powell Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-373">Suite 310</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-374">Emeryville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:stateprovnameen" id="ixv-375">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-376">94608</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-377">(510)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-378">204-7200</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:boolballotbox" id="ixv-379">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:boolballotbox" id="ixv-380">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:boolballotbox" id="ixv-381">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:boolballotbox" id="ixv-382">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-</span> 4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange on</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-383">Common Stock, $0.0075 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-384">XOMA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen" id="ixv-385">The Nasdaq Global Market</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" id="ixv-386">8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" id="ixv-387">XOMAP</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" format="ixt-sec:exchnameen" id="ixv-388">The Nasdaq Global Market</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" id="ixv-389">Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" id="ixv-390">XOMAO</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" format="ixt-sec:exchnameen" id="ixv-391">The Nasdaq Global Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-09-17_to_2025-09-17" format="ixt-sec:boolballotbox" id="ixv-392">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;2.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Completion of Acquisition or Disposition of Assets. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, XOMA Royalty Corporation (&#8220;<span style="text-decoration:underline">XOMA</span>&#8221;) entered into an Agreement and Plan of Merger, dated August&#160;4, 2025 (the &#8220;<span style="text-decoration:underline">Merger Agreement</span>&#8221;), with HilleVax, Inc., a Delaware corporation (&#8220;<span style="text-decoration:underline">HilleVax</span>&#8221;), and XRA 4 Corp., a Delaware corporation and a wholly owned subsidiary of XOMA (&#8220;<span style="text-decoration:underline">Merger Sub</span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Merger Agreement, and upon the terms and subject to the conditions thereof, on September&#160;16, 2025, XOMA and Merger Sub completed a tender offer to purchase all of HilleVax&#8217;s issued and outstanding shares of common stock, par value $0.0001 per share (the &#8220;<span style="text-decoration:underline">Shares</span>&#8221;), for a price per Share of (i) $1.95 in cash (the &#8220;<span style="text-decoration:underline">Cash Amount</span>&#8221;), payable subject to any applicable tax withholding and without interest, plus (ii)&#160;one <span style="white-space:nowrap">non-transferable</span> contractual contingent value right (each, a &#8220;<span style="text-decoration:underline">CVR</span>&#8221;), which shall represent the right to receive potential payments, in cash, described in, and subject to and in accordance with the terms and conditions of, the Contingent Value Rights Agreement, dated September&#160;17, 2025 (the &#8220;<span style="text-decoration:underline">CVR Agreement</span>&#8221;), by and among XOMA, Merger Sub, Broadridge Corporate Issuer Solutions, LLC (&#8220;Broadridge&#8221;), a Pennsylvania limited liability company, as rights agent, and Dr.&#160;Robert Hershberg, solely in his capacity as the initial representative, agent and <span style="white-space:nowrap"><span style="white-space:nowrap">attorney-in-fact</span></span> of the Holders (as defined therein), issuable without interest (such amount, the &#8220;<span style="text-decoration:underline">CVR Amount</span>,&#8221; and together with the Cash Amount, the &#8220;<span style="text-decoration:underline">Offer Price</span>&#8221;), all upon the terms and subject to the conditions described in the Offer to Purchase, dated August&#160;18, 2025 (together with any amendments or supplements thereto, the &#8220;<span style="text-decoration:underline">Offer to Purchase</span>&#8221;), and in the related Letter of Transmittal (together with any amendments or supplements thereto, the &#8220;<span style="text-decoration:underline">Letter of Transmittal</span>,&#8221; which, together with the Offer to Purchase, constituted the &#8220;<span style="text-decoration:underline">Offer</span>&#8221;), copies of which are attached to the Tender Offer Statement on Schedule TO filed with the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) on August&#160;18, 2025 as exhibits (a)(1)(A) and (a)(1)(B), respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offer and related withdrawal rights expired as scheduled, one minute after 11:59 p.m. Eastern Time on Monday, September&#160;15, 2025 (such date and time, the &#8220;<span style="text-decoration:underline">Expiration Time</span>&#8221;), and the Offer was not extended. According to Broadridge, the depositary and paying agent for the Offer, as of the Expiration Time, a total of 39,214,689 Shares were validly tendered, and not validly withdrawn pursuant to the Offer, representing approximately 77.48% of the outstanding Shares. All conditions to the Offer, including the Minimum Tender Condition (as defined in the Merger Agreement), were satisfied or waived and XOMA and Merger Sub accepted for payment all Shares validly tendered and not validly withdrawn in the Offer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">XOMA completed the acquisition of HilleVax on September&#160;17, 2025, by causing Merger Sub to merge with and into HilleVax (the &#8220;<span style="text-decoration:underline">Merger</span>&#8221;) pursuant to the Merger Agreement without a vote of the HilleVax stockholders in accordance with Section&#160;251(h) of the General Corporation Law of the State of Delaware (the &#8220;<span style="text-decoration:underline">DGCL</span>&#8221;). At the effective time of the Merger (the &#8220;<span style="text-decoration:underline">Effective Time</span>&#8221;), Merger Sub was merged with and into HilleVax, the separate existence of Merger Sub ceased and HilleVax continued as a wholly owned subsidiary of XOMA (the &#8220;<span style="text-decoration:underline">Surviving Corporation</span>&#8221;). At the Effective Time, each Share issued and outstanding immediately prior to the Effective Time (other than Shares (i)&#160;owned by HilleVax, XOMA, Merger Sub or any direct or indirect wholly owned subsidiary of XOMA or Merger Sub prior to the Effective Time, (ii)&#160;irrevocably accepted for payment pursuant to the Offer, or (iii)&#160;held by any stockholder who is entitled to demand and has properly demanded the appraisal of such Shares in accordance with, and in compliance in all respects with, the DGCL) was automatically cancelled, extinguished and converted into the right to receive an amount in cash equal to the Offer Price (including the CVR), without interest. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the terms of the Merger Agreement, immediately prior to the Offer Closing Time (as defined in the Merger Agreement), (i) each HilleVax stock option to purchase Shares with a per Share exercise price less than the Cash Amount (each, an &#8220;<span style="text-decoration:underline">In the Money Option</span>&#8221;) that was outstanding as of immediately prior to the Offer Closing Time accelerated and became fully vested and was by virtue of the Merger automatically cancelled and terminated and converted into the right to receive, subject to the terms of the Merger Agreement, (a)&#160;an amount in cash (without interest) equal to the product obtained by multiplying (1)&#160;the excess of the Cash Amount over the exercise price per share of the Shares underlying such In the Money Option at the Effective Time by (2)&#160;the number of Shares underlying such In the Money Option, plus (b)&#160;one CVR with respect to each Share underlying such In the Money Option at the Effective Time, (ii)&#160;each HilleVax stock option to purchase Shares with a per Share exercise price equal to or greater than the Cash Amount (each, an &#8220;Out of the Money Option&#8221;) that was outstanding as of immediately prior to the Offer Closing Time by virtue of the Merger was automatically cancelled for no consideration and the holder thereof shall have no further rights with respect thereto, subject to the terms of the Merger Agreement, and (iii)&#160;each HilleVax restricted stock unit award that was outstanding as of immediately prior to the Offer Closing Time accelerated and became fully vested and was, by virtue of the Merger, automatically cancelled and terminated and converted into the right to receive, (a)&#160;an amount in cash without interest, equal to the product obtained by multiplying (1)&#160;the Cash Amount by (2)&#160;the number of Shares underlying such HilleVax restricted stock unit award at the Effective Time and (b)&#160;one CVR for each Share underlying such HilleVax restricted stock unit award at the Effective Time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the Merger Agreement, the CVR Agreement and the transactions contemplated thereby do not purport to be complete and are qualified in their entirety by reference to the Merger Agreement and the CVR Agreement, copies of which are filed as Exhibit 2.1 and Exhibit 2.2 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated by reference herein. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;17, 2025, XOMA issued a press release announcing the completion of the Merger. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)&#8195;Financial Statements of Business Acquired. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements of HilleVax and related notes as of and for the years ended December&#160;31, 2024 and 2023 and the unaudited financial statements of HilleVax as of June&#160;30, 2025 and 2024 and for the periods then ended and related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form&#160;8-K within the period specified in Item&#160;9.01(a)(3) of Form&#160;8-K. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&#8195;Pro Forma Financial Information. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information of XOMA and HilleVax as of and for the six&#160;months ended June&#160;30, 2025 and the year ended December&#160;31, 2024 and the related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form&#160;8-K within the period specified in Item&#160;9.01(a)(3) of Form&#160;8-K. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#8195;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d48493dex21.htm">Agreement and Plan of Merger, dated August&#160;4, 2025, by and among XOMA Royalty Corporation, HilleVax, Inc. and XRA 4 Corp.* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d48493dex22.htm">Contingent Value Rights Agreement, dated September&#160;17, 2025, by and among XOMA Royalty Corporation, XRA 4 Corp., Broadridge Corporate Issuer Solutions, LLC and Dr.&#160;Robert Hershberg, solely in his capacity as the initial representative, agent and <span style="white-space:nowrap"><span style="white-space:nowrap">attorney-in-fact</span></span> of the Holders. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/791908/000119312525205563/d13490dex99a5b.htm">Press Release issued by XOMA Royalty Corporation on September&#160;17, 2025 (incorporated herein by reference to Exhibit&#160;(a)(5)(B) to the <span style="white-space:nowrap">Schedule&#160;TO-T/A</span> filed by XOMA Royalty Corporation on September&#160;17, 2025). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Certain exhibits, annexes and schedules have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> The Company hereby undertakes to furnish supplemental copies of any of the omitted exhibits, annexes and schedules upon request by the SEC; provided, however, that the Company may request confidential treatment pursuant to <span style="white-space:nowrap">Rule&#160;24b-2</span> of the Exchange Act for any annexes or schedules so furnished. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">XOMA ROYALTY CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: September&#160;23, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Owen Hughes</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold">Name:</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Owen Hughes</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold">Title:</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d48493dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DATED AS OF AUGUST&nbsp;4, 2025 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMONG </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>XOMA ROYALTY
CORPORATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>XRA 4 CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HILLEVAX, INC.
</B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation and Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II THE OFFER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.03</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.04</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger Without Meeting of Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.05</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effects of Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.06</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificate of Incorporation and Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.07</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.08</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect on Capital Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.09</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Merger Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Equity Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Contingent Value Right</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Due Organization; Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organizational Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.03</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; Binding Nature of Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.04</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Vote Required</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.05</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT> Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.06</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.07</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SEC Filings; Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.08</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.09</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property; Leasehold</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Agreements, Contracts and Commitments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance; Permits; Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Proceedings; Judgements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee and Labor Matters; Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Financial Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Privacy and Data Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Trade Control Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Information Supplied</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Rights Agreement; Anti-Takeover Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Opinion of Financial Advisor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organization, Standing and Power</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.03</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; Execution and Delivery; Enforceability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.04</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Conflicts; Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.05</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Information Supplied</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.06</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.07</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.08</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ownership of the Company Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.09</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Sufficient Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Competing Businesses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Foreign Person</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI COVENANTS RELATING TO CONDUCT OF BUSINESS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Business of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII ADDITIONAL AGREEMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Access to Information; Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reasonable Best Efforts; Notification; Regulatory Filings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.03</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.04</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.05</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.06</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.07</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stockholder Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.08</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rule <FONT STYLE="white-space:nowrap">14d-10</FONT> Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.09</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger Sub and Surviving Corporation Compliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Stock Exchange <FONT STYLE="white-space:nowrap">De-listing;</FONT> SEC Filings; Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Control of Other Party&#8217;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Anti-Takeover Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>FIRPTA Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Parent Stockholder Consent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII CONDITIONS PRECEDENT TO THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;8.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Each Party&#8217;s Obligation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX TERMINATION, AMENDMENT AND WAIVER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.03</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.04</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendment; Extension; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.05</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Procedure for Termination, Amendment, Extension or Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE X GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.01</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nonsurvival of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.02</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.03</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.04</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.05</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement; Third-Party Beneficiaries; No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.06</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.07</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.08</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Specific Enforcement; Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.09</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Parent Guarantee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exhibits </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Conditions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Incorporation of the Surviving Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of CVR Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBIT D</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Tender and Support Agreement</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Schedules </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Closing Net Cash</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prepaid Expenses, Receivables and Deposits</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Company Disclosure Letter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Parent Disclosure Letter</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER, dated as of August&nbsp;4, 2025 (this &#8220;<B><I>Agreement</I></B>&#8221; and, such date, the
&#8220;<B><I>Agreement Date</I></B>&#8221;), by and among XOMA Royalty Corporation, a Nevada corporation (&#8220;<B><I>Parent</I></B>&#8221;), XRA 4 Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (&#8220;<B><I>Merger
Sub</I></B>&#8221;), and HilleVax, Inc., a Delaware corporation (the &#8220;<B><I>Company</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on the terms and
subject to the conditions of this Agreement, Parent has agreed to cause Merger Sub to commence a cash tender offer (as it may be amended from time to time in accordance with the terms of this Agreement, the &#8220;<B><I>Offer</I></B>&#8221;) to
purchase all the outstanding shares of common stock, par value $0.0001 per share, of the Company (the &#8220;<B><I>Company Common Stock</I></B>&#8221;) for a price per share of the Company Common Stock of (i) $1.95 (the &#8220;<B><I>Cash
Amount</I></B>&#8221;), which Cash Amount is based on an estimated amount of Closing Net Cash as of the date of this Agreement equal to $102,950,000 (the &#8220;<B><I>Signing Net Cash</I></B>&#8221;), payable without interest, <U>plus</U>
(ii)&nbsp;one contingent value right (a &#8220;<B><I>CVR</I></B>&#8221;) (such amount, or any different amount per share paid pursuant to the Offer to the extent permitted under this Agreement, being the &#8220;<B><I>CVR Amount</I></B>&#8221;),
issuable without interest, which shall represent the right to receive potential payments, in cash, without interest, described in, and subject to and in accordance with the terms and conditions of, the CVR Agreement (the Cash Amount plus the CVR
Amount, collectively being the &#8220;<B><I>Offer Price</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on the terms and subject to the conditions set forth in
this Agreement and in accordance with Section&nbsp;251(h) of the Delaware General Corporation Law (the &#8220;<B><I>DGCL</I></B>&#8221;), Merger Sub shall be merged with and into the Company (the &#8220;<B><I>Merger</I></B>&#8221;), with the Company
continuing as the surviving corporation, and pursuant to the Merger, each share of the Company Common Stock that is not validly tendered and irrevocably accepted for purchase pursuant to the Offer, except as provided in this Agreement, shall be
converted in the Merger into the right to receive an amount equal to the Merger Consideration, net to the seller in cash and without interest; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent, Merger Sub and the Company acknowledge and agree that the Merger shall be governed by and effected under Section&nbsp;251(h)
of the DGCL and, subject to the terms of this Agreement, effected as soon as practicable following the consummation (as defined in Section&nbsp;251(h)(6) of the DGCL) of the Offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution of this Agreement, and as a condition and inducement to the willingness of Parent and Merger Sub to
enter into this Agreement, certain of the Company&#8217;s stockholders are entering into tender and support agreements with Parent and Merger Sub, substantially in the form attached hereto as <U>Exhibit D</U> (each, a &#8220;<B><I>Support
Agreement</I></B>&#8221;) pursuant to which, among other things, such stockholders have agreed to tender their Company Common Stock to Merger Sub in the Offer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, upon the terms and subject to the conditions set forth in this Agreement, at or prior to the Offer Closing Time, Company, the
Representative thereunder and the Rights Agent will enter into the CVR Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of the Company (the &#8220;<B><I>Company
Board&#8221;</I></B>) has unanimously (i)&nbsp;determined that the Offer, the Merger and the other transactions contemplated by this Agreement and the CVR Agreement (collectively, the &#8220;<B><I>Transactions</I></B>&#8221;) are fair to and in the
best interests of the Company and the Company Stockholders, (ii)&nbsp;approved and declared advisable the Merger and the execution, delivery and performance by the Company of this Agreement and the consummation of the Transactions,
(iii)&nbsp;resolved that this Agreement and the Merger shall be governed by and effected under Section&nbsp;251(h) of the DGCL and that the Merger shall be consummated as soon as practicable following the Offer Closing Time and (iv)&nbsp;recommended
that the Company Stockholders accept the Offer and tender their shares of the Company Common Stock pursuant to the Offer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
Board of Directors of each of Parent and Merger Sub has duly authorized and approved the execution, delivery and performance by each of Parent and Merger Sub of this Agreement and the consummation by Parent and Merger Sub of the Transactions, and
the Board of Directors of Merger Sub has declared this Agreement and the Transactions advisable and recommended that Parent, as sole stockholder of Merger Sub, adopt this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent, Merger Sub and the Company desire to make certain representations, warranties, covenants and agreements in connection with
the Offer and the Merger and also to prescribe various conditions to the Offer and the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, the parties hereto agree
as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.01 <U>Definitions</U>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Acceptable Confidentiality Agreement</I></B>&#8221; means a customary confidentiality agreement that contains confidentiality
provisions that are no less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement; <U>provided</U> that such confidentiality agreement (i)&nbsp;shall permit the Company and its Representatives to comply with
the Company&#8217;s obligations in this Agreement and (ii)&nbsp;may omit to contain a &#8220;standstill&#8221; or similar obligation to the extent that Parent has been, or is, concurrently with the entry by the Company into such confidentiality
agreement, released from any &#8220;standstill&#8221; or other similar obligation in the Confidentiality Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Affiliate</I></B>&#8221; means, with respect to any Person, any other Person that directly, or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with such first Person. The term &#8220;<B><I>control</I></B>&#8221; (including the terms &#8220;<B><I>controlling</I></B>,&#8221; &#8220;<B><I>controlled by</I></B>&#8221; and
&#8220;<B><I>under common control with</I></B>&#8221;) means possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity, whether through ownership of voting securities or other
interests, by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Authorizations</I></B>&#8221; means any approvals, authorizations, certificates,
registrations, licenses, exemptions, permits and consents of Governmental Entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Book-Entry Shares</I></B>&#8221; means shares of the Company Common Stock not
represented by certificates and held in the Direct Registration System. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Business Day</I></B>&#8221; means any day on which
the principal offices of the SEC in Washington, D.C., are open to accept filings or, in the case of determining a date when any payment is due, any day on which banks are not required or authorized by Law to close in New York, New York or Boston,
Massachusetts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Buyer Entities</I></B>&#8221; means, collectively, Parent and Merger Sub. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Closing Net Cash</I></B>&#8221; means, without duplication, (i)&nbsp;the sum of the Company&#8217;s cash and cash equivalents and
marketable securities as of immediately prior to the Offer Closing Time, determined in accordance with GAAP, applied on a basis consistent with the Company&#8217;s application thereof in the Company&#8217;s consolidated financial statements
(including the aggregate exercise price of all of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Options), <I><U>plus</U></I> (ii)&nbsp;the prepaid expenses, receivables and deposits of the Company
set forth on <U>Schedule </U><U>II</U>, <I><U>plus</U></I> (iii)&nbsp;expenses paid, or liabilities incurred, as of immediately prior to the Offer Closing Time, that are approved in writing to be covered by the Company&#8217;s Existing D&amp;O
Policies in excess of the deductible and within overall policy limits, <I><U>minus</U></I> (iv)&nbsp;the sum of the Company&#8217;s consolidated short-term and long-term contractual obligations and liabilities (including Indebtedness) accrued or
incurred by or on behalf of the Company as of immediately prior to the Offer Closing Time, <I><U>minus</U></I> (v)&nbsp;the Transaction Expenses to the extent unpaid as of immediately prior to the Offer Closing Time, <I><U>minus</U></I>
(vi)&nbsp;the Estimated Costs Post-Merger Closing, each in a manner consistent with <U>Schedule I</U> hereto, which is attached for illustrative purposes only. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Code</I></B>&#8221; means the U.S. Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>COBRA</I></B>&#8221; means the Consolidated Omnibus Budget Reconciliation Act of 1985, as set forth in Section&nbsp;4980B of the
Code and Part 6 of Title I of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Combined Group</I></B>&#8221; means a group of Persons that elects to file a Tax Return
or pay a Tax, or is required to or otherwise files a Tax Return or pays a Tax, as an affiliated group, consolidated group, combined group, unitary group or other similar group for purposes of applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Associate</I></B>&#8221;<B> </B>means any current or former employee, officer, director, independent contractor or other <FONT
STYLE="white-space:nowrap">non-employee</FONT> service provider of Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Balance
Sheet</I></B>&#8221; means the audited balance sheets of Company for the years ended December&nbsp;31, 2023 and December&nbsp;31, 2024<B>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Capital Stock</I></B>&#8221;<B> </B>means Company Common Stock and Company Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Employee Plan</I></B>&#8221; means any Employee Plan that Company or any of its Subsidiaries (i)&nbsp;sponsors,
maintains, administers, or contributes to, or (ii)&nbsp;provides benefits under or through, or (iii)&nbsp;has any obligation to contribute to or provide benefits under or through, or (iv) may reasonably be expected to have any liability with respect
to, or (v)&nbsp;utilizes to provide benefits to or otherwise cover any Company Associate (or their spouses, dependents, or beneficiaries). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Equity Awards</I></B>&#8221; means the Company Options and Company
Restricted Stock Unit Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company ESPP</I></B>&#8221; means the Company 2022 Employee Stock Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Intellectual Property Rights</I></B>&#8221; means all Intellectual Property Rights owned by the Company, <FONT
STYLE="white-space:nowrap">co-owned</FONT> by the Company, or exclusively licensed to the Company or any of its Subsidiaries, in each case, excluding Intellectual Property Rights licensed to the Company under the Takeda License Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Material Adverse Effect</I></B>&#8221; means any change, event, condition, development, circumstance, state of facts,
effect or occurrence that has a material adverse effect on (i)&nbsp;the business, financial condition, assets, properties or results of operations of the Company or (ii)&nbsp;the ability of the Company to consummate the Transactions; provided that,
for purposes of clause (i), none of the following shall be taken into account in determining whether there has been a Company Material Adverse Effect: any change, event, condition, development, circumstance, state of facts, effect or occurrence to
the extent resulting from or arising out of (A)&nbsp;general conditions (or changes therein) in the industries in which the Company operates, (B)&nbsp;general economic or regulatory, legislative or political conditions (or changes therein),
including any actual or potential stoppage, shutdown, default or similar event or occurrence affecting a national or federal government, or securities, credit, banking, financial or other capital markets conditions (including changes generally in
prevailing interest rates, currency exchange rates, credit markets or equity price levels or trading volumes), in each case, in the United States, the European Union or elsewhere in the world, (C)&nbsp;any change in applicable Law or GAAP after the
date hereof, (D)&nbsp;geopolitical conditions, the outbreak or escalation of hostilities, any acts or threats of war (whether or not declared), sabotage or terrorism, or any escalation or worsening of any of the foregoing, (E)&nbsp;any epidemic,
pandemic (including <FONT STYLE="white-space:nowrap">COVID-19),</FONT> disease outbreak or other public health-related event (or escalation or worsening of any such events or occurrences, including, in each case, the response of Governmental
Officials (including <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures)), hurricane, tornado, flood, fire, volcano, earthquake or other natural or <FONT STYLE="white-space:nowrap">man-made</FONT> disaster or any other national or
international calamity, crisis or disaster, (F)&nbsp;the failure, in and of itself, of the Company to meet any internal or external forward-looking projections, forecasts, estimates or predictions in respect of any financial or operating metrics
before, on or after the Agreement Date, or changes in the market price or trading volume of the Company Common Stock or the credit rating of the Company (it being understood that the underlying facts giving rise or contributing to such failure or
change may be taken into account in determining whether there has been a Company Material Adverse Effect if such facts are not otherwise excluded under this definition), (G) the announcement, pendency or performance of any of the Transactions,
including the identity of, or any facts or circumstances relating to, Parent, Merger Sub or their respective Affiliates, any stockholder Proceeding (direct or derivative) in respect of this Agreement or any of the Transactions and any loss of or
change in relationship, contractual or otherwise, with any Governmental Entity, supplier, vendor, service provider, collaboration partner, licensor, licensee or any other party having business dealings with the Company (including the exercise, or
prospective exercise, by any party of any rights that arise upon a change of control), or departure of any employees or officers, of the Company (<U>provided</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that this clause (G)&nbsp;shall not apply to the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;4.05</U> or the condition set forth in clause (ii)&nbsp;of
<U>Exhibit</U><U></U><U>&nbsp;A</U> to the extent relating to such representations and warranties), (H) the Company&#8217;s compliance with the covenants contained in this Agreement, or (I)&nbsp;any action taken by the Company at Parent&#8217;s
express written request or with Parent&#8217;s express written consent, except in the case of clause (A), (B), (C), (D) or (E), to the extent that the Company is disproportionately affected thereby as compared with other participants in the
industries in which the Company operates (in which case the incremental disproportionate impact or impacts may be taken into account in determining whether there has been a Company Material Adverse Effect). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Outstanding Shares</I></B>&#8221; means the total number of shares of the Company Common Stock, including all shares
underlying the Company Options and Company Restricted Stock Unit Awards, that are issued and outstanding as of immediately prior to the Offer Closing Time, and assuming the exercise of all <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Options outstanding as of the Effective Time. No <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Options
shall be included in the total number of shares of the Company Common Stock outstanding for purposes of determining the Company Outstanding Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Options</I></B>&#8221;<B> </B>means options to purchase shares of Company Common Stock granted by Company under the
Company 2021 Equity Incentive Plan or the Company 2022 Incentive Award Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Registered Intellectual Property
Rights</I></B>&#8221; means all Registered Intellectual Property Rights within the Company Intellectual Property Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Restricted Stock Unit Awards</I></B>&#8221; means restricted stock unit awards covering shares of Company Common Stock
granted by Company under the Stock Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Stockholders</I></B>&#8221; means the holders of shares of outstanding
Company Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Stock Plans</I></B>&#8221; means the Company 2021 Equity Incentive Plan, the Company 2022
Incentive Award Plan and the Company ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Company Takeover Proposal</I></B>&#8221; means any inquiry, proposal or offer
from any Person or group (other than Parent and its Subsidiaries) relating to (i)&nbsp;any direct or indirect acquisition or purchase, in a single transaction or a series of related transactions, of (A) 20% or more (based on the fair market value
thereof, as determined by the Company Board of the assets of the Company or (B) 20% or more of the aggregate voting power of the capital stock of the Company, (ii)&nbsp;any tender offer, exchange offer, merger, consolidation, business combination,
recapitalization, liquidation, dissolution, binding share exchange or similar transaction involving the Company that, if consummated, would result in any Person or group (or the stockholders of any Person) beneficially owning, directly or
indirectly, 20% or more of the aggregate voting power of the capital stock of the Company or of the surviving entity or the resulting direct or indirect parent of the Company or such surviving entity, other than, in each case, the Transactions or
(iii)&nbsp;any combination of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Consent</I></B>&#8221; means any consent, approval, license, permit, order or
authorization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Contract</I></B>&#8221; means, with respect to any Person, any legally binding
contract, lease, license, indenture, note, bond, agreement, concession, franchise or other instrument to which such Person or its Subsidiaries is a party or by which any of their respective properties or assets is bound. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I><FONT STYLE="white-space:nowrap">COVID-19</FONT></I></B>&#8221; means the coronavirus disease caused by the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2,</FONT></FONT> and any variants or evolutions thereof or other epidemics, pandemics or disease outbreaks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</I></B>&#8221; means any quarantine, &#8220;shelter in place,&#8221;
&#8220;stay at home,&#8221; social distancing, shutdown, closure, sequester or other Law, order, directive, guideline or recommendation by any Governmental Entity or public health agency in connection with or in response to <FONT
STYLE="white-space:nowrap">COVID-19</FONT> and all guidelines and requirements, such as social distancing, cleaning, and other similar or related measures of the Occupational Safety and Health Administration and the Centers for Disease Control and
Prevention; provided that such matters are implemented in a reasonable manner and for a reasonable period of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Direct
Registration System</I></B>&#8221; means the service that provides for electronic direct registration of securities in a record holder&#8217;s name on the Company&#8217;s transfer books and allows shares to be transferred between record holders
electronically. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Enforceability Exceptions</I></B>&#8221;<B> </B>means the (i)&nbsp;Laws of general application relating to
bankruptcy, insolvency and the relief of debtors and (ii)&nbsp;rules of law governing specific performance, injunctive relief and other equitable remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Environmental Law</I></B>&#8221;<B> </B>means any federal, state, local or foreign Law relating to pollution or protection of
human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any law or regulation relating to emissions, discharges, releases or threatened releases of Hazardous Materials, or
otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>ERISA</I></B>&#8221; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>ERISA Affiliate</I></B>&#8221;<B> </B>means, with respect to any Entity, any other Person that would be treated as a single
employer with such Entity, part of the same &#8220;controlled group&#8221; as such Entity or under common control with such Entity under Sections 414(b),(c),(m) or (o)&nbsp;of the Code, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Estimated Costs Post-Merger Closing</I></B>&#8221; means, without duplication (including duplication of any amounts included in
Transaction Expenses or Indebtedness) the unpaid costs that the Surviving Corporation would reasonably be expected to incur after the Offer Closing Time, including costs associated with: (i)&nbsp;the Wind-Down Process, including (x)&nbsp;any related
clinical activities (including closing down clinical studies and (y)&nbsp;remaining lease-related obligations (including rent, common area maintenance, property taxes, insurance, utilities, janitorial services and other administrative fees), in each
case, incurred in connection with the Wind-Down Process; and (ii)&nbsp;any existing legal proceedings that commenced prior to the Offer Closing Time; but in each case of clause (i)&nbsp;and (ii), excluding any such costs that are required to be paid
by Parent or Merger Sub hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Exchange Act</I></B>&#8221; means the Securities Exchange Act of 1934, as
amended, together with the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>FDA</I></B>&#8221; means the U.S. Food and Drug
Administration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>FDCA</I></B>&#8221; means the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167; 301 et seq.), as
amended, and all regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>GAAP</I></B>&#8221; means generally accepted accounting principles in
the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Governmental Entity</I></B>&#8221; means any supranational, national, federal, state, municipal,
provincial, local or other government, domestic or foreign, or any court, administrative agency or commission or other governmental authority or instrumentality exercising legislative, judicial, regulatory or administrative functions of or
pertaining to supranational, national, federal, state, municipal, provincial or local government, including any department, commission, board, agency, bureau, subdivision, instrumentality or other regulatory, administrative, judicial or arbitral
authority, whether domestic or foreign, and in each case, of competent jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Governmental Official</I></B>&#8221;
means any official or employee of any government, or any department, agency, or instrumentality thereof, any political party or official thereof, any candidate for political office, any official or employee of any public international organization,
or any person acting in an official capacity for or on behalf of any such government, department, agency, instrumentality, party, or public international organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Hazardous Materials</I></B>&#8221;<B> </B>means any pollutant, chemical, substance and any toxic, infectious, carcinogenic,
reactive, corrosive, ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid or gas, that is subject to regulation, control or remediation under any Environmental Law, including without
limitation, crude oil or any fraction thereof, and petroleum products or <FONT STYLE="white-space:nowrap">by-products.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Health Care Laws</I></B>&#8221; means the FDCA, the Public Health Service Act (42 U.S.C. &#167;&#167; 201 et seq.), the
Anti-Kickback Statute (42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7b(b)),</FONT> the False Statements Law (42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7b(a)),</FONT> the Civil Monetary Penalties Law (42 U.S.C. <FONT
STYLE="white-space:nowrap">&#167;1320a-7a),</FONT> the False Claims Act (31 U.S.C. &#167;&nbsp;3729 et seq.), the Physician Payments Sunshine Act (42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7h),</FONT> and the exclusions law (42 U.S.C. <FONT
STYLE="white-space:nowrap">&#167;1320a-7).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Incidental Contracts</I></B>&#8221; means all (a)&nbsp;shrink-wrap,
click-wrap and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> Contracts for commercially available software or services, (b)&nbsp;material transfer agreements, (c)&nbsp;Contracts that are ancillary to a
sale of products or services to customers or the purchase or use of software, services, equipment, reagents or other materials, <FONT STYLE="white-space:nowrap">(d)&nbsp;non-disclosure</FONT> agreements entered into in the ordinary course of
business, <FONT STYLE="white-space:nowrap">(e)&nbsp;non-exclusive</FONT> license agreements for cell lines, viruses and research tools, <FONT STYLE="white-space:nowrap">(f)&nbsp;non-material</FONT> services agreements entered into in the ordinary
course of business and (g)&nbsp;offer letters, employment agreements, consulting or contractor agreements and invention assignment agreements entered into with employees and contractors of the Company or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Indebtedness</I></B>&#8221; means, with respect to the Company or its
Subsidiaries, and without duplication (including without duplication of any amounts included in Transaction Expenses) (i)&nbsp;indebtedness for borrowed money, (ii)&nbsp;debt obligations evidenced by bonds, debentures, notes or similar instruments,
(iii)&nbsp;net obligations under any short-term or long-term contracts, including any installment sale contracts, to the extent actually terminated, (iv)&nbsp;all guarantees and arrangements having the economic effect of a guarantee of the Company
or its Subsidiaries of any Indebtedness of any other Person, to the extent called or drawn upon, (v)&nbsp;any deferred purchase price obligations for assets, property, securities, business or services, including seller notes, holdback, or similar
payments (whether contingent or otherwise) calculated as the maximum amount payable under or pursuant to such obligation, (vi)&nbsp;net obligations under any interest rate swap, forward contract, currency or other hedging arrangement, derivative or
similar transaction, to the extent actually terminated, (vii)&nbsp;any Unpaid Taxes, (viii)&nbsp;any unfunded benefit liability with respect to any retirement or deferred compensation plan, program, agreement or arrangement, (ix)&nbsp;any accrued
and unused vacation, paid time off or similar leave, and any accrued and unpaid severance obligations, or bonuses or commissions and any other bonuses or commissions that relate to the period prior to the Offer Closing Time, irrespective of whether
accrued, and in each case, the employer portion of any Taxes related thereto and (x)&nbsp;all obligations or undertakings to maintain or cause to be maintained the financial position of others or to purchase the obligations of others.
&#8220;Indebtedness&#8221; shall not include any intercompany Indebtedness of the Company or any Indebtedness incurred by Parent or its Affiliates (and subsequently assumed by the Company) at the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Intellectual Property Rights</I></B>&#8221; means any and all intellectual property and similar proprietary rights throughout the
world, including any and all state, United States, international and/or foreign or other territorial or regional rights in, arising out of or associated with any of the following: (i)&nbsp;United States, foreign and international patents, patent
applications, including all provisionals, nonprovisionals, substitutions, divisional, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues, renewals, extensions, supplementary
protection certificates, reexaminations, term extensions, confirmations, certificates of invention and the equivalents of any of the foregoing, statutory invention registrations, invention disclosures and inventions (collectively,
&#8220;<B><I>Patents</I></B>&#8221;), (ii) trademarks, service marks, trade names, domain names, corporate names, brand names, URLs or other names and locators associated with the internet, trade dress, logos and other source identifiers, including
registrations and applications for registration thereof and goodwill associated therewith and symbolized thereby, (iii)&nbsp;works of authorship (whether or not copyrightable) and all copyrights, copyrightable works, derivative works, including
registrations and applications for registration thereof, and all renewals, extensions, restorations or reversions of the foregoing, including all rights of authorship, use, publication, publicity, reproduction, distribution, income, performance and
transformation, (iv)&nbsp;software, including all source code, object code, firmware, development tools files, records and data, all media on which any of the foregoing is recorded, and all related documentation, (v)&nbsp;all inventions, invention
disclosures, improvements, formulae, customer lists, trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> (including recipes, specifications, formulae, manufacturing and other processes, operating procedures, methods, techniques and all
research and development information), technology, technical data, databases, data collections, confidential information and other proprietary rights and intellectual property, whether patentable or not, and all documentation relating to any of the
foregoing, (vi)&nbsp;all United States and foreign rights arising under or associated with any of the foregoing, and (vii)&nbsp;all rights to sue or recover and retain damages and costs and attorneys&#8217; fees for the past, present or future
infringement, dilution, misappropriation, or other violation of any of the foregoing anywhere in the world. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Intervening Event</I></B>&#8221; means an event, change, effect, development,
condition or occurrence material to the Company that was not known or reasonably foreseeable by the Company Board as of the Agreement Date (or if known or reasonably foreseeable, the consequences of which were not known or reasonably foreseeable);
<U>provided</U> that in no event shall any of the following constitute or contribute to an Intervening Event: (i)&nbsp;changes in the financial or securities markets or general economic or political conditions in the United States, (ii)&nbsp;changes
(including changes in applicable Law) or conditions generally affecting the industry in which the Company operates, (iii)&nbsp;the announcement of this Agreement or the Transactions, (iv)&nbsp;changes in the market price or trading volume of the
Company Common Stock (it being understood that the underlying facts giving rise or contributing to such change may be taken into account in determining whether there has been an Intervening Event), (v) the Company&#8217;s meeting or exceeding any
internal or published budgets, projections, forecasts or predictions of financial performance for any period (it being understood that the underlying facts giving rise or contributing to such change may be taken into account in determining whether
there has been an Intervening Event), (vi) any facts relating solely to Parent or its Affiliates or (vii)&nbsp;the receipt, existence or terms of any Company Takeover Proposal or any inquiry, offer, request or proposal that would reasonably be
expected to lead to a Company Takeover Proposal, or the consequences of any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Option</I></B>&#8221; means each
Company Option that has a per share exercise price that is less than the Cash Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>IRS</I></B>&#8221; means the U.S.
Internal Revenue Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Key Employee</I></B>&#8221;<B> </B>means, with respect to any Person, (i)&nbsp;an executive
officer of such Person; and (ii)&nbsp;any employee of such Person, that reports directly to the board of directors of such Person, or to an executive officer of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Judgment</I></B>&#8221; means a judgment, order, injunction or decree of any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>knowledge</I></B>&#8221; means (a)&nbsp;in the case of the Company, the actual knowledge, as of the Agreement Date, of the
individuals listed in Section&nbsp;1.01(a) of the Company Disclosure Letter and (b)&nbsp;in the case of Parent and Merger Sub, the actual knowledge, as of the Agreement Date, of the individuals listed in Section&nbsp;1.01(a) of the Parent Disclosure
Letter, in each case, following reasonable inquiry of such individual&#8217;s direct reports who are current employees as of the Agreement Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Law</I></B>&#8221; means any statute, law, ordinance, regulation, rule, act, code, order, constitution, treaty, common law,
judgment, decree, award, writ, ruling, injunction, other requirement or rule of law of any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Liens</I></B>&#8221; means pledges, licenses, liens, charges, mortgages, encumbrances and security interests of any kind or
nature whatsoever. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>made available</I></B>&#8221; means (unless otherwise specified), with respect to a particular document,
item or other piece of information, (i)&nbsp;inclusion and availability in the virtual data room hosted on Ideals by the Company in connection with the Transactions on or prior to 4:00 p.m., Eastern time or (ii)&nbsp;as disclosed in the forms,
reports, schedules, statements, exhibits and other documents (including exhibits, financial statements and schedules thereto and all other information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
incorporated therein and amendments and supplements thereto) filed with (or furnished to) the SEC by the Company at least two Business Days to the extent publicly available on the SEC&#8217;s
Electronic Data Gathering Analysis and Retrieval System, each of clauses (i)&nbsp;and (ii), on the day prior to the Agreement Date and continuously through the Agreement Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Multiemployer Plan</I></B>&#8221; means a &#8220;multiemployer plan,&#8221; as defined in Section&nbsp;3(37) or 4001 (a)(3) of
ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Multiple Employer Plan</I></B>&#8221; means a &#8220;multiple employer plan&#8221; as described in
Section&nbsp;413(c) of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Multiple Employer Welfare Arrangement</I></B>&#8221; means a &#8220;multiple employer welfare
arrangement&#8221; within the meaning of Section&nbsp;3(40) of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Nasdaq</I></B>&#8221; means The Nasdaq Global Market.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Organizational Documents</I></B>&#8221;<B> </B>means, with respect to any Person (other than an individual), (i)&nbsp;the
certificate or articles of association or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability company, operating or partnership agreement and other similar documents adopted or
filed in connection with the creation, formation or organization of such Person and (ii)&nbsp;all bylaws, regulations and similar documents or agreements relating to the organization or governance of such Person, in each case, as amended or
supplemented </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Option
</I></B>&#8221; means each Company Option that has a per share exercise price that is equal to or greater than the Cash Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Pandemic Response Law</I></B>&#8221; means the Coronavirus Aid, Relief, and Economic Security Act, the Families First Coronavirus
Response Act of 2020, the Taxpayer Certainty and Disaster Tax Relief Act of 2020, the American Rescue Plan Act of 2021, IRS Notice <FONT STYLE="white-space:nowrap">2020-65,</FONT> any amendments to any of the foregoing, and any other similar
analogous future, or additional federal, state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law or administrative guidance that addresses or is intended to benefit taxpayers in response to the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and associated economic downturn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Parent Material Adverse
Effect</I></B>&#8221; means any change, effect, event or occurrence that prevents, prohibits, impairs or delays or is reasonably likely to prevent, prohibit, impair or delay Parent or Merger Sub from consummating the Offer, the Merger and the other
Transactions on or before the Outside Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Permitted Lien</I></B>&#8221; means (i)&nbsp;a defect or irregularity in title,
(ii)&nbsp;an easement or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-way,</FONT></FONT> (iii)&nbsp;a Lien for Taxes not yet due and payable or being contested in good faith through appropriate Proceedings and for which
adequate reserves have been maintained in accordance with GAAP, <FONT STYLE="white-space:nowrap">(iv)&nbsp;non-exclusive</FONT> licenses to Intellectual Property Rights granted in the ordinary course of business, (v)&nbsp;liens that have arisen in
the ordinary course of business and that do not (in any case or in the aggregate) materially detract from the value of the assets subject thereto or materially impair the operations of the Company, (vi)&nbsp;statutory liens to secure obligations to
landlords, lessors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or renters under leases or rental agreements, (vii)&nbsp;deposits or pledges made in connection with, or to secure payment of, workers&#8217; compensation, unemployment insurance or similar
programs mandated by Law, (viii)&nbsp;statutory liens in favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies and (ix)&nbsp;liens arising under applicable securities Law, and/or (x)&nbsp;other
similar matters that would not reasonably be expected to, individually or in the aggregate, materially impair the continued use and operation of the assets to which they relate in the business of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Person</I></B>&#8221; means any individual, firm, corporation, partnership, company, limited liability company, estate, trust,
joint venture, association, organization, Governmental Entity or other entity of any kind or nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Personal
Information</I></B>&#8221;<B> </B>means data and information concerning an identifiable natural person that is considered &#8220;personal information,&#8221; &#8220;personally identifiable information or a similar term and regulated or protected by
one or more Privacy Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period</I></B>&#8221; means any taxable
period, or portion thereof in the case of a Straddle Period, that ends on or prior to the Merger Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Privacy
Laws</I></B>&#8221;<B> </B>mean Laws relating to privacy, data security and/or collection, use or other processing of Personal Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Proceeding</I></B>&#8221; means any private, governmental, or administrative claim, counterclaim, proceeding, suit, arbitration,
hearing, litigation, action, charge, complaint or audit, in each case whether civil, criminal, administrative, judicial or investigative, or any appeal therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Registered Intellectual Property Rights</I></B>&#8221; means all Intellectual Property Rights that are the subject of an
application, certificate, filing, registration, or other document issued by, filed with, or recorded by, any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Regulatory Authority</I></B>&#8221; means any national or supranational Governmental Entity, including the FDA, with
responsibility for granting any licenses, clearances, authorizations, certifications, permits, registrations or approvals with respect to the Company Product Candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Regulatory Authorizations</I></B>&#8221; means any approvals, clearances, authorizations, registrations, certifications, licenses
and permits granted by any Regulatory Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Representative</I></B>&#8221; of any Person means such Person&#8217;s
officers, directors, employees, investment bankers, attorneys, other advisors or other representatives acting in the scope of his, her or its service to such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Sarbanes-Oxley Act</I></B>&#8221; means the Sarbanes-Oxley Act of 2002. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>SEC</I></B>&#8221; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Securities Act</I></B>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Subsidiary</I></B>&#8221; of any Person means another Person, an amount of the
voting securities, other voting ownership or voting partnership interests of which is sufficient to elect at least a majority of its Board of Directors or other governing body (or, if there are no such voting interests, 50% or more of the equity
interests of which) is owned directly or indirectly by such first Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Superior Company Proposal</I></B>&#8221; means any
written <I>bona fide</I> Company Takeover Proposal received after the Agreement Date and that if consummated would result in a Person or group (or the stockholders of any Person) owning, directly or indirectly, (i) 50% or more of the aggregate
voting power of the capital stock of the Company or of the surviving entity or the resulting direct or indirect parent of the Company or such surviving entity or (ii) 50% or more (based on the fair market value thereof, as determined in good faith
by the Company Board of the consolidated assets of the Company on terms and conditions which the Company Board determines, in good faith, after consultation with outside counsel and its independent financial advisor, (A)&nbsp;would reasonably be
expected to be more favorable from a financial point of view to the Company Stockholders than the Transactions, taking into account all the terms and conditions (including all financial, regulatory, financing, conditionality, legal and other terms
and conditions) of such proposal and this Agreement (including any changes to the terms of this Agreement proposed by Parent pursuant to <U>Section</U><U></U><U>&nbsp;6.02(b)</U>); and (B)&nbsp;is reasonably likely to be completed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Takeda License Agreement</I></B>&#8221; means that certain License Agreement, by and between the Company and Takeda Vaccines,
Inc., dated July 2021, and subsequently terminated on August&nbsp;1, 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Tax Return</I></B>&#8221; means all Tax returns,
declarations, statements, reports, claims for refund, disclosures, elections, estimates, schedules, forms and information returns relating to Taxes, and any attachment thereto or amendment thereof, filed or required to be filed with any Governmental
Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Taxes</I></B>&#8221; means any and all federal, state, provincial, local, foreign and other taxes, customs,
tariffs, imposts, levies, duties, imposts, fees or other like assessments or charges imposed by a Governmental Authority, together with all interest, penalties and additions imposed with respect to such amounts, including, without limitation
(i)&nbsp;taxes imposed on, or measured by, income, franchise, profits or gross receipts; and (ii)&nbsp;ad valorem, value added, capital gains, sales, goods and services, use, real or personal property, excessive payment, excessive credit transfer,
capital stock, license, branch, payroll, estimated, withholding, commercial activity, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, environmental, employment, social security (or similar), unemployment, compensation,
utility, severance, production, excise, stamp, occupation, premium, windfall profits, transfer and gains taxes, and customs duties, including, in each case, liability for the payment of any such amounts as a result of (x)&nbsp;being a member of a
Combined Group, or (y)&nbsp;being a party to any Tax Sharing Agreement or Tax receivable agreement (or other similar or analogous agreement, express or implied) or joint, several, transferee or successor liability, operation of Law, or otherwise.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Tax Sharing Agreement</I></B>&#8221; means any tax sharing, tax indemnity, tax allocation or similar agreement with a third
party (but excluding any agreements entered into in the ordinary course of business the principal purpose of which is unrelated to Taxes). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Transaction Expenses</I></B>&#8221; means, without duplication (including
without duplication of any amounts included in Indebtedness), all fees and expenses incurred or payable by the Company and the Company&#8217;s Subsidiaries (including any such fees or expenses that the Company or any of the Company&#8217;s
Subsidiaries or, in the case of (ii)&nbsp;and (iii) below, Parent or Merger Sub, is legally obligated to pay or reimburse) at or prior to the Offer Closing Time in connection with the transactions contemplated by this Agreement and the CVR
Agreement, including (i)&nbsp;any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses of legal counsel, accountants, financial advisors, investment bankers, brokers, consultants, and other
advisors engaged by the Company; (ii) 50% of the fees paid to the SEC in connection with filing the Offer Documents and the Schedule <FONT STYLE="white-space:nowrap">14D-9,</FONT> and any amendments and supplements thereto, with the SEC; (iii) 50%
of any fees and expenses in connection with the printing, mailing and distribution of the Offer Documents and the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> and any amendments and supplements thereto; (iv)&nbsp;any fees, expenses and
premiums incurred in connection with the D&amp;O Tail Policies; and (v)&nbsp;any <FONT STYLE="white-space:nowrap">&#8220;single-trigger&#8221;</FONT> (or &#8220;double trigger,&#8221; to the extent payable pursuant to Company Employee Plans as in
effect on the Agreement Date), bonus, severance, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> payments, payments payable under any transaction bonus agreements in connection with the consummation
of the Offer (the &#8220;<B><I>Closing Management Bonus Payments</I></B>&#8221;) or similar payment obligations that become due or payable to any director, officer, employee or consultant of the Company upon, and solely as a result of, the
consummation of the transactions contemplated by this Agreement and the CVR Agreement, including the employer portion of any payroll Taxes associated therewith (<U>provided</U>, that Transaction Expenses shall not include any (A)&nbsp;amounts
payable as a result of any arrangements implemented or actions taken (other than pursuant to any Company Employee Plan as in effect on the Agreement Date) by or at the direction or request of the Parent or its Affiliates (including the Surviving
Corporation), (B)&nbsp;amounts discharged by the Company prior to the Merger Closing, (C)&nbsp;Transfer Taxes and (D)&nbsp;amounts payable resulting from any termination of employment or service after the Offer Closing Time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Treasury Regulations</I></B>&#8221; means the Treasury regulations promulgated under the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Unpaid Taxes</I></B>&#8221; means an amount equal to all accrued but unpaid Tax liabilities of the Company for any <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period (which shall not be less than zero with respect to any Tax in any jurisdiction), determined (i)&nbsp;in accordance with <U>Section</U><U></U><U>&nbsp;7.06(b)</U>, (ii) on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">jurisdiction-by-jurisdiction</FONT></FONT> basis, and (iii)&nbsp;without taking into account any loss carryovers, refunds (or credits in lieu thereof) or any other tax attributes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>WARN Act</I></B>&#8221; means the Worker Adjustment and Retraining Notification Act of 1988, as amended, and any similar or
related law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Willful Breach</I></B>&#8221; means a material breach, or a material failure to perform, any covenant,
representation, warranty, or agreement set forth in this Agreement, in each case, that is the consequence of an intentional or willful act or omission by a party hereto with the knowledge that the taking of such act or failure to take such act would
result in, constitute or cause a material breach or material failure to perform this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Wind-Down
Process</I></B>&#8221; means the process related to the winding down of the operations of the Company and its Subsidiaries, in a manner consistent with any applicable Contract terms, applicable Laws, applicable clinical standards and applicable
ethical practices. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the following terms is defined in the Section set forth opposite such term:<SUP
STYLE="font-size:75%; vertical-align:top"> </SUP> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Accounting Firm</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(c)(vi)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Adverse Recommendation Change</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.02(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Agreement</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Agreement Date</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Appraisal Shares</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.08(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Cash Amount</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Cash Determination Time</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(c)(ii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Certificate of Merger</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Certificates</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Closing Cash Calculation</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(c)(ii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Closing Cash Schedule</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(c)(ii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Company</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Company Board Recommendation</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Company Common Stock</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Company Notice</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.02(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Company Option Cash Consideration</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.10(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Company Termination Fee</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;9.03(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Confidentiality Agreement</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>CVR</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>CVR Agreement</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>CVR Amount</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>D&amp;O Tail Policies</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.03(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>DGCL</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Dispute Notice</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(c)(iii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Effective Time</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Existing D&amp;O Policies</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.03(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Expense Reimbursement Payment</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;9.03(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>FDA Application Integrity Policy</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.13(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Indemnified Party</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.03(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Legal Restraints</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;8.01(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Maximum Amount</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.03(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Merger</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Merger Closing</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Merger Closing Date</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Merger Consideration</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.08(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Merger Sub</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Minimum Tender Condition</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Exhibit&nbsp;A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Offer</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Offer Closing Time</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Offer Conditions</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Offer Documents</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Offer Price</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Outside Date</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;9.01(b)(i)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Parent</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Parent Disclosure Letter</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Article V</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Paying Agent</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Payment Fund</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Qualifying Company Takeover Proposal</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.02(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Response Time</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(c)(iii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Unit Cash Consideration</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.10(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Rights Agent</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT></I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.02(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;262</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.08(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Signing Net Cash</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder List Date</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;2.02(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Support Agreement</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Surviving Corporation</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Takeover Law</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Termination Condition</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Exhibit&nbsp;A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Transfer Taxes</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.02 <U>Interpretation and Rules of Construction</U>. The headings contained in this Agreement
and in the table of contents to this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. References to &#8220;this Agreement&#8221; shall include the Company Disclosure Letter
and the Parent Disclosure Letter. All Exhibits annexed to this Agreement or referred to in this Agreement are hereby incorporated in and made a part of this Agreement as if set forth in full in this Agreement. Any terms used in the Company
Disclosure Letter, the Parent Disclosure Letter, any Exhibit or any certificate or other document made or delivered pursuant to this Agreement but not otherwise defined therein shall have the meaning as defined in this Agreement. The definitions of
terms in this Agreement shall apply equally to the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The word &#8220;will&#8221; shall
be construed to have the same meaning as the word &#8220;shall.&#8221; The words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed, in each case, to be followed by the phrase &#8220;without limitation.&#8221;
The word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#8220;if.&#8221; All references to &#8220;dollars&#8221; or
&#8220;$&#8221; shall refer to the lawful currency of the United States. Unless the context requires otherwise (i)&nbsp;any definition of or reference to any Contract, instrument or other document or any Law in this Agreement shall be construed as
referring to such Contract, instrument or other document or Law as from time to time amended, supplemented or otherwise modified, including comparable successor law and references to all attachments thereto and instruments incorporated therein, but
only to the extent, in the case of any amendment, supplement or other modification to any Contract, instrument or other document listed in the Company Disclosure Letter or the Parent Disclosure Letter, that such amendment, supplement or other
modification has been made available to the other party and is also listed on the appropriate section of the Company Disclosure Letter or the Parent Disclosure Letter, as applicable, (ii)&nbsp;any reference in this Agreement to any Person shall be
construed to include such Person&#8217;s successors and permitted assigns, (iii)&nbsp;the words &#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder,&#8221; and words of similar import, shall be construed to refer to this Agreement in its
entirety and not to any particular provision hereof, (iv)&nbsp;all references in this Agreement to Articles, Sections and Exhibits shall be construed to refer to Articles and Sections </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of, and Exhibits to, this Agreement, unless otherwise indicated, (v)&nbsp;references to clauses without a cross-reference to a Section or subsection are references to clauses within the same
Section or, if more specific, subsection and (vi)&nbsp;references from or through any date shall mean, unless otherwise specified, from and including or through and including, respectively. This Agreement shall be construed without regard to any
presumption or rule requiring construction or interpretation against the party hereto drafting or causing any instrument to be drafted. The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event
an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party hereto by virtue of the
authorship of any provision of this Agreement. Unless indicated otherwise, (A)&nbsp;any action required to be taken by or on a day or business day may be taken until 11:59 p.m., Eastern Time, on such day or business day, (B)&nbsp;all references to
&#8220;days&#8221; shall be to calendar days unless otherwise indicated as a &#8220;Business Day&#8221; and (C)&nbsp;all days, business days, times and time periods contemplated by this Agreement will be determined by reference to Eastern Time.
Unless indicated otherwise, all mathematical calculations contemplated by this Agreement shall be rounded to the fourth decimal place, except in respect of payments, which shall be rounded down to the nearest whole United States cent. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFER
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.01 <U>The Offer</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Commencement and Term of the Offer</U>. Provided that this Agreement shall not have been terminated in accordance with
<U>Section</U><U></U><U>&nbsp;9.01</U>, subject to the terms and conditions of this Agreement, as promptly as practicable (but in no event later than ten (10)&nbsp;Business Days after the Agreement Date), the Buyer Entities shall commence (within
the meaning of the applicable rules and regulations of the SEC) the Offer at the Offer Price. The obligations of the Buyer Entities to, irrevocably accept for payment, and pay for, any shares of the Company Common Stock tendered pursuant to the
Offer shall be subject only to the satisfaction or waiver of the conditions set forth on <U>Exhibit</U><U></U><U>&nbsp;A</U> (the &#8220;<B><I>Offer Conditions</I></B>&#8221;). The initial expiration date of the Offer shall be at the time that is
one minute following 11:59&nbsp;p.m., Eastern time, on the date that is twenty (20)&nbsp;Business Days (determined using <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-1(g)(3)</FONT> of the Exchange Act) after the date the Offer is first commenced
(within the meaning of Rule <FONT STYLE="white-space:nowrap">14d-2</FONT> promulgated under the Exchange Act). The Buyer Entities expressly reserve the right to waive, in their sole discretion, in whole or in part, any Offer Condition or modify the
terms of the Offer in any manner not inconsistent with this Agreement, except that the Minimum Tender Condition shall not be waived, and, without the prior written consent of the Company, the Buyer Entities shall not, (i)&nbsp;reduce the number of
shares of the Company Common Stock subject to the Offer, (ii)&nbsp;reduce the Offer Price, (iii)&nbsp;waive, amend or modify the Termination Condition, (iv)&nbsp;add to the Offer Conditions or impose any other conditions on the Offer or amend,
modify or supplement any Offer Condition in any manner adverse to the holders of the Company Common Stock, (v)&nbsp;except as otherwise provided in this <U>Section</U><U></U><U>&nbsp;2.01</U>, terminate, or extend or otherwise amend or modify the
expiration date of, the Offer, (vi)&nbsp;change the form or terms of consideration payable in the Offer, (vii)&nbsp;otherwise amend, modify or supplement any of the terms of the Offer in any manner adverse to the holders of the Company Common Stock
or (viii)&nbsp;provide any &#8220;subsequent offering period&#8221; in accordance with Rule <FONT STYLE="white-space:nowrap">14d-11</FONT> of the Exchange Act. Notwithstanding the foregoing or anything to the contrary in this
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement, unless this Agreement has been validly terminated in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, (A) the Buyer Entities may elect to (and if so requested by the Company,
the Buyer Entities shall), extend the Offer for one or more consecutive increments of such duration as requested by the Company (or if not so requested by the Company, as determined by the Buyer Entities), but not more than ten (10)&nbsp;Business
Days each (or for such longer period as may be agreed to by the Buyer Entities and the Company), if (I)&nbsp;at the scheduled expiration date of the Offer any of the Offer Conditions (including the Minimum Tender Condition) shall not have been
satisfied or waived (if permitted hereunder), until such time as such conditions shall have been satisfied or waived (if permitted hereunder) or (II)&nbsp;at the scheduled expiration date of the Offer, <U>Section</U><U></U><U>&nbsp;2.01(c)(v)</U>
applies as to the determination of the Closing Net Cash and the resolution of the matters described in <U>Section</U><U></U><U>&nbsp;2.01(c)(vi)</U> has not been finalized, and (B)&nbsp;the Buyer Entities shall extend the Offer for the minimum
period required by any rule, regulation or interpretation or position of the SEC or the staff thereof or Nasdaq, in each case that are applicable to the Offer; <U>provided</U> that the Buyer Entities shall not, and shall not be required to, extend
the Offer beyond the Outside Date and, in the case of the Minimum Tender Condition being the only condition not satisfied under clause (I)&nbsp;of the foregoing (other than conditions that by their nature are only satisfied as of the Offer Closing
Time), the Buyer Entities shall not be required to extend the Offer to a date later than the Outside Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the terms and subject only
to the conditions of the Offer and this Agreement, the Buyer Entities shall irrevocably accept for payment, and pay for, all shares of the Company Common Stock validly tendered and not properly withdrawn pursuant to the Offer that Merger Sub becomes
obligated to purchase pursuant to the Offer as promptly as practicable after the expiration of the Offer and, in any event, no more than three (3)&nbsp;Business Days after the expiration of the Offer. The time at which Merger Sub first irrevocably
accepts for purchase the shares of the Company Common Stock tendered in the Offer is referred to as the &#8220;<B><I>Offer Closing Time</I></B>.&#8221; The Offer may not be terminated or withdrawn prior to its expiration date (as such expiration
date may be extended and <FONT STYLE="white-space:nowrap">re-extended</FONT> in accordance with this <U>Section</U><U></U><U>&nbsp;2.01(a)</U>), unless this Agreement is validly terminated in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>.
If this Agreement is validly terminated in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, Merger Sub shall promptly and irrevocably terminate the Offer and return, and shall cause any depository acting on behalf of Merger Sub to return, all
tendered shares of the Company Common Stock to the registered holders thereof. Nothing contained in this <U>Section</U><U></U><U>&nbsp;2.01(a)</U> shall affect any termination rights set forth in <U>Section</U><U></U><U>&nbsp;9.01</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Schedule TO; Offer Documents</U>. As promptly as reasonably practicable on the date of commencement of the Offer, the Buyer Entities
shall (i)&nbsp;file with the SEC a Tender Offer Statement on Schedule TO with respect to the Offer, which shall include an offer to purchase and a related letter of transmittal and summary advertisement containing the terms set forth in this
Agreement and <U>Exhibit</U><U></U><U>&nbsp;A</U> (such Schedule TO, as amended from time to time, and the documents included therein pursuant to which the Offer will be made, together with any supplements or amendments thereto, the
&#8220;<B><I>Offer Documents</I></B>&#8221;) and (ii)&nbsp;disseminate the Offer Documents to the holders of the Company Common Stock as and to the extent required by applicable Law. The Company shall furnish to the Buyer Entities all information
concerning the Company required by applicable Law to be set forth in the Offer Documents. Each of the Buyer Entities and the Company shall promptly correct any information provided by it for use in the Offer Documents if and to the extent that such
information shall have become false or misleading in any material respect, and to correct any material omissions therefrom, and the Buyer Entities shall take all steps necessary to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amend or supplement the Offer Documents and to cause the Offer Documents, as so amended or supplemented, to be filed with the SEC and disseminated to the holders of the Company Common Stock, in
each case, as and to the extent required by applicable Law. The Buyer Entities shall promptly provide the Company and its counsel with copies of any written comments, and shall inform the Company and its counsel of any oral comments, that the Buyer
Entities or their counsel may receive from the SEC or its staff with respect to the Offer Documents promptly after the receipt of such comments. Except from and after an Adverse Recommendation Change, prior to the filing of the Offer Documents
(including any amendment or supplement thereto) with the SEC or the dissemination thereof to the holders of the Company Common Stock, or responding to any comments of the SEC or its staff with respect to the Offer Documents, the Buyer Entities shall
(A)&nbsp;provide the Company and its counsel a reasonable opportunity to review and comment on such Offer Documents or response (it being understood that the Company and its counsel shall provide any comments thereon as soon as reasonably
practicable) and (B)&nbsp;give reasonable and good faith consideration to any comments made by the Company or its counsel. The Buyer Entities shall respond promptly to any comments of the SEC or its staff with respect to the Offer Documents. In
addition, the Buyer Entities shall cause the Offer Documents (i)&nbsp;to comply in all material respects with the Exchange Act and other applicable laws and (ii)&nbsp;to not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that no covenant is made by the Buyer Entities with
respect to information supplied by or on behalf of the Company for inclusion or incorporation by reference in the Offer Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Confirmation of Closing Net Cash</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) If, between the Agreement Date and the Offer Closing Time, the outstanding shares of the
Company Common Stock are changed into a different number or class of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification, recapitalization or other
similar transaction, then the Offer Price shall be appropriately adjusted and such adjustment to the Offer Price shall provide to the holders of shares of Company Common Stock the same economic effect as contemplated by this Agreement prior to such
action. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Except as otherwise contemplated in this <U>Section</U><U></U><U>&nbsp;2.01(c)</U>, on the tenth (10th)&nbsp;Business Day
before the scheduled expiration of the Offer (including as extended pursuant to <U>Section</U><U></U><U>&nbsp;2.01(a)</U>), the Company shall deliver to Parent a schedule (the &#8220;<B><I>Closing Cash Schedule</I></B>&#8221;) setting forth, in
reasonable detail, the Company&#8217;s good faith, estimated calculation of Closing Net Cash (the &#8220;<B><I>Closing Cash Calculation</I></B>&#8221;) as of the close of business on the date of the Offer Closing Time (the &#8220;<B><I>Cash
Determination Time</I></B>&#8221;) based on such scheduled expiration of the Offer. The Company shall make available to Parent, as reasonably requested by Parent, the work papers and <FONT STYLE="white-space:nowrap">back-up</FONT> materials used or
any other relevant information useful in preparing the Closing Cash Schedule, including <FONT STYLE="white-space:nowrap">close-out</FONT> memos or other forms of written affirmation from vendors that either no more money is due or an amount of money
is due that is reflected on the Closing Cash Schedule. If reasonably requested by Parent, reasonable access to the Company&#8217;s accountants and counsel at reasonable times and upon reasonable notice will be provided by the Company in order to
permit Parent to review the Closing Cash Calculation. The Closing Cash Calculations shall include the Company&#8217;s determination, as of the Cash Determination Time, of the Cash Amount and each component thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Parent shall have the right to dispute any part of the Closing Cash Calculation by
delivering a written notice (for which email will suffice) (a &#8220;<B><I>Dispute Notice</I></B>&#8221;) to that effect to the Company on or prior to 11:59 p.m., Eastern Time, on the fifth (5th) Business Day following Parent&#8217;s receipt of the
Closing Cash Schedule (the &#8220;<B><I>Response Time</I></B>&#8221;), which Dispute Notice shall identify in reasonable detail the nature and amounts of any proposed revisions to the proposed Closing Cash Calculation and shall be accompanied by a
reasonably detailed explanation for the basis for such revisions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) If, on or prior to the Response Time, Parent notifies the Company
in writing that it has no objections to the Closing Cash Calculation or if Parent fails to deliver a Dispute Notice as provided in <U>Section</U><U></U><U>&nbsp;2.01(c)(iii)</U> prior to the Response Time, then the Closing Cash Calculation as set
forth in the Closing Cash Schedule shall be deemed to have been finally determined for purposes of this Agreement and shall represent the Closing Net Cash at the Cash Determination Time for purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) If Parent delivers a Dispute Notice on or prior to the Response Time, then Representatives of the Company and Parent shall promptly (and
in no event later than one (1)&nbsp;Business Day thereafter) meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of the Closing Net Cash, which agreed upon Closing Net Cash amount shall be deemed
to have been finally determined for purposes of this Agreement and shall represent the Closing Net Cash at the Cash Determination Time for purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) If Representatives of the Company and Parent are unable to negotiate an agreed-upon determination of Closing Net Cash as of the Cash
Determination Time pursuant to <U>Section</U><U></U><U>&nbsp;2.01(c)(v)</U> within three (3)&nbsp;Business Days after delivery of the Dispute Notice (or such other period as the Company and Parent may mutually agree upon), then any remaining
disagreements as to the calculation of Closing Net Cash shall be referred to for resolution to KPMG, or, if such accounting firm is unable to serve, the Company and Parent shall, within two (2)&nbsp;Business Days, appoint by mutual agreement the
office of an impartial nationally or regionally recognized firm of independent certified public accountants other than the Company&#8217;s accountants or Parent&#8217;s accountants (the &#8220;<B><I>Accounting Firm</I></B>&#8221;). The Company and
Parent shall promptly deliver to the Accounting Firm the work papers and <FONT STYLE="white-space:nowrap">back-up</FONT> materials used in preparing the Closing Cash Schedule and the Dispute Notice, and the Company and Parent shall use commercially
reasonable efforts to cause the Accounting Firm to make its determination within three (3)&nbsp;Business Days of accepting its selection. The Company and Parent shall be afforded the opportunity to present to the Accounting Firm any materials
related to the unresolved disputes and to discuss the issues with the Accounting Firm; <U>provided</U> that no such presentation or discussion shall occur without the presence of a Representative of each of the Company and Parent. The determination
of the Accounting Firm shall be limited to the disagreements submitted to the Accounting Firm. The determination of the amount of Closing Net Cash made by the Accounting Firm shall be made in writing delivered to each of the Company and Parent,
shall be final and binding on the Company and Parent and shall (absent manifest error) be deemed to have been finally determined for purposes of this Agreement and to represent the Closing Net Cash at the Cash Determination Time
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for purposes of this Agreement. The Buyer Entities shall extend the expiration date of the Offer until the resolution of the matters described in this
<U>Section</U><U></U><U>&nbsp;2.01(c)(vi)</U>; <U>provided</U>, that the Buyer Entities shall not, and shall not be required to, extend the Offer beyond the Outside Date. The fees and expenses of the Accounting Firm shall be allocated between the
Company and Parent in the same proportion that the disputed amount of the Closing Net Cash that was unsuccessfully disputed by such party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Closing Net Cash
amount and the Company&#8217;s portion of such fees and expenses shall be included in the calculation of Transaction Expenses. If this <U>Section</U><U></U><U>&nbsp;2.01(c)(vi)</U> applies as to the determination of the Closing Net Cash at the Cash
Determination Time with respect to a scheduled expiration of the Offer, upon resolution of the matter in accordance with this <U>Section</U><U></U><U>&nbsp;2.01(c)(vi)</U>, the parties shall not be required to determine Closing Net Cash again
(solely with respect to such applicable scheduled expiration of the Offer) even though such applicable expiration of the Offer may occur later. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.02 <U>Company Actions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT></U>. On the date the Offer Documents are filed with the SEC, or as promptly
thereafter as practicable (but in no event later than the first (1st) Business Day following the date on which the Offer Documents are filed), the Company shall file with the SEC a Solicitation/Recommendation Statement on Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT> with respect to the Offer, (such Schedule <FONT STYLE="white-space:nowrap">14D-9,</FONT> as amended from time to time, together with any exhibits, amendments or supplements thereto, the &#8220;<B><I>Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT></I></B>&#8221;), including a description of the Company Board Recommendation (subject to <U>Section</U><U></U><U>&nbsp;6.02</U>) and shall disseminate the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT>
to the holders of the Company Common Stock, as and to the extent required by applicable U.S. federal securities Law. The Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> shall also contain and constitute the notice of appraisal rights required
to be delivered by the Company under Section&nbsp;262(d)(2) of the DGCL at the time the Company first files the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> with the SEC and the fairness opinion delivered by Leerink Partners LLC. The
Company shall set the record date for the holders of Company Common Stock to receive such notice of appraisal rights as the same date as the Stockholder List Date and shall disseminate the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT>
including such notice of appraisal rights to such holders to the extent required by section 262(d) of the DGCL. Parent and Merger Sub shall furnish to the Company all information concerning Parent and Merger Sub required by applicable Law to be set
forth in the Schedule <FONT STYLE="white-space:nowrap">14D-9.</FONT> Each of the Company, Parent and Merger Sub shall promptly correct any information provided by it for use in the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> if and to the
extent that such information shall have become false or misleading in any material respect, and to correct any material omissions therefrom, and the Company shall take all steps necessary to amend or supplement the Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT> and to cause the Schedule <FONT STYLE="white-space:nowrap">14D-9,</FONT> as so amended or supplemented, to be filed with the SEC and disseminated to the holders of the Company Common Stock, in each case, as
and to the extent required by applicable Law. Except from and after an Adverse Recommendation Change or in connection with any disclosures made in compliance with <U>Section</U><U></U><U>&nbsp;6.02</U>, Company shall provide Parent and its counsel
with copies of any written comments, and shall inform Parent and its counsel of any oral comments, that the Company or its counsel may receive from the SEC or its staff with respect to the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT>
promptly after the receipt of such comments. Except from and after an Adverse Recommendation Change or in connection with any disclosures made in compliance with <U>Section</U><U></U><U>&nbsp;6.02</U>, prior to the filing of the Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT> (including any amendment or supplement thereto) with the SEC or the dissemination thereof to the holders of the Company Common Stock, or responding to any comments of the SEC or its staff
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with respect to the Schedule <FONT STYLE="white-space:nowrap">14D-9,</FONT> the Company shall (x)&nbsp;provide Parent and its counsel a reasonable opportunity to review and comment on such
Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> or response (it being understood that Parent and its counsel shall provide any comments thereon as soon as reasonably practicable) and (y)&nbsp;give reasonable and good faith consideration to
any comments made by Parent or its counsel. The Company shall respond promptly to any comments of the SEC or its staff with respect to the Schedule <FONT STYLE="white-space:nowrap">14D-9.</FONT> The Company hereby approves of and consents to the
Offer, the Merger and the Transactions and the inclusion in the Offer Documents of a description of the Company Board Recommendation (except to the extent that the Company Board shall have withdrawn or modified the Company Board Recommendation in
accordance with <U>Section</U><U></U><U>&nbsp;6.02(b)</U>). In addition, the Company shall cause the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> (i)&nbsp;to comply in all material respects with the Exchange Act and other applicable laws
and (ii)&nbsp;to not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading; provided, however, that no covenant is made by the Company with respect to information supplied by or on behalf of Parent or Merger Sub for inclusion or incorporation by reference in the Schedule
<FONT STYLE="white-space:nowrap">14D-9.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Stockholder Information</U>. In connection with the Offer, the Company shall cause
its transfer agent to promptly furnish the Buyer Entities with mailing labels containing the names and addresses of the record holders of shares of the Company Common Stock as of the most recent practicable date preceding the date on which the Offer
is commenced and of those Persons becoming record holders subsequent to such date, together with copies of all lists of stockholders, security position listings, computer files and all other information in the Company&#8217;s possession or control
regarding the beneficial owners of shares of the Company Common Stock, and shall furnish to the Buyer Entities such information and reasonable assistance (including updated lists of stockholders, security position listings and computer files) as the
Buyer Entities may reasonably request in communicating the Offer and disseminating the Offer Documents to the Company Stockholders. The date of the list of stockholders used to determine the persons to whom the Offer Documents and the Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT> are first disseminated is referred to as the &#8220;<B><I>Stockholder List Date</I></B>.&#8221; Subject to the requirements of applicable Law, and except for such steps as are necessary to disseminate the
Offer Documents and any other documents necessary to consummate the Transactions, the Buyer Entities shall hold in confidence, in accordance with the Confidentiality Agreement, the information contained in any such labels, listings and files, shall
use such information only in connection with the Offer and the Merger and, if this Agreement shall be terminated, shall, upon request, deliver to the Company or destroy (and shall direct their agents to deliver to the Company or destroy) all copies
of such information (and certify in writing to the Company such destruction, if applicable). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.01 <U>The Merger</U>. On the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL
(including Section&nbsp;251(h) of the DGCL), Merger Sub shall be merged with and into the Company at the Effective Time. At the Effective Time, the separate corporate existence of Merger Sub shall cease and the Company shall continue as the
surviving corporation (the &#8220;<B><I>Surviving Corporation</I></B>&#8221;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.02 <U>Merger Closing</U>. The closing of the Merger (the &#8220;<B><I>Merger
Closing</I></B>&#8221;) shall take place remotely via the electronic exchange of documents and signature pages at 9:00 a.m., Eastern time, on a date to be specified by Parent and the Company, which date shall be as soon as practicable following the
Offer Closing Time, subject to the satisfaction or (to the extent permitted by Law) waiver by the party or parties hereto entitled to the benefits thereof of the conditions set forth in <U>Article VIII</U>, other than those conditions that by their
nature are to be satisfied at the Merger Closing (but in no event later than the second (2nd)&nbsp;Business Day following such satisfaction or waiver of such conditions), unless another date, time or place is mutually agreed to in writing by Parent
and the Company. The date on which the Merger Closing occurs is referred to in this Agreement as the &#8220;<B><I>Merger Closing Date</I></B>.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.03 <U>Effective Time</U>. Prior to the Merger Closing, Parent and the Company shall prepare, and on the Merger Closing Date,
the Company shall file with the Secretary of State of the State of Delaware, a certificate of merger or other appropriate documents (in any such case, the &#8220;<B><I>Certificate of Merger</I></B>&#8221;) executed in accordance with the relevant
provisions of the DGCL and shall make all other filings or recordings required under the DGCL to effectuate the Merger. The Merger shall become effective at such time as the Certificate of Merger is duly filed with the Secretary of State of the
State of Delaware or at such other time as Parent and the Company shall agree and specify in the Certificate of Merger. The time at which the Merger becomes effective is referred to in this Agreement as the &#8220;<B><I>Effective
Time</I></B>.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.04 <U>Merger Without Meeting of Stockholders</U>. The Merger shall be governed by and effected under
Section&nbsp;251(h) of the DGCL, without a vote on the adoption of this Agreement by the holders of shares of the Company Common Stock. The parties hereto agree to take all necessary and appropriate action to cause the Merger to become, and that the
Merger shall become, effective as soon as practicable following the consummation (within the meaning of Section&nbsp;251(h) of the DGCL) of the Offer, without a vote of stockholders of the Company in accordance with Section&nbsp;251(h) of the DGCL.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.05 <U>Effects of Merger</U>. The Merger shall have the effects provided in this Agreement and as set forth in the DGCL.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.06 <U>Certificate of Incorporation and Bylaws</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Immediately following the Effective Time, the certificate of incorporation of the Surviving Corporation shall be amended and restated in
its entirety to be in the form attached as <U>Exhibit B</U> and, as so amended and restated, such certificate of incorporation shall be the certificate of incorporation of the Surviving Corporation, until thereafter changed or amended as provided
therein or permitted by applicable Law (including the DGCL), subject to <U>Section</U><U></U><U>&nbsp;7.03</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The bylaws of Merger
Sub as in effect immediately prior to the Effective Time shall be the bylaws of the Surviving Corporation immediately following the Effective Time until thereafter changed or amended as provided therein or permitted by applicable Law, subject to
<U>Section</U><U></U><U>&nbsp;7.03</U>, except that references to the name of Merger Sub shall be replaced by the name of the Surviving Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.07 <U>Directors and Officers</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The directors of Merger Sub immediately prior to the Effective Time shall be appointed as the directors of the Surviving Corporation
immediately following the Effective Time, until the earlier of their resignation or removal or until their respective successors are duly elected and qualified, as the case may be. The Company shall request each director of the Company immediately
prior to the Effective Time to execute and deliver a letter effectuating his or her resignation as a member of the Company Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
officers of Merger Sub immediately prior to the Effective Time shall be the officers of the Surviving Corporation, until the earlier of their resignation or removal or until their respective successors are duly elected or appointed and qualified, as
the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.08 <U>Effect on Capital Stock</U>. At the Effective Time, by virtue of the Merger and without any action
on the part of the holder of any shares of the Company Common Stock or any shares of capital stock of Merger Sub: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Capital Stock of
Merger Sub</U>. Each share of capital stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and become one fully paid and nonassessable share of common stock, par value $0.01 per share, of the
Surviving Corporation and shall constitute the only outstanding shares of capital stock of the Surviving Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Cancelation
of Treasury Stock and Certain Other Stock</U>. Each share of Company Common Stock that (i)&nbsp;is owned by the Company immediately prior to the Effective Time, (ii)&nbsp;was owned by Parent, Merger Sub or any other Subsidiary of Parent at the
commencement of the Offer and is owned by Parent, Merger Sub or any other Subsidiary of Parent immediately prior to the Effective Time or (iii)&nbsp;was irrevocably accepted for purchase in the Offer shall no longer be outstanding and, in each case,
shall automatically be canceled and shall cease to exist, and no consideration shall be delivered or deliverable in exchange therefor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Conversion of Company Common Stock</U>. Except as provided in <U>Section</U><U></U><U>&nbsp;3.08(b)</U> and <U>Section</U><U></U><U>&nbsp;3.08(d)</U>, each share of the Company Common Stock issued and outstanding immediately prior to the
Effective Time shall be converted into the right to receive the Offer Price without interest (the &#8220;<B><I>Merger Consideration</I></B>&#8221;). As of the Effective Time, all such shares of the Company Common Stock shall no longer be outstanding
and shall automatically be canceled and shall cease to exist, and each holder of any such shares of the Company Common Stock shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration in accordance with
this <U>Section</U><U></U><U>&nbsp;3.08(c)</U>. For the avoidance of doubt, at the Effective Time, any repurchase rights of the Company or other similar restrictions on shares of Company Common Stock shall lapse in full and will be of no further
force or effect, and all shares of Company Common Stock shall be fully vested as of the Effective Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Appraisal Rights</U>.
Notwithstanding anything in this Agreement to the contrary, shares (&#8220;<B><I>Appraisal Shares</I></B>&#8221;) of the Company Common Stock that are outstanding immediately prior to the Effective Time and that are held by any Person who is
entitled to demand and properly demands appraisal of such Appraisal Shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL (&#8220;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;262</I></B>&#8221;) shall not be
converted into the Merger Consideration as provided in <U>Section</U><U></U><U>&nbsp;3.08(c)</U>, but instead, at the Effective Time, the Appraisal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Shares shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each holder of any such Appraisal Shares shall cease to have any rights with respect
thereto, except the right to receive payment of the fair value of such Appraisal Shares in accordance with Section&nbsp;262; <U>provided</U> that if any such holder shall fail to perfect or otherwise shall waive, withdraw or lose the right to
appraisal under Section&nbsp;262 with respect to such Appraisal Shares or a court of competent jurisdiction shall determine that such holder is not entitled to the relief provided by Section&nbsp;262, then the right of such holder to receive the
fair value of such holder&#8217;s Appraisal Shares shall cease and such Appraisal Shares shall be deemed to have been converted as of the Effective Time into, and to have become exchangeable solely for, the right to receive the Merger Consideration
as provided in <U>Section</U><U></U><U>&nbsp;3.08(c)</U>. The Company shall give prompt written notice to Parent of any demands received by the Company for appraisal of any shares of the Company Common Stock, and Parent shall have the right to
participate in, and direct all negotiations and Proceedings with respect to such demands. The Company shall not, without the prior written consent of Parent, make any payment with respect to, or settle or offer to settle, any such demands, or agree
to do any of the foregoing. Prior to the Offer Closing Time, Parent shall not, except with the prior written consent of the Company, require the Company to make any payment with respect to any demands for appraisal or offer to settle or settle any
such demands. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.09 <U>Payment of Merger Consideration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Paying Agent</U>. Not less than three (3)&nbsp;Business Days before the Merger Closing Date, Parent shall select a bank or trust company
reasonably acceptable to the Company to act as paying agent (the &#8220;<B><I>Paying Agent</I></B>&#8221;) for the payment of the Cash Amount pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U>. At or promptly after the Effective Time (and in any
event, within two (2)&nbsp;Business Days of the Merger Closing Date), Parent shall deposit with the Paying Agent, for the benefit of holders of shares of the Company Common Stock, cash in U.S. dollars sufficient to pay the Cash Amount at the
Effective Time pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U> (such cash being hereinafter referred to as the &#8220;<B><I>Payment Fund</I></B>&#8221;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Payment Procedure</U>. As promptly as reasonably practicable (but in no event later than two (2)&nbsp;Business Days) after the Effective
Time, the Surviving Corporation or Parent shall cause the Paying Agent to mail to each holder of record of a certificate or certificates that, immediately prior to the Effective Time, represented outstanding shares of the Company Common Stock (the
&#8220;<B><I>Certificates</I></B>&#8221;) that were converted into the right to receive the Merger Consideration pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U>&nbsp;(i) a letter of transmittal (which shall specify that delivery shall be
effected, and risk of loss and title to the Certificates shall pass, only upon proper delivery of the Certificates to the Paying Agent, and shall be in such form and have such other provisions as are customary and reasonably acceptable to the
Company and Parent) and (ii)&nbsp;instructions for effecting the surrender of the Certificates in exchange for the Merger Consideration. Upon surrender of a Certificate to the Paying Agent for cancelation, together with such letter of transmittal,
duly executed and in proper form and such other documents as may reasonably be required by the Paying Agent, the holder of such Certificate shall be entitled to receive, in exchange therefor, the Merger Consideration into which the shares of the
Company Common Stock theretofore represented by such Certificate shall have been converted pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U>, and the Certificate so surrendered shall forthwith be canceled. In the event of a transfer of ownership
of the Company Common Stock that is not registered in the transfer records of the Company, payment may be made to a Person other than the Person in whose name the Certificate so surrendered is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registered, if such Certificate shall be properly endorsed or otherwise be in proper form for transfer and the Person requesting such payment shall pay any transfer, stamp, registration or other
similar Taxes required by reason of the payment to a Person other than the registered holder of such Certificate or establish to the good faith satisfaction of Parent that any such Tax has been paid or is not applicable. Until surrendered as
contemplated by this <U>Section</U><U></U><U>&nbsp;3.09</U>, each Certificate shall be deemed at any time after the Effective Time to represent only the right to receive upon such surrender, the Merger Consideration (without interest) into which the
shares of the Company Common Stock theretofore represented by such Certificate have been converted pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U>. No interest shall be paid or accrue on the cash payable upon surrender of any Certificate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Treatment of Book-Entry Shares</U>. No holder of record of Book-Entry Shares shall be required to deliver a Certificate or a letter of
transmittal to the Paying Agent to receive the Merger Consideration in respect of such Book-Entry Shares. In lieu thereof, such holder of record shall, upon receipt by the Paying Agent of an &#8220;agent&#8217;s message&#8221; in customary form (or
such other evidence, if any, as the Paying Agent may reasonably request), be entitled to receive the Merger Consideration into which such Book-Entry Shares shall have been converted pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U>, and the
Surviving Corporation or Parent shall cause the Paying Agent to pay and deliver as promptly as reasonably practicable after the Effective Time (but in no event later than five (5)&nbsp;Business Days after the Effective Time to each such holder of
record as of the Effective Time), an amount of U.S. dollars equal to the aggregate Cash Amount (without interest) to which such holder is entitled hereunder, and such Book-Entry Shares shall forthwith be canceled. Payment of the Cash Amount with
respect to Book-Entry Shares shall only be made to the Person in whose name such Book-Entry Shares are registered. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Adjustments</U>.
If, between the Agreement Date and the Effective Time, the outstanding shares of the Company Common Stock are changed into a different number or class of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse
stock split, consolidation of shares, reclassification, recapitalization or other similar transaction, then the Merger Consideration shall be appropriately adjusted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>No Further Ownership Rights in the Company Common Stock</U>. The Merger Consideration paid in accordance with the terms of this
<U>Article III</U> as a result of the conversion of any shares of the Company Common Stock shall be deemed to have been paid in full satisfaction of all rights pertaining to such shares of the Company Common Stock. After the Effective Time there
shall be no further registration of transfers on the stock transfer books of the Surviving Corporation of shares of the Company Common Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, any
Certificates are presented to the Surviving Corporation or the Paying Agent for any reason, such Certificates shall be canceled and exchanged as provided in this <U>Article III</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Lost, Stolen or Destroyed Certificates</U>. Notwithstanding the requirements to surrender a Certificate contained in
<U>Section</U><U></U><U>&nbsp;3.09</U>, if any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the
Surviving Corporation, the posting by such Person of a bond, in such reasonable amount as Parent may direct, as indemnity against any claim that may be made against it with respect to such Certificate, the Paying Agent will pay, in exchange for the
shares of the Company Common Stock formerly represented by such lost, stolen or destroyed Certificate, the applicable Merger Consideration to be paid in respect of such shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Payment Fund</U>. Any portion of the Payment Fund (and any interest or
other income earned thereon) that remains undistributed as of the twelve (12)-month anniversary of the Merger Closing Date shall be delivered to the Company or its designated Affiliate, upon demand, and any former holder of the Company Common Stock
entitled to payment of the Cash Amount who has not theretofore complied with this <U>Article III</U> shall thereafter look only to the Company or any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">successor-in-interest</FONT></FONT> of the Company for payment of its claim for the Cash Amount (subject to applicable abandoned property, escheat and other similar Law). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>No Liability</U>. None of Parent, Merger Sub, the Company, the Surviving Corporation and the Paying Agent shall be liable to any Person
in respect of any cash from the Payment Fund delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If any Certificate has not been surrendered prior to the date on which the Merger Consideration in
respect of such Certificate would otherwise escheat to or become the property of any Governmental Entity, any such Merger Consideration in respect of such Certificate shall, to the extent permitted by applicable Law, immediately prior to such date
become the property of the Surviving Corporation or its designated Affiliate, free and clear of any claims or interest of any such holders or their successors, assigns or personal representative previously entitled thereto, subject to the claims of
any former holder of the Company Common Stock entitled to payment of Merger Consideration who has not theretofore complied with this <U>Article III</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Investment of Payment Fund</U>. The Payment Fund shall be invested by the Paying Agent as directed by Parent. Nothing contained in this
<U>Section</U><U></U><U>&nbsp;3.09(i)</U> and no investment losses resulting from the investment of the Payment Fund shall diminish the rights of the Company Stockholders entitled to payment of the Cash Amount to receive the Cash Amount. To the
extent there are losses or the Payment Fund for any reason (including Appraisal Shares losing their status as such) is less than the level required to promptly pay the Cash Amount pursuant to <U>Section</U><U></U><U>&nbsp;3.08(c)</U>, Parent shall
replace, restore or add to the cash in the Payment Fund to ensure the prompt payment of the Merger Consideration. Any interest and other income resulting from such investments shall be the property of, and paid to, Parent or its designated
Affiliate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Withholding Rights</U>. Notwithstanding anything to the contrary, each of the Company, the Surviving Corporation, Parent
and the Paying Agent shall be entitled to deduct and withhold from the amounts otherwise payable pursuant to this Agreement or the Offer such amounts as are required to be deducted and withheld with respect to the making of such payment under the
Code or under any provision of state, local or foreign Law. Amounts so deducted or withheld shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction or withholding was made. Provided IRS
Forms <FONT STYLE="white-space:nowrap">W-9</FONT> or <FONT STYLE="white-space:nowrap">W-8</FONT> have been provided, Parent shall (i)&nbsp;use commercially reasonable efforts to provide advance notice of any such deduction or withholding (other than
with respect to amounts paid as compensation) and (ii)&nbsp;cooperate with the Company and any holders of Company Common Stock or Company Equity Awards to obtain any affidavits, certificates and other documents as may reasonably be expected to
afford to the Company and such holders reduction of or relief from any such deduction or withholding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.10 <U>Equity Awards</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of immediately prior to the Offer Closing Time, each Company Option that is then outstanding but not then vested or exercisable shall
become immediately vested and exercisable in full. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At the Effective Time, each <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Option that is then outstanding shall be canceled and the holder thereof shall be entitled to receive (A)&nbsp;an amount in cash without interest, equal to the product obtained by multiplying
(x)&nbsp;the excess of the Cash Amount over the exercise price per share of the Company Common Stock underlying such Company Option at the Effective Time by (y)&nbsp;the number of shares of the Company Common Stock underlying such Company Option
(such amount, the &#8220;<B><I>Company Option Cash Consideration</I></B>&#8221;) and (B)&nbsp;one CVR for each share of the Company Common Stock underlying such Company Option at the Effective Time. Parent shall cause the Surviving Corporation to
pay the Company Option Cash Consideration at or reasonably promptly after the Effective Time (but in no event later than five (5)&nbsp;Business Days after the Effective Time). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) At the Effective Time, each
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Out-of-the-Money</FONT></FONT></FONT> Option that is then outstanding shall be automatically cancelled for no consideration and the holder thereof
shall have no further rights with respect thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of immediately prior to the Offer Closing Time, each Company Restricted Stock
Unit Award that is then outstanding but not then vested shall become immediately vested in full. At the Effective Time, each Company Restricted Stock Unit Award that is then outstanding shall be canceled and the holder thereof shall be entitled to
receive (i)&nbsp;an amount in cash without interest, equal to the product obtained by multiplying (x)&nbsp;the Cash Amount by (y)&nbsp;the number of shares of the Company Common Stock underlying such Company Restricted Stock Unit Award at the
Effective Time (such amount, the &#8220;<B><I>Restricted Stock Unit Cash Consideration</I></B>&#8221;) and (ii)&nbsp;one CVR for each share of the Company Common Stock underlying such Company Restricted Stock Unit Award at the Effective Time. Parent
shall cause the Surviving Corporation to pay the Restricted Stock Unit Cash Consideration at or reasonably promptly after the Effective Time (but in no event later than five (5)&nbsp;Business Days after the Effective Time). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to the Effective Time, the Company shall take all reasonable actions required to (A)&nbsp;terminate the Company ESPP, as of
immediately prior to the Merger Closing Date and (B)&nbsp;provide that no new offering period shall commence after the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Prior to the Effective Time, the Company Board (or, if appropriate, any committee thereof administering any Company Stock Plan) shall adopt
such resolutions or take such action by written consent in lieu of a meeting, providing for the transactions contemplated by this <U>Section</U><U></U><U>&nbsp;3.10</U>. The Company shall provide that, on and following the Effective Time, no holder
of any Company Equity Awards shall have the right to acquire any equity interest in the Company or the Surviving Corporation in respect thereof and each Company Stock Plan shall terminate as of the Effective Time; <U>provided</U>, that the Company
ESPP shall terminate in accordance with <U>Section</U><U></U><U>&nbsp;3.10(c)</U> hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.11 <U>Contingent Value Right</U>. At or prior to the Offer Closing Time,
Parent will authorize and duly adopt, execute and deliver, and will ensure that a duly qualified rights agent with respect to the CVRs mutually agreeable to Parent and the Company (a &#8220;<B><I>Rights Agent</I></B>&#8221;) executes and delivers, a
contingent value rights agreement in substantially the form attached as <U>Exhibit C</U> (the &#8220;<B><I>CVR Agreement</I></B>&#8221;), subject to any reasonable revisions to the CVR Agreement that are requested by such Rights Agent or the
Representative thereunder (provided that such revisions are not, individually or in the aggregate, materially detrimental to any holder of CVRs). Parent and the Company shall cooperate, including by making changes to the form of CVR Agreement, as
necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act or any applicable state securities or &#8220;blue sky&#8221; Laws. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (i)&nbsp;as set forth in the written disclosure schedule delivered by the Company to Parent (the &#8220;<B><I>Company Disclosure
Letter</I></B>&#8221;)<B> </B>or (ii)&nbsp;as<B> </B>disclosed in the Company SEC<B> </B>Documents (as defined below) filed with the SEC prior to the date hereof and publicly available on the SEC&#8217;s Electronic Data Gathering Analysis and
Retrieval system (but (A)&nbsp;without giving effect to any amendment thereof filed with, or furnished to the SEC on or after the date hereof and (B)&nbsp;excluding any disclosures in any &#8220;forward-looking statements&#8221; disclaimer or in any
other section to the extent they are forward-looking statements; <U>provided</U> that any factual information contained within such disclosure shall not be excluded), the Company represents and warrants to Parent as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.01 <U>Due Organization; Subsidiaries</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Company and its Subsidiaries is a corporation or other legal entity duly incorporated or otherwise organized, validly existing
and in good standing under the Laws of the jurisdiction of its incorporation or organization and has all necessary power and authority: (i)&nbsp;to conduct its business in the manner in which its business is currently being conducted, (ii)&nbsp;to
own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used and (iii)&nbsp;to perform its obligations under all Contracts by which it is bound. All of the Company&#8217;s
Subsidiaries are wholly owned by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company and its Subsidiaries is licensed and qualified to do business, and
is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business in the manner in which its business is currently being conducted requires such licensing or qualification other
than in jurisdictions where the failure to be so qualified individually or in the aggregate would not be reasonably expected to have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth on <U>Section</U><U></U><U>&nbsp;4.01(c)</U> of the Company Disclosure Letter, the Company has no other Subsidiaries
and the Company does not directly or indirectly own any capital stock of, or any equity ownership or profit sharing interest of any nature in, or control directly or indirectly, any other Person. The Company is not and has not otherwise been,
directly or indirectly, a party to, member of or participant in any partnership, joint venture or similar business entity. The Company has not agreed and is not obligated to make, nor is the Company </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Person. The Company has not, at any time, been a general partner
of, and has not otherwise been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.02 <U>Organizational Documents</U>. The Company has delivered to Parent accurate and complete copies of the Organizational
Documents of the Company. The Company is not in breach or violation of its Organizational Documents in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.03 <U>Authority; Binding Nature of Agreement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and to
consummate the Transactions. The execution and delivery by the Company of this Agreement and, assuming that the Transactions are consummated in accordance with Section&nbsp;251(h) of the DGCL, the consummation by the Company of the Transactions has
been duly authorized by all necessary corporate action on the part of the Company. The Company Board, at a meeting duly called and held, duly and by unanimous vote of the Company Board adopted resolutions (i)&nbsp;determining that the Offer, the
Merger and the other Transactions are fair to and in the best interest of the Company and the Company Stockholders, (ii)&nbsp;approving and declaring advisable the Merger and the execution, delivery and performance by the Company of this Agreement
and the consummation of the Transactions, (iii)&nbsp;resolving that this Agreement and the Merger shall be governed by and effected under Section&nbsp;251(h) of the DGCL and that the Merger shall be consummated as soon as practicable following the
Offer Closing Time and (iv)&nbsp;recommending that the Company Stockholders accept the Offer and tender their shares of the Company Common Stock pursuant to the Offer (the &#8220;<B><I>Company Board Recommendation</I></B>&#8221;), which resolutions,
as of the Agreement Date, have not been rescinded, modified or withdrawn in any way. This Agreement has been duly executed and delivered by the Company and, assuming the due authorization, execution and delivery by Parent, constitutes the legal,
valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the scheduled expiration of the Offer, the Company Board or the compensation committee of the Company Board has, or will have,
(i)&nbsp;duly and unanimously adopted resolutions approving as an &#8220;employment compensation, severance or other employee benefit arrangement&#8221; within the meaning of Rule 14d-10(d)(1) under the Exchange Act each agreement, plan, program,
arrangement or understanding entered into or established by the Company or any of its former Subsidiaries on or before the date hereof with or on behalf of any of its officers, directors or employees, including the terms of <U>Section 3.08</U>,
<U>Section 3.10</U> and <U>Section 7.03</U>, and (ii)&nbsp;taken all other actions reasonably necessary to satisfy the requirements of the non-exclusive safe harbor under Rule <FONT STYLE="white-space:nowrap">14d-10(d)</FONT> under the Exchange Act
with respect to the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.04 <U>No Vote Required</U>. Assuming the Transactions are consummated in accordance with
Section&nbsp;251(h) of the DGCL and assuming the accuracy of the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;5.08</U>, no stockholder votes or consents are needed to authorize this Agreement or for consummation of the
Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.05 <U><FONT STYLE="white-space:nowrap">Non-Contravention;</FONT>
Consents</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The execution and delivery by the Company of this Agreement do not, and the consummation of the Offer, the Merger and
the other Transactions and compliance with the terms hereof will not, conflict with, or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancelation or
acceleration of any obligation or loss of a material benefit under, or result in the creation of any Lien other than any Permitted Lien upon any of the properties or assets of the Company or its Subsidiaries under, any provision of (i)&nbsp;the
Company&#8217;s Organizational Documents, (ii)&nbsp;any Material Contract to which the Company is or its Subsidiaries are a party or (iii)&nbsp;subject to the filings and other matters referred to in <U>Section</U><U></U><U>&nbsp;4.05(b)</U>, any
Judgment or, assuming the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;5.08</U> are true and correct, any Law, in either case, that is applicable to the Company or its Subsidiaries or its and their properties or assets,
other than, in the case of clauses (ii)&nbsp;and (iii), any such items that would not reasonably be expected to, individually or in the aggregate, have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No Consent of, or registration, declaration or filing with, or permit from, any Governmental Entity, is required to be obtained or made by
or with respect to the Company in connection with the execution, delivery and performance of this Agreement or the consummation of the Transactions, other than (i)&nbsp;the filing with the SEC of (A)&nbsp;the Schedule
<FONT STYLE="white-space:nowrap">14D-9</FONT> and (B)&nbsp;such reports under the Exchange Act as may be required in connection with this Agreement, the Offer, the Merger and the other Transactions, (ii)&nbsp;the filing of the Certificate of Merger
with the Secretary of State of the State of Delaware and appropriate documents with the relevant authorities of the other jurisdictions in which the Company is qualified to do business, (iii)&nbsp;such filings as may be required under the rules and
regulations of Nasdaq, and (iv)&nbsp;such other items the failure of which to obtain or make would not reasonably be expected to, individually or in the aggregate, have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.06 <U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of (i) 500,000,000 shares of common stock, par value $0.0001 per share
(&#8220;<B><I>Company Common Stock</I></B>&#8221;), of which 50,141,064 shares have been issued and are outstanding as of the close of business on July&nbsp;31, 2025 (the &#8220;<B><I>Measurement Date</I></B>&#8221;) and (ii)&nbsp;50,000,000 shares
of preferred stock, par value $0.0001 per share (&#8220;<B><I>Company Preferred Stock</I></B>&#8221;), of which no shares have been issued and are outstanding as of the close of business on the Measurement Date. The Company does not hold any shares
of its capital stock in its treasury. From the Measurement Date to the Agreement Date, there have been no issuances by the Company of shares of capital stock or other voting securities or equity interests of the Company or options, warrants,
convertible or exchangeable securities, stock-based performance units or other rights to acquire shares of capital stock or other voting securities or equity interests of the Company or other rights that give the holder thereof any economic or
voting interest of a nature accruing to the holders of the Company Common Stock, other than the issuance of the Company Common Stock upon the exercise of Company Options or vesting of Company Restricted Stock Unit Awards in accordance with their
terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All of the outstanding shares of Company Common Stock have been duly authorized and
validly issued, and are fully paid and nonassessable and are free of any Liens other than Liens set forth in the Organizational Documents or under applicable securities Laws. None of the outstanding shares of Company Common Stock is entitled or
subject to any preemptive right, right of participation, right of maintenance or any similar right and none of the outstanding shares of Company Common Stock is subject to any right of first refusal in favor of the Company. Except as contemplated
herein, the Company is not bound by any Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares
of Company Common Stock. Other than pursuant to the Company Stock Plans and the Company Equity Awards thereunder, the Company is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase,
redeem or otherwise acquire any outstanding shares of Company Common Stock or other securities. <U>Section</U><U></U><U>&nbsp;4.06(b)</U> of the Company Disclosure Letter accurately and completely lists all repurchase rights held by the Company with
respect to shares of Company Common Stock and specifies which of those repurchase rights are currently exercisable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Section</U><U></U><U>&nbsp;4.06(c)</U> of the Company Disclosure Letter sets forth a true and complete list, as of the Measurement Date, of each outstanding Company Option and Company Restricted Stock Unit Award, including: (i)&nbsp;the name (or
employee identification number) of the holder, (ii)&nbsp;the number of shares of Company Common Stock subject to such Company Option or Company Restricted Stock Unit Award, (iii)&nbsp;the exercise price of each Company Option, (iv)&nbsp;the date of
grant, (v)&nbsp;the applicable vesting schedule, including the number of vested and unvested shares, and (vi)&nbsp;the expiration date, as applicable. The Company has made available to Parent accurate and complete copies of the following (except for
such documents that are filed as an exhibit to a Company SEC Document): (A) the standard form of agreement evidencing Company Options and Company Restricted Stock Unit Awards; and (B)&nbsp;each agreement evidencing a Company Option or Company
Restricted Stock Unit Award that does not conform in all material respects to the standard form agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth on
<U>Section</U><U></U><U>&nbsp;4.06(c)</U> of the Company Disclosure Letter, there is no: (i)&nbsp;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other
securities of the Company, (ii)&nbsp;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of the Company having the right to vote), (iii)
stockholder rights plan (or similar plan commonly referred to as a &#8220;poison pill&#8221;) or Contract under which the Company is or may become obligated to sell or otherwise issue any shares of its capital stock or any other securities or
(iv)&nbsp;condition or circumstance that may give rise to or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive any shares of capital stock or other securities of the Company.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) All outstanding shares of Company Common Stock and other securities of the Company have been issued and granted in material compliance
with (i)&nbsp;all applicable securities laws and other applicable Law and (ii)&nbsp;all requirements set forth in applicable Contracts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.07 <U>SEC Filings; Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has filed or furnished, as applicable, on a timely basis all forms, schedules, statements, certifications, reports and
documents required to be filed or furnished by it with the SEC under the Securities Act, or the Exchange Act and the Sarbanes-Oxley Act and all rules and regulations of the SEC promulgated by the SEC thereunder (as the case may be) since
January&nbsp;1, 2023 (the &#8220;<B><I>Company SEC</I></B><B> </B><B><I>Documents</I></B>&#8221;). As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such
filing), each of the Company SEC<B> </B>Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be) and as of the time they were filed, none of the Company SEC<B>
</B>Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. The certifications and statements required by (i)&nbsp;Rule <FONT STYLE="white-space:nowrap">13a-14</FONT> under the Exchange Act and (ii) 18 U.S.C. &#167;1350 (Section 906 of the Sarbanes-Oxley Act) relating to the Company SEC<B>
</B>Documents (collectively, the &#8220;<B><I>Company Certifications</I></B>&#8221;) are accurate and complete and comply as to form and content with all applicable Laws. As used in this <U>Section</U><U></U><U>&nbsp;4.07</U>, the term
&#8220;file&#8221; and variations thereof shall be broadly construed to include any manner in which a document or information is furnished, supplied or otherwise made available to the SEC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The financial statements (including any related notes) contained or incorporated by reference in the Company SEC<B> </B>Documents:
(i)&nbsp;complied as to form in all material respects with the Securities Act and the Exchange Act, as applicable, and the published rules and regulations of the SEC applicable thereto, (ii)&nbsp;were prepared in accordance with GAAP (except as may
be indicated in the notes to such financial statements or, in the case of unaudited financial statements, as permitted by Form <FONT STYLE="white-space:nowrap">10-Q</FONT> of the SEC, and except that the unaudited financial statements are subject to
normal and recurring <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments that are not reasonably expected to be material in amount) applied on a consistent basis unless otherwise noted therein throughout the periods indicated and
(iii)&nbsp;fairly present, in all material respects, the financial position of the Company as of the respective dates thereof and the results of operations and cash flows of the Company for the periods covered thereby. Other than as expressly
disclosed in the Company SEC<B> </B>Documents filed prior to the date hereof, there has been no material change in the Company&#8217;s accounting methods or principles that would be required to be disclosed in the Company&#8217;s financial
statements in accordance with GAAP. The books of account and other financial records of the Company and each of its Subsidiaries are true and complete in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company&#8217;s auditor has at all times since the date of enactment of the <FONT STYLE="white-space:nowrap">Sarbanes-Oxley</FONT> Act
been: (i)&nbsp;a registered public accounting firm (as defined in Section&nbsp;2(a)(12) of the <FONT STYLE="white-space:nowrap">Sarbanes-Oxley</FONT> Act), (ii) to the knowledge of the Company, &#8220;independent&#8221; with respect to the Company
within the meaning of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act and (iii)&nbsp;to the knowledge of the Company, in compliance with subsections (g)&nbsp;through (l) of Section&nbsp;10A of the Exchange Act and the
rules and regulations promulgated by the SEC and the Public Company Accounting Oversight Board thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth on
<U>Section</U><U></U><U>&nbsp;4.07(d)</U> of the Company Disclosure Letter, the Company has not received any comment letter from the SEC or the staff thereof or any correspondence from Nasdaq or the staff thereof relating to the delisting or
maintenance of listing of Company Common Stock on Nasdaq. The Company has not disclosed any unresolved comments in the Company SEC<B> </B>Documents. The Company is in compliance in all material respects with the applicable listing and other rules
and regulations of Nasdaq. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) There have been no formal internal investigations regarding financial reporting or
accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, or general counsel of the Company, the Company Board or any committee thereof, other than ordinary
course audits or reviews of accounting policies and practices or internal controls required by the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as set
forth on <U>Section</U><U></U><U>&nbsp;4.07(f)</U> of the Company Disclosure Letter, the Company is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act, the Exchange Act and the applicable listing and
governance rules and regulations of Nasdaq. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company has established and maintains a system of internal control over financial
reporting (as defined in Rules <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> and <FONT STYLE="white-space:nowrap">15d-l5(f)</FONT> of the Exchange Act) that is sufficient to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance that the Company maintains records that in reasonable detail accurately
and fairly reflect the Company&#8217;s transactions and dispositions of assets. The Company has disclosed to the Company&#8217;s auditors and the Audit Committee of the Company Board (and made available to the Company a summary of the significant
aspects of such disclosure)&nbsp;(A) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the Company&#8217;s ability to record,
process, summarize and report financial information and (B)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in the Company or its Subsidiaries&#8217; internal control over financial
reporting. Except as disclosed in the Company SEC<B> </B>Documents filed prior to the date hereof, the Company&#8217;s internal control over financial reporting is effective and the Company has not identified any material weaknesses in the design or
operation of the Company&#8217;s internal control over financial reporting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither the Company nor its Subsidiaries have effected,
entered into or created any securitization transaction or <FONT STYLE="white-space:nowrap">&#8220;off-balance</FONT> sheet arrangement&#8221; (as defined in Item 303(b) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange
Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.08 <U>Absence of Changes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth on <U>Section</U><U></U><U>&nbsp;4.08</U> of the Company Disclosure Letter, since April&nbsp;1, 2025, other than the
Wind-Down Process, (i)&nbsp;the Company and its Subsidiaries have conducted its business only in the ordinary course of business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related
thereto) and (ii)&nbsp;there has not been any change, event, condition, development, circumstance, effect or occurrence that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From April&nbsp;1, 2025 to the Agreement Date, the Company has conducted its business in accordance with the Wind-Down Process, and during
such period there has not been: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) except for any transactions under the Company Stock Plan, any declaration, setting
aside, accrual or payment of any dividend on, or making of any other distribution (whether in cash, stock, equity securities or property) in respect of, any capital stock of the Company (except for shares of Company Capital Stock from terminated
employees, directors or consultants of the Company); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any split, combination or reclassification of any capital stock of the Company
or any issuance or the authorization of any issuance of any other securities in respect of, in lieu of or in substitution for shares of capital stock of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any change in accounting methods, principles or practices by the Company (other than any immaterial change thereto), except as required
(A)&nbsp;by GAAP (or any authoritative interpretation thereof), including pursuant to standards, guidelines and interpretations of the Financial Accounting Standards Board or any similar organization or (B)&nbsp;by Law, including Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> promulgated under the Securities Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any sale, lease (as lessor), exclusive license or other
disposition of (including through any <FONT STYLE="white-space:nowrap">&#8220;spin-off&#8221;),</FONT> or pledge, encumbrance or other Lien imposed upon (other than a Permitted Lien), any properties or assets (other than Intellectual Property) that
are material, individually or in the aggregate, to the Company except (A)&nbsp;sales or other dispositions of inventory and excess or obsolete properties or assets in the ordinary course of business, (B)&nbsp;pursuant to Contracts to which the
Company is a party made available to Parent and in effect prior to the date of the Company Balance Sheet and (C)&nbsp;in accordance with the Wind-Down Process; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any sale, assignment, lease, exclusive license, transfer or other disposition of, pledge, encumbrance or other Lien imposed upon (other
than a Permitted Lien), or permitting to lapse or abandonment of, any Intellectual Property Rights owned by the Company that is material, individually or in the aggregate, to the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) any acquisition, in a single transaction or a series of related transactions, whether by merging or consolidating with, or by purchasing
an equity interest in or a portion of the assets of, or by any other similar manner, any business or any corporation, partnership, limited liability company, joint venture, association or other business organization or division thereof or any other
Person (other than the Company); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) in each case with respect to the Company or any of its Subsidiaries: any filing of or change to a
material Tax election, any change to an annual Tax accounting period or any adoption of or change to a material method of Tax accounting, any filing of an amended material Tax Return, any failure to timely file any material Tax Return required to be
filed (taking into account extensions obtained in the ordinary course of business) or pay any material amount of Taxes that is due and owing by the Company or any of its Subsidiaries, any entry into a closing agreement within the meaning of
Section&nbsp;7121 of the Code (or any similar provision of state, local or foreign Law), any settlement or compromise of a material Tax liability or refund, any consent to any extension or waiver of any limitation period with respect to any material
claim or assessment for Taxes (excluding extensions of time to file Tax Returns obtained in the ordinary course of business), any grant of any power of attorney with respect to material Taxes, or any entry into any Tax Sharing Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) any Contract to which the Company or its Subsidiaries are a party that
(A)&nbsp;materially restricts the ability of the Company or its Affiliates, including following the Offer Closing Time, Parent and its Affiliates (other than in the case of Parent and its Affiliates, due to the operation of Contracts to which Parent
or any of its Affiliates is a party prior to the Offer Closing Time) following the Merger Closing, to compete in any business or with any Person in any geographical area, (B)&nbsp;requires the Company or its Affiliates, including following the Offer
Closing Time, Parent and its Affiliates (other than, in the case of Parent and its Affiliates, due to the operation of Contracts to which Parent or any of its Affiliates is a party prior to the Offer Closing Time) following the Merger Closing, to
conduct any business on a &#8220;most favored nations&#8221; basis with any third party in any material respect, (C)&nbsp;grants a third party development (other than solely for or on behalf of the Company or its Affiliates), marketing or
distribution rights with respect to the Company&#8217;s products, (D)&nbsp;requires the Company or its Affiliates to purchase a minimum quantity of goods or supplies relating to the Company Product Candidates in favor of any third party, or
(E)&nbsp;obligates the Company or its Affiliates to purchase or otherwise obtain any product or service exclusively from any third party or sell any product or service exclusively to any third party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) any Contract to which the Company or its Subsidiaries are a party with any academic institution or Governmental Entity that provides for
the provision of funding to the Company or its Subsidiaries for research and development activities involving the creation of any material Intellectual Property Rights for the Company or its Subsidiaries in respect of the Company Product Candidates;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) any Contract to which the Company or its Subsidiaries are a party, other than with respect to any partnership that is wholly owned by
the Company, that relates to the formation, creation, operation, management or control of any legal partnership or any joint venture entity pursuant to which the Company or its Subsidiaries have an obligation (contingent or otherwise) to make a
material investment in or material extension of credit to any Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) any Contract between the Company or its Subsidiaries and any
Governmental Entity, except for clinical study agreements, sponsored research agreements, materials transfer agreements and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements entered into in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) any settlement or compromise of, or written offer or proposal to settle or compromise, any Proceeding involving or against the Company
or its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) except as required pursuant to the terms of any Company Employee Plan in effect as of the date of the Company
Balance Sheet, (A)&nbsp;any granting to any director or employee of the Company of any increase in compensation, bonus, severance or termination pay, or (B)&nbsp;any entry by the Company into any employment, consulting, severance or termination
agreement with any director or any employee; in any such case of (A)&nbsp;or (B), other than as disclosed in the Company SEC Documents or Section&nbsp;4.08 or Section&nbsp;4.16 of the Company Disclosure Letter; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) any agreement on the part of the Company or its Subsidiaries to do any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.09 <U>Absence of Undisclosed </U><U>Liabilities</U>. Neither the Company nor
any of its Subsidiaries has any liability of a type required to be reflected or reserved for on a balance sheet prepared in accordance with GAAP, except for: (a)&nbsp;liabilities disclosed, reflected or reserved against in the latest Company Balance
Sheet, (b)&nbsp;normal and recurring current liabilities that have been incurred by the Company or its Subsidiaries since the date of the latest Company Balance Sheet in the ordinary course of business (none of which relates to any breach of
contract, breach of warranty, tort, infringement, or violation of Law), (c) liabilities for performance of obligations of the Company or any of its Subsidiaries under the Company&#8217;s Contracts or Company Employee Plans, (d)&nbsp;liabilities
incurred in connection with the Transactions or the Wind-Down Process and (e)&nbsp;liabilities listed in <U>Section</U><U></U><U>&nbsp;4.09</U> of the Company Disclosure Letter. As of the Agreement Date, neither the Company nor its Subsidiaries has
taken any actions that were intended to manipulate any element of the calculation of Closing Net Cash in a manner adverse to Parent or Merger Sub. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.10 <U>Real Property; Leasehold</U>. Neither the Company nor any of its Subsidiaries owns or has ever owned any real property.
The Company has made available to Parent (a)&nbsp;an accurate and complete list of all real properties with respect to which the Company directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the
possession of or leased by the Company or any of its Subsidiaries and (b)&nbsp;copies of all leases under which any such real property is possessed (the &#8220;<B><I>Company Real Estate Leases</I></B>&#8221;), each of which is in full force and
effect, with no existing material default thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.11 <U>Intellectual Property</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;4.11(a)</U> of the Company Disclosure Letter sets forth a true and complete list, as of the date hereof, of
all material Company Registered Intellectual Property Rights, together with the name of the current owner(s), the applicable jurisdictions and the application or registration numbers. Except as otherwise indicated, the Company is the exclusive
owner, a <FONT STYLE="white-space:nowrap">co-owner,</FONT> or an exclusive licensee of all material Company Registered Intellectual Property Rights set forth in <U>Section</U><U></U><U>&nbsp;4.11(a)</U> of the Company Disclosure Letter, free and
clear of any Liens other than Permitted Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To the knowledge of the Company, except as would not, individually or in the aggregate,
have a Company Material Adverse Effect, the Company takes commercially reasonable steps to have each Person who is or was an employee or contractor of the Company and who is or was involved in the creation or development of any material Intellectual
Property Rights owned by the Company execute a valid agreement containing an assignment to the Company of such employee&#8217;s or contractor&#8217;s rights to such material Intellectual Property Rights. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the knowledge of the Company, all material Company Registered Intellectual Property Rights that have been issued or that have completed
registration are valid and enforceable. Except as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect, and to the knowledge of the Company, since January&nbsp;1, 2023, the Company has not
received written notice from any third party challenging the validity, enforceability or ownership of any material Company Registered Intellectual Property Rights, nor is the Company currently a party to any proceeding relating to any such
challenge, except for office actions and other ex parte proceedings in the ordinary course of prosecuting or maintaining such Company Registered Intellectual Property Rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as would not, individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, and to the knowledge of the Company, since January&nbsp;1, 2023 until the date hereof, the Company has not received any written notice from any third party that the operation of the business of Company as is
currently conducted, or the Company Product Candidates, infringe or misappropriate the Intellectual Property Rights of any third party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the knowledge of the Company, except for any infringements or misappropriations that would not, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect, no third party is currently infringing or misappropriating any material Company Intellectual Property Rights. Except as would not, individually or in the aggregate, reasonably be
expected to have a Company Material Adverse Effect, and to the knowledge of the Company, the Company is not currently a party to any proceeding (i)&nbsp;challenging the validity, enforceability or ownership of any third party Intellectual Property
Rights or (ii)&nbsp;asserting that the operation of the business of any third party, or any third party products or services, infringes or misappropriates any Company Intellectual Property Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.12 <U>Agreements</U><U>, Contracts and Commitments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;4.12</U> of the Company Disclosure Letter lists the following Contracts in effect as of the date of this
Agreement other than any Company Employee Plans (each, a &#8220;<B><I>Company Material Contract</I></B>&#8221;<B> </B>and collectively, the &#8220;<B><I>Company Material Contracts</I></B>&#8221;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) each Contract that would be required to be filed by the Company as a &#8220;material contract&#8221; pursuant to Item 601(b)(10) of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) each Contract that is a collective bargaining
agreement or other agreement or arrangement with any labor union, works council or labor organization; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) each Contract for the
employment or engagement of any individual on an employee, consulting or other basis that provides for annual base compensation in excess of $100,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) each Contract with any Company Associate that provides for retention, change in control, transaction or other similar payments or
benefits, whether or not payable as a result of the Transactions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) each Contract relating to any agreement of indemnification or
guaranty not entered into in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) each Contract containing (A)&nbsp;any covenant limiting the freedom of
the Company or any of its Subsidiaries to engage in any line of business or compete with any Person, or limiting the development, manufacture, or distribution of the Company&#8217;s products or services, (B)&nbsp;any most-favored pricing
arrangement, (C)&nbsp;any exclusivity provision or (D)&nbsp;any <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) other than any Contract that can be terminated for convenience on notice by the
Company, each Contract to which the Company or its Subsidiaries are a party that provides for recurring annual minimum payments or receipts (other than milestone, royalty or similar payments or other contingent payments) in excess of $100,000
pursuant to its express terms; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) each Contract relating to the disposition or acquisition of material assets or any ownership
interest in any Entity, in each case, involving payments in excess of $100,000 after the date of this Agreement or has outstanding any purchase price adjustment, <FONT STYLE="white-space:nowrap">&#8220;earn-out,&#8221;</FONT> material payment or
similar obligations on the part of the Company or its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) each Contract to which the Company or its Subsidiaries are a
party relating to any indebtedness for borrowed money, financial guaranty, mortgages, indentures, loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in
excess of $100,000 or creating any material Liens with respect to any assets of the Company or any loans or debt obligations with officers or directors of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) each Contract to which the Company or any of its Subsidiaries are a party pursuant to which (A)&nbsp;the Company or its Subsidiaries have
continuing milestone or similar contingent payments obligations, including upon the achievement of regulatory or commercial milestones or payment of royalties or other amounts calculated based upon any revenues or income of the Company or its
Subsidiaries, in each case, that could result in payments in excess of $100,000, and in each case, excluding indemnification and performance guarantee obligations provided for in the ordinary course of business; (B)&nbsp;the Company or any of its
Subsidiaries grant to or receive from any third party any license to, or covenant not to sue or other right with respect to, any material Intellectual Property Rights; or (C)&nbsp;the Company or its Subsidiaries have ongoing performance obligations
relating to any material research, development and/or collaboration programs or <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and/or clinical trials and studies with respect to the Company Product Candidates; in each case ((A)-(C)), other
than Incidental Contracts; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) each Contract with any Person, including any financial advisor, broker, finder, investment banker or
other Person, providing advisory services to the Company in connection with the Transactions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) each Contract to which the Company or
any of its Subsidiaries is a party or by which any of their assets and properties is currently bound, which involves annual obligations of payment by, or annual payments to, the Company or such Subsidiary in excess of $100,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) a Company Real Estate Lease; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) any other Contract that is not terminable at will (with no penalty or payment) by the Company or any of its Subsidiaries, and
(A)&nbsp;which involves payment or receipt by the Company or such Subsidiary after the date of this Agreement under any such agreement, contract or commitment of more than $100,000 in the aggregate, or obligations after the date of this Agreement in
excess of $25,000 in the aggregate or (B)&nbsp;that is material to the business or operations of the Company and its Subsidiaries taken as a whole; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) each stockholders&#8217;, investors rights&#8217;, registration rights or similar
Contract to which the Company is a party (excluding Contracts governing Company Options and Company Restricted Stock Unit Awards); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) each Contract with or binding upon the Company or its Subsidiaries, or its and their properties or assets that is of the type that would
be required to be disclosed under Item 404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
Company has delivered or made available to Parent accurate and complete copies of all Company Material Contracts, including all amendments thereto. There are no Company Material Contracts that are not in written form. The Company has not, nor, to
the Company&#8217;s knowledge as of the date of this Agreement, has any other party to a Company Material Contract, breached, violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or
conditions of any Company Material Contract in such manner as would permit any other party to cancel or terminate any such Company Material Contract, or would permit any other party to seek damages which would reasonably be expected to have a
Company Material Adverse Effect. As to the Company and its Subsidiaries, as of the date of this Agreement, each Company Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No
Person is renegotiating, or has a right pursuant to the terms of any Company Material Contract to change, any material amount paid or payable to the Company under any Company Material Contract or any other material term or provision of any Company
Material Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.13 <U>Compliance; Permits; Restrictions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries is, and since January&nbsp;1, 2023, has been, in compliance with all applicable Laws, except where
the failure to so comply would not, whether individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. No investigation, claim, suit, proceeding, audit, Judgement, or other action by any Governmental Entity
is pending or, to the knowledge of the Company, threatened against the Company or any of its Subsidiaries, which if determined unfavorably to such Person would reasonably be expected to have a Company Material Adverse Effect. There is no agreement
or Judgement binding upon the Company or any of its Subsidiaries which (i)&nbsp;has or could reasonably be expected to have the effect of prohibiting or materially impairing any business practice of the Company or any of its Subsidiaries, any
acquisition of material property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted, (ii)&nbsp;is reasonably likely to have an adverse effect on the Company&#8217;s
ability to comply with or perform any covenant or obligation under this Agreement or (iii)&nbsp;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Transactions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company and its Subsidiaries holds, and is in compliance with the terms of, all Governmental Authorizations that are required
for the operation of the business of the Company as currently conducted (collectively, the &#8220;<B><I>Company Permits</I></B>&#8221;), except where the failure to hold or comply with the terms of such Company Permits would not, whether
individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. To the knowledge of the Company, since January&nbsp;1, 2023, no event has occurred which allows, or after
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notice or lapse of time would reasonably be expected to allow, revocation, termination or material impairment of the rights of the holder of any Company Permits, where such revocation,
termination, or impairment would reasonably be expected to have a Company Material Adverse Effect. All material Company Permits are in full force and effect, and no Proceeding is pending or, to the knowledge of the Company, threatened, which seeks
to revoke, substantially limit, suspend, or materially modify any Company Permit, the revocation, limitation, suspension or modification of which would reasonably be expected to have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of the Company and its Subsidiaries is, and since January&nbsp;1, 2023, has been, in compliance with all Health Care Laws applicable
to the Company&#8217;s or its Subsidiaries&#8217; product candidates (collectively, the &#8220;<B><I>Company Product Candidates</I></B>&#8221;), except where any failure to so comply would not, whether individually or in the aggregate, reasonably be
expected to have a Company Material Adverse Effect. Except in either case as would not reasonably be expected to, individually or in the aggregate, result in a Company Material Adverse Effect, (x)&nbsp;the Company has filed, maintained or furnished
with the applicable Regulatory Authorities all required filings, declarations, listings, registrations, submissions, amendments, modifications, notices and responses to notices, applications and supplemental applications, reports (including all
adverse event/experience reports) and other information (collectively, the &#8220;<B><I>Health Care Submissions</I></B>&#8221;) and (y)&nbsp;all such Health Care Submissions were complete and accurate and in compliance with applicable Health Care
Laws when filed (or were corrected or completed in a subsequent filing). There are no Proceedings pending or, to the knowledge of the Company, threatened with respect to an alleged material violation by the Company or any of its Subsidiaries of any
applicable Health Care Law promulgated by the FDA comparable Governmental Entity. Since January&nbsp;1, 2023, neither the Company nor any Subsidiary has had any Company Product Candidate manufacturing site subject to an FDA or comparable
Governmental Entity shutdown or material import or export prohibition, nor received any unresolved FDA <FONT STYLE="white-space:nowrap">Form-483</FONT> or other Governmental Entity notice of inspectional observations, warning letters, untitled
letters or requirements to make changes to any Company Product Candidate, that in each case, if not complied with, would reasonably be expected to result in a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All clinical, <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and other studies and tests conducted by or on behalf of, or sponsored
by, the Company or its Subsidiaries, in which the Company Product Candidates have participated, were and, if still pending, are being conducted in compliance in all material respects applicable Laws to which such studies and tests are or were
subject, including the FDCA and its applicable implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58 and 312, and any other applicable regulations governing the conduct of such <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies or
clinical trials. Neither the Company nor any of its Subsidiaries has received any written notices, correspondence, or other written communications from any the FDA or any comparable Governmental Entity or institutional review board of any action to
place a clinical hold order on, or otherwise terminate, materially delay, or suspend any clinical studies currently being conducted by or on behalf of, or sponsored by, the Company or any of its Subsidiaries with respect to the Company Product
Candidates, other than ordinary course communications regarding the design and implementation of such clinical trials, and to the knowledge of the Company, there are no reasonable grounds for the same. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) None of the Company, any of its Subsidiaries, any of its respective directors, officers,
employees, or, to knowledge of the Company, any of its contractors or agents, (i)&nbsp;is the subject of any pending or, to the knowledge of the Company, threatened investigation in respect of its business or products by the FDA pursuant to its
&#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; policy as stated at 56 Fed. Reg. 46191 (September 10, 1991) (the &#8220;<B><I>FDA Application Integrity Policy</I></B>&#8221;) and any amendments thereto, or
by any other similar Governmental Entity pursuant to any similar policy, (ii)&nbsp;has made any materially false statements on, or material omissions from, any notifications, applications, approvals, reports and other submissions made to FDA or any
similar Governmental Entity that would reasonably be expected to provide a basis for FDA to invoke the FDA Application Integrity Policy or for any similar Governmental Entity to invoke a similar policy, (iii)&nbsp;since January&nbsp;1, 2023, has
been excluded, suspended or debarred from participation in any government health care program or human clinical research, or (iv)&nbsp;since January&nbsp;1, 2023, has been convicted of any crime that could reasonably be expected to result in a
material debarment or exclusion under (A) 21 U.S.C. Section&nbsp;335a, (B) 42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7,</FONT> or (C)&nbsp;any other applicable Law. Neither the Company nor any of its Subsidiaries is a party to or has
any reporting obligations under any corporate integrity agreements, monitoring agreements, deferred or <FONT STYLE="white-space:nowrap">non-prosecution</FONT> agreements, consent decrees, settlement orders, or similar agreements with or imposed by
any Governmental Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) No Company Product Candidate that is or has been manufactured, tested, distributed, held or marketed by or on
behalf of the Company has been subject to any material recall or product withdrawal (whether voluntarily or otherwise) or, to the Company&#8217;s knowledge, has been adulterated or misbranded. No Proceedings (whether complete or pending) seeking the
recall, withdrawal, or seizure of any such Company Product Candidate are pending or, to the knowledge of the Company, threatened against the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.14 <U>Proceedings; Judgements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Section</U><U></U><U>&nbsp;4.14</U> of the Company Disclosure Letter, there is no pending Proceeding and, to the
knowledge of the Company, no Person has threatened in writing to commence any Proceeding: (i)&nbsp;that involves the Company or any of its Subsidiaries or any Company Associate (in his or her capacity as such) or any of the material assets owned or
used by the Company or any of its Subsidiaries or (ii)&nbsp;that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Transactions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) There is no Judgement to which the Company or any of its Subsidiaries, or any of the material assets owned or used by the Company or any of
its Subsidiaries is subject. To the knowledge of the Company, no officer or other Key Employee of the Company or any of its Subsidiaries is subject to any Judgement that prohibits such officer or employee from engaging in or continuing any conduct,
activity or practice relating to the business of the Company or any of its Subsidiaries or to any material assets owned or used by the Company or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.15 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Company and its Subsidiaries has timely filed or caused to be timely filed all U.S. federal and state income Tax Returns and
other material Tax Returns that were required to be filed by or with respect to it under applicable Law (taking into account any valid extensions of time to file). All such Tax Returns were correct and complete in all material respects and have been
prepared in compliance with all applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All material amounts of Taxes due and owing by, imposed on or required to be paid by
or with respect to the Company and each of its Subsidiaries (whether or not shown on any Tax Return) have been timely paid. The unpaid Taxes of the Company as of the date of the latest Company Balance Sheet did not exceed in any material respect the
accruals and reserves for Taxes (other than any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the face of the latest Company Balance Sheet. Since the date of the latest Company Balance
Sheet, neither the Company nor any of its Subsidiaries has incurred any material liability for Taxes outside the ordinary course of business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Section&nbsp;4.16(d) of the Company Disclosure Schedule lists the Tax classification of each of the Company and its Subsidiaries since its
formation for U.S. federal income Tax purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of the Company and its Subsidiaries complied in all material respects with all
applicable Law relating to the payment, collection, withholding, and remittance of Taxes (including information reporting requirements) with respect to payments made to any employee, independent contractor, creditor, stockholder, or other third
party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) There are no Liens for material Taxes (other than Permitted Liens) upon any of the assets of the Company or any of its
Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) No deficiencies for a material amount of Taxes of the Company or any of its Subsidiaries have been claimed, proposed or
assessed by any Governmental Authority in writing that have not been paid, settled or withdrawn. There is no material audit, examination or other governmental proceeding in respect of any Taxes of the Company or any of its Subsidiaries that is
pending (or, based on written notice, threatened) or in progress. Neither the Company nor any of its Subsidiaries has waived any statute of limitations in respect of material Taxes which has not yet expired or agreed to any extension of time with
respect to a material Tax assessment or deficiency (excluding extensions of time to file Tax Returns obtained in the ordinary course of business) which has not yet expired. The Company has not granted to any Person any power of attorney that will
remain in force following the Merger Closing Date with respect to any Tax matter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither the Company nor any of its Subsidiaries is a
party to any Tax Sharing Agreement that would have a continuing effect after the Merger Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither the Company nor any of
its Subsidiaries has any material liability for the Taxes of any Person (other than the Company or its Subsidiaries) under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local,
or foreign Law) or as a transferee or successor, or by contract with a third party (other than a contract entered into in the ordinary course of business a principal purpose of which is not related to Taxes). Neither the Company nor any of its
Subsidiaries is now nor has ever been a member of a Combined Group (other than a Combined Group the parent of which is the Company). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) No claim has been made by a Governmental Authority in writing (or, to the knowledge of
the Company, orally) in a jurisdiction wherein which the Company or any of its Subsidiaries do not file a Tax Return that the Company or any of its Subsidiaries, as applicable, are subject to taxation by that jurisdiction. The Company and each of
its Subsidiaries have at all times been exclusively resident for all Tax purposes in their jurisdiction of incorporation. Neither the Company nor any of its Subsidiaries has ever had a permanent establishment (within the meaning of an applicable Tax
treaty) or otherwise had an office or fixed place of business in a country other than the country in which it is organized. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Neither
the Company nor any of its Subsidiaries has been a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; within the meaning of Section&nbsp;355(a)(1)(A) of the Code in a distribution intended to qualify for <FONT
STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355 of the Code (or any similar provision of state, local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> law). Neither the Company nor any of its Subsidiaries has
distributed stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section&nbsp;355 of the Code or Section&nbsp;361 of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Neither the Company nor any of its Subsidiaries has entered into any transaction that constitutes a &#8220;listed transaction&#8221; for
purposes of Treasury Regulations <FONT STYLE="white-space:nowrap">Sections&nbsp;1.6011-4(b)(2)</FONT> or <FONT STYLE="white-space:nowrap">301.6111-2(b)(2).</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Neither the Company nor any of its Subsidiaries has been, or is, a U.S. real property holding company within the meaning of
Section&nbsp;897(c) of the Code during the applicable period specified in Section&nbsp;897(c)(1)(A)(ii) of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Neither the
Company nor any of its Subsidiaries (i)&nbsp;has received or sought any benefit or relief with respect to Taxes pursuant to a Pandemic Response Law or (ii)&nbsp;is subject to a Tax holiday, or Tax incentive or grant (or any or similar or analogous
arrangement with any Governmental Authority) in any jurisdiction that will terminate (or be subject to a clawback or recapture) as a result of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Neither the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material item of
deduction from, taxable income for any taxable period (or portion thereof) beginning after the Merger Closing Date as a result of any: (i)&nbsp;change in method of accounting pursuant to Section&nbsp;481 of the Code (or any similar provision of
state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) for a taxable period ending on or prior to the Merger Closing Date; (ii)&nbsp;&#8220;closing agreement&#8221; as described in Section&nbsp;7121 of the Code (or any corresponding,
similar or analogous provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) executed on or prior to the Merger Closing Date (and prior to the Merger Closing); (iii)&nbsp;installment sale or open transaction disposition
made at or prior to the Merger Closing; (iv)&nbsp;prepaid amount, advance payments or deferred revenue received or accrued by the Company or its Subsidiaries on or prior to the Merger Closing Date other than in respect of such amounts reflected in
the Company Balance Sheet or received in the ordinary course of business since the date of the latest Company Balance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sheet; (v)&nbsp;an intercompany transaction or excess loss account described in the Treasury Regulations under Section&nbsp;1502 of the Code; (vi)&nbsp;the application of Sections 702, 951, 951A
or 1293 of the Code (or any corresponding, similar or analogous provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) with respect to any income, gain, deductions or losses arising prior to the Merger Closing and not
attributable to any income, gain, deductions or losses of Parent, its Affiliates or any Combined Group in which the Company may be a member following the Merger Closing (and not attributable to any direct or indirect equity interests held by such
Persons or Combined Group), or any &#8220;gain recognition agreement&#8221; pursuant to Section&nbsp;367 of the Code executed by the Company or its Subsidiaries prior to the Merger Closing; or (vii)&nbsp;the application of any Pandemic Response Law.
The Company does not have any liability for Taxes under 965 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The Company and its Subsidiaries are in material compliance
with all escheat and state unclaimed or abandoned property laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.16 <U>Employee and Labor Matters; Benefit Plans</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Neither the Company nor any of its Subsidiaries is a party to, bound by the terms of, or has a duty to bargain under, any collective
bargaining agreement or other Contract with a labor union, works council or labor organization representing any Company Associate, and there are no labor unions, works council or labor organizations representing or, to the knowledge of the Company,
purporting to represent or seeking to represent any Company Associates, including through the filing of a petition for representation election. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;4.16(b)</U> of the Company Disclosure Letter lists all material Company Employee Plans. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As applicable with respect to each material Company Employee Plan, the Company has made available to Parent, true and complete copies of
(i)&nbsp;the plan document, including all amendments thereto, and in the case of an unwritten Employee Plan, a written description of all material terms thereof, (ii)&nbsp;all related trust instruments or other funding-related documents and
insurance contracts, (iii)&nbsp;the summary plan description and each summary of material modifications thereto, (iv)&nbsp;the financial statements for the most recent year for which such financial statements are available (in audited form, if
available or required by ERISA) and, where applicable, annual reports with any Governmental Entity (<I>e.g.</I>,<I> </I>Form 5500 and all schedules thereto), (v) the most recent IRS determination or opinion letter, (vi)&nbsp;written results of any
required compliance testing for the three most recent plan years, and (vii)&nbsp;all material, <FONT STYLE="white-space:nowrap">non-routine</FONT> notices, filings or correspondence during the past three years with any Governmental Entity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Company Employee Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has received a favorable determination
letter or may rely on a favorable opinion letter with respect to such qualified status from the IRS to the effect that such plan is qualified under Section&nbsp;401(a) of the Code and the related trust is exempt from federal income Taxes under
Section&nbsp;501(a) of the Code. To the knowledge of the Company, nothing has occurred that would reasonably be expected to cause the loss of the qualified status of any such Company Employee Plan or the Tax exempt status of any related trust. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each Company Employee Plan has been established, maintained and operated in compliance,
in all material respects, with its terms and all applicable Laws, including, without limitation, the Code and ERISA. No Proceeding (other than those relating to routine claims for benefits) is pending or, to the knowledge of the Company, threatened
with respect to any Company Employee Plan. All payments and/or contributions required to have been made with respect to all Company Employee Plans have been made in accordance with the terms of the applicable Company Employee Plan and applicable Law
in all material respects and neither the Company nor any Company ERISA Affiliate has any liability for any such unpaid contributions with respect to any Company Employee Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Company, any of its Subsidiaries nor any of their ERISA Affiliates maintains, contributes to or is required to contribute to,
or has any liability with respect to (i)&nbsp;any &#8220;employee benefit plan&#8221; (within the meaning of Section&nbsp;3(2) of ERISA) that is or was subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code, (ii)&nbsp;a
Multiemployer Plan, (iii)&nbsp;any Multiple Employer Plan, or (iv)&nbsp;any Multiple Employer Welfare Arrangement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as set forth
on Section&nbsp;4.16(g) of the Company Disclosure Letter, no Company Employee Plan provides for medical or other welfare benefits to any Company Associate beyond termination of service or retirement, other than (i)&nbsp;pursuant to applicable Law
(the full cost of which is borne by such Person or such Person&#8217;s dependents or beneficiaries) or (ii)&nbsp;continuation coverage through the end of the month in which such termination or retirement occurs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as set forth on Section&nbsp;4.16(h) of the Company Disclosure Letter, no Company Employee Plan is subject to any law of a foreign
jurisdiction outside of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Each Company Employee Plan has complied in all material respects with Section&nbsp;409A of
the Code, to the extent applicable, and no compensation has been or would reasonably be expected to be includable in the gross income of any Company Associate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company and its Subsidiaries are, and since January&nbsp;1, 2023 have been, in compliance in all material respects with all applicable
Laws respecting labor, employment and employment practices, including terms and conditions of employment, worker classification (including the classification of individual independent contractors and exempt and
<FONT STYLE="white-space:nowrap">non-exempt</FONT> employees), Tax withholding, prohibited discrimination, harassment, equal employment, fair employment practices, meal and rest periods, immigration status, employee safety and health, wages
(including overtime wages), compensation, hours of work, plant closure, and layoff notices (e.g., the WARN Act). There are no Proceedings pending or, to the knowledge of the Company, threatened or reasonably anticipated against the Company or any of
its Subsidiaries relating to any Company Associate. The Company is not a party to a conciliation agreement, consent decree or other agreement or Judgement with any federal, state, or local agency or Governmental Entity with respect to employment
practices. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The Company has not incurred any liability or obligation under the WARN Act that remains unsatisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) There has never been, nor to the knowledge of the Company has there been any threat of,
any strike, slowdown, work stoppage, lockout, job action, union, organizing activity, question concerning representation or any similar activity or dispute, affecting the Company or its Subsidiaries. No event has occurred within the past six
(6)&nbsp;months, and no condition or circumstance exists, that would reasonably be expected to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, job action, union organizing activity, question
concerning representation or any similar activity or dispute. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) There is no contract, agreement, plan or arrangement to which the
Company or any of its Subsidiaries is a party or by which it is bound to make any payment or compensate any Company Associate for Taxes incurred pursuant to Section&nbsp;4999 or Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Except as set forth on <U>Section</U><U></U><U>&nbsp;4.16(n)</U> of the Company Disclosure Letter, neither the execution and delivery of
this Agreement, the shareholder approval of this Agreement, nor the consummation of the Transactions (either alone or in conjunction with any other event, including without limitation, a termination of employment) will result in any (i)&nbsp;payment
(including severance, forgiveness of indebtedness or otherwise) or benefit becoming due to any Company Associate, (ii)&nbsp;increase in any benefits or the compensation payable under any Company Employee Plan, or (iii)&nbsp;acceleration of the time
of payment, funding or vesting of any such compensation or benefits or any loan forgiveness to any Company Associate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.17
<U>Environmental Matters</U>. Since January&nbsp;1, 2023, the Company and each of its Subsidiaries has complied with all applicable Environmental Laws, which compliance includes the possession by the Company of all permits and other Governmental
Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in compliance that, individually or in the aggregate, would not result in a Company Material Adverse
Effect. Neither the Company nor any of its Subsidiaries has received since January&nbsp;1, 2023, any written notice or other communication (in writing or otherwise), whether from a Governmental Entity, citizens group, employee or otherwise, that
alleges that the Company or any of its Subsidiaries is not in compliance with any Environmental Law, and, to the knowledge of the Company, there are no circumstances that may prevent or interfere with the Company&#8217;s or any of its
Subsidiaries&#8217; compliance with any Environmental Law in the future, except where such failure to comply would not reasonably be expected to have a Company Material Adverse Effect. To the knowledge of the Company: (a)&nbsp;no current or prior
owner of any property leased or controlled by the Company or any of its Subsidiaries has received since January&nbsp;1, 2023, any written notice or other communication relating to property owned or leased at any time by the Company or any of its
Subsidiaries, whether from a Governmental Entity, citizens group, employee or otherwise, that alleges that such current or prior owner or the Company or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to
such property, (b)&nbsp;neither the Company nor any of its Subsidiaries has any material liability under any Environmental Law, and (c)&nbsp;neither the Company nor its Subsidiaries have treated, stored, handled, transported, generated, disposed of,
arranged for the disposal of, released, exposed any Person to, or owned or operated any property or facility contaminated by, any Hazardous Substance, in each case as would give rise to liability under applicable Environmental Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.18 <U>Insurance</U>. The Company has made available to Parent accurate and
complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of the Company and its Subsidiaries. Each of such insurance policies is in full
force and effect and the Company and its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, since January&nbsp;1, 2023, neither the Company nor
any of its Subsidiaries has received any notice or other communication regarding any actual or possible: (a)&nbsp;cancellation or invalidation of any insurance policy or (b)&nbsp;refusal or denial of any coverage, reservation of rights or rejection
of any material claim under any insurance policy. Each of the Company and its Subsidiaries has provided timely written notice to the appropriate insurance carrier(s) of each Proceeding pending against the Company or such Subsidiary for which the
Company or such Subsidiary has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Proceeding, or informed the Company or any of its Subsidiaries of its intent to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.19 <U>No Financial Advisors</U>. Except as set forth on <U>Section</U><U></U><U>&nbsp;4.19</U> of the Company Disclosure
Letter, no broker, finder or investment banker is entitled to any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Transactions based upon arrangements made by or on
behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.20 <U>Privacy and Data Security</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the past three (3)&nbsp;years, each of the Company and its Subsidiaries has complied with (i)&nbsp;applicable Privacy Laws;
(ii)&nbsp;the Company&#8217;s published and posted policies relating to the Company and its Subsidiaries&#8217; processing of Personal Information, as applicable to each of the Company and any of its Subsidiaries; and (iii)&nbsp;applicable terms of
any Contracts relating to privacy, security, collection or use of Personal Information of any individuals (including clinical trial participants, patients, patient family members, caregivers or advocates, physicians and other health care
professionals, clinical trial investigators, researchers, pharmacists) that interact with Company or any of its Subsidiaries in connection with the operation of the Company&#8217;s and its Subsidiaries&#8217; business (collectively, (i) &#8211;
(iii), the &#8220;<B><I>Data Protection Requirements</I></B>&#8221;), except for such noncompliance as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. To the knowledge
of the Company, during the past three (3)&nbsp;years, no claims have been asserted or threatened against the Company by any Person alleging a violation of the Data Protection Requirements. Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, to the knowledge of the Company, during the past three (3)&nbsp;years, there have been no data security incidents or personal data breaches related to Personal Information in the
custody or control of the Company or any service provider acting on behalf of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect, the information technology assets and equipment of the Company and its Subsidiaries (collectively, &#8220;<B><I>Company IT Systems</I></B>&#8221;) are adequate for, and
operate and perform in all respects as required in connection with the operation of the business of the Company and its Subsidiaries as currently conducted, and to the knowledge of the Company, are free and clear of all material bugs, errors,
defects, Trojan horses, time bombs, malware and other corruptants. The Company and its Subsidiaries have implemented and maintain commercially reasonable physical, technical and administrative safeguards designed to protect Personal Information
processed by the Company and its Subsidiaries, any other material confidential information and the integrity and security of Company IT Systems used in connection with their businesses, and during the past three (3)&nbsp;years, there have been no
breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.21 <U>Certain Payments</U>. For the five (5)&nbsp;years immediately preceding
the date hereof, neither the Company nor any of its Subsidiaries nor, to the knowledge of the Company, any of their respective directors, executives, Representatives, agents or employees (a)&nbsp;has used or is using any corporate funds for any
illegal contributions, gifts, entertainment or other unlawful expenses relating to political activity, (b)&nbsp;has used or is using any corporate funds for any direct or indirect unlawful payments to any foreign or domestic governmental officials
or employees, (c)&nbsp;has violated or is violating any provision of the Foreign Corrupt Practices Act of 1977, as amended, (d)&nbsp;has established or maintained, or is maintaining, any unlawful fund of corporate monies or other properties, or
(e)&nbsp;has made any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful payment of any nature. Since January&nbsp;1, 2023 to the Agreement Date, the Company and its Subsidiaries are not, nor have been, to the knowledge of
the Company, under administrative, civil, or criminal investigation, indictment, information, suspension, debarment, or audit (other than a routine contract audit) by any party, in connection with alleged or possible violations of any Law that
prohibits bribery, corruption, fraud, or other improper payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.22 <U>Trade Control Laws</U>. Since April&nbsp;24, 2019,
the Company and its Subsidiaries have been in material compliance with all applicable import, export control, and economic and trade sanctions laws, regulations, statutes, and orders, including the Export Administration Regulations, the
International Traffic in Arms Regulations, and the regulations administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (the &#8220;<B><I>Trade Laws</I></B>&#8221;) and have obtained, or are otherwise qualified to
rely upon, all material import and export licenses, consents, notices, waivers, approvals, orders, authorizations, registrations, declarations or other authorizations from, and made any filings with, any Governmental Entity required for (a)&nbsp;the
import, export, and reexport of products, services, software and technologies and (b)&nbsp;releases of technologies and software to foreign nationals (the &#8220;<B><I>Trade Approvals</I></B>&#8221;). There are no pending or threatened claims
against the Company or its Subsidiaries, nor any actions, conditions, facts, or circumstances that would reasonably be expected to give rise to any material future claims with respect to the Trade Laws or Trade Approvals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.23 <U>Information Supplied</U>. None of the information supplied or to be supplied by or on behalf of the Company for inclusion
or incorporation by reference in the Offer Documents or the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> will, at the time such document is filed with the SEC, at any time it is amended or supplemented or at the time it is first published,
sent or disseminated to the Company Stockholders, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they are made, not misleading;
<U>provided</U> that the Company makes no representation or warranty with respect to information furnished in writing by or on behalf of Parent or Merger Sub specifically for inclusion or incorporation by reference in any such document. The Schedule
<FONT STYLE="white-space:nowrap">14D-9</FONT> will comply as to form in all material respects with the requirements of the Exchange Act, except that no representation or warranty is made by the Company with respect to statements included or
incorporated by reference therein based on information supplied by or on behalf of Parent or Merger Sub for inclusion or incorporation by reference therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.24 <U>No Rights Agreement; Anti-Takeover Provisions</U>. As of the Agreement
Date, the Company is not party to a stockholder rights agreement, &#8220;poison pill&#8221; or similar anti-takeover agreement or plan. The Company Board has taken all action necessary to render Section&nbsp;203 of the DGCL and any other takeover, <FONT
STYLE="white-space:nowrap">anti-takeover,</FONT> moratorium, &#8220;fair price,&#8221; &#8220;control share,&#8221; or similar Law inapplicable to the Offer and the Merger. Assuming the accuracy of the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;5.08</U>, no restrictions of any other &#8220;business combination,&#8221; &#8220;control share acquisition,&#8221; &#8220;fair price,&#8221; &#8220;moratorium&#8221; or other anti-takeover Laws (each, a
&#8220;<B><I>Takeover Law</I></B>&#8221;) apply or will apply to the Company pursuant to this Agreement or the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.25 <U>Opinion of Financial Advisor</U>. The Company Board has received the opinion of Leerink Partners LLC, independent
financial advisor to the Company Board, dated the date hereof, to the effect that, based upon and subject to the various assumptions, qualifications and limitations set forth therein, as of such date, the Cash Amount proposed to be paid to the
holders of shares of Company Common Stock (other than (a)&nbsp;(i) shares of Company Common Stock owned by the Company immediately prior to the Effective Time, (ii)&nbsp;shares of Company Common Stock owned by Parent, Merger Sub or any other
Subsidiary of Parent at the commencement of the Offer which are owned by Parent, Merger Sub or any other Subsidiary of Parent immediately prior to the Effective Time and (iii)&nbsp;solely with respect to the Merger, shares of Company Common Stock
irrevocably accepted for purchase in the Offer, each of which shall automatically be canceled and shall cease to exist, and (b)&nbsp;Appraisal Shares) pursuant to the terms of this Agreement is fair, from a financial point of view, to such holders.
It is agreed and understood that such opinion is for the benefit of the Company Board and may not be relied upon by Parent or Merger Sub. The Company will make available to Parent and Merger Sub a signed copy of such opinion as soon as possible
following the Agreement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.26 <U>No Other Representations or Warranties</U>. The Company hereby acknowledges and agrees
that, except for the representations and warranties contained in this Agreement, neither the Company nor any of its Subsidiaries nor any other person on behalf of the Company or its Subsidiaries makes any express or implied representation or
warranty with respect to the Company or its Subsidiaries or with respect to any other information provided to Parent, its stockholders or any of its Affiliates in connection with the Transactions, and (subject to the express representations and
warranties of the Company set forth in <U>Article IV</U> (in each case as qualified and limited by the Company Disclosure Letter)) none of Parent, its Representatives, stockholders or members, has relied on any such information (including the
accuracy or completeness thereof). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except set forth in the letter, dated as of the Agreement Date, from the Parent and Merger Sub to the Company (which shall be arranged in
numbered and lettered sections corresponding to the numbered and lettered sections contained in this <U>Article V</U>, and the disclosure in any section shall be deemed to qualify or apply to other sections in this <U>Article V</U> to the extent
that it is reasonably apparent on its face that such disclosure also qualifies or applies to such other sections) (the &#8220;<B><I>Parent Disclosure Letter</I></B>&#8221;), Parent and Merger Sub, jointly and severally, represent and warrant to the
Company that: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.01 <U>Organization, Standing and Power</U>. Each of Parent and Merger Sub is
duly organized, validly existing and in good standing under the Laws of the jurisdiction in which it is organized (in the case of good standing, to the extent the concept is recognized by such jurisdiction) and has full corporate power and authority
to conduct its businesses as presently conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.02 <U>Merger Sub</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Merger Sub was formed solely for the purpose of entering into the Transactions, and since the date of its incorporation, Merger Sub has not
carried on any business, conducted any operations or incurred any liabilities or obligations other than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The authorized capital stock of Merger Sub consists of 100 shares of common stock, par value $0.01 per share, all of which have been
validly issued, are fully paid and nonassessable and are owned directly or indirectly by Parent free and clear of any Liens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.03 <U>Authority; Execution and Delivery; Enforceability</U>. Each of Parent and Merger Sub has all requisite corporate power
and authority to execute and deliver this Agreement and the CVR Agreement and to consummate the Transactions, subject, in the case of the Merger, to the adoption of this Agreement by Parent, as sole stockholder of Merger Sub (which shall occur
immediately following the execution of this Agreement). The execution and delivery by each of Parent and Merger Sub of this Agreement and the consummation by it of the Transactions have been duly authorized by all necessary corporate action on the
part of Parent and Merger Sub, subject, in the case of the Merger, to the adoption of this Agreement by Parent, as sole stockholder of Merger Sub (which shall occur immediately following the execution of this Agreement). Neither the approval and
adoption of this Agreement nor the consummation of the Offer, the Merger or the other Transactions requires any approval of the stockholders of Parent. Each of Parent and Merger Sub has duly executed and delivered this Agreement, and, assuming due
authorization, execution and delivery by the Company, this Agreement constitutes its, and at the Offer Closing Time the CVR Agreement will constitute Parent&#8217;s, legal, valid and binding obligation, enforceable against it in accordance with its
terms (subject to the Enforceability Exceptions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.04 <U>No Conflicts; Consents</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The execution and delivery by each of Parent and Merger Sub of this Agreement and the CVR Agreement do not, and the consummation of the
Offer, the Merger and the other Transactions and compliance with the terms hereof will not, conflict with, or result in any violation of, or default (with or without notice or lapse of time, or both) under, any provision of (i)&nbsp;the
organizational documents of Parent, Merger Sub or any of Parent&#8217;s Subsidiaries, (ii)&nbsp;any Contract to which Parent or any of its Subsidiaries is party or by which any of their respective properties or assets is bound or (iii)&nbsp;subject
to the filings and other matters referred to in <U>Section</U><U></U><U>&nbsp;5.04(b)</U>, any Judgment or Law applicable to Parent or any of its Subsidiaries or their respective properties or assets, other than, in the case of clauses (ii)&nbsp;and
(iii), any such items that would not reasonably be expected to, individually or in the aggregate, have a Parent Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No Consent of, or registration, declaration or filing with, or permit from, any
Governmental Entity is required to be obtained or made by or with respect to Parent or any of its Subsidiaries in connection with the execution, delivery and performance of this Agreement or the CVR Agreement or the consummation of the Transactions,
other than (i)&nbsp;the filing with the SEC of (A)&nbsp;the Offer Documents and (B)&nbsp;such reports under the Exchange Act, as may be required in connection with this Agreement, the CVR Agreement, the Offer, the Merger and the other Transactions,
(ii)&nbsp;the filing of the Certificate of Merger with the secretary of the State of Delaware, (iii)&nbsp;compliance with the rules and regulations of any national security exchange on which securities of Parent or the Company are listed and
(iv)&nbsp;such other items that the failure of which to obtain or make would not reasonably be expected to, individually or in the aggregate, have a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.05 <U>Information Supplied</U>. None of the information supplied or to be supplied by or on behalf of Parent or Merger Sub for
inclusion or incorporation by reference in the Offer Documents or the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> will, at the time such document is filed with the SEC, at any time it is amended or supplemented or at the time it is first
published, sent or given to the Company Stockholders, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they are made, not
misleading. The Offer Documents will comply as to form in all material respects with the requirements of the Exchange Act and the rules and regulations thereunder, except that no representation or warranty is made by Parent or Merger Sub with
respect to statements included or incorporated by reference therein based on information supplied by or on behalf of the Company for inclusion or incorporation by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.06 <U>Brokers</U>. No broker, investment banker, financial advisor or other Person is entitled to any broker&#8217;s,
finder&#8217;s, financial advisor&#8217;s or other similar fee or commission in connection with the Offer, the Merger and the other Transactions based upon arrangements made by or on behalf of Parent or any of its Affiliates, directors, officers or
employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.07 <U>Litigation</U>. There is no Proceeding pending or, to the knowledge of Parent, threatened against Parent
or any Subsidiary of Parent that would reasonably be expected to, individually or in the aggregate, have a Parent Material Adverse Effect, nor is there any Judgment outstanding against Parent or any Subsidiary of Parent that would reasonably be
expected to, individually or in the aggregate, have a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.08 <U>Ownership of the Company
Common Stock</U>. Neither Parent nor Merger Sub is, nor at any time for the past three years has been, an &#8220;interested stockholder&#8221; of the Company as defined in Section&nbsp;203 of the DGCL. As of the date hereof, Parent or a Subsidiary
of Parent beneficially own no shares of the Company Common Stock and none of Parent or any Subsidiary of Parent (i)&nbsp;owns (as such term is defined in Section&nbsp;203 of the DGCL), directly or indirectly, any other shares of the Company Common
Stock or other securities convertible into, exchangeable for, or exercisable for shares of the Company Common Stock or any securities of any Subsidiary of the Company or (ii)&nbsp;has any rights to acquire any shares of the Company Common Stock
except pursuant to this Agreement. Parent and each of its Subsidiaries are affiliates of Merger Sub as such term is defined in section 251(h) of the DGCL. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.09 <U>Sufficient Funds</U>. Parent has (or has available to it), and will
have as of the Offer Closing Time and Effective Time sufficient cash available to pay all amounts to be paid by Parent and Merger Sub in connection with this agreement and the Merger Transactions, including Parent&#8217;s and Merger Sub&#8217;s
costs and expenses and the aggregate Offer Price, Merger Consideration and Cash Amount on the terms and conditions contained in this agreement, and there is not, nor will there be, any restriction on the use of such cash or cash equivalents for such
purpose. In no event shall the receipt or availability of any funds or financing by or to Parent, Merger Sub or any of their respective Affiliates or any other financing transaction be a condition to any of the obligations of Parent or Merger Sub
hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.10 <U>Competing Businesses</U>. None of Parent or any of its Affiliates owns any controlling interest in any
person that is developing products in the same markets in which Parent or Merger Sub operate that would reasonably be expected to have an adverse effect on the ability of Parent to consummate the Merger and the Transactions in a timely manner in
accordance with the terms hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.11 <U>No Foreign Person</U>. Neither Parent nor Merger Sub is a foreign person, as
defined in 31 C.F.R. &#167; 800.224. Each of Buyer and Merger Sub further represent that the transaction contemplated by this Agreement will not result in foreign control (as defined in 31&nbsp;.F.R. &#167; 800.208) of the Company, and does not
constitute direct or indirect investment in the Company by any foreign person that affords the foreign person with any of the access, rights, or involvement contemplated under 31 C.F.R. &#167; 800.211(b). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS
RELATING TO CONDUCT OF BUSINESS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.01 <U>Conduct of Business of the Company</U>. From the Agreement Date to the earlier
of the Offer Closing Time and the termination of this Agreement in accordance with its terms (the &#8220;<B><I><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period</I></B>&#8221;), except as consented to in writing in advance by Parent (which
consent shall not be unreasonably withheld, delayed or conditioned) or as otherwise specifically required by this Agreement, the Company shall use commercially reasonable efforts to carry on its business in the ordinary course of business. In
addition, except as set forth in <U>Section</U><U></U><U>&nbsp;6.01</U> of the Company Disclosure Letter or otherwise expressly and specifically permitted or required by this Agreement or required by applicable Law, during the <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Period, neither the Company nor its Subsidiaries shall do any of the following without the prior written consent of Parent (which consent shall not be unreasonably withheld, delayed or conditioned): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;(i) enter into any new line of business or enter into any agreement, arrangement or commitment that is in excess of $50,000 or
materially limits or otherwise restricts the Company or its affiliates, including, following the Merger Closing, Parent and its affiliates (other than in the case of Parent and its affiliates, due to the operation of Parent&#8217;s or its
affiliates&#8217; own Contracts), from time to time engaging or competing in any line of business or in any geographic area or (ii)&nbsp;otherwise enter into any agreements, arrangements or commitments in excess of $50,000 or imposing material
restrictions on its assets, operations or business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;(i) declare, set aside, establish a record date in respect of, accrue or pay any
dividends on, or make any other distributions (whether in cash, stock, equity securities or property) in respect of, any of its capital stock, (ii)&nbsp;split, combine or reclassify any of its capital stock or issue or authorize the issuance of any
other securities in respect of, in lieu of or in substitution for shares of its capital stock or (iii)&nbsp;repurchase, redeem, offer to redeem or otherwise acquire, directly or indirectly any shares of capital stock of the Company or options,
warrants, convertible or exchangeable securities, stock-based performance units or other rights to acquire any such shares of capital stock, except for (A)&nbsp;acquisitions of shares of the Company Common Stock in connection with the withholding or
surrender of shares of the Company Common Stock by holders of Company Equity Awards outstanding on the Agreement Date in order to pay the exercise price of Company Options or to satisfy Tax obligations with respect to awards granted pursuant to the
Company Stock Plans outstanding on the Agreement Date, and (B)&nbsp;the acquisition by the Company of Company Equity Awards in connection with the forfeiture of such awards, in each case, in accordance with their terms; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) issue, grant, deliver, sell, authorize, pledge or otherwise encumber any shares of its capital stock or options, warrants, convertible or
exchangeable securities, <FONT STYLE="white-space:nowrap">stock-based</FONT> performance units or other rights to acquire such shares or any other rights that give any person the right to receive any economic interest of any nature accruing to the
holders of the Company Common Stock, other than issuances of the Company Common Stock upon the vesting and settlement of the Company Restricted Stock Unit Awards, issuances of the Company Common Stock upon the exercise of Company Options in
accordance with their terms, issuances of the Company Common Stock pursuant to the Company ESPP in accordance with its terms or the withholding of shares of Company Common Stock upon the vesting and settlement of Company Restricted Stock Unit Awards
to satisfy Tax withholding obligations thereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) amend its Organizational Documents (except for immaterial or ministerial
amendments); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) form any Subsidiary or acquire or agree to acquire, directly or indirectly, in a single transaction or a series of
related transactions, whether by merging or consolidating with, or by purchasing a substantial equity interest in or a substantial portion of the assets of, or by any other manner, any assets outside of the ordinary course of business, any business
or any corporation, partnership, limited liability company, joint venture, association or other business organization or division thereof or any other Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) except as provided pursuant to the terms of any Company Employee Plan as in effect on the Agreement Date or pursuant to applicable Law,
(i)&nbsp;adopt, enter into, establish, amend or modify any collective bargaining agreement, Company Employee Plan (or plan or arrangement that would be a Company Employee Plan if in effect on the Agreement Date), (ii) grant to any director, employee
or individual service provider of the Company any increase in base compensation, (iii)&nbsp;grant to any director, employee or individual service provider of the Company any increase in severance or termination pay, (iv)&nbsp;pay or award, or commit
to pay or award, any bonuses or incentive or equity compensation, (v)&nbsp;enter into any employment, retention, consulting, change in control, severance or termination agreement with any director, employee or individual service provider of the
Company, (vi)&nbsp;take any action to vest or accelerate any rights or benefits under any Company Employee Plan, or the funding of any payments or benefits under any Company Employee Plan or (vii)&nbsp;hire any employee or individual service
provider; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) make any change in accounting methods, principles or practices, except as may be
required (i)&nbsp;by GAAP (or any authoritative interpretation thereof), including pursuant to standards, guidelines and interpretations of the Financial Accounting Standards Board or any similar organization or (ii)&nbsp;by Law, including
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated under the Securities Act, in each case, as agreed to by the Company&#8217;s independent public accountants; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) sell, lease (as lessor), license or otherwise transfer (including through any
<FONT STYLE="white-space:nowrap">&#8220;spin-off&#8221;),</FONT> or pledge, encumber or otherwise subject to any Lien (other than a Permitted Lien), any properties or assets (other than Intellectual Property Rights) except (i)&nbsp;sales or other
dispositions of inventory and excess or obsolete properties or assets in the ordinary course of business or (ii)&nbsp;pursuant to Contracts to which the Company is a party made available to Parent and in effect prior to the Agreement Date or
(iii)&nbsp;in accordance with the Wind-Down Process; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) sell, assign, lease, license, transfer, pledge, encumber (other than Permitted
Liens) or otherwise dispose of, permit to lapse or abandon any material Company Intellectual Property Rights that are owned by the Company, other than as required by applicable Law or in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;(i) incur or modify the terms of (including by extending the maturity date thereof) any indebtedness for borrowed money or guarantee
any such indebtedness of another Person, issue or sell any debt securities or warrants or other rights to acquire any debt securities of the Company, guarantee any debt securities of another Person, enter into any &#8220;keep well&#8221; or other
agreement to maintain any financial statement condition of another Person or enter into any arrangement having the economic effect of any of the foregoing or (ii)&nbsp;make any loans, advances or capital contributions to, or investments in, any
other Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) make or agree to make any capital expenditures; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) commence any Proceeding or pay, discharge, settle, compromise or satisfy (i)&nbsp;any pending or threatened claims, liabilities or
obligations relating to a Proceeding (absolute, accrued, asserted or unasserted, contingent or otherwise), other than any such payment, discharge, settlement, compromise or satisfaction of a claim solely for money damages in the ordinary course of
business in an amount not to exceed $100,000 per payment, discharge, settlement, compromise or satisfaction or $100,000 in the aggregate for all such payments, discharges, settlements, compromises or satisfactions, provided such amounts are taken
into account in the calculation of Closing Net Cash or (ii)&nbsp;any litigation, arbitration, proceeding or dispute that relates to the Transactions (which shall be governed exclusively by <U>Section</U><U></U><U>&nbsp;7.07</U> hereof); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) make, change or revoke any material Tax election, make or change any annual Tax accounting period or any method of Tax accounting, file any
amended material Tax Return, fail to timely file any material Tax Return required to be filed by it (taking into account extensions obtained in the ordinary course of business) or fail to pay any Tax that is due and payable (taking into account any
applicable extension), enter into any closing agreement within the meaning of Section&nbsp;7121 of the Code (or any similar provision of state, local or foreign Law), settle or compromise any material Tax claim, incur any material liability for
Taxes outside the ordinary course of business, file any Tax Return other than on a basis consistent with past practice, or consent to any extension or waiver of any limitation period with respect to any claim or assessment for Taxes (excluding
extensions of time to file Tax Returns obtained in the ordinary course of business), grant any power of attorney with respect to Taxes, or enter into any Tax Sharing Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) amend, cancel or terminate any insurance policy naming the Company or its Subsidiaries
as an insured, a beneficiary or a loss payable payee without obtaining comparable substitute insurance coverage; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) adopt a plan or
agreement of complete or partial liquidation or dissolution, merger, consolidation, restructuring, recapitalization or other reorganization (other than the Merger); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) except in the ordinary course of business or in connection with any transaction to the extent specifically permitted by any other subclause
of this <U>Section</U><U></U><U>&nbsp;6.01</U>, enter into, terminate or materially modify in any respect, or expressly release any material rights under, any Material Contract or any Contract that, if existing on the Agreement Date, would have been
a Material Contract; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) renew or enter into any agreement containing a <FONT STYLE="white-space:nowrap">non-compete,</FONT> exclusivity, <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> or similar clause that would restrict or limit, in any material respect, the operations of the Company or any of its Subsidiaries; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) authorize, commit or agree to take any of the foregoing actions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.02 <U>No Solicitation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall not, and the Company shall instruct its Representatives not to, (i)&nbsp;directly or indirectly solicit, initiate or
knowingly encourage or knowingly facilitate any inquiries, proposals or offers that constitute or would reasonably be expected to lead to a Company Takeover Proposal or (ii)&nbsp;directly or indirectly engage in, enter into or participate in any
discussions or negotiations with any Person (other than Parent, Merger Sub or any designees or Representatives of Parent or Merger Sub) regarding, furnish to any Person (other than Parent, Merger Sub or any designees or Representatives of Parent or
Merger Sub) any material <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or afford access to the business, properties, assets, books or records of the Company to, or take any other action to knowingly facilitate
or knowingly encourage any effort by any Person (other than Parent, Merger Sub or any designees or Representatives of Parent or Merger Sub), in each case, in connection with or in response to any inquiry, offer or proposal that constitutes, or would
reasonably be expected to lead to, any Company Takeover Proposal (other than, solely in response to an inquiry that did not result from a material breach of this <U>Section</U><U></U><U>&nbsp;6.02(a)</U>, to refer the inquiring person to this
<U>Section</U><U></U><U>&nbsp;6.02</U> and to limit its communication exclusively to such referral or to clarify the terms thereof in writing). The Company shall, and shall cause its directors and officers to, and shall use its reasonable best
efforts to cause its Representatives to, immediately (i)&nbsp;cease all solicitations, discussions and negotiations regarding any inquiry, proposal or offer pending on the Agreement Date that constitutes, or would reasonably be expected to lead to,
a Company Takeover Proposal, (ii)&nbsp;request the prompt return or destruction of all confidential information previously furnished to any Person (other than Parent, Merger Sub or any designees or Representatives of Parent or Merger Sub) within the
last six </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
months for the purposes of evaluating a possible Company Takeover Proposal and (iii)&nbsp;terminate access to any physical or electronic data rooms relating to a possible Company Takeover
Proposal. Notwithstanding anything to the contrary contained in the foregoing or any other provision of this Agreement, at any time during the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, in response to a Company Takeover Proposal
made after the Agreement Date that did not result from a material breach of this <U>Section</U><U></U><U>&nbsp;6.02(a)</U>, in the event that the Company Board determines, in good faith, after consultation with outside counsel and an independent
financial advisor, that such Company Takeover Proposal constitutes or could reasonably be expected to lead to a Superior Company Proposal (a &#8220;<B><I>Qualifying Company Takeover Proposal</I></B>&#8221;), the Company may (A)&nbsp;enter into an
Acceptable Confidentiality Agreement with any Person or group of Persons making such Qualifying Company Takeover Proposal, (B)&nbsp;furnish information with respect to the Company to the Person or group of Persons making such Qualifying Company
Takeover Proposal and its or their Representatives pursuant to an Acceptable Confidentiality Agreement so long as the Company concurrently or promptly thereafter (in any event within one (1)&nbsp;Business Day) provides Parent, in accordance with the
terms of the Confidentiality Agreement, any material <FONT STYLE="white-space:nowrap">non-public</FONT> information with respect to the Company furnished to such other Person or group of Persons that was not previously furnished to Parent and
(C)&nbsp;participate in discussions or negotiations with such Person or group of Persons and its or their Representatives regarding such Qualifying Company Takeover Proposal (including soliciting the making of a revised Qualifying Company Takeover
Proposal); <U>provided</U> that the Company may only take the actions described in clauses (A), (B) or (C)&nbsp;above if the Company Board determines, in good faith, after consultation with outside counsel, that the failure to take any such action
would reasonably be likely to be inconsistent with its fiduciary duties under applicable Law. Wherever the term &#8220;<B><I>group</I></B>&#8221; is used in this <U>Section</U><U></U><U>&nbsp;6.02(a)</U>, it is used as defined in Rule <FONT
STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company Board nor any committee thereof shall (i)&nbsp;(A)
withdraw, qualify or modify in a manner adverse to Parent or Merger Sub, or publicly withdraw, qualify or modify in a manner adverse to Parent or Merger Sub, the Company Board Recommendation or resolve or agree to take any such action,
(B)&nbsp;publicly adopt, endorse, approve or recommend, or propose publicly to adopt, endorse, approve or recommend, any Company Takeover Proposal, (C)&nbsp;if any Company Takeover Proposal is structured as a tender offer or exchange offer (other
than by Parent or an Affiliate of Parent), fail to recommend, within five (5)&nbsp;business days (as defined in Rule <FONT STYLE="white-space:nowrap">14d-1(f)</FONT> promulgated under the Exchange Act) after such commencement, against acceptance by
the Company Stockholders of such tender offer or exchange offer or (D)&nbsp;fail to include the Company Board Recommendation in the Schedule <FONT STYLE="white-space:nowrap">14D-9</FONT> when disseminated to the Company Stockholders (any action
described in this clause (i)&nbsp;being referred to in this Agreement as an &#8220;<B><I>Adverse Recommendation Change</I></B>&#8221;) or (ii)&nbsp;enter into any letter of intent, memorandum of understanding, acquisition agreement, merger
agreement, or other agreement relating to or that would reasonably be expected to lead to, any Company Takeover Proposal (other than an Acceptable Confidentiality Agreement entered into in accordance with <U>Section</U><U></U><U>&nbsp;6.02(a)</U>),
or resolve, agree or publicly propose to take any such action. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to contrary in the foregoing or any other
provision of this Agreement, the Company Board may, in response to a Company Takeover Proposal that did not result from a material breach of this <U>Section</U><U></U><U>&nbsp;6.02</U> effect an Adverse Recommendation Change if (1)&nbsp;the Company
Board determines in good faith, after consultation with outside counsel, such Company Takeover Proposal constitutes a Superior Company Proposal, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(2) the Company Board shall have given Parent at least four (4)&nbsp;Business Days&#8217; prior written notice (a &#8220;<B><I>Company Notice</I></B>&#8221;) of its intention to take such action
and a description of the reasons for taking such action (which, subject to any restrictions pursuant to any confidentiality agreement in effect, shall specify the identity of the Person who made such Superior Company Proposal and the material terms
and conditions of such Superior Company Proposal and attach the most current version of the relevant transaction agreement), (3) the Company shall have negotiated, and shall have used its reasonable best efforts to cause its Representatives to
negotiate, in good faith, with Parent during such notice period, to the extent Parent wishes to negotiate, to enable Parent to revise the terms of this Agreement in response to such Company Takeover Proposal, (4)&nbsp;following the end of such
notice period, the Company Board shall have considered in good faith any revisions to this Agreement irrevocably committed to in writing by Parent, and shall have determined in good faith, after consultation with outside counsel, that failure to
effect such Adverse Recommendation Change would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law. In the event of any material change to any of the financial terms (including the form and amount of
consideration) of such Company Takeover Proposal, the Company shall deliver to Parent an additional Company Notice consistent with that described in clause (2)&nbsp;of this proviso and a renewed notice period under clause (2)&nbsp;of this proviso
shall commence (except that the four (4)-Business Day notice period referred to in clause (2)&nbsp;of this proviso shall instead be equal to two (2)&nbsp;Business Days) during which time the Company shall be required to comply with the requirements
of this <U>Section</U><U></U><U>&nbsp;6.02(c)</U> anew with respect to such additional Company Notice, including clauses (1)&nbsp;through (4) of this proviso. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to contrary in the foregoing or any other provision of this Agreement, the Company Board may, in response to an
Intervening Event, effect an Adverse Recommendation Change if (1)&nbsp;the Company Board determines in good faith, after consultation with outside counsel, that the failure to make an Adverse Recommendation Change in response to such Intervening
Event would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law, (2)&nbsp;the Company Board shall have given Parent at least four (4)&nbsp;Business Days&#8217; prior written notice through a Company Notice of its
intention to take such action and a description of the reasons for taking such action (which shall include a reasonably detailed description of the underlying facts giving rise to such action), (3) the Company shall have negotiated, and shall have
used its reasonable best efforts to cause its Representatives to negotiate, in good faith, with Parent during such notice period, to the extent Parent wishes to negotiate, to enable Parent to revise the terms of this Agreement in response to such
Intervening Event, (4)&nbsp;following the end of such notice period, the Company Board shall have considered in good faith any revisions to this Agreement irrevocably committed to in writing by Parent, and shall have determined in good faith, after
consultation with outside counsel, that failure to effect such Adverse Recommendation Change in response to such Intervening Event would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law. In the event of any
material change in any event, occurrence or facts relating to such Intervening Event, the Company shall deliver to Parent an additional Company Notice consistent with that described in clause (2)&nbsp;of this proviso and a renewed notice period
under clause (2)&nbsp;of this proviso shall commence (except that the four (4)-Business Day notice period referred to in clause (2)&nbsp;of this proviso shall instead be equal to two (2)&nbsp;Business Days) during which time the Company shall be
required to comply with the requirements of this <U>Section</U><U></U><U>&nbsp;6.02(d)</U> anew with respect to such additional Company Notice, including clauses (1)&nbsp;through (4) of this proviso. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Nothing contained in this <U>Section</U><U></U><U>&nbsp;6.02</U> or elsewhere in this
Agreement shall prohibit the Company from (i)&nbsp;taking and disclosing to its stockholders a position contemplated by Rule <FONT STYLE="white-space:nowrap">14d-9</FONT> or Rule <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> promulgated under the
Exchange Act (or any similar communication to stockholders), including making any &#8220;stop, look and listen&#8221; communication to the stockholders of the Company or (ii)&nbsp;making any disclosure to its stockholders if the Company Board
determines, in good faith, after consultation with outside counsel, that the failure to take such action would be reasonably expected to be inconsistent with its fiduciary duties or applicable Law; <U>provided</U> that any such action that would
otherwise constitute an Adverse Recommendation Change shall be made only in compliance with <U>Section</U><U></U><U>&nbsp;6.02(a)</U>, <U>Section</U><U></U><U>&nbsp;6.02(b)</U>, <U>Section</U><U></U><U>&nbsp;6.02(c)</U> and
<U>Section</U><U></U><U>&nbsp;6.02(d)</U> (it being understood that: (A)&nbsp;any &#8220;stop, look and listen&#8221; letter or similar communication limited to the information described in Rule <FONT STYLE="white-space:nowrap">14d-9(f)</FONT> under
the Exchange Act and (B)&nbsp;any disclosure of information to the Company Stockholders that describes the Company&#8217;s receipt of a Company Takeover Proposal and the operation of this Agreement with respect thereto and contains a statement that
the Company Board, as applicable, has not effected an Adverse Recommendation Change shall be deemed to not be an Adverse Recommendation Change). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except to the extent the Company is prohibited from giving Parent such notice by any confidentiality agreement in effect as of the date
hereof, in addition to the requirements set forth in <U>Section</U><U></U><U>&nbsp;6.02(b)</U>, <U>Section</U><U></U><U>&nbsp;6.02(c)</U> and <U>Section</U><U></U><U>&nbsp;6.02(d)</U>, the Company shall, as promptly as reasonably practicable and in
any event within one (1)&nbsp;Business Day after receipt thereof, advise Parent in writing of (i)&nbsp;any Company Takeover Proposal or any inquiry, proposal or offer that the Company Board in good faith believes could reasonably be expected to lead
to a Company Takeover Proposal and (ii)&nbsp;the material terms and conditions of such Company Takeover Proposal or inquiry, proposal or offer (including, if applicable, copies of any written requests, proposals or offers, including proposed term
sheets and agreements relating thereto, and any subsequent material amendments or modifications thereto) and the identity of the Person making any such Company Takeover Proposal or inquiry, proposal or offer. Commencing upon the provision of any
notice referred to in the previous sentence, the Company and its Representatives shall keep Parent informed on a reasonably prompt basis as to any material developments with respect to any such Company Takeover Proposal or inquiry, proposal or offer
(and any subsequent material amendments or modifications thereto), and shall provide Parent with a copy of any material written correspondence, documents or agreements delivered to or by the Company or its Representatives that contain any material
amendments thereto or any material change to the scope or material terms or conditions thereof (or, if not delivered in writing, a summary of any such material amendments or material changes). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL
AGREEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.01 <U>Access to Information; Confidentiality</U>. During the
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, except if prohibited by any applicable Law, the Company shall afford to Parent and to Parent&#8217;s Representatives, reasonable access during normal business hours (under the supervision
of appropriate personnel and in a manner that does not unreasonably interfere with the normal operation of the business of the Company)to its properties, books and records, Contracts and personnel, and, during such period, the Company shall use
reasonable best efforts to furnish, as promptly as reasonably practicable, to Parent such information concerning its business, properties and personnel as Parent or Parent&#8217;s Representatives may reasonably request for the purpose of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transition planning and not for the purpose of any adverse action or dispute between the parties or their Affiliates; <U>provided</U> that any such access shall be afforded and any such
information shall be furnished at Parent&#8217;s expense. Notwithstanding the immediately preceding sentence, the Company shall not be required to afford access or furnish information to the extent (i)&nbsp;such information is subject to the terms
of a confidentiality agreement with a third party entered into prior to the Agreement Date or granting such access would violate any obligations of the Company with respect to confidentiality to any third party or otherwise breach, contravene or
violate, constitute a default under, or give a third party the right to terminate or accelerate an obligation under, any then effective Contract to which the Company is a party, (ii)&nbsp;such information relates to the applicable portions of the
minutes of the meetings of the Company Board where the Company Board discussed (or is information otherwise related to)&nbsp;(A) the Transactions or any similar transaction involving the sale of the Company, or a material portion of its assets, to,
the license of a material portion of the Company&#8217;s assets to, or combination of the Company with, any other Person, (B)&nbsp;any Company Takeover Proposal or (C)&nbsp;any Intervening Event, or (iii)&nbsp;the Company determines in good faith
after consulting with counsel that affording such access or furnishing such information would reasonably be expected to jeopardize or result in a waiver of any attorney-client privilege, work product doctrine or other applicable privilege applicable
to such information, violate applicable Law or result in antitrust risk for the Company; <U>provided</U> that the Company will use its reasonable efforts to communicate the applicable information to Parent in a way that would not violate any
applicable Law, Contract or obligation or waive such a privilege. Nothing in this <U>Section</U><U></U><U>&nbsp;7.01</U> or elsewhere in this Agreement shall be construed to require the Company or any Representatives of any of the foregoing to
prepare any reports, analyses, appraisals, opinions or other information. All information exchanged or accessed pursuant to this <U>Section</U><U></U><U>&nbsp;7.01</U> shall be subject to the confidentiality letter agreement dated November&nbsp;11,
2023 between the Company and Parent, as amended (the &#8220;<B><I>Confidentiality Agreement</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.02
<U>Reasonable Best Efforts; Notification; Regulatory Filings</U>. Upon the terms and subject to the conditions set forth in this Agreement, each of the parties hereto shall, and shall cause their respective Subsidiaries to, use its reasonable best
efforts to promptly take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other parties hereto in doing, all things necessary, proper or advisable to consummate and make effective, as promptly
as reasonably practicable and in any event prior to the Outside Date, the Offer, the Merger and the other Transactions, including (i)&nbsp;causing each of the Offer Conditions and each of the conditions to the Merger set forth in <U>Article VIII</U>
to be satisfied, in each case as promptly as reasonably practicable after the Agreement Date, (ii)&nbsp;the obtaining of all necessary or advisable actions or <FONT STYLE="white-space:nowrap">non-actions,</FONT> waivers and consents from, the making
of all necessary registrations, declarations and filings with, and the taking of all reasonable steps as may be necessary to avoid a Proceeding by, any Governmental Entity with respect to this Agreement or the Transactions, (iii)&nbsp;the defending
or contesting of any Proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Transactions, including seeking to have any stay or temporary restraining order entered by any court or other Governmental
Entity vacated or reversed and (iv)&nbsp;the execution and delivery of any additional instruments necessary to consummate the Transactions and to fully carry out the purposes of this Agreement. In addition and without limiting the foregoing, the
Company, the Company Board shall (A)&nbsp;take all action necessary to ensure that no restrictions on business combinations of any Takeover Law or similar statute or regulation is or becomes applicable to any Transaction or this Agreement and
(B)&nbsp;if the restrictions on business combinations of any Takeover Law or similar statute or regulation becomes applicable to any Transaction or this Agreement, use its reasonable best efforts to take all action necessary to ensure that the
Transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise to minimize the effect of such statute or regulation on the Transactions and this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.03 <U>Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All rights to indemnification and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time (and
rights to advancement of expenses) now existing in favor of any Person who is or prior to the Effective Time becomes, or has been at any time prior to the Agreement Date, a director, officer, employee or agent (including as a fiduciary with respect
to an employee benefit plan) of the Company or its predecessors (each, an &#8220;<B><I>Indemnified Party</I></B>&#8221;) as provided in the Company Charter, the Company Bylaws or any indemnification agreement between such Indemnified Party and the
Company that is in effect as of the Agreement Date and that has been made available to Parent (i)&nbsp;shall be assumed by the Surviving Corporation and Parent, without further action, at the Effective Time, (ii)&nbsp;shall survive the Merger,
(iii)&nbsp;shall continue in full force and effect in accordance with their terms with respect to any claims against any such Indemnified Party arising out of such acts or omissions and (iv)&nbsp;for a period of six years following the Agreement
Date, shall not be amended, repealed or otherwise modified in any manner that would adversely affect any right thereunder of any such Indemnified Party, and Parent and the Surviving Corporation shall be bound thereby to the fullest extent available
under the DGCL or other applicable Law for a period of six years from the Effective Time, and any claim made pursuant to such rights within such <FONT STYLE="white-space:nowrap">six-year</FONT> period shall continue to be subject to this
<U>Section</U><U></U><U>&nbsp;7.03(a)</U> and the rights provided under this <U>Section</U><U></U><U>&nbsp;7.03(a)</U> until full and final disposition of such claim. Parent shall cause the Surviving Corporation to perform its obligations under this
<U>Section</U><U></U><U>&nbsp;7.03(a)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting <U>Section</U><U></U><U>&nbsp;7.03(a)</U> or any rights of any Indemnified
Party pursuant to any indemnification agreement set forth on <U>Section</U><U></U><U>&nbsp;7.03(b)</U> of the Company Disclosure Letter, from and after the Offer Closing Time, in the event of any threatened or actual Proceeding, whether civil,
criminal or administrative, based in whole or in part on, or arising in whole or in part out of, or pertaining to (i)&nbsp;the fact that an Indemnified Party is or was a director, officer, employee or agent (including as a fiduciary with respect to
an employee benefit plan) of the Company, any of its former Subsidiaries or any of their respective predecessors or (ii)&nbsp;this Agreement or any of the Transactions, whether in any case asserted or arising before or after the Effective Time,
Parent shall or shall cause the Surviving Corporation to indemnify and hold harmless, as and to the fullest extent permitted by applicable Law, each such Indemnified Party against any losses, claims, damages, liabilities, costs, expenses (including
reasonable attorney&#8217;s fees and expenses in advance of the final disposition of any Proceeding to each Indemnified Party to the fullest extent permitted by applicable Law upon receipt of any undertaking required by applicable Law), judgments,
fines and amounts paid in settlement of or in connection with any such threatened or actual Proceeding. Parent shall, and shall cause the Surviving Corporation to, cooperate with an Indemnified Party in the defense of any matter for which such
Indemnified Party could seek indemnification hereunder; <U>provided</U>, that Parent and the Surviving Corporation shall be entitled to assume the defense and appoint lead counsel for such defense, except to the extent otherwise provided in an
indemnification agreement set forth in the Company Disclosure Letter. Parent and the Surviving Corporation shall not settle, compromise or consent to the entry of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
judgment in any threatened or actual Proceeding for which indemnification could be sought by an Indemnified Party hereunder, unless such settlement, compromise or consent includes an
unconditional release of such Indemnified Party from all liability arising out of such Proceeding or such Indemnified Party otherwise consents in advance in writing to such settlement, compromise or consent. Parent and the Surviving
Corporation&#8217;s obligations under this <U>Section</U><U></U><U>&nbsp;7.03(b)</U> shall continue in full force and effect for the period beginning upon the Offer Closing Time and ending six years from the Effective Time; <U>provided</U> that all
rights to indemnification in respect of any Proceeding asserted or made within such period shall continue until the final disposition of such Proceeding. Parent shall cause the Surviving Corporation to perform its obligations under this
<U>Section</U><U></U><U>&nbsp;7.03(b)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At or prior to the Effective Time, following good faith consultation with Parent, the
Company shall obtain and fully pay the premium for &#8220;tail&#8221; directors&#8217; and officers&#8217; liability insurance policies in respect of acts or omissions occurring at or prior to the Effective Time (including for acts or omissions
occurring in connection with the approval of this Agreement and the consummation of the Transactions) for the period beginning upon the Offer Closing Time and ending six years from the Effective Time (the &#8220;<B><I>D&amp;O Tail
Policies</I></B>&#8221;), covering each Indemnified Party and containing terms (including with respect to coverage and amounts) and conditions (including with respect to deductibles and exclusions) that are in the aggregate, no less favorable to any
Indemnified Party than those of the Company&#8217;s directors&#8217; and officers&#8217; liability insurance policies in effect on the Agreement Date (the &#8220;<B><I>Existing D&amp;O Policies</I></B>&#8221;); <U>provided</U> that the maximum
aggregate annual premium for such &#8220;tail&#8221; insurance policies shall not exceed 250% of the aggregate annual premium payable by the Company for coverage pursuant to its most recent renewal under the Existing D&amp;O Policies (the
&#8220;<B><I>Maximum Amount</I></B>&#8221;) and the full cost of such &#8220;tail&#8221; insurance policies shall be included as Transaction Expenses. If such &#8220;tail&#8221; insurance policies have been obtained by the Company, Parent shall
cause such &#8220;tail&#8221; insurance policies to be maintained in full force and effect, for their full term, and cause all obligations thereunder to be honored by it and the Surviving Corporation. In the event the Company does not obtain such
&#8220;tail&#8221; insurance policies, then, for the period beginning upon the Offer Closing Time and ending six years from the Effective Time, Parent shall either purchase such &#8220;tail&#8221; insurance policies or Parent shall maintain in
effect the Existing D&amp;O Policies in respect of acts or omissions occurring at or prior to the Effective Time (including for acts or omissions occurring in connection with the approval of this Agreement and the consummation of the Transactions);
<U>provided</U> that neither Parent nor the Surviving Corporation shall be required to pay an aggregate annual premium for such insurance policies in excess of the Maximum Amount; <U>provided</U>, <U>further</U>, that if the annual premium of such
insurance coverage exceeds such Maximum Amount, Parent or the Surviving Corporation shall be obligated to obtain the maximum amount of coverage available for the Maximum Amount, but in such case shall purchase coverage as favorable to the
Indemnified Parties as is available for the Maximum Amount as long as such substitution does not result in gaps or lapses of coverage with respect to matters occurring at or prior to the Effective Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that (i)&nbsp;Parent or the Surviving Corporation (or any of their respective successors or assigns)&nbsp;(A) consolidates
with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger or (B)&nbsp;transfers or conveys all or a substantial portion of its properties or other assets to any Person or
(ii)&nbsp;Parent or any of its successors or assigns dissolves the Surviving Corporation, then, and in each such case, Parent shall cause proper provision to be made so that the applicable successors and assigns or transferees of Parent or the
Surviving Corporation, as applicable, expressly assume the obligations set forth in this <U>Section</U><U></U><U>&nbsp;7.03</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) From and after the Offer Closing Time, the obligations of Parent and the Surviving
Corporation under this <U>Section</U><U></U><U>&nbsp;7.03</U> shall survive the consummation of the Merger and shall not be terminated or modified in such a manner as to adversely affect any Indemnified Party to whom this
<U>Section</U><U></U><U>&nbsp;7.03</U> applies without the written consent of such affected Indemnified Party. The provisions of this <U>Section</U><U></U><U>&nbsp;7.03</U> are, from and after the Offer Closing Time, intended to be for the benefit
of, and shall be enforceable by, each Indemnified Party, their heirs and their representatives, and are in addition to, and not in substitution for, any other rights to which each Indemnified Party is entitled, whether pursuant to Law, Contract or
otherwise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Parent shall pay all reasonable and documented expenses, including reasonable attorneys&#8217; fees, that may be incurred
by any Indemnified Party in successfully enforcing the indemnity and other obligations provided in this <U>Section</U><U></U><U>&nbsp;7.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.04 <U>Fees and Expenses</U>. Except as set forth in <U>Section</U><U></U><U>&nbsp;7.03</U> (<I>Indemnification</I>),
<U>Section</U><U></U><U>&nbsp;7.06</U> (<I>Transfer Taxes</I>) and <U>Section</U><U></U><U>&nbsp;9.03</U> (<I>Termination Fee</I>), all fees and expenses incurred in connection with this Agreement, the Offer, the Merger and the other Transactions
shall be paid by the party incurring such fees or expenses, whether or not the Offer or the Merger is consummated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.05
<U>Public Announcements</U>. Parent and Merger Sub, on the one hand, and the Company, on the other hand, shall consult with each other before issuing, and provide each other the opportunity to review and comment upon, any press release or other
public statements with respect to the Offer, the Merger and the other Transactions, and shall not issue any such press release or make any such public statement prior to such consultation, except as may be required by applicable Law, court process
or by obligations pursuant to any listing agreement with any national or foreign securities exchange; <U>provided</U> that the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;7.05</U> shall not apply to any release, announcement or
disclosure made or proposed to be made by the Company with respect to a Company Takeover Proposal, Superior Company Proposal, Intervening Event, or Adverse Recommendation Change that is not the result of a material breach of
<U>Section</U><U></U><U>&nbsp;6.02</U>. The parties hereto agree that the initial press release to be issued with respect to the Transactions shall be in the form heretofore agreed to by the parties hereto and that the press release to be issued at
the Merger Closing shall state the Cash Amount as finally determined in accordance with <U>Section</U><U></U><U>&nbsp;2.01(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.06 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as provided in <U>Section</U><U></U><U>&nbsp;3.09(b)</U>, all stock transfer, real estate transfer, documentary, stamp, recording,
excise and other similar Taxes (including interest, penalties and additions to any such Taxes) imposed on the Transactions (&#8220;<B><I>Transfer Taxes</I></B>&#8221;) shall be paid by Parent or Merger Sub when due, and the Company shall reasonably
cooperate with Merger Sub and Parent in preparing, executing and filing any Tax Returns with respect to such Transfer Taxes. Transfer Taxes shall not include any Taxes or fees based in whole or in part upon income, profits, or gain. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the case of any taxable period that includes (but does not end on) the Merger Closing
Date (a &#8220;<B><I>Straddle Period</I></B>&#8221;), (i) the amount of any property and similar ad valorem Taxes of the Company for a Straddle Period which relate to the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period shall be deemed
to be the amount of such Tax for the entire taxable period multiplied by a fraction the numerator of which is the number of days in the taxable period ending on (and including) the Merger Closing Date and the denominator of which is the number of
days in the Straddle Period, and (ii)&nbsp;the amount of any other Taxes of the Company for the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period shall be determined based on an interim closing of the books as of the close of business
on the Merger Closing Date. For purposes of the preceding sentence, exemptions, credits, allowances or deductions that are calculated on an annual basis (including depreciation and amortization deductions computed as if the Merger Closing Date was
the last day of the Straddle Period) shall be allocated between the portion of the Straddle Period ending on the Merger Closing Date and the portion of the Straddle Period thereafter in proportion to the number of days in each such portion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.07 <U>Stockholder Litigation</U>. During the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Period, subject to execution
of a customary joint defense agreement and the preservation of the attorney-client or other applicable privilege, protection under the work product or other doctrine and protection of confidential information and except if the Company Board has made
an Adverse Recommendation Change, the Company shall provide Parent an opportunity to review and to propose comments to all material filings or responses to be made by the Company in connection with any Proceedings commenced, or to the knowledge of
the Company, threatened in writing, by or on behalf of one or more stockholders of the Company, against the Company and its directors relating to any Transaction, and the Company shall give reasonable and good faith consideration to any comments
proposed by Parent. In no event shall the Company enter into, agree to or publicly disclose any settlement with respect to such Proceedings without Parent&#8217;s consent, such consent not to be unreasonably withheld, delayed or conditioned, except
(i)&nbsp;to the extent such settlement is fully covered by the Company&#8217;s insurance policies (other than any applicable deductible) or (ii)&nbsp;such settlement relates solely to the provision of additional disclosure in the Schedule <FONT
STYLE="white-space:nowrap">14D-9,</FONT> but, in each case, only if such settlement would not result in the imposition of any restriction on the business or operations of the Company or its Affiliates. The Company shall notify Parent promptly of the
commencement or written threat of any Proceedings of which it has received notice or become aware and shall keep Parent promptly and reasonably informed regarding any such Proceedings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.08 <U>Rule <FONT STYLE="white-space:nowrap">14d-10</FONT> Matters</U>. Prior to the scheduled expiration of the Offer, the
Company (acting through the Company Board and the compensation committee of the Company Board) shall use reasonable best efforts to cause to be exempt under Rule <FONT STYLE="white-space:nowrap">14d-10(d)</FONT> promulgated under the Exchange Act
any employment compensation, severance or other employee benefit arrangement that has been, or after the Agreement Date will be, entered into by the Company with current or future directors, officers or employees of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.09 <U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> Matters</U>. Prior to the Effective Time, Parent shall, and the
Company may, take all steps required to cause any dispositions or cancellations or deemed dispositions or cancellations of Company equity securities (including derivative securities (as defined in Rule
<FONT STYLE="white-space:nowrap">16a-1(c)</FONT> under the Exchange Act)) in connection with this Agreement or the Transactions by each individual who is a director or officer of the Company who is a covered Person for purposes of Section&nbsp;16 of
the Exchange Act and the rules and regulations thereunder to be exempt under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.10 <U>Merger Sub and Surviving Corporation Compliance</U>. Parent shall cause
Merger Sub or the Surviving Corporation, as applicable, to comply with all of its respective obligations under this Agreement and Merger Sub shall not engage in any activities of any nature except as provided in or contemplated by this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.11 <U>Stock Exchange <FONT STYLE="white-space:nowrap">De-listing;</FONT> SEC Filings; Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Surviving Corporation shall cause the Company&#8217;s securities to be <FONT STYLE="white-space:nowrap">de-listed</FONT> from Nasdaq
and <FONT STYLE="white-space:nowrap">de-registered</FONT> under the Exchange Act as promptly as practicable following the Effective Time and in any event no more than ten (10)&nbsp;days after the Merger Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Until the Effective Time, the Company shall (i)&nbsp;maintain its listing on Nasdaq and comply in all material respects with the applicable
provisions of the Sarbanes-Oxley Act and the appliable current listing and governance rules and regulations of Nasdaq, (ii)&nbsp;file all reports and documents (including period reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT> or <FONT
STYLE="white-space:nowrap">10-Q)</FONT> with the SEC on a timely basis and in compliance with the applicable requirements of the Exchange Act, the Sarbanes-Oxley Act and all rules and regulations promulgated by the SEC thereunder; and
(iii)&nbsp;prepare any financial statements (including any related notes) to be filed with any periodic reports in compliance in all material respects with the published rules and regulations of the SEC applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.12 <U>No Control of Other Party</U><U>&#8217;</U><U>s Business</U>. Nothing contained in this Agreement is intended to give
Parent or Merger Sub, directly or indirectly, the right to control or direct the Company&#8217;s operations prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this
Agreement, complete control and supervision over its operations, subject to the provisions in <U>Section</U><U></U><U>&nbsp;6.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.13 <U>Anti-Takeover Provisions</U>. Each of Parent and the Company and the Company Board (and any committee empowered to take
such action, if applicable) will cooperate and take all actions reasonably available to render any Takeover Law inapplicable to this Agreement, the Offer, Offer Documents, the Merger or any of the transactions contemplated by this Agreement. Nothing
in the foregoing shall be interpreted to require the Company Board (or a duly authorized committee thereof) to take any action that would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law or following an
Adverse Recommendation Change. Neither Parent, Merger Sub nor the Company shall take any action that would cause this Agreement, the Merger, the Offer or the other transactions contemplated by this Agreement to be subject to the requirements imposed
by any such Takeover Laws; provided, however, that nothing in the foregoing shall be interpreted to require the Company or the Company Board (or a duly authorized committee thereof) to refrain from taking any action that would reasonably be expected
to be inconsistent with the fiduciary duties of the Company Board under applicable Law or any other action following an Adverse Recommendation Change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.14 <U>FIRPTA Certificate</U>. At the Merger Closing, the Company shall deliver to Parent a certificate pursuant to Treasury
Regulations Sections <FONT STYLE="white-space:nowrap">1.1445-2(c)</FONT> and 1.897-2(h), together with a form of notice to the IRS in accordance with the requirements of Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.897-2(h),</FONT> in each case, in form and substance reasonably acceptable to Parent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.15 <U>Employee Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Effective as of the day immediately preceding the day on which the Effective Time occurs, the Company shall terminate any and all 401(k)
plans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent shall use commercially reasonable efforts to provide continuation coverage under the group health plans maintained by
Parent pursuant to COBRA to all employees of the Company as of the Merger Closing Date and former employees of the Company receiving COBRA continuation coverage as of the Merger Closing Date for eighteen (18)&nbsp;months following the Merger Closing
Date; <U>provided</U>, <U>however</U>, that if Parent determines prior to the Merger Closing Date in its reasonable discretion that it is unable to provide COBRA continuation coverage to such individuals, Parent shall provide written notice of such
inability to provide COBRA continuation coverage to the Company Board and the Company shall provide the payments set forth in Item 4 of Section&nbsp;6.01(f) of the Company Disclosure Schedule to the affected individuals, pursuant to the terms set
forth therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent or its Affiliates (including the Company) shall take the actions set forth on <U>Schedule 7.15(c)</U> of the
Company Disclosure Schedule with respect to the terms and conditions of any post-Closing consulting arrangements with the employees and consultants to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The provisions of this <U>Section</U><U></U><U>&nbsp;7.15</U> are for the sole benefit of Parent and the Company and no provision of this
Agreement shall (i)&nbsp;create any third-party beneficiary or other rights in any Person other than Parent and Company, including rights in respect of any benefits that may be provided, directly or indirectly, under any Company Employee Plan or any
employee benefit plan of Parent or any Affiliate, or rights to continued employment or service with the Company or Parent (or any Affiliate thereof), (ii) be construed as an amendment, waiver or creation of any Company Employee Plan, or any employee
benefit plan of Parent or any Affiliate, (iii), subject to the requirements explicitly set forth in this <U>Section</U><U></U><U>&nbsp;7.15</U>, serve as a limitation on the ability of the Company, Parent or applicable Affiliate to amend, waive,
create, suspend or terminate any Company Employee Plan, or any employee benefit plan of Parent or any Affiliate, or (iv)&nbsp;limit the ability of the Company, Parent or applicable Affiliate to terminate the employment of any employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.16 <U>Certain Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent hereby acknowledges that the Company may establish a special payroll cycle in order to cause the Company to pay the Closing
Management Bonus Payments on the date on which the Effective Time occurs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent shall pay or shall cause the Company to pay the
payments under each Company Employee Plan Set forth on <U>Section</U><U></U><U>&nbsp;4.16(b)</U> (as amended as permitted by the terms of this Agreement), promptly upon each such payment becoming payable under the terms of the applicable Company
Employee Plan or upon any earlier date(s) set forth on the Company Disclosure Letter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.17 <U>Parent Stockholder Consent</U>. Immediately following the execution and
delivery of this Agreement by each of the parties hereto, Parent shall duly execute and deliver a written consent in its capacity as the sole stockholder of Merger Sub duly adopting this Agreement and the transactions contemplated hereby in
accordance with the DGCL and the certificate of incorporation and bylaws of Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.18 <U>Merger</U>. Following the
Offer Closing Time, each of Parent, Merger Sub and the Company shall take all necessary and appropriate actions to cause the Merger to become effective as soon as practicable after the Offer Closing Time, without a meeting of the Company
Stockholders, in accordance with Section&nbsp;251(h) of the DGCL and upon the terms and subject to the conditions of this Agreement. In furtherance, and without limiting the generality of the foregoing, neither Parent nor Merger Sub shall, and shall
not permit and shall cause their respective Representatives not to, take any action that could render Section&nbsp;251(h) of the DGCL inapplicable to the Merger. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS
PRECEDENT TO THE MERGER </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;8.01 <U>Conditions to Each Party</U><U>&#8217;</U><U>s Obligation</U>. The respective obligation
of each party hereto to effect the Merger is subject to the satisfaction or waiver on or prior to the Effective Time of the following conditions, any and all of which may be waived in whole or in part by mutual consent of Parent, Merger Sub and the
Company, as the case may be, to the extent permitted by applicable Law: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>No Legal Restraints</U>. No Judgment issued, or other legal
restraint or prohibition imposed, in each case, by any Governmental Entity of competent jurisdiction, or applicable Law, in each case, (collectively, &#8220;<B><I>Legal Restraints</I></B>&#8221;) preventing or prohibiting the consummation of the
Merger shall be in effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Consummation of the Offer</U>. Merger Sub shall have irrevocably accepted for payment all shares of the
Company Common Stock validly tendered and not properly withdrawn pursuant to the Offer and Merger Sub shall have consummated the Offer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION,
AMENDMENT AND WAIVER </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.01 <U>Termination</U>. This Agreement may be terminated at any time prior to the Offer Closing
Time, notwithstanding adoption of this Agreement by Parent as sole stockholder of Merger Sub: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written consent of Parent,
Merger Sub and the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by either Parent or the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) if (A)&nbsp;the Offer Closing Time shall not have occurred on or before 11:59&nbsp;p.m., Eastern time, on February&nbsp;4, 2026 (the
&#8220;<B><I>Outside Date</I></B>&#8221;) or (B)&nbsp;the Offer shall have expired or been terminated and have not been extended in accordance with its terms and in accordance with this Agreement without Merger Sub having accepted for payment any
shares of the Company Common Stock tendered in the Offer; <U>provided</U> that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9.01(b)(i)</U> shall not be available to any party hereto if the failure of the Offer
Closing Time to occur on or before the Outside Date (in the case of the foregoing clause&nbsp;(A)) or the failure of Merger Sub to accept for payment any shares of the Company Common Stock tendered in the Offer (in the case of the foregoing clause
(B)) is primarily due to a material breach of this Agreement by such party; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) if any Legal Restraint permanently preventing or
prohibiting the consummation of the Offer or the Merger shall be in effect and shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <U>provided</U> that the right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;9.01(b)(ii)</U> shall not be available to any party hereto if such Legal Restraint is primarily due to such party&#8217;s failure to comply in all material respects with its obligations under
<U>Section</U><U></U><U>&nbsp;7.02</U> in respect of any such Legal Restraint; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by Parent, if the Company breaches or fails to perform
any of its representations, warranties or covenants contained in this Agreement, which breach or failure to perform individually or in the aggregate with all such other breaches or failures to perform (i)&nbsp;would result in the failure of an Offer
Condition and (ii)&nbsp;cannot be or has not been cured prior to the earlier of (x) 30 days after the giving of written notice to the Company of such breach or failure to perform and (y)&nbsp;the Outside Date; <U>provided</U> that Parent and Merger
Sub are not then in material breach of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by Parent if an Adverse Recommendation Change has occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by Parent if a failure of the condition set forth in clause (vi)&nbsp;of <U>Exhibit</U><U></U><U>&nbsp;A</U> has occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Company, if (i)&nbsp;Merger Sub fails to commence the Offer in violation of <U>Section</U><U></U><U>&nbsp;2.01</U> (other than
primarily due to a material violation by the Company of its obligations under <U>Section</U><U></U><U>&nbsp;2.02</U>), (ii) Merger Sub shall have terminated the Offer prior to its expiration date (as such expiration date may be extended in
accordance with <U>Section</U><U></U><U>&nbsp;2.01(a)</U>), other than in accordance with this Agreement, (iii)&nbsp;Merger Sub shall have failed to extend the Offer when required to do so in accordance with the terms of <U>Article II</U>, or
(iv)&nbsp;all of the Offer Conditions have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the time Merger Sub consummates the Offer, but subject to such conditions being able to be satisfied or
waived) as of immediately prior to the expiration of the Offer and the Offer Closing Time shall not have occurred within three (3)&nbsp;Business Days following the expiration of the Offer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by the Company, if (i)&nbsp;(x)&nbsp;Parent or Merger Sub breaches any of its representations or warranties contained in this Agreement,
which breach had or would reasonably be expected to, individually or in the aggregate with all such other breaches, result in a Parent Material Adverse Effect or (y)&nbsp;Parent or Merger Sub breaches or fails to perform any of its covenants
contained in this Agreement in any material respect, and (ii)&nbsp;the applicable breach or failure to perform cannot be or has not been cured prior to the earlier of (x)&nbsp;thirty (30) days after the giving of written notice to Parent or Merger
Sub of such breach or failure to perform and (y)&nbsp;the Outside Date; <U>provided</U>, in each case, that the Company is not then in material breach of this Agreement; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by the Company, if (i)&nbsp;the Company Board authorizes the Company to terminate this
Agreement to enter into a definitive written agreement with respect to a Superior Company Proposal, (ii)&nbsp;the Company Board have complied in all material respects with their obligations under <U>Section</U><U></U><U>&nbsp;6.02(b)</U> in respect
of such Superior Company Proposal and (iii)&nbsp;the Company has paid, or simultaneously with the termination of this Agreement pays, the Company Termination Fee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The party hereto desiring to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9.01</U> (other than pursuant to
<U>Section</U><U></U><U>&nbsp;9.01(a)</U>) shall give written notice of such termination to each other party hereto and specify the applicable provision or provisions hereof pursuant to which such termination is being effected. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.02 <U>Effect of Termination</U>. In the event of termination of this Agreement by either the Company or Parent as provided in
<U>Section</U><U></U><U>&nbsp;9.01</U>, this Agreement shall forthwith become void and have no effect, without any liability or obligation on the part of Parent or Merger Sub, on the one hand, or the Company, on the other hand, the last sentence of
<U>Section</U><U></U><U>&nbsp;7.01</U>, this <U>Section</U><U></U><U>&nbsp;9.02</U>, <U>Section</U><U></U><U>&nbsp;9.03</U> and <U>Article X</U>, and any definitions contained in this Agreement and referred to but not contained in any such
provisions, which provisions and definitions shall survive such termination. Without limiting the generality of the foregoing, Parent and Merger Sub acknowledge and agree that any failure of Parent or Merger Sub to satisfy its obligations to
irrevocably accept for payment or pay for the shares of the Company Common Stock following satisfaction of the Offer Conditions, and any failure of Parent to cause the Merger to be effective following the satisfaction of the conditions set forth in
<U>Article VIII</U>, will be deemed to constitute a Willful Breach of a covenant of this Agreement. Nothing herein shall relieve any party or parties hereto, as applicable, from any liability or damage resulting from any fraud or Willful Breach of
this Agreement that occurs prior to such termination (which liability or damages the parties acknowledge and agree shall not be limited to reimbursement of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
fees, costs or expenses incurred in connection with the transactions contemplated hereby, and such party shall have the right to seek damages based on loss of the economic benefit of the transactions contemplated by this Agreement to the Company and
the Company Stockholders). The parties hereto acknowledge and agree that, to the extent Parent or Merger Sub is required to pay damages in connection with the termination of this Agreement that exceeds the Company&#8217;s expenses or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in connection with this Agreement and the transactions contemplated hereby, including any disputes related thereto, such excess represents an
amount of damages payable in respect of losses suffered by the Company and by Persons who are Company Stockholders as of the date on which this Agreement is terminated in respect of Company Shares </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.03 <U>Termination Fees</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall pay to Parent a fee equal to $2,475,000 (the &#8220;<B><I>Company Termination Fee</I></B>&#8221;) if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Company terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01(h)</U> (<I>Superior Company Proposal</I>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Parent terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01(d)</U> (<I>Adverse Recommendation Change</I>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;(A) after the Agreement Date, a <I>bona fide</I> Company Takeover Proposal is publicly proposed or announced or shall have become
publicly known or otherwise communicated to management of the Company or the Company Board, and such Company Takeover Proposal is not publicly withdrawn or, if not publicly proposed or announced, communicated to the Company Board or management, is
not withdrawn in the case of this Agreement being subsequently terminated pursuant to <U>Section</U><U></U><U>&nbsp;9.01(b)(i)</U> (<I>Outside Date</I>) and the Minimum Tender Condition has not been satisfied prior to such termination
(<I>provided</I>, that the conditions to the Offer set forth in clause (i)&nbsp;of Schedule 1 are satisfied at the time of such termination), prior to the date that is two (2)&nbsp;Business Days prior to the final expiration date of the Offer,
(B)&nbsp;this Agreement is terminated by either Parent or the Company pursuant to <U>Section</U><U></U><U>&nbsp;9.01(b)(i)</U> (<I>Outside Date</I>) (but in the case of a termination by the Company, only if at such time Parent would not be
prohibited from terminating this Agreement pursuant to the proviso in <U>Section</U><U></U><U>&nbsp;9.01(b)(i)</U> (<I>Outside Date</I>)), and (C)&nbsp;within twelve (12)&nbsp;months after such termination, the Company consummates any Company
Takeover Proposal or the Company enters into a definitive agreement with respect to any Company Takeover Proposal that is subsequently consummated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this <U>Section</U><U></U><U>&nbsp;9.03(a)</U>, the term &#8220;<B><I>Company Takeover Proposal</I></B>&#8221; shall have the
meaning set forth in the definition of Company Takeover Proposal contained in <U>Section</U><U></U><U>&nbsp;1.01</U> except that all references to 20% shall be deemed references to 50%. Any fee due under this
<U>Section</U><U></U><U>&nbsp;9.03(a)</U> shall be paid by wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds to an account designated by Parent, (1)&nbsp;in the case of clause (i), prior to or simultaneously with, and as a
condition to the effectiveness of, such termination of this Agreement, (2)&nbsp;in the case of clause (ii), within two (2)&nbsp;Business Days after the date of such termination of this Agreement and (3)&nbsp;in the case of clause&nbsp;(iii), within
two (2)&nbsp;Business Days after the consummation of such a transaction. The parties hereto acknowledge and agree that in no event shall the Company be required to pay the Company Termination Fee or the Expense Reimbursement Payment on more than one
occasion, whether or not the Company Termination Fee may be payable under more than one provision of this Agreement at the same or at different times and the occurrence of different events. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall pay to Parent an expense reimbursement payment equal to the reasonable and documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses incurred by or on behalf of Parent or its Affiliates in connection with the transactions contemplated by this Agreement and the CVR Agreement up to a maximum of $990,000 (the
&#8220;<B><I>Expense Reimbursement Payment</I></B>&#8221;) if Parent terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01(e)</U> (<I>Minimum Cash Condition</I>). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Acceptance by Parent of the Company Termination Fee due under <U>Section</U><U></U><U>&nbsp;9.03(a)(i)</U> shall constitute acceptance by
Parent of the validity of any termination of this Agreement under <U>Section</U><U></U><U>&nbsp;9.01(h)</U> (<I>Superior Company Proposal</I>). In the event the Company Termination Fee or the Expense Reimbursement Payment described in this
<U>Section</U><U></U><U>&nbsp;9.03</U> is paid to Parent in accordance with <U>Section</U><U></U><U>&nbsp;9.03(a)</U> or <U>Section</U><U></U><U>&nbsp;9.03(b)</U>, such Company Termination Fee or Expense Reimbursement Payment shall be deemed to be
liquidated damages for any and all losses </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or damages suffered or incurred by Parent or Merger Sub and constitute their sole and exclusive remedy of Parent and Merger Sub against the Company and its current, former or future stockholders
and Representatives for any loss suffered as a result of the failure of the Transactions to be consummated, and none of the Company and its current, former or future stockholders or Representatives shall have any further liability or obligation
relating to or arising out of this Agreement or the Transactions; <U>provided</U> that nothing contained in this Agreement shall relieve any party hereto from liability for any Willful Breach of this Agreement. If the Company fails to pay in a
timely manner the Company Termination Fee or the Expense Reimbursement Payment due pursuant to <U>Section</U><U></U><U>&nbsp;9.03(a)</U> or <U>Section</U><U></U><U>&nbsp;9.03(b)</U> and, in order to obtain such payment, Parent makes a claim that
results in a judgment for the Company Termination Fee or the Expense Reimbursement Payment, the Company shall pay to Parent its reasonable and documented costs and expenses (including reasonable and documented attorneys&#8217; fees and expenses) in
connection with such suit, together with interest on the Company Termination Fee or the Expense Reimbursement Payment (as applicable) at the prime rate as published in The Wall Street Journal in effect on the date such payment was required to be
made through the date such payment was actually received. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of the parties hereto acknowledges that the agreements contained in
this <U>Section</U><U></U><U>&nbsp;9.03</U> are an integral part of the Transactions and that, without these agreements, the parties hereto would not enter into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.04 <U>Amendment; Extension; Waiver</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement may be amended by the parties hereto at any time prior to the Effective Time; provided, that following the Offer Closing
Time, this Agreement may not be amended in any manner that causes the Merger Consideration to differ from the Offer Price. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This
Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties hereto. Any agreement on the part of a party hereto to any extension or waiver with respect to this Agreement shall be valid only if set forth in
an instrument in writing signed on behalf of such party. The failure of any party hereto to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.05 <U>Procedure for Termination, Amendment, Extension or Waiver</U>. A termination of this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;9.01</U> or an amendment of this Agreement or an extension or waiver with respect to this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.04</U> shall, in order to be effective, require, in the case of Parent or
Merger Sub, action by its Board of Directors, and in the case of the Company, action by the Company Board or the duly authorized designee of the Company Board. Termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01</U> shall
not require the approval of the stockholders of the Company or Parent as sole stockholder of Merger Sub. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.01 <U>Nonsurvival of Representations and Warranties</U>. None of the representations and warranties in this Agreement or in
any instrument delivered pursuant to this Agreement shall survive the Effective Time. This <U>Section</U><U></U><U>&nbsp;10.01</U> shall not limit any covenant or agreement of the parties hereto that by its terms contemplates performance after the
Effective Time. The Confidentiality Agreement shall (i)&nbsp;survive termination of this Agreement in accordance with its terms and (ii)&nbsp;terminate as of the Effective Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.02 <U>Notices</U>. Any notice, request, or demand desired or required to be
given hereunder will be in writing and will be given by personal delivery, email delivery, or overnight courier service, in each case addressed as respectively set forth below or to such other address as any party hereto will have previously
designated by such a notice. The effective date of any notice, request, or demand will be the date of personal delivery, the date on which email is sent (provided that the sender of such email does not receive a written notification of delivery
failure) or one (1)&nbsp;day after it is delivered to a reputable overnight courier service, as the case may be, in each case properly addressed as provided in this Agreement and with all charges prepaid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) if to Parent or Merger Sub, to </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">XOMA Royalty Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2200
Powell Street, Suite 310 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attention: Legal Department, Bradley Sitko </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email: [***] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy (which
shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">One Embarcadero Center Suite 2600 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attention: Ryan A. Murr; Branden C. Berns </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email: rmurr@gibsondunn.com; bberns@gibsondunn.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) if to the Company, to </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">HilleVax, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">321 Harrison Ave,
5th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Boston, MA 02118 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attention: Rob Hershberg </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email:
Rhershberg@hillevax.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">650 Town Center Drive, 20th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Costa Mesa, CA 92626 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attention:
Daniel Rees; Matt Bush </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email: Daniel.Rees@lw.com; Matt.Bush@lw.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.03 <U>Severability</U>. If any term or other provision of this Agreement is
determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule or law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect.
Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as
closely as possible in an acceptable manner to the end that Transactions are fulfilled to the extent possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.04
<U>Counterparts</U>. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and
delivered to the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by facsimile or other electronic image scan transmission (e.g., DocuSign or Adobe Sign) shall be effective as delivery of a manually
executed counterpart of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.05 <U>Entire Agreement; Third-Party Beneficiaries; No Other Representations or
Warranties</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement (including all Exhibits, Annexes and Schedules, including the Company Disclosure Letter, attached to
this Agreement), the CVR Agreement (including all Exhibits, Annexes or Schedules thereto), the Support Agreements (including all Exhibits, Annexes or Schedules thereto) and the Confidentiality Agreement (i)&nbsp;constitute the entire agreement, and
supersede all prior agreements and understandings, both written and oral, among the parties hereto and their Affiliates, or any of them, with respect to the subject matter of this Agreement and the Confidentiality Agreement and (ii)&nbsp;except for
<U>Section</U><U></U><U>&nbsp;7.03</U>, are not intended to confer upon any Person other than the parties hereto any rights or remedies, <U>provided</U>, that the Company shall have the right, on behalf of the Company Stockholders (each of whom are
third party beneficiaries of this Agreement to the extent required for this proviso to be enforceable), to pursue specific performance as set forth in <U>Section</U><U></U><U>&nbsp;10.08(a)</U> or, if specific performance is not sought or granted as
a remedy, damages in accordance with this Agreement (which may include the benefit of the bargain lost by such Company Stockholders) in the event of a breach hereof by Parent or Merger Sub of this Agreement, it being agreed that in no event shall
any such Company Stockholders be entitled to enforce any of their rights, or any of Parent&#8217;s or Merger Sub&#8217;s obligations, under this Agreement in the event of any such breach, but rather the Company shall have the sole and exclusive
right to do so, as agent for such Company Stockholders. Notwithstanding clause (ii)&nbsp;of the immediately preceding sentence, following the Effective Time the provisions of <U>Article III</U> shall be enforceable by holders of Certificates and
holders of Book-Entry Shares solely to the extent necessary to receive the Merger Consideration to which such holders are entitled to thereunder, and the provisions of <U>Section</U><U></U><U>&nbsp;3.10</U> shall be enforceable by holders of awards
under the Company Stock Plans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for the representations and warranties contained in <U>Article IV</U>, each of Parent and Merger
Sub acknowledges that neither the Company nor any Person on behalf of the Company makes, and neither Parent nor Merger Sub is relying on, any other express or implied representation or warranty with respect to the Company or with respect to any
other information made available to Parent or Merger Sub in connection with the Transactions (including with respect to the accuracy or completeness thereof). In connection with the due diligence investigation of the Company by Parent and Merger
Sub, Parent and Merger Sub have received and may continue to receive from the Company certain estimates, projections, forecasts and other forward-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
looking information, as well as certain business plans and cost-related plan information, regarding the Company&#8217;s business and operations. Parent and Merger Sub hereby acknowledge that
there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking information, with which Parent and Merger Sub are familiar, that Parent and Merger Sub are making their own evaluation of the
adequacy and accuracy of all estimates, projections, forecasts and other forward-looking information, as well as such business plans and cost-related plans, furnished to them (including the reasonableness of the assumptions underlying such
estimates, projections, forecasts, forward-looking information, business plans or cost-related plans), and that neither Parent nor Merger Sub has relied upon the Company or its stockholders, directors, officers, employees, Affiliates, advisors,
agents or other Representatives, or any other Person, with respect thereto. Accordingly, each of Parent and Merger Sub hereby acknowledge that neither the Company nor its stockholders, directors, officers, employees, Affiliates, advisors, agents or
other Representatives, nor any other Person, has made or is making any representation or warranty or has or shall have any liability (whether pursuant to this Agreement, in tort or otherwise) with respect to such estimates, projections, forecasts,
forward-looking information, business plans or cost-related plans (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, <FONT STYLE="white-space:nowrap">forward-looking</FONT> information, business plans
or cost-related plans), except as expressly set forth in <U>Article IV</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except for the representations and warranties contained in
<U>Article V</U>, the Company acknowledges that none of Parent, Merger Sub and any other Person on behalf of Parent or Merger Sub makes, and the Company is not relying on, any other express or implied representation or warranty with respect to
Parent or Merger Sub or with respect to any other information made available to the Company in connection with the Transactions (including with respect to the accuracy or completeness thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.06 <U>Governing Law</U>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of
Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.07
<U>Assignment</U>. Neither this Agreement nor any of the rights, interests or obligations under this Agreement shall be assigned, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of
the other parties hereto; <U>provided</U> that Merger Sub may assign, in its sole discretion, any of or all its rights, interests and obligations under this Agreement to Parent or to any direct or indirect wholly owned Subsidiary of Parent, but no
such assignment shall relieve Merger Sub or Parent of any of its obligations under this Agreement; <U>provided</U>, <U>further</U>, that any such assignment shall not take place after the commencement of the Offer and shall not otherwise materially
impede or delay the consummation of the Transactions or otherwise materially impede the rights of the Company Stockholders under this Agreement. Any purported assignment without such consent shall be void. Subject to the preceding sentences, this
Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties hereto and their respective successors and assigns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.08 <U>Specific Enforcement; Jurisdiction</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were
not performed in accordance with its specific terms or were otherwise breached, and that monetary damages, even if available, would not be an adequate remedy therefor. It is accordingly agreed that the parties hereto shall be entitled to an
injunction or injunctions, or any other appropriate form of equitable relief, to prevent breaches of this Agreement and to enforce specifically the performance of the terms and provisions of this Agreement in any court referred to in
<U>Section</U><U></U><U>&nbsp;10.08(b)</U>, without proof of damages or otherwise (and each party hereto hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other
remedy to which they are entitled at law or in equity. The right to specific enforcement shall include the right of the Company to cause the Buyer Entities to cause the Offer, the Merger and the other Transactions to be consummated on the terms and
subject to the conditions set forth in this Agreement. The parties hereto further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, nor to assert that a remedy of
monetary damages would provide an adequate remedy. Each of the parties hereto acknowledges and agrees that the right of specific enforcement is an integral part of the Transactions and without such right, none of the parties hereto would have
entered into this Agreement. If, prior to any termination of this Agreement or the Outside Date, any party hereto brings any Proceeding, in each case, in accordance with <U>Section</U><U></U><U>&nbsp;10.08(b)</U>, to enforce specifically the
performance of the terms and provisions hereof by any other party hereto, the Outside Date shall automatically be extended by (i)&nbsp;the amount of time during which such Proceeding is pending, plus twenty (20)&nbsp;Business Days or (ii)&nbsp;such
other time period established by the court presiding over such Proceeding, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the parties hereto hereby
irrevocably submits to the exclusive jurisdiction of the courts of the State of Delaware and to the jurisdiction of the United States District Court for the State of Delaware, for the purpose of any Proceeding arising out of or relating to this
Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement thereof, and each of the parties hereto hereby irrevocably agrees that all claims with respect to such Proceeding may be
heard and determined exclusively in the Delaware Court of Chancery or, solely if the Delaware Court of Chancery does not have subject matter jurisdiction thereof, any other court of the State of Delaware or any federal court sitting in the State of
Delaware. Each of the parties hereto (i)&nbsp;consents to submit itself to the personal jurisdiction of the Delaware Court of Chancery, any other court of the State of Delaware and any federal court sitting in the State of Delaware in the event any
Proceeding arises out of this Agreement, the Offer, the Merger or any of the other Transactions, (ii)&nbsp;agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court,
(iii)&nbsp;irrevocably consents to the service of process in any Proceeding arising out of or relating to this Agreement, the Offer, the Merger or any of the other Transactions, on behalf of itself or its property, by U.S. registered mail to such
party&#8217;s respective address set forth in <U>Section</U><U></U><U>&nbsp;10.02</U> (<U>provided</U> that nothing in this <U>Section</U><U></U><U>&nbsp;10.08(b)</U> shall affect the right of any party hereto to serve legal process in any other
manner permitted by Law) and (iv)&nbsp;agrees that it will not bring any Proceeding relating to this Agreement, the Offer, the Merger or any of the other Transactions in any court other than the Delaware Court of Chancery (or, solely if the Delaware
Court of Chancery shall be unavailable, any other court of the State of Delaware or any federal court sitting in the State of Delaware). The parties hereto agree that a final trial court judgment in any such Proceeding shall be conclusive and may be
enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law; <U>provided</U> that nothing in the foregoing shall restrict any party&#8217;s rights to seek any post-judgment relief regarding, or any appeal from,
such final trial court judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.09 <U>WAIVER OF JURY TRIAL</U>. EACH PARTY HERETO HEREBY WAIVES, TO THE
FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY PROCEEDING ARISING OUT OF THIS AGREEMENT, THE OFFER, THE MERGER OR ANY OF THE OTHER TRANSACTIONS. EACH PARTY HERETO (A)&nbsp;CERTIFIES THAT NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH PARTY WOULD NOT, IN THE EVENT OF ANY PROCEEDING, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES
HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS <U>SECTION</U><U></U><U>&nbsp;10.09</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.10 <U>Remedies</U>. Except as otherwise provided in this Agreement, the rights and remedies provided in this Agreement shall
be cumulative and not exclusive of any rights or remedies provided by applicable Law, and the exercise by a party hereto of any one remedy will not preclude the exercise of any other remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.11 <U>Cooperation</U>. The parties hereto agree to provide reasonable cooperation with each other and to execute and deliver
such further documents, certificates, agreements and instruments and to take such actions as may be reasonably requested by the other parties hereto to evidence or effect the Transactions and to carry out the intent and purposes of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.12 <U>Parent Guarantee</U>. Parent agrees to take all action necessary to cause the Merger Sub or the Surviving
Corporation, as applicable, and, during the period between the Offer Closing Time and the Effective Time, to perform all of its agreements, covenants and obligations under this Agreement. Parent unconditionally guarantees to the Company the full and
complete performance by the Merger Sub or the Surviving Corporation, as applicable, of its respective obligations under this Agreement and shall be liable for any breach of any representation, warranty, covenant or obligation of the Merger Sub or
the Surviving Corporation, as applicable, under this Agreement. Parent hereby waives diligence, presentment, demand of performance, filing of any claim, any right to require any proceeding first against Merger Sub or the Surviving Corporation, as
applicable, protest, notice and all defenses and demands whatsoever in connection with the performance of its obligations set forth in this <U>Section</U><U></U><U>&nbsp;10.12</U>. Parent shall not have any right of subrogation, reimbursement or
indemnity whatsoever, nor any right of recourse to security for any of the agreements, covenants and obligations of Merger Sub or the Surviving Corporation under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Blank; Signature Pages Follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Parent, Merger Sub and the Company have duly executed this Agreement,
all as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XOMA Royalty Corporation</B>, as Parent</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Owen Hughes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Owen Hughes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XRA 4 Corp.</B>, as Merger Sub</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Owen Hughes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Owen Hughes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President, Treasurer and Secretary</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>GREEMENT</SMALL> <SMALL>AND</SMALL>
P<SMALL>LAN</SMALL> <SMALL>OF</SMALL> M<SMALL>ERGER</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Parent, Merger Sub and the Company have duly executed this Agreement,
all as of the date first written above. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HilleVax, Inc.</B>, as Company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Hershberg, M.D., Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Robert Hershberg, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chairman, President and Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>GREEMENT</SMALL> <SMALL>AND</SMALL>
P<SMALL>LAN</SMALL> <SMALL>OF</SMALL> M<SMALL>ERGER</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT&nbsp;A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Offer Conditions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other term of the Offer or the Agreement, the Buyer Entities shall not be required to, accept for payment or, subject to
any applicable rules and regulations of the SEC, including Rule <FONT STYLE="white-space:nowrap">14e-1(c)</FONT> under the Exchange Act (relating to the Buyer Entities&#8217; obligation to pay for or return tendered shares of the Company Common
Stock promptly after the termination or withdrawal of the Offer), pay for any shares of the Company Common Stock tendered pursuant to the Offer (and not theretofore accepted for payment or paid for) unless there shall have been validly tendered in
the Offer (and not properly withdrawn) prior to the expiration of the Offer that number of shares of the Company Common Stock (excluding shares tendered pursuant to guaranteed delivery procedures that have not yet been &#8220;received&#8221; by the
&#8220;depository,&#8221; as such terms are defined by Section&nbsp;251(h) of the DGCL) that, represent at least one share of Company Common Stock more than 50% of the number of Company Common Stock that are then issued and outstanding as of the
expiration of the Offer (such condition, the &#8220;<B><I>Minimum Tender Condition</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, notwithstanding any
other term of the Offer or this Agreement, the Buyer Entities shall not be required to accept for payment or, subject as aforesaid, to pay for any shares of the Company Common Stock not theretofore accepted for payment or paid for if, at the
then-scheduled expiration of the Offer, any of the following conditions exists: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) there shall be any Legal Restraint in effect
preventing or prohibiting the consummation of the Offer, the Merger or any of the other transactions contemplated by the Merger Agreement or CVR Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;(A) any representation or warranty of the Company set forth in <U>Article IV</U> (other than those set forth in
<U>Section</U><U></U><U>&nbsp;4.01(a)</U> (<I>Due Organization; Subsidiaries</I>), <U>Section</U><U></U><U>&nbsp;4.03</U> (<I>Authority; Binding Nature of Agreement</I>), <U>Section</U><U></U><U>&nbsp;4.04</U> (<I>No Vote Required</I>),
<U>Section</U><U></U><U>&nbsp;4.05(a)(i)</U> (<I>Non</I><I><FONT STYLE="white-space:nowrap">-Contravention</FONT></I>), <U>Section</U><U></U><U>&nbsp;4.06</U> (<I>Capitalization</I>), <U>Section</U><U></U><U>&nbsp;4.08(a)(ii)</U> (<I>No Material
Adverse Effect</I>), <U>Section</U><U></U><U>&nbsp;4.19</U> (<I>No Financial Advisors</I>) and <U>Section</U><U></U><U>&nbsp;4.25</U> (<I>Opinion of Financial Advisor</I>)) shall not be true and correct as of the Agreement Date and at and as of the
Offer Closing Time as if made on and as of the Offer Closing Time, except to the extent such representation or warranty expressly relates to a specified date (in which case on and as of such specified date), other than for such failures to be true
and correct that have not had or would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect (for purposes of determining the satisfaction of this condition, without regard to any qualifications or
exceptions contained therein as to &#8220;materiality&#8221; or &#8220;Company Material Adverse Effect&#8221;), (B) any representation or warranty of the Company set forth in <U>Section</U><U></U><U>&nbsp;4.01(a)</U> (<I>Due Organization;
Subsidiaries</I>), <U>Section</U><U></U><U>&nbsp;4.03</U> (<I>Authority; Binding Nature of Agreement</I>), <U>Section</U><U></U><U>&nbsp;4.04</U> (<I>No Vote Required</I>), <U>Section</U><U></U><U>&nbsp;4.05(a)(i)</U> (<I><FONT
STYLE="white-space:nowrap">Non-Contravention</FONT></I>), <U>Section</U><U></U><U>&nbsp;4.06</U> (<I>Capitalization</I>) (other than with respect to <U>Section</U><U></U><U>&nbsp;4.05(a)</U> and (c)), <U>Section</U><U></U><U>&nbsp;4.19</U> (<I>No
Financial Advisors</I>) and <U>Section</U><U></U><U>&nbsp;4.25</U> (<I>Opinion of Financial Advisor</I>), and the Closing Cash Schedule shall not be true and correct in all material respects as of the Agreement Date and at and as of the Offer
Closing Time as if made on and as of the Offer Closing Time, except to the extent such representation or warranty expressly relates to a specified date (in which case on and as of such specified date), (C) any representation or warranty of the
Company set forth in <U>Section</U><U></U><U>&nbsp;4.05(a)</U> and (c) (<I>Capitalization</I>) shall not be true and correct other than in <I>de minimis</I> respects at and as of such time, except to the extent such representation or warranty
expressly relates to a specified date (in which case on and as of such specified date) and (D)&nbsp;any representation or warranty of the Company set forth in <U>Section</U><U></U><U>&nbsp;4.08(a)(ii)</U> (<I>No Material Adverse Effect</I>) shall
not be true and correct in all respects as of such time; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Company shall have failed to perform in all material respects the obligations to
be performed by it as of such time under this Agreement, including without limitation the Company&#8217;s obligations under <U>Section</U><U></U><U>&nbsp;6.02</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Parent shall have failed to receive from the Company a certificate, dated as of the date on which the Offer expires and signed by an
executive officer of the Company, certifying to the effect that the Offer Conditions set forth in clauses (ii)&nbsp;and (iii) have been satisfied as of immediately prior to the expiration of the Offer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) this Agreement shall have been validly terminated in accordance with its terms (the &#8220;<B><I>Termination Condition</I></B>&#8221;); or
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;the Closing Net Cash as finally determined pursuant to <U>Section</U><U></U><U>&nbsp;2.01(c)</U> is less than $102,950,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing conditions shall be in addition to, and not a limitation of, the rights of the Buyer Entities to extend, terminate or modify the
Offer in accordance with the terms and conditions of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing conditions are for the sole benefit of the Buyer
Entities and, subject to the terms and conditions of this Agreement and the applicable rules and regulations of the SEC, may be waived by the Buyer Entities in whole or in part at any time and from time to time in their sole discretion (other than
the Minimum Tender Condition and the Termination Condition, which may not be waived by the Buyer Entities). The failure by the Buyer Entities or any other Affiliate of the Buyer Entities at any time to exercise any of the foregoing rights shall not
be deemed a waiver of any such right, the waiver of any such right with respect to particular facts and circumstances shall not be deemed a waiver with respect to any other facts and circumstances and each such right shall be deemed an ongoing right
that may be asserted at any time and from time to time. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HILLEVAX, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10.5pt; font-family:Times New Roman" ALIGN="center">*&nbsp;*&nbsp;*&nbsp;*&nbsp;*&nbsp;*&nbsp;*&nbsp;* </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>I. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of this
corporation is HilleVax, Inc. (the &#8220;<U>Corporation</U>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>II. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street in the City of Wilmington,
County of New Castle 19801, and the name of the registered agent of the Corporation in the State of Delaware at such address is The Corporation Trust Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>III. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of this
Corporation is to engage in any lawful act or activity for which a corporation may be organized under the Delaware General Corporation Law (the &#8220;<U>DGCL</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IV. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Corporation is
authorized to issue only one class of stock, to be designated Common Stock. The total number of shares of Common Stock presently authorized is one hundred (100), each having a par value of one cent ($0.01). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>V. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A.</B> The
management of the business and the conduct of the affairs of the Corporation shall be vested in its Board of Directors. The number of directors which shall constitute the whole Board of Directors shall be fixed by the Board of Directors in the
manner provided in the bylaws of the Corporation (the &#8220;<U>Bylaws</U>&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>B.</B> The Board of Directors is expressly
empowered to adopt, amend or repeal the Bylaws of the Corporation. The stockholders shall also have power to adopt, amend or repeal the Bylaws of the Corporation; provided, however, that, in addition to any vote of the holders of any class or series
of stock of the Corporation required by law or by this Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of at least a majority of the voting power of all of the then outstanding shares of
the capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>C.</B>
Unless and except to the extent that the Bylaws of this Corporation shall so require, the election of directors of this Corporation need not be by written ballot. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VI. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A.</B> The
Corporation shall provide indemnification as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Actions, Suits and Proceedings Other than by or in the Right of the Corporation</U>. The Corporation shall
indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the
Corporation) by reason of the fact that he or she is or was, or has agreed to become, a director or officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner,
employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (including any </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
employee benefit plan) (all such persons being referred to hereafter as an &#8220;<U>Indemnitee</U>&#8221;), or by reason of any action alleged to have been taken or omitted in such capacity,
against all expenses (including attorneys&#8217; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee Retirement Income Security Act of 1974), and amounts paid in settlement actually and
reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the
best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement,
conviction or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the best interests
of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Actions or Suits by or in the Right of the Corporation</U>. The Corporation shall indemnify any Indemnitee
who was or is a party to or threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that Indemnitee is or was, or has agreed
to become, a director or officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation,
partnership, joint venture, trust or other enterprise (including any employee benefit plan), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees) and, to the extent
permitted by law, amounts paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which
Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Corporation, except that no indemnification shall be made under this Section&nbsp;2 in respect of any claim, issue or matter as to which Indemnitee shall have been
adjudged to be liable to the Corporation, unless, and only to the extent, that the Court of Chancery of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of such liability
but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such expenses (including attorneys&#8217; fees) which the Court of Chancery of Delaware or such other court shall deem proper.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Indemnification for Expenses of Successful Party</U>. Notwithstanding any other provisions of this Article
VI, to the extent that an Indemnitee has been successful, on the merits or otherwise, in defense of any action, suit or proceeding referred to in Sections 1 and 2 of this Article VI, or in defense of any claim, issue or matter therein, or on appeal
from any such action, suit or proceeding, Indemnitee shall be indemnified against all expenses (including attorneys&#8217; fees) actually and reasonably incurred by or on behalf of Indemnitee in connection therewith. Without limiting the foregoing,
if any action, suit or proceeding is disposed of, on the merits or otherwise (including a disposition without prejudice), without (i)&nbsp;the disposition being adverse to Indemnitee, (ii)&nbsp;an adjudication that Indemnitee was liable to the
Corporation, (iii)&nbsp;a plea of guilty or nolo contendere by Indemnitee, (iv)&nbsp;an adjudication that Indemnitee did not act in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the
Corporation, and (v)&nbsp;with respect to any criminal proceeding, an adjudication that Indemnitee had reasonable cause to believe his or her conduct was unlawful, Indemnitee shall be considered for the purposes hereof to have been wholly successful
with respect thereto. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notification and Defense of Claim</U>. As a condition precedent to an Indemnitee&#8217;s right to be
indemnified, such Indemnitee must notify the Corporation in writing as soon as practicable of any action, suit, proceeding or investigation involving such Indemnitee for which indemnity will or could be sought. With respect to any action, suit,
proceeding or investigation of which the Corporation is so notified, the Corporation will be entitled to </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
participate therein at its own expense and/or to assume the defense thereof at its own expense, with legal counsel reasonably acceptable to Indemnitee. After notice from the Corporation to
Indemnitee of its election so to assume such defense, the Corporation shall not be liable to Indemnitee for any legal or other expenses subsequently incurred by Indemnitee in connection with such action, suit, proceeding or investigation, other than
as provided below in this Section&nbsp;4. Indemnitee shall have the right to employ his or her own counsel in connection with such action, suit, proceeding or investigation, but the fees and expenses of such counsel incurred after notice from the
Corporation of its assumption of the defense thereof shall be at the expense of Indemnitee unless (i)&nbsp;the employment of counsel by Indemnitee has been authorized by the Corporation, (ii)&nbsp;counsel to Indemnitee shall have reasonably
concluded that there may be a conflict of interest or position on any significant issue between the Corporation and Indemnitee in the conduct of the defense of such action, suit, proceeding or investigation or (iii)&nbsp;the Corporation shall not in
fact have employed counsel to assume the defense of such action, suit, proceeding or investigation, in each of which cases the fees and expenses of counsel for Indemnitee shall be at the expense of the Corporation, except as otherwise expressly
provided by this Article VI. The Corporation shall not be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Corporation or as to which counsel for Indemnitee shall have reasonably made
the conclusion provided for in clause (ii)&nbsp;above. The Corporation shall not be required to indemnify Indemnitee under this Article VI for any amounts paid in settlement of any action, suit, proceeding or investigation effected without its
written consent. The Corporation shall not settle any action, suit, proceeding or investigation in any manner which would impose any penalty or limitation on Indemnitee without Indemnitee&#8217;s written consent. Neither the Corporation nor
Indemnitee will unreasonably withhold or delay its consent to any proposed settlement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Advance of Expenses</U>. Subject to the provisions of Section&nbsp;6 of this Article VI, in the event of any
threatened or pending action, suit, proceeding or investigation of which the Corporation receives notice under this Article VI, any expenses (including attorneys&#8217; fees) incurred by or on behalf of an Indemnitee in defending an action, suit,
proceeding or investigation or any appeal therefrom shall be paid by the Corporation in advance of the final disposition of such matter; provided, however, that the payment of such expenses incurred by or on behalf of Indemnitee in advance of the
final disposition of such matter shall be made only upon receipt of an undertaking by or on behalf of Indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined that Indemnitee is not entitled to be indemnified
by the Corporation as authorized in this Article VI; and provided further that no such advancement of expenses shall be made under this Article VI if it is determined (in the manner described in Section&nbsp;6 of this Article VI) that
(i)&nbsp;Indemnitee did not act in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation, or (ii)&nbsp;with respect to any criminal action or proceeding, Indemnitee had reasonable
cause to believe his or her conduct was unlawful. Such undertaking shall be accepted without reference to the financial ability of Indemnitee to make such repayment. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Procedure for Indemnification and Advancement of Expenses</U>. In order to obtain indemnification or
advancement of expenses pursuant to Section&nbsp;1, 2, 3 or 5 of this Article VI, an Indemnitee shall submit to the Corporation a written request. Any such advancement of expenses shall be made promptly, and in any event within 60 days after receipt
by the Corporation of the written request of Indemnitee, unless (i)&nbsp;the Corporation has assumed the defense pursuant to Section&nbsp;4 of this Article VI (and none of the circumstances described in Section&nbsp;4 of this Article VI that would
nonetheless entitle the Indemnitee to indemnification for the fees and expenses of separate counsel have occurred) or (ii)&nbsp;the Corporation determines within such <FONT STYLE="white-space:nowrap">60-day</FONT> period that Indemnitee did not meet
the applicable standard of conduct set forth in Section&nbsp;1, 2 or 5 of this Article VI, as the case may be. Any such indemnification, unless ordered by a court, shall be made with respect to requests under Section&nbsp;1 or 2 of this Article VI
only as authorized in the specific case upon a determination by the Corporation that the indemnification of Indemnitee is proper because Indemnitee has met the applicable standard of conduct set forth in Section&nbsp;1 or 2 of this Article VI, as
the </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
case may be. Such determination shall be made in each instance (a)&nbsp;by a majority vote of the directors of the Corporation consisting of persons who are not at that time parties to the
action, suit or proceeding in question (&#8220;<U>disinterested directors</U>&#8221;), whether or not a quorum, (b)&nbsp;by a committee of disinterested directors designated by majority vote of disinterested directors, whether or not a quorum,
(c)&nbsp;if there are no disinterested directors, or if the disinterested directors so direct, by independent legal counsel (who may, to the extent permitted by law, be regular legal counsel to the Corporation) in a written opinion, or (d)&nbsp;by
the stockholders of the Corporation. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I></I><U>Remedies</U><I></I>. The right to indemnification or advancement of expenses as granted by this
Article VI shall be enforceable by Indemnitee in any court of competent jurisdiction. Neither the failure of the Corporation to have made a determination prior to the commencement of such action that indemnification is proper in the circumstances
because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Corporation pursuant to Section&nbsp;6 of this Article VI that Indemnitee has not met such applicable standard of conduct, shall be a defense to the
action or create a presumption that Indemnitee has not met the applicable standard of conduct. In any suit brought by Indemnitee to enforce a right to indemnification, or brought by the Corporation to recover an advancement of expenses pursuant to
the terms of an undertaking, the Corporation shall have the burden of proving that Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article VI. Indemnitee&#8217;s expenses (including attorneys&#8217; fees)
reasonably incurred in connection with successfully establishing Indemnitee&#8217;s right to indemnification, in whole or in part, in any such proceeding shall also be indemnified by the Corporation. Notwithstanding the foregoing, in any suit
brought by Indemnitee to enforce a right to indemnification hereunder it shall be a defense that the Indemnitee has not met any applicable standard for indemnification set forth in the DGCL. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Limitations</U>. Notwithstanding anything to the contrary in this Article VI, except as set forth in
Section&nbsp;7 of this Article VI, the Corporation shall not indemnify an Indemnitee pursuant to this Article VI in connection with a proceeding (or part thereof) initiated by such Indemnitee unless the initiation thereof was approved by the Board
of Directors of the Corporation. Notwithstanding anything to the contrary in this Article VI, the Corporation shall not indemnify an Indemnitee to the extent such Indemnitee is reimbursed from the proceeds of insurance, and in the event the
Corporation makes any indemnification payments to an Indemnitee and such Indemnitee is subsequently reimbursed from the proceeds of insurance, such Indemnitee shall promptly refund indemnification payments to the Corporation to the extent of such
insurance reimbursement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Subsequent Amendment</U>. No amendment, termination or repeal of this Article VI or of the relevant
provisions of the DGCL or any other applicable laws shall adversely affect or diminish in any way the rights of any Indemnitee to indemnification under the provisions hereof with respect to any action, suit, proceeding or investigation arising out
of or relating to any actions, transactions or facts occurring prior to the final adoption of such amendment, termination or repeal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Other Rights</U>. The indemnification and advancement of expenses provided by this Article VI shall not be
deemed exclusive of any other rights to which an Indemnitee seeking indemnification or advancement of expenses may be entitled under any law (common or statutory), agreement or vote of stockholders or disinterested directors or otherwise, both as to
action in Indemnitee&#8217;s official capacity and as to action in any other capacity while holding office for the Corporation, and shall continue as to an Indemnitee who has ceased to be a director or officer, and shall inure to the benefit of the
estate, heirs, executors and administrators of Indemnitee. Nothing contained in this Article VI shall be deemed to prohibit, and the Corporation is specifically authorized to enter into, agreements with officers and directors providing
indemnification rights and procedures different from those set forth in this Article VI. In addition, the Corporation may, to the extent authorized from time to time by its Board of Directors, grant indemnification rights to other employees or
agents of the Corporation or other persons serving the Corporation and such rights may be equivalent to, or greater or less than, those set forth in this Article VI. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Partial Indemnification</U>. If an Indemnitee is entitled under any provision of this Article VI to
indemnification by the Corporation for some or a portion of the expenses (including attorneys&#8217; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee Retirement Income Security Act of
1974) or amounts paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with any action, suit, proceeding or investigation and any appeal therefrom but not, however, for the total amount thereof, the
Corporation shall nevertheless indemnify Indemnitee for the portion of such expenses (including attorneys&#8217; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee Retirement Income Security
Act of 1974) or amounts paid in settlement to which Indemnitee is entitled. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Insurance</U>. The Corporation may purchase and maintain insurance, at its expense, to protect itself and
any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise (including any employee benefit plan) against any expense, liability or loss incurred by him or her in any such
capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Savings Clause</U>. If this Article VI or any portion hereof shall be invalidated on any ground by any court
of competent jurisdiction, then the Corporation shall nevertheless indemnify each Indemnitee as to any expenses (including attorneys&#8217; fees), liabilities, losses, judgments, fines (including excise taxes and penalties arising under the Employee
Retirement Income Security Act of 1974) and amounts paid in settlement in connection with any action, suit, proceeding or investigation, whether civil, criminal or administrative, including an action by or in the right of the Corporation, to the
fullest extent permitted by any applicable portion of this Article VI that shall not have been invalidated and to the fullest extent permitted by applicable law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Definitions</U>. Terms used herein and defined in Section&nbsp;145(h) and Section&nbsp;145(i) of the DGCL
shall have the respective meanings assigned to such terms in such Section&nbsp;145(h) and Section&nbsp;145(i). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VII.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in
the manner now or hereafter prescribed by statute, and all rights conferred upon the stockholders herein are granted subject to this reservation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Remainder of this page intentionally left blank] </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF CONTINGENT VALUE RIGHTS AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [&#149;], 202[&#149;] (this &#8220;<B><I>Agreement</I></B>&#8221;), is entered into by and
between XOMA Royalty Corporation, a Nevada corporation (&#8220;<B><I>Parent</I></B>&#8221;), XRA 4 Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (&#8220;<B><I>Merger Sub</I></B>&#8221; and together with Parent, the
&#8220;<B><I>Buyer Entities</I></B>&#8221;), [&#149;], a [&#149;], as Rights Agent (as defined herein), and Dr.&nbsp;Robert Hershberg, solely in his capacity as the initial representative, agent and attorney
<FONT STYLE="white-space:nowrap">in-fact</FONT> of the Holders (the &#8220;<B><I>Representative</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent, Merger Sub and HilleVax, Inc., a Delaware corporation (the &#8220;<B><I>Company</I></B>&#8221;), have entered into an
Agreement and Plan of Merger, dated as of August 4, 2025 (the &#8220;<B><I>Merger Agreement</I></B>&#8221;), pursuant to which Merger Sub will merge with and into the Company (the &#8220;<B><I>Merger</I></B>&#8221;), with the Company surviving the
Merger as a wholly owned Subsidiary of Parent; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Merger Agreement, and in accordance with the terms and conditions
thereof, the Buyer Entities shall deliver to holders of outstanding Company Common Stock, Company Restricted Stock Unit Awards, and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Options certain CVRs (as
defined herein) of the Company (collectively, the &#8220;<B><I>Initial Holders</I></B>&#8221;), pursuant to the terms and subject to the conditions hereinafter described; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Whereas, the Legacy Assets of the Company may require maintenance and development to allow Parent to maximize the value of the Legacy Assets
prior to disposition on behalf of the Holders, and the parties desire to preserve the ability for Parent (with the consent of the Representative) to take certain actions such as the issuance of equity to maintain the Legacy Assets intellectual
property rights, financing the development of the Legacy Assets and enlistment of services of employees or consultants in connection therewith; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Buyer Entities desire that the Rights Agent act as its agent for the purposes of effecting the distribution of the CVRs to the
Initial Holders and performing the other services described in this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Initial Holders desire that the
Representative act as their agent for the purposes of accomplishing the intent and implementing the provisions of this Agreement and facilitating the consummation of the transactions contemplated hereby and performing the other services described in
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, the parties
agree, for the equal and proportionate benefit of all Holders (as defined herein), as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS: CERTAIN RULES OF CONSTRUCTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;1.1</U> Definitions. Capitalized terms used but not otherwise defined herein have the meanings ascribed thereto
in the Merger Agreement. References to the Company and Merger Sub herein apply to the surviving corporation of the Merger with the Company from and after the Effective Time. As used in this Agreement, the following terms will have the following
meanings: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Acting Holders</I></B>&#8221; means, at the time of determination, Holders of
not less than thirty percent (30%) of outstanding CVRs as set forth in the CVR Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Affiliate</I></B>&#8221; of any
particular Person means any other Person controlling, controlled by or under common control with such particular Person. For the purposes of this definition, &#8220;controlling,&#8221; &#8220;controlled&#8221; and &#8220;control&#8221; mean the
possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Assignee</I></B>&#8221; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Business Day</I></B>&#8221; means a day, other than a Saturday, Sunday or public holiday (including Nasdaq holidays), on which
banks are not required or authorized by Law to close in New York, New York or Boston, Massachusetts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Change of
Control</I></B>&#8221; means (a)&nbsp;a sale or other disposition of all or substantially all of the assets of any of the Buyer Entities on a consolidated basis (other than to any Subsidiary (direct or indirect) of Parent), (b) a merger or
consolidation involving any of the Buyer Entities in which neither the Buyer Entities is the surviving entity, and (c)&nbsp;any other transaction involving any of the Buyer Entities in which such Buyer Entity is the surviving or continuing entity
but in which the stockholders of the Buyer Entity immediately prior to such transaction own less than 50% of the Buyer Entity&#8217;s voting power immediately after the transaction, in the case of each of the foregoing clauses (a), (b) and (c),
whether effected directly or indirectly, and whether effected in a single transaction or a series of related transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Closing</I></B>&#8221; means the consummation of the Merger and the transactions contemplated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Closing Date</I></B>&#8221; means the date of the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Code</I></B>&#8221; means the United States Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Contract</I></B>&#8221; means any written or oral agreement, contract, subcontract, lease,
<FONT STYLE="white-space:nowrap">sub-lease,</FONT> occupancy agreement, binding understanding, obligation, promise, instrument, indenture, mortgage, note, option, warranty, purchase order, license, sublicense, commitment or undertaking of any
nature, which, in each case, is legally binding upon a party or on any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVRs</I></B>&#8221; means the
contractual contingent value rights of Holders that are granted by the Buyer Entities to Initial Holders as additional consideration for the Offer and the Merger pursuant to the terms of the Offer and the Merger Agreement. Unless otherwise specified
herein, for purposes of this Agreement all the CVRs shall be considered as part of and shall act as one class only. For the avoidance of doubt, the Buyer Entities shall grant CVRs only to the Initial Holders, and shall not grant CVRs to any other
Persons at any other time during the pendency of this Agreement, pursuant and subject to the terms hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Payment Amount</I></B>&#8221; means, for a given Holder, an amount equal to
the product of (a)&nbsp;the CVR Proceeds and (b)&nbsp;(i) the total number of CVRs entitled to receive such CVR Proceeds held by such Holder divided by (ii)&nbsp;the total number of CVRs entitled to receive such CVR Proceeds held by all Holders as
each reflected on the CVR Register as of the close of business on the date prior to the date of payment (rounded down to the nearest whole cent). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Payment Date</I></B>&#8221; means (a)&nbsp;with respect to any Net Cash Excess (if any), no later than 30 days following the
final determination of the Final Net Cash; (b)&nbsp;with respect to any Legacy Assets Transaction Proceeds described in clause (i)&nbsp;of such definition, no later than 30 days following the later of (i)&nbsp;the final determination of the Final
Net Cash and (ii)&nbsp;receipt of the corresponding portion of Gross Proceeds by Parent or any of its Affiliates, pursuant to which Legacy Assets Transaction Proceeds are payable to Holders; (c)&nbsp;with respect to any Legacy Assets Transaction
Proceeds described in clause (ii)&nbsp;of such definition, no later than 30 days following the end of the Legacy Assets Transaction Period if there are any Remaining Funds; and (d)&nbsp;with respect to Legacy Receivable Amounts, no later than 30
days following the later of (i)&nbsp;the final determination of the Final Net Cash and (ii)&nbsp;the receipt or realization, as applicable, of any amount of the Legacy Receivable Amount (e.g., the realization of Savings described in clause (c),
clause (d)&nbsp;or clause (e)&nbsp;of the definition of &#8220;<B><I>Legacy Receivable Amounts</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Payment
Notice</I></B>&#8221; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.4(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Proceeds</I></B>&#8221;
means the amount equal to (i)&nbsp;the Legacy Assets Transaction Proceeds, if any, <U>plus</U> (ii)&nbsp;the Legacy Receivable Amount, if any, <U>plus</U> (iii)&nbsp;Net Cash Excess, if any, and <U>minus</U> (iv)&nbsp;Net Cash Shortfall, if any.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Register</I></B>&#8221; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Delaware Courts</I></B>&#8221; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>DTC</I></B>&#8221; means The Depository Trust Company or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Effective Time</I></B>&#8221; means the date and time of the effectiveness of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Equity Award CVR</I></B>&#8221; means each CVR received by a Holder in respect of each share of Company Common Stock underlying
Company Restricted Stock Unit Awards and/or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Options held by such Holder, as set forth in the CVR Register. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Expiration Date</I></B>&#8221; means two years following the Closing Date, <U>provided, that</U>, to the extent a Legacy Assets
Transaction takes place during the Legacy Assets Transaction Period, the Expiration Date shall be the earliest to occur of (I)&nbsp;the date that is the fifth (5th) anniversary of the date upon which any product resulting from the Legacy Assets is
approved for marketing and sale by regulatory authorities in a country, and (II)&nbsp;the mailing by the Rights Agent to the address of each Holder as reflected in the CVR Register of all CVR Payment Amounts (if any) required to be paid for Legacy
Assets Transaction Proceeds under the terms of this Agreement, as set forth in <U>Section</U><U></U><U>&nbsp;6.8(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Final Net Cash</I></B>&#8221; means the amount of Closing Net Cash,
recalculated by Parent pursuant to the procedures set forth in <U>Section</U><U></U><U>&nbsp;2.5</U> herein not later than the date that is 90 days following the Merger Closing Date (such date, the &#8220;<B><I>Final Net Cash Determination
Date</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Governmental Body</I></B>&#8221; means any federal, state, provincial, local, municipal, foreign or
other governmental or quasi-governmental authority, including, any arbitrator or arbitral body, mediator and applicable securities exchanges, or any department, minister, agency, commission, commissioner, board, subdivision, bureau, agency,
instrumentality, court or other tribunal of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Gross Proceeds</I></B>&#8221; means, without duplication,
the sum of all cash consideration and the value of any and all consideration of any kind that is paid to, or is received by, Parent or any of its Affiliates during the Legacy Assets CVR Period in respect of a Legacy Assets Transaction, solely as
such consideration relates to a Legacy Asset, as determined in good faith. The value of any securities (whether debt or equity) or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property constituting Gross Proceeds shall be determined as
follows: (A)&nbsp;the value of securities for which there is an established public market shall be equal to the volume weighted average of their closing market prices for the five (5)&nbsp;trading days ending the day prior to the date of payment to,
or receipt by, Parent or its relevant Affiliate, and (B)&nbsp;the value of securities that have no established public market and the value of consideration that consists of other <FONT STYLE="white-space:nowrap">non-cash</FONT> property, shall be
the fair market value thereof as of the date of payment to, or receipt by, Parent or its relevant Affiliate; <U>provided</U>, that Parent may elect, upon prompt notice to the Representative after receipt of consideration, to have any securities or
other <FONT STYLE="white-space:nowrap">non-cash</FONT> property specified in the foregoing clause (B)&nbsp;be deemed as Gross Proceeds only upon the earlier of (1)&nbsp;the receipt by Parent or any of its Affiliates of cash in respect of the sale or
other liquidation by Parent or its Affiliates of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property, and the value of such cash shall be Gross Proceeds upon receipt by Parent or any of its Affiliates, or (2)&nbsp;the
second (2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP>) anniversary of receipt of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property, and the value of such consideration shall be Gross Proceeds as of such
date with a value equal to the greater of (x)&nbsp;the fair market value of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property as of the date originally received by Parent or its relevant Affiliate or (y)&nbsp;the
fair market value of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property as of such date, and all other consideration, if any, paid to or received by Parent or any of its Affiliates will be deemed Gross Proceeds upon
receipt by Parent or its relevant Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Harrison Lease</I></B>&#8221; means that certain Lease, dated March&nbsp;14,
2022, between the Company and B9 LS Harrison&nbsp;&amp; Washington LLC (&#8220;<B><I>Landlord</I></B>&#8221;) regarding the premises (the &#8220;<B><I>Premises</I></B>&#8221;) on the fifth floor of the building known as 321 Harrison Avenue, Boston,
Massachusetts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Harrison Lease Arrangement</I></B>&#8221; means that, immediately following the Effective Time, the Company
shall transfer funds allocated to all future lease payment obligations under the Harrison Lease to a bank account maintained by Parent or its Affiliate and, unless the Harrison Lease is assigned or subleased, Parent shall use such funds and fulfill
lease payment obligations under the Harrison Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Harrison Sublease</I></B>&#8221; means that certain Sublease Agreement,
dated as of July 31, 2025, by and between the Company and Stellaromics, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Holder</I></B>&#8221; means, at the relevant time, a Person in whose name a CVR
is registered in the CVR Register at the applicable time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Kangh License Agreement</I></B>&#8221; means that certain
Exclusive License Agreement, dated as of January&nbsp;6, 2024, by and between the Company and Chengdu Kanghua Biological Products Co., Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Law</I></B>&#8221; means any foreign or U.S. federal, state or local law (including common law), treaty, statute, code, order,
ordinance, approval, authorization, certificate, registration, exemption, consent, license, order, permit and other similar authorizations, rule, regulation, or other requirement issued, enacted, adopted, promulgated, implemented or otherwise put
into effect by or under the authority of any Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets</I></B>&#8221; means all of the
Company&#8217;s and the Company&#8217;s Affiliates&#8217; right, title and interest in and to all Intellectual Property Rights and other assets and rights related to <FONT STYLE="white-space:nowrap">HIL-216,</FONT> including the Kangh License
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets and Expense Fund</I></B>&#8221; means a portion of the Closing Net Cash equal to $250,000, of which
$25,000 shall be paid at Closing to the Representative as compensation for serving as the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets CVR
Period</I></B>&#8221; means the period beginning on the Closing Date and ending on the Expiration Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets
Transaction</I></B>&#8221; means a financing arrangement for, or the sale, transfer, license or other disposition by Parent or any of its Affiliates, including the Company (after the Merger), of all or any part of any Legacy Assets, in each case
during the Legacy Assets Transaction Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets Transaction Agreement</I></B>&#8221; means a definitive
agreement, contract or other definitive arrangement entered into by Parent or any of its Affiliates, including the Company (after the Merger) or Parent NewCo, and any Person who is not an Affiliate of Parent providing for a Legacy Assets
Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets Transaction Period</I></B>&#8221; means the period beginning on the Effective Time and ending two
years following the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets Transaction Proceeds</I></B>&#8221; means (i) 90% of the Net Proceeds and
(ii)&nbsp;if there remain any unused funds in the Legacy Assets and Expense Fund following the end of the Legacy Assets Transaction Period (<I>&#8220;</I><B><I>Remaining Funds</I></B>&#8221;), 100% of such Remaining Funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Receivable Amount</I></B>&#8221; means cash payments equal to (a)&nbsp;the return of the security deposit by the Landlord,
which equals $1,631,365.5 after deducting any amount used, applied or retained by the Landlord pursuant to the Harrison Lease, (b)&nbsp;any interest accrued on the bank account referenced in the definition of &#8220;Harrison Lease Arrangement&#8221;
calculated on an annual basis for each successive <FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date, (c)&nbsp;if the Harrison Lease is assigned or subleased within twelve (12)&nbsp;months of the Closing Date
(including pursuant to the Harrison Sublease), 100% of the amount equal to the lease payment obligations assigned to or assumed by any subtenant under the Harrison Lease (including pursuant to the Harrison Sublease) (such assigned lease payment
obligations, the &#8220;<B><I>Savings</I></B>&#8221;) calculated on an annual basis for each successive <FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date (provided, that the Harrison Sublease shall be included for
purposes of this clause (c)), (d)&nbsp;if the Harrison Lease is assigned or subleased after twelve (12)&nbsp;months of the Closing Date, 90% of the applicable Savings calculated on an annual basis for each successive
<FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date, and (e)&nbsp;if any subtenant under the Harrison Lease extends the terms of such subtenant&#8217;s sublease (including pursuant to the Harrison Sublease), 100% of
the applicable Savings calculated on an annual basis for each successive <FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Net Cash Excess</I></B>&#8221; means, if Final Net Cash is greater than the
Signing Net Cash, then the amount equal to (a)&nbsp;Final Net Cash, <U>minus</U> (b)&nbsp;the Signing Net Cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Net Cash
Shortfall</I></B>&#8221; means, if Final Net Cash is less than the Signing Net Cash, then the amount equal to (a)&nbsp;Signing Net Cash, <U>minus</U> (b)&nbsp;the Final Net Cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Net Proceeds</I></B>&#8221; means, for each Legacy Assets Transaction, the Gross Proceeds minus Permitted Deductions, as
calculated in a manner consistent with generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and
statements and pronouncements of the Financial Accounting Standards Board (&#8220;<B><I>GAAP</I></B>&#8221;). For clarity, (i)&nbsp;if Permitted Deductions exceed Gross Proceeds as it relates to a certain Legacy Assets Transaction, any excess
Permitted Deductions shall be applied against Gross Proceeds in a subsequent Legacy Assets Transaction, and (ii)&nbsp;if any of the Gross Proceeds or Permitted Deduction are not in U.S. dollars, currency conversion to U.S. dollars shall be made by
using the exchange rate prevailing at the JP Morgan Chase Bank or its successor entity on the date of receipt of such Gross Proceeds or date of payment of relevant Permitted Deductions, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Officer&#8217;s Certificate</I></B>&#8221; means a certificate signed by an authorized officer of the applicable Buyer Entity, in
his or her capacity as such an officer, and delivered to the Rights Agent and the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Permitted CVR
Transfer</I></B>&#8221; means: a transfer of CVRs (a)&nbsp;upon death of a Holder by will or intestacy; (b)&nbsp;pursuant to a court order; (c)&nbsp;by operation of law (including by consolidation or merger) or without consideration in connection
with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; (d)&nbsp;in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner and, if
applicable, through an intermediary, to the extent allowable by DTC; or (e)&nbsp;as provided in <U>Section</U><U></U><U>&nbsp;2.8</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Permitted Deductions</B>&#8221; means the sum of, without duplication, the following costs or expenses that are, in the aggregate,
in excess of the Legacy Assets Fund: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) any applicable Taxes (including any applicable value added or sales taxes) imposed on Gross
Proceeds (and which are either imposed on Parent or its Affiliates or otherwise reduce the amount of Gross Proceeds received by Parent or its Affiliates) and, without duplication, any income or other similar Taxes payable by Parent or any of its
Affiliates that would not have been incurred by Parent or its Affiliates but for the Gross Proceeds having been received or accrued by the Company or its Subsidiaries (in each case, regardless of the due date of such Taxes); <U>provided</U><U>,
that</U> for purposes of calculating income Taxes payable by Parent or its Affiliates in respect of the Gross Proceeds, such income Taxes shall be calculated without taking into account any net operating losses or other Tax attributes generated by
Parent or its Affiliates or Company or any Subsidiary of the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) any reasonable and documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (excluding, for the avoidance of doubt, any Taxes) incurred by Parent or any of its Affiliates (with the Representative&#8217;s prior written consent) after the Merger in
connection with the applicable Legacy Asset(s) in respect of a Legacy Assets Transaction, including technology transfer costs, contractual expenses or any costs in respect of head licenses for sublicensed technology and the development or
prosecution, maintenance or enforcement by Parent or any of its Subsidiaries of intellectual property rights but excluding any costs related to a breach of this Agreement, including costs incurred in litigation in respect of the same; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;(i) any reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs
and expenses (excluding, for the avoidance of doubt, any Taxes) incurred by Parent or any of its Affiliates (with the Representative&#8217;s prior written consent) in connection with any Legacy Assets Transaction and business development related
efforts with respect to the relevant Legacy Asset(s) during the Legacy Assets Transaction Period, and (ii)&nbsp;maintenance costs related to the CVRs or the Legacy Assets (including fees and expenses related to the Rights Agent and the
Representative); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) any reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs (excluding, for the avoidance of doubt, any Taxes) incurred or accrued by Parent or any of its Affiliates (with the Representative&#8217;s prior
written consent) after the Merger in connection with Parent&#8217;s commercially reasonable efforts to negotiate or enter into any Legacy Assets Transaction Agreement or consummate a Legacy Assets Transaction, including any Representative&#8217;s
fee, Right&#8217;s Agent fee, any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee, service fee or other fee, commission or expense owed to any broker, finder, investment bank, auditor, accountant, counsel, advisor or
other third party in relation thereto (but excluding any costs or expenses previously deducted from Gross Proceeds and, for clarity, excluding any costs incurred or accrued and reflected in the Closing Cash Schedule, as finally determined in
accordance with the Merger Agreement as of the Cash Determination Time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Person</I></B>&#8221; means any individual, firm,
corporation, limited liability company, partnership, trust or other entity, and shall include any successor (by merger or otherwise) thereof or thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Representative Expenses</I></B>&#8221; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.6(g)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Representative Group</I></B>&#8221; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.6(g)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Rights Agent</I></B>&#8221; means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent
will have become such pursuant to the applicable provisions of this Agreement, and thereafter &#8220;<B><I>Rights Agent</I></B>&#8221; will mean such successor Rights Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Subsidiary</I></B>&#8221; means, with respect to any Person, any corporation, partnership, association, limited liability
company, unlimited liability company or other business entity of which (a)&nbsp;if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of
directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof or (b)&nbsp;if a partnership, association, limited
liability company, or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association, limited
liability company or other business entity if such Person or Persons are allocated a majority of partnership, association, limited liability company or other business entity gains or losses or otherwise control the managing director, managing
member, general partner or other managing Person of such partnership, association, limited liability company or other business entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Rules of Construction</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As used in this Agreement, any noun or pronoun will be deemed to include the plural as well as the singular and to cover all genders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement will be construed without regard to any presumption or rule requiring construction or interpretation against the party
drafting or causing any instrument to be drafted. The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be
construed as jointly drafted by the parties hereto and no presumption of burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As used in this Agreement, the words &#8220;include,&#8221; &#8220;includes,&#8221; or &#8220;including&#8221; will be deemed to be
followed by the words &#8220;without limitation.&#8221; The words &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221; &#8220;hereto,&#8221; and &#8220;hereunder&#8221; and words of similar import when used in this Agreement will refer
to this Agreement as a whole and not to any particular provision of this Agreement. The word &#8220;or&#8221; will not be exclusive. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
When reference is made in this Agreement to an Article or Section, such reference will refer to Articles and Sections of this Agreement, as the case may be, unless otherwise indicated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and
shall not be referred to in connection with the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) All references to $ are to United
States dollars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTINGENT VALUE RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>CVRs; Authority; Appointment of Rights Agent</U>. The CVRs represent the contractual rights of Holders to receive
contingent cash payment of the aggregate CVR Proceeds from the Buyer Entities pursuant to this Agreement. Each of the Buyer Entities has all requisite corporate power and authority to execute and deliver this Agreement and to perform its obligations
hereunder and to consummate the transactions contemplated by this Agreement. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the
part of the Buyer Entities and no other corporate proceedings on the part of the Buyer Entities are necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by
the Buyer Entities and, assuming the due authorization, execution </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and delivery by the Rights Agent and the Representative, constitutes a legal, valid and binding obligation of the Buyer Entities, enforceable against the Buyer Entities in accordance with its
terms. Neither the execution and delivery of this Agreement nor the performance by the Buyer Entities of its respective obligations hereunder or the consummation of the transactions contemplated hereby will (i)&nbsp;conflict with, or result in any
violation of any provision of the certificate of incorporation, bylaws and other similar organizational documents of the Buyer Entities, or (ii)&nbsp;conflict with, or result in any violation of or default (with or without notice or lapse of time,
or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation under, any loan or credit agreement, note, mortgage, indenture, lease, or other agreement, obligation, instrument, permit, concession, franchise,
license, judgment, order, decree, statute, law, ordinance, rule or regulation applicable to the Buyer Entities or its respective properties or assets which violation, in the case of clause (ii), individually or in the aggregate, would reasonably be
expected to be material to the Buyer Entities. No consent, approval, order or authorization of, or registration, declaration, notice or filing with, any Governmental Body is required by or with respect to the Buyer Entities in connection with the
execution and delivery of this Agreement by the Buyer Entities or the consummation by the Buyer Entities of the transactions contemplated hereby. The Buyer Entities hereby appoint [&#149;] as the Rights Agent to act as rights agent for the Buyer
Entities in accordance with the instructions hereinafter set forth in this Agreement, and [&#149;] hereby accepts such appointment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Nontransferable</U>. The CVRs may not be sold, assigned, transferred, pledged, encumbered or in any other manner
transferred or disposed of, in whole or in part, other than through a Permitted CVR Transfer. Any attempted sale, assignment, transfer, pledge, encumbrance or disposition of CVRs, in whole or in part, in violation of this Section&nbsp;2.2 shall be
void ab initio and of no effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>No Certificate; Registration; Registration of Transfer; Change of Address</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The CVRs will be issued and distributed by the Buyer Entities to each Holder in book-entry form only and will not be evidenced by a
certificate or other instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Rights Agent will keep a register (the &#8220;<B><I>CVR Register</I></B>&#8221;) for the purpose
of (i)&nbsp;identifying the Holders of CVRs and (ii)&nbsp;registering CVRs and Permitted CVR Transfers thereof. The CVR Register will initially show one position for Cede&nbsp;&amp; Co. representing all the Company Common Stock held by DTC on behalf
of the street holders of the Company Common Stock held by such Holders as of immediately prior to the Effective Time. The Rights Agent will have no responsibility whatsoever directly to the street name holders with respect to transfers of CVRs
unless and until such CVRs are transferred into the name of such street name holders in accordance with <U>Section&nbsp;2.2</U>. With respect to any payments to be made under <U>Section&nbsp;2.4</U> below, the Rights Agent will accomplish the
payment to any former street name holders of Company Common Stock by sending one lump payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to such street name holders. Upon a
written request of the Acting Holders or the Representative to the Buyer Entities, the Buyer Entities will cause the Rights Agent to make available to the Representative, as applicable, a list of the other Holders, the number of CVRs held by each
Holder, the contact information, including email address, maintained by the Rights Agent with respect to each Holder and such other information relating to this Agreement as may be reasonably requested by the Representative and is information that
is typically stored by a rights agent in accordance with general industry practices for similar types of engagements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subject to the restrictions on transferability set forth in <U>Section&nbsp;2.2</U> and
subject to the Rights Agent&#8217;s bona fide procedures to validate the identity of a Holder, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer, in form reasonably satisfactory to the Rights
Agent pursuant to its guidelines, duly executed by the Holder thereof, the Holder&#8217;s attorney duly authorized in writing, the Holder&#8217;s personal representative duly authorized in writing, or the Holder&#8217;s survivor (with written
documentation evidencing such Person&#8217;s status as the Holder&#8217;s survivor), and setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice and proper validation of the identity of such
Holder, the Rights Agent will, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of
<U>Section&nbsp;2.2</U>), register the transfer of the CVRs in the CVR Register. As a condition of such transfer, the Buyer Entities and the Rights Agent may require a transferring Holder or its transferee to pay to the applicable Governmental Body
any transfer, stamp, documentary, registration, or other similar Tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section
of this Agreement that requires the payment by a Holder of a CVR of such applicable Taxes or charges unless and until the Rights Agent is reasonably satisfied that all such Taxes or charges have been paid or that such Taxes or charges are not
applicable. All duly transferred CVRs registered in the CVR Register will be the valid obligations of the Buyer Entities and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the
transfer by the transferor. No transfer of a CVR will be valid until registered in the CVR Register in accordance with this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
A Holder may make a written request to the Rights Agent to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written notice and proper validation of the
identity of such Holder, the Rights Agent will promptly record the change of address in the CVR Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Payment
Procedures: Notices</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If a Legacy Assets Transaction Agreement is entered into during the Legacy Assets Transaction Period, then
the Buyer Entities shall promptly deliver to the Rights Agent (with a copy to the Representative) written notice indicating that a Legacy Assets Transaction Agreement has been entered into and a copy of the Legacy Assets Transaction Agreement and
any ancillary agreements thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) On or prior to each CVR Payment Date and subject to <U>Section&nbsp;4.2</U>, the Buyer Entities
shall deliver to the Rights Agent (with a copy to the Representative)&nbsp;(i) written notice indicating that (A)&nbsp;the Holders are entitled to receive one or more payments with respect to CVR Proceeds; (B)&nbsp;the source and trigger event for
such payment of CVR Proceeds; and (C)&nbsp;if applicable, (x)&nbsp;a detailed calculation of Gross Proceeds (including any calculations and/or supporting documentation applicable to any allocation determination for consideration related or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not related to a Legacy Asset), Net Proceeds and any Permitted Deductions used to calculate such Legacy Assets Transaction Proceeds with reasonable supporting detail for such Permitted Deductions
or (y)&nbsp;a detailed calculation of any Legacy Receivable Amount, with reasonable supporting documentation with respect to any component thereof, including but not limited to any interest accrued or Savings (each such notice, a &#8220;<B><I>CVR
Payment Notice</I></B>&#8221;), (ii) a letter of instruction setting forth, for each CVR, the CVR Payment Amount with respect thereto (including each component included in the calculation thereof) and (iii)&nbsp;any other letter of instruction
reasonably required by the Rights Agent. On or prior to any CVR Payment Date and subject to <U>Section&nbsp;4.2</U>, the Buyer Entities shall deliver to the Rights Agent the CVR Payment Amounts required by <U>Section&nbsp;4.2</U>. All amounts
delivered by the Buyer Entities hereunder shall be delivered in U.S. dollars. For the avoidance of doubt, the Buyer Entities shall have no further liability in respect of the relevant CVR Payment Amount upon delivery of such CVR Payment Amount in
accordance with this Section&nbsp;2.4(b) and the satisfaction of each of the Buyer Entities&#8217; obligations set forth in this <U>Section&nbsp;2.4(b)</U> and <U>Section&nbsp;2.6</U>. With respect to cash deposited by the Buyer Entities with the
bank or financial institution designated by the Rights Agent (which shall be Wells Fargo, U.S. Bank or another bank or financial institution of substantially equivalent national reputation and financial standing), the Rights Agent agrees to cause
such bank or financial institution to establish and maintain a separate demand deposit account, therefor in the name of the Rights Agent for the benefit of the Buyer Entities. The Rights Agent will only draw upon cash in such account(s) as required
from time to time in order to make payments as required under this Agreement and any applicable Tax withholding payments pursuant to <U>Section&nbsp;2.6(b)</U> herein. The Rights Agent shall have no responsibility or liability for any diminution of
funds that may result from any deposit or investment made by the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party, in the absence of fraud, bad
faith or willful misconduct by or on behalf of the Rights Agent. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest,
dividends or earnings to the Buyer Entities, the Representative, any Holder or any other party. The Rights Agent is acting as an agent hereunder and is not a debtor of the Buyer Entities in respect of cash deposited hereunder. For the avoidance of
doubt, the Buyer Entities and Representative acknowledge that (i)&nbsp;the Rights Agent is not a bank or a trust company, (ii)&nbsp;the Rights Agent is not acting in any sort of capacity as an &#8220;escrow&#8221; or similar agent hereunder, and
(iii)&nbsp;nothing in this Agreement shall be construed as requiring the Rights Agent to perform any services that would require registration with any governmental authority as a bank or a trust company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Rights Agent will promptly, and in any event within ten (10)&nbsp;Business Days after receipt of the CVR Payment Notice as well as any
letter of instruction reasonably required by the Rights Agent, send each Holder at its registered address a copy of the CVR Payment Notice (at the Buyer Entities&#8217; sole cost and expense) and, following the applicable CVR Payment Date, promptly
(or, with respect to any Equity Award CVRs, to the extent required to be exempt from Section&nbsp;409A of the Code, on or prior to the last date within the applicable &#8220;short-term deferral&#8221; period as set forth in Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(4))</FONT> pay the CVR Payment Amount (i)&nbsp;to each of the Holders (other than Holders who received Equity Award CVRs) by check mailed to the address of each Holder as reflected in the CVR
Register as of the close of business on the CVR Payment Date and (ii)&nbsp;with respect to Holders who received Equity Award CVRs, through the payroll system, or any successor payroll system, of Parent or any of its Affiliates, including the
Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Any portion of the CVR Payment Amount that remains undistributed to a Holder six
(6)&nbsp;months after the date of the delivery of the applicable CVR Payment Date will be delivered by the Rights Agent to the Buyer Entities, upon demand, and any Holder will thereafter look only to the Buyer Entities for payment of the CVR Payment
Amount, without interest, but such Holder will have no greater rights against the Buyer Entities than those accorded to general unsecured creditors of the Buyer Entities under applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) None of the Buyer Entities, any of its Affiliates, or the Rights Agent will be liable to any Person in respect of the CVR Payment Amount
delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite the Buyer Entities&#8217;, any of its Affiliates&#8217; or the Rights Agent&#8217;s commercially reasonable efforts to deliver the CVR
Payment Amount to the applicable Holder, the CVR Payment Amount has not been paid prior to two (2)&nbsp;years after the applicable CVR Payment Date (or immediately prior to such earlier date on which the CVR Payment Amount would otherwise escheat to
or become the property of any Governmental Body), the CVR Payment Amount will, to the extent permitted by applicable Law, become the property of the Buyer Entities, free and clear of all claims or interest of any Person previously entitled thereto.
In addition to and not in limitation of any other indemnity obligation herein, the Buyer Entities agree to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject
to in connection with transferring such property to the Buyer Entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Calculation of Final Net Cash</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On the tenth (10th)&nbsp;Business Day before the Final Net Cash Determination Date, Parent shall deliver to the Representative a schedule
(the &#8220;<B><I>Final Net Cash Schedule</I></B>&#8221;) setting forth, in reasonable detail, Parent&#8217;s good faith, estimated calculation of Final Net Cash (the &#8220;<B><I>Final Net Cash Calculation</I></B>&#8221;) as of the close of
business on the Final Net Cash Determination Date (the &#8220;<B><I>Final Net Cash Determination Time</I></B>&#8221;). Parent shall make available to the Representative, as reasonably requested by the Representative, the work papers and <FONT
STYLE="white-space:nowrap">back-up</FONT> materials used or any other relevant information useful in preparing the Final Net Cash Schedule, including <FONT STYLE="white-space:nowrap">close-out</FONT> memos or other forms of written affirmation from
vendors that either no more money is due or an amount of money is due that is reflected on the Final Net Cash Schedule. If reasonably requested by the Representative, reasonable access to Parent&#8217;s and the Surviving Corporation&#8217;s
accountants and counsel at reasonable times and upon reasonable notice will be provided by Parent in order to permit the Representative to review the Final Net Cash Calculation. The Final Net Cash Calculations shall include Parent&#8217;s
determination, as of the Final Net Cash Determination Time, of the Cash Amount and each component thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Representative shall
have the right to dispute any part of the Final Net Cash Calculation by delivering a Dispute Notice to that effect to Parent on or prior to 11:59 p.m., Eastern Time, on the fifth (5th) Business Day following the Representative&#8217;s receipt of the
Final Net Cash Schedule (the &#8220;<B><I>Response Time</I></B>&#8221;), which Dispute Notice shall identify in reasonable detail the nature and amounts of any proposed revisions to the proposed Final Net Cash Calculation and shall be accompanied by
a reasonably detailed explanation for the basis for such revisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If, on or prior to the Response Time, the Representative notifies Parent in writing that
it has no objections to the Final Net Cash Calculation or if the Representative fails to deliver a Dispute Notice prior to the Response Time, then the Final Net Cash Calculation as set forth in the Final Net Cash Schedule shall be deemed to have
been finally determined for purposes of this Agreement and shall represent the Final Net Cash at the Final Net Cash Determination Time for purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the Representative delivers a Dispute Notice on or prior to the Response Time, then Parent and the Representative shall promptly (and in
no event later than one (1)&nbsp;Business Day thereafter) meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of the Final Net Cash, which agreed upon Final Net Cash amount shall be deemed to
have been finally determined for purposes of this Agreement and shall represent the Final Net Cash at the Final Net Cash Determination Time for purposes of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If Parent and the Representative are unable to negotiate an agreed-upon determination of Final Net Cash as of the Final Net Cash
Determination Time pursuant to this <U>Section&nbsp;2.5</U> within three (3)&nbsp;Business Days after delivery of the Dispute Notice (or such other period as Parent and the Representative may mutually agree upon), then any remaining disagreements as
to the calculation of Final Net Cash shall be referred to for resolution to the Accounting Firm. Parent and the Representative shall promptly deliver to the Accounting Firm the work papers and <FONT STYLE="white-space:nowrap">back-up</FONT>
materials used in preparing the Final Net Cash Schedule and the Dispute Notice, and Parent and the Representative shall use commercially reasonable efforts to cause the Accounting Firm to make its determination within three (3)&nbsp;Business Days of
accepting its selection. Parent and the Representative shall be afforded the opportunity to present to the Accounting Firm any materials related to the unresolved disputes and to discuss the issues with the Accounting Firm; provided that no such
presentation or discussion shall occur without the presence of each of Parent and the Representative. The determination of the Accounting Firm shall be limited to the disagreements submitted to the Accounting Firm. The determination of the amount of
Final Net Cash made by the Accounting Firm shall be made in writing delivered to each of Parent and the Representative, shall be final and binding on Parent and the Representative and shall (absent manifest error) be deemed to have been finally
determined for purposes of this Agreement and to represent the Final Net Cash at the Final Net Cash Determination Time for purposes of this Agreement. The fees and expenses of the Accounting Firm shall be allocated between Parent and the
Representative in the same proportion that the disputed amount of the Final Net Cash that was unsuccessfully disputed by such party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Final Net Cash amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except to the extent any portion of the CVR Payment Amount is required to be treated as interest pursuant to applicable Law, the Buyer
Entities and the Representative intend that, for all U.S. federal and applicable state and local income tax purposes, (i)&nbsp;the CVRs received in respect of Company Common Stock (which for avoidance of doubt does not include the Equity Award CVRs)
will be treated as additional consideration paid with respect to such Company Common Stock in connection with the Offer or the Merger, as the case may be and (ii)&nbsp;any CVR Payment Amount paid in respect of any Equity Award CVR will be treated as
compensation in the year in which the CVR Payment Amount is made (and not upon the receipt of such CVR). The Buyer Entities and its Affiliates (including the Company after the Merger) shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(and the Buyer Entities shall instruct the Rights Agent to) report for all Tax purposes in a manner consistent with the foregoing (including as relates to any interest), and none of the parties
will take any position to the contrary on any U.S. federal, state and local Tax Returns or for other U.S. federal and applicable state and local income tax purposes, unless otherwise required by applicable Law or a &#8220;determination&#8221; within
the meaning of Section&nbsp;1313(a) of the Code (or a similar determination under applicable state or local Law). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to any
Permitted Deductions, the Buyer Entities and its Affiliates (including the Company after the Merger) and the Rights Agent shall be entitled to, and the Buyer Entities will instruct the Rights Agent or its applicable Affiliate to, deduct and
withhold, or cause to be deducted or withheld, from each CVR Payment Amount or any other amounts otherwise payable pursuant to this Agreement such amounts as may be required to be deducted and withheld therefrom under applicable Law. With respect to
Holders who received Equity Award CVRs, any such withholding may be made, or caused to be made, by the Buyer Entities through the payroll system or any successor payroll system of the Buyer Entities or any of its Affiliates, including the Company.
Prior to making (or causing to be made) any Tax deduction or withholding pursuant to this <U>Section&nbsp;2.6(b)</U>, the Rights Agent will (and the Buyer Entities shall instruct the Rights Agent to) provide the opportunity for the Holders to
provide properly completed and duly executed Internal Revenue Service Forms <FONT STYLE="white-space:nowrap">W-9</FONT> or applicable Form <FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable, or any other reasonably appropriate forms or
information from Holders in order to eliminate or reduce withholding. The Rights Agent shall and the Buyer Entities shall (or shall cause its applicable Affiliate to), as applicable, promptly and timely remit, or cause to be promptly and timely
remitted, any amounts withheld in respect of Taxes to the appropriate Governmental Body. To the extent any amounts are so deducted and withheld and properly remitted, such amounts shall be treated for all purposes of this Agreement as having been
paid to the Person in respect of whom such deduction and withholding was made. Promptly following such withholding, the Buyer Entities will (or will instruct its applicable Affiliate or the Rights Agent to) deliver to the Person to whom such amounts
would otherwise have been paid reasonably acceptable evidence of such withholding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Buyer Entities and the Representative intend
that each payment provided under this Agreement with respect to an Equity Award CVR (the &#8220;<B><I>Payments</I></B>&#8221;) is a separate &#8220;payment&#8221; for purposes <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(i)</FONT> of
the U.S. Treasury Regulations. For the avoidance of doubt, the Buyer Entities and the Representative intend that the Payments satisfy, to the greatest extent possible, the exemption from the application of Section&nbsp;409A of the Code and the
Treasury Regulations and other guidance issued thereunder and any state law of similar effect (collectively &#8220;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#8221;) provided under Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(4)</FONT> and, to the extent not so exempt, that the Payments comply, and this Agreement be interpreted to the greatest extent possible, as consistent with Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)(iv)(A)&#8212;that</FONT> is, as &#8220;transaction-based compensation.&#8221; To the extent this Agreement (and any definitions hereunder), or any payments hereunder, are not exempt, they shall
be construed in a manner that complies with Section&nbsp;409A, including by reason of satisfying the &#8220;transaction-based compensation&#8221; provisions thereunder, including the five-year post-Closing payment limitation therein, and shall
incorporate by reference all required definitions and payment terms. Notwithstanding the foregoing, none of the Buyer Entities, the Company or their respective board, or any of their respective representatives make any representation or warranty and
will have no liability to a Holder or transferee or any other Person if any payments under any provisions of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement are determined to constitute deferred compensation under Section&nbsp;409A of the Code (or any similar U.S. state tax law) that are subject to certain additional federal, state or other
taxes. The Buyer Entities may provide each recipient of an Equity Award CVR with a notice or award agreement setting forth the terms and condition of the Holder&#8217;s entitlement to payments under such Equity Award CVR in accordance with the terms
of this Agreement. The Rights Agent makes no representations or warranties with respect to tax treatment of the CVRs. None of the Rights Agent, its Affiliates or the services provided by the Rights Agent hereunder are intended to provide legal, tax
or financial advice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7 No <U>Voting, Dividends or Interest; No Equity or Ownership Interest in Parent or any of its
Affiliates</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The CVRs will not have any voting or dividend rights, and interest will not accrue on any amounts payable on the CVRs
to any Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The CVRs will not represent any equity or ownership interest in Parent, any constituent corporation party to the Merger
or any of their respective Affiliates. It is hereby acknowledged and agreed that a CVR shall not constitute a security of Parent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each
Holder, by virtue of the approval of the Merger and this Agreement by the Initial Holders or the receipt of any consideration in connection with the Merger, and without any further action of any of the Holders or the Company, acknowledges and agrees
to the appointment and authority of the Representative, as of the Offer Closing Time, to act as the exclusive representative, agent and true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT>
of such Holder and all Holders as set forth in this Agreement, which shall include the power and authority of the Representative to (i)&nbsp;incur and pay expenses on behalf of the Holders as required hereunder, (ii)&nbsp;exercise the audit rights
under <U>Section&nbsp;4.4</U>, and (iii)&nbsp;take or refrain from taking the actions specified herein and any other actions relating to the subject matter of this Agreement reasonably deemed necessary or appropriate by the Representative.
Notwithstanding the foregoing, the Representative shall have no obligation to act on behalf of the Holders, except as expressly provided herein and in the Representative Engagement Agreement, and for the avoidance of doubt, the Representative shall
have no obligations of the Representative under the Merger Agreement or any ancillary agreement, schedule or exhibit thereto other than this Agreement. All actions taken by the Representative in accordance with the terms of this Agreement and the
Representative Engagement Agreement shall be binding upon each Holder and such Holder&#8217;s successors as if expressly confirmed and ratified in writing by such Holder, and all defenses which may be available to any Holder to contest, negate or
disaffirm any such action of the Representative taken in good faith under this Agreement or the Representative Engagement Agreement are waived. Each Holder agrees that such Holder will not threaten, bring, commence, institute, maintain, prosecute or
voluntarily aid any action, which challenges the validity of or seeks to enjoin the operation of any provision of this Agreement, including the provisions relating to the authority of the Representative to act on behalf of such Holder and all
Holders as set forth in this Agreement. The Representative shall be entitled to: (A)&nbsp;rely upon the CVR Register and associated list of Holders, (B)&nbsp;rely upon any signature reasonably believed by it to be genuine, and (C)&nbsp;reasonably
assume that a signatory has proper authorization to sign on behalf of the applicable Holder or other party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent, its board of directors and its officers and Affiliates will not be deemed to
have any fiduciary or similar duties to any Holder by virtue of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) It is hereby acknowledged and agreed that the CVRs and
the possibility of any payment hereunder with respect thereto are highly speculative and subject to numerous factors outside of Parent&#8217;s control, and there is no assurance that Holders will receive any payments under this Agreement or in
connection with the CVRs. The Parties acknowledge that it is possible that no Legacy Assets Transaction will occur during the Legacy Assets Transaction Period and that there will not be any Gross Proceeds that may be the subject of a CVR Payment
Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Ability to Renounce or Abandon CVR</U>. Notwithstanding anything to the contrary contained herein, any Holder
or Holder&#8217;s successor or assign pursuant to a Permitted CVR Transfer may, at any time, at such Holder&#8217;s option, agree to renounce, in whole or in part, its rights under this Agreement and abandon all of such Holder&#8217;s remaining
rights in a CVR by transferring such CVR to the Buyer Entities without consideration therefor, effected by written notice to the Rights Agent, the Representative and the Buyer Entities, which renouncement and abandonment notice, if given, shall be
irrevocable. Nothing in this Agreement shall prohibit the Buyer Entities or any of its Affiliates from offering to acquire or acquiring any CVRs for consideration from the Holders, in private transactions or otherwise, in its sole discretion. Any
CVRs acquired by the Buyer Entities or any of its Affiliates shall be automatically deemed extinguished and no longer outstanding for purposes of the definition of Acting Holders and <U>ARTICLE VI</U> and <U>Section&nbsp;6.3</U> hereunder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE RIGHTS
AGENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Certain Duties and Responsibilities</U>. The provisions of this Section&nbsp;3 below shall survive the
termination of this Agreement, the exercise or expiration of the Rights, and the resignation, replacement or removal of the Rights Agent, and the exercise, termination and expiration of the CVRs. The Rights Agent will not have any liability for any
actions taken or not taken in connection with this Agreement, except to the extent of its bad faith, gross negligence, fraud or willful misconduct (in each case as determined by a court of competent jurisdiction). IN NO EVENT WILL THE RIGHTS AGENT
BE LIABLE FOR ANY SPECIAL, INDIRECT, INCIDENTAL, PUNITIVE OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT (INCLUDING LOST PROFITS, DAMAGE TO REPUTATION OR LOST SAVINGS), EVEN IF FORESEEABLE AND EVEN IF RIGHTS AGENT HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Certain Rights of Rights Agent</U>. The Rights Agent undertakes to
perform only the duties and obligations as are specifically set forth in this Agreement, and no implied covenants or obligations will be read into this Agreement against the Rights Agent. In addition, the Buyer Entities and the Representative (on
behalf of the Holders) each agree that the Rights Agent shall have the following rights: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Rights Agent may rely on and will be
protected and held harmless by Parent in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, power of attorney, endorsement, direction, consent, order or other paper or document
believed by it in good faith to be genuine and to have been signed, executed and, where necessary, verified or acknowledged or presented by the proper party or parties; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Rights Agent may rely on and shall be held harmless by Parent in acting upon written
(including electronically transmitted) or oral instructions from the Buyer Entities, the Representative or any Holder with respect to any matter relating to its acting as Rights Agent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) whenever the Rights Agent deems it desirable that a matter be proved or established prior to taking or omitting any action hereunder, the
Rights Agent may (i)&nbsp;rely upon an Officer&#8217;s Certificate, which certificate shall be full authorization and protection to the Rights Agent, and (ii)&nbsp;the Rights Agent shall, in the absence of bad faith, gross negligence, fraud or
willful misconduct on its part (in each case as determined by a court of competent jurisdiction), incur no liability and be held harmless by Parent for or in respect of any action taken or omitted to be taken by it under the provisions of this
Agreement in reliance upon such Officer&#8217;s Certificate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the Rights Agent may engage and consult with counsel of its selection and
the written advice of such counsel or any opinion of counsel will, in the absence of bad faith, gross negligence, fraud or willful misconduct (in each case as determined by a court of competent jurisdiction), provide full and complete authorization
and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the
CVR Proceeds; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to, any of
the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) the Rights Agent will have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution
and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by Parent), nor shall it be responsible for any
breach by Parent of any covenant or condition contained in this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Rights Agent shall not be required to perform any
action if such action would cause the Rights Agent to violate any applicable law, regulation or court order; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) the Rights Agent shall
not be deemed to have any knowledge of any event of which it was to receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for failing to take any action in connection therewith, unless and until
it has received such notice in writing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) the Rights Agent shall not assume any obligations or relationship of agency or trust
with the Representative or any Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Parent agrees to indemnify the Rights Agent and its affiliates, and its and their respective
employees, officers, directors, representatives and advisors for, and hold such Persons harmless against, any loss, liability, damage, judgment, fine, penalty, cost or expense (each, a &#8220;<B><I>Loss</I></B>&#8221;) arising out of or in
connection with the Rights Agent&#8217;s duties under this Agreement, including the reasonable, documented and necessary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses of defending
the Rights Agent against any claims, charges, demands, actions or suits arising out of or in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement or enforcing its rights hereunder,
unless such Loss has been determined by a court of competent jurisdiction to be a result of Rights Agent&#8217;s gross negligence, bad faith, fraud or willful misconduct; <U>provided, that</U> this <U>Section&nbsp;3.2(l)</U> shall not apply with
respect to income, receipt, franchise or similar Taxes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Parent agrees (i)&nbsp;to pay the fees and expenses of the Rights Agent in
connection with this Agreement as agreed upon in writing by the Rights Agent and Parent on or prior to the date hereof and (ii)&nbsp;to reimburse the Rights Agent for all reasonable, documented and necessary <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses paid or incurred by the Rights Agent in connection with the administration by the Rights Agent of its duties hereunder, including all stamp and transfer Taxes (and excluding for the
avoidance of doubt any income, receipt, franchise or similar) and governmental charges, except that Parent will have no obligation to pay the fees of the Rights Agent or reimburse the Rights Agent for the fees of counsel in connection with any
lawsuit initiated by the Rights Agent on behalf of itself, except in the case of any suit enforcing the provisions of <U>Section&nbsp;2.4(a)</U>, <U>Section&nbsp;2.4(b)</U>, <U>Section&nbsp;2.4(c)</U>, <U>Section&nbsp;2.4(d)</U> or
<U>Section&nbsp;3.2</U>, if Parent is found by a court of competent jurisdiction to be liable to the Rights Agent or the Holders, as applicable in such suit; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in
the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to
it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Resignation and Removal; Appointment of Successor</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Rights Agent may resign at any time by giving written notice thereof to Parent (with a copy to the Representative) specifying a date
when such resignation will take effect, which notice will be sent at least sixty (60)&nbsp;days prior to the date so specified but in no event will such resignation become effective until a successor Rights Agent has been appointed. The
Representative shall have the right to remove the Rights Agent at any time by specifying a date when such removal will take effect but no such removal will become effective until a successor Rights Agent has been appointed. Notice of such removal
will be given by the Representative to Rights Agent (with a copy to Parent), which notice will be sent at least sixty (60)&nbsp;days prior to the date so specified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Rights Agent provides notice of its intent to resign, is removed pursuant to
<U>Section&nbsp;3.3(a)</U> or becomes incapable of acting, Parent and the Representative, acting in concert, will, as soon as is reasonably possible, appoint a qualified successor Rights Agent who, unless otherwise consented to in writing by the
Acting Holders, shall be a stock transfer agent of national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with
<U>Section&nbsp;3.4</U>, become the successor Rights Agent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent will give notice of each resignation and each removal of a Rights
Agent and each appointment of a successor Rights Agent by mailing written notice of such event by first-class mail to the Holders as their names and addresses appear in the CVR Register. Each notice will include the name and address of the successor
Rights Agent. If Parent fails to send such notice within ten (10)&nbsp;Business Days after acceptance of appointment by a successor Rights Agent in accordance with <U>Section&nbsp;3.4</U>, the successor Rights Agent will cause the notice to be
mailed at the expense of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Transition Support</U>. As long as all fees and charges that are due and payable to
the Rights Agent for the Rights Agent&#8217;s services performed under this Agreement have been paid, the Rights Agent will cooperate with Parent, the Representative and any successor Rights Agent as reasonably requested in connection with the
transition of the duties and responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including transferring the CVR Register to the successor Rights Agent. The Rights Agent shall be entitled
to reimbursement by Parent for costs and expenses related to such transition services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Acceptance of Appointment by
Successor</U>. Every successor Rights Agent appointed pursuant to <U>Section&nbsp;3.3(b) </U>hereunder will execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of
this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent. On request of Parent or the successor Rights
Agent, the retiring Rights Agent will execute and deliver an instrument transferring to the successor Rights Agent all the rights, powers, trusts and duties of the retiring Rights Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>List of Holders</U>. Parent will furnish or cause to be furnished to the Rights Agent (with a copy to the
Representative)&nbsp;(a) in such form as Parent receives from the Company&#8217;s transfer agent (or other agent performing similar services for Parent), the names, email addresses and addresses of the Holders of such securities and (b)&nbsp;in the
case of Holders of Equity Award CVRs, the names and addresses of the Holders of such securities set forth in the books and records of the Company, in each case, within thirty (30)&nbsp;days of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Payment of CVR Payment Amounts</U>. The Buyer Entities shall, promptly following receipt of a payment of CVR Proceeds,
deposit with the Rights Agent, for payment to the Holders in accordance with <U>Section&nbsp;2.4</U>, the aggregate amount necessary to pay the CVR Payment Amount to each Holder; <U>provided</U>, that the Buyer Entities shall aggregate multiple
payments of CVR Proceeds until the aggregate amount reaches $500,000 and that such exception does not apply to the final payment of CVR Proceeds which shall occur no later than 30 days following the applicable CVR Payment Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Discretion and Decision-Making Authority</U>. Notwithstanding anything
herein to the contrary, but subject to Parent&#8217;s obligations as set forth herein, (a)&nbsp;Parent and its Affiliates shall have the power and right to control all aspects of their businesses and operations (and all of their assets and
products), and subject to its compliance with the terms of this Agreement, Parent and its Affiliates may exercise or refrain from exercising such power and right as it may deem appropriate and in the best overall interests of Parent and its
Affiliates and its and their stockholders, rather than the interest of the Holders, and (b)&nbsp;following the Legacy Assets Transaction Period, the Company shall be permitted to take any action in respect of the Legacy Assets; provided, that,
during the Legacy Assets Transaction period: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Solely if requested in writing by the Representative, Parent shall (or shall cause its
Affiliates to) enter into one or more Legacy Assets Transaction Agreements; provided, however, that Parent shall not be required to enter into a Legacy Assets Transaction Agreement if such arrangement would result in the Legacy Assets being required
by GAAP to be consolidated in the financial statements of Parent following the consummation of the transactions contemplated by such Legacy Assets Transaction Agreement. For the avoidance of doubt, neither Parent nor any of its Affiliates may enter
into a Legacy Assets Transaction Agreement without the prior written consent of the Representative. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent shall (or shall cause its
Affiliates to) utilize the Legacy Assets and Expense Fund to take all actions reasonably necessary or advisable (subject to the prior written consent of the Representative) to maintain, advance and maximize the value of the Legacy Assets and pursue
one or more Legacy Assets Transactions (collectively, the &#8220;<B><I>Purpose</I></B>&#8221;), including but not limited to (i)&nbsp;the transfer of the Legacy Assets out of the Company and into a newly formed special purpose vehicle or other
similar structure (&#8220;<B><I>Parent NewCo</I></B>&#8221;), (ii) the issuance of any amount of new equity interests in Parent NewCo to bona fide third party investors and financing sources (iii)&nbsp;the issuance of any amount of new incentive
awards to Parent NewCo employees and/or consultants for services to Parent NewCo for the advancement of the Legacy Assets and pursuit of Legacy Assets Transactions, and (iii)&nbsp;any amount of new equity interests in Parent NewCo to maintain,
retain or improve the intellectual property, including the license, with respect to the Legacy Assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent shall not, before the
expiration of the Legacy Assets Transaction Period, terminate or negatively impact the required maintenance of Legacy Assets, including by failing to preserve and maintain the Legacy Assets. Solely if requested in writing by the Representative,
Parent shall terminate the Legacy Assets and wind down prosecution and maintenance costs relating to the Legacy Assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent shall
comply with all prosecution, maintenance and other obligations relating to the Intellectual Property Rights within the Legacy Assets required by any license or related term set forth in any Legacy Assets Transaction Agreement, to the extent such
Intellectual Property Rights are contemplated by said Legacy Assets Transaction Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Audit Right</U>. Parent agrees to maintain, for at least six months
after the applicable CVR Payment Date, all books and records relevant to the calculation of a CVR Payment Amount and the amount of Gross Proceeds, Net Proceeds and Permitted Deductions. Subject to reasonable advance written notice from the
Representative and prior execution and delivery by it and an independent accounting firm of national reputation chosen by the Representative (the &#8220;<B><I>Accountant</I></B>&#8221;) of a reasonable and customary confidentiality/nonuse agreement,
Parent shall permit the Representative and the Accountant, acting as agent of the Representative (on behalf of the Holders), to have access during normal business hours to the books and records of Parent as may be reasonably necessary to audit the
calculation of such CVR Payment Amount, the calculation of the amount of Gross Proceeds, Net Proceeds and Permitted Deductions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Assignments</U>. The Buyer Entities shall not, in whole or in part, assign any of its obligations under this Agreement
other than in accordance with the terms of Section&nbsp;6.3. At any time, the Representative may resign (in which case the Acting Holders shall promptly appoint a successor Representative (reasonably acceptable to the Buyer Entities)) and may assign
any of its rights or obligations under this Agreement (or this Agreement in its entirety) to any third party (reasonably acceptable to the Buyer Entities) to serve as a successor Representative, provided, that such assignee executes a written
joinder to this Agreement assuming the rights and duties of the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Additional Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the Legacy Assets Transaction Period, Parent shall, and shall cause its Subsidiaries, licensees and rights transferees to, use
commercially reasonable efforts to enter into one or more Legacy Assets Transaction Agreements as promptly as practicable following the Effective Time. During the Legacy Assets Transaction Period, Parent shall, and shall cause its Affiliates to, use
commercially reasonable efforts to (i)&nbsp;preserve and maintain the Legacy Assets (including with respect to its obligations in <U>Section&nbsp;4.3</U>), (ii) pursue any Legacy Assets Transaction required to advance the Legacy Assets and
(iii)&nbsp;take all other actions reasonably necessary and advisable to advance and maximize the value of the Legacy Assets in connection with achieving one or more Legacy Assets Transactions. Parent shall consult with the Representative on all
efforts taken by Parent and its Affiliates in compliance with Parent&#8217;s obligations under this <U>Section&nbsp;4.6(a)</U> and <U>Section&nbsp;4.3</U> herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any of the Buyer Entities desires to consummate a Change of Control prior to the final CVR Payment Date, such Buyer
Entity or its successor, as applicable depending upon the structure of the Change of Control, will cause the Person acquiring the Buyer Entity to assume the Buyer Entity&#8217;s or its successor&#8217;s (as applicable depending upon the structure of
the Change of Control) obligations, duties and covenants under this Agreement. No later than five (5)&nbsp;Business Days after the consummation of any Change of Control, the Buyer Entity will deliver to the Rights Agent an Officer&#8217;s
Certificate, stating that such Change of Control complies with this <U>Section&nbsp;4.6(b)</U> and that all conditions precedent herein relating to such transaction have been complied with. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Until such time as the Expiration Date occurs, (i)&nbsp;Parent shall, and shall cause
its Subsidiaries to, maintain records in the ordinary course of business pursuant to record-keeping procedures normally used by Parent and its Subsidiaries regarding its activities (including its resources and efforts) with respect to entering into
Legacy Assets Transaction Agreements and (ii)&nbsp;to the extent Parent licenses, sells, assigns or otherwise transfers intellectual property and other rights (including, without limitation, all data, marketing authorizations and applications for
marketing authorization), assets, rights, powers, privileges and Contracts, Parent will require the licensee, purchaser, assignee, or transferee, as applicable to provide the information necessary for Parent to comply with its obligations under this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Upon the reasonable written request from the Representative, and subject to the Representative executing a customary
confidentiality agreement in the event the information provided would constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information of Parent, Parent will provide (i)&nbsp;during the Legacy Assets Transaction Period, the
Representative with a written update in reasonable detail describing the progress, status and anticipated trajectory of efforts in respect of Legacy Assets Transactions and (ii)&nbsp;the anticipated timing of receiving payments in respect of such
Legacy Assets Transactions, in each case up to one time in a fiscal quarter of each calendar year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Parent shall, and shall cause its
Affiliates, including the Company, to, until such time as this Agreement is terminated pursuant to <U>Section&nbsp;6.8</U>, (i) comply in all material respects with their respective covenants and obligations under each Legacy Assets Transaction
Agreement, and (ii)&nbsp;consider the interests of the Holders under this Agreement in good faith, and not take any action, or fail to take any action, the primary purpose of which is to circumvent the purpose of this Agreement and the intent of the
parties, including by reducing the amount of Legacy Assets Transaction Proceeds. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Representative nor (if applicable) its
members, managers, directors, officers, contractors, agents and employees (collectively, the &#8220;<B><I>Representative Group</I></B>&#8221;), shall be liable to any Holder for any action or failure to act in connection with the acceptance or
administration of the Representative&#8217;s responsibilities hereunder unless and only to the extent such action or failure to act constitutes gross negligence, fraud or willful misconduct. The Holders shall indemnify, defend and hold harmless the
Representative Group from and against any and all losses, claims, damages, liabilities, fees, costs, expenses (including fees, disbursements and costs of counsel and other skilled professionals and in connection with seeking recovery from insurers),
judgments, fines, amounts paid in settlement (collectively, the &#8220;<B><I>Representative Expenses</I></B>&#8221;) incurred without gross negligence, fraud or willful misconduct on the part of the Representative and arising out of or in connection
with the acceptance or administration of its duties hereunder. Such Representative Expenses may be recovered first, from the Legacy Assets and Expense Fund, second, from any distribution of CVR Payment Amounts otherwise distributable to the Holders
at the time of distribution, and third, directly from the Holders. The immunities and rights to indemnification shall survive the resignation or removal of the Representative or any termination of this Agreement. The Holders acknowledge that the
Representative shall not be required to expend or risk its own funds or otherwise incur any financial liability in the exercise or performance of any of its powers, rights, duties or privileges or pursuant to this Agreement or the transactions
contemplated hereby or thereby. Furthermore, the Representative shall not be required to take any action unless the Representative has been provided with funds, security or indemnities which, in its reasonable determination, are sufficient to
protect the Representative against the costs, expenses and liabilities which may be incurred by the Representative in performing such actions. The powers, immunities and rights to indemnification granted to the Representative Group hereunder:
(i)&nbsp;are coupled with an interest and shall be irrevocable and survive the death, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
incompetence, bankruptcy or liquidation of any Holder and shall be binding on any successor thereto, and (ii)&nbsp;shall survive the delivery of an assignment by any Holder of the whole or any
fraction of his, her or its interest in the CVR Proceeds. The Legacy Assets and Expense Fund Amount shall be held by Parent in a segregated client account and shall be used only with the consent of the Representative (A)&nbsp;for the Purpose and
(B)&nbsp;for the purposes of paying directly or reimbursing the Representative for any Representative Expenses incurred pursuant to this Agreement. The Representative is not acting as a withholding agent or in any similar capacity in connection with
the Legacy Assets and Expense Fund and has no tax reporting or income distribution obligations with respect to the Legacy Assets and Expense Fund. The Holders will not receive any interest on the Legacy Assets and Expense Fund and assign to the
Representative any such interest. The Representative may instruct the Rights Agent to contribute funds to the Legacy Assets and Expense Fund from the CVR Payment Amounts otherwise distributable to any Holders, on a pro rata basis. As soon as
reasonably determined by the Representative that the Legacy Assets and Expense Fund is no longer required to be withheld, Parent shall distribute the remaining Legacy Assets and Expense Fund, if any, to the Rights Agent for further distribution to
the Holders in such proportions as though the amount of the remaining Legacy Assets and Expense Fund constituted CVR Proceeds hereunder (provided, that, any amounts remaining from the amounts contributed to the Legacy Assets and Expense Fund from
the CVR Payment Amounts otherwise distributable to any Holders pursuant to the previous sentence shall first be distributed to such Holders in proportion to such Holders&#8217; respective contributions). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Amendments without Consent of Holders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Without the consent of any Holders, the Representative, the Buyer Entities and the Rights Agent, at any time and from time to time, may
enter into one or more amendments hereto, for any of the following purposes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) to evidence the succession of another
Person to the Buyer Entities and the assumption by any such successor of the covenants of the Buyer Entities herein as provided in <U>Section&nbsp;6.3</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) to add to the covenants of the Buyer Entities such further covenants, restrictions, conditions or provisions as the
Representative, the Buyer Entities and the Rights Agent will consider to be for the protection of the Holders; <U>provided, that</U>, in each case, such provisions do not adversely affect the interests of the Holders; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other
provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; <U>provided, that</U>, in each case, such provisions do not adversely affect the interests of the Holders; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) as may be necessary or appropriate to ensure that the CVRs are not
subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, and to ensure that the CVRs are not subject to any similar registration
or prospectus requirement under applicable securities laws outside of the United States; <U>provided, that</U>, in each case, such provisions do not adversely affect the interests of the Holders; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) as may be necessary or appropriate to ensure that the Company complies with applicable Law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) to evidence the succession of another Person as a successor Rights Agent or the Representative and the assumption by any
such successor of the covenants and obligations of the Rights Agent or the Representative, as applicable, herein in accordance with <U>Section&nbsp;3.3</U> and <U>Section&nbsp;3.4</U>; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless
such addition, elimination or change is adverse to the interests of the Holders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without the consent of any Holders and the Buyer
Entities, the Rights Agent, in its sole and absolute discretion, at any time and from time to time, may enter into one or more amendments hereto, to reduce the number of CVRs, in the event any Holder agrees to renounce and abandon such
Holder&#8217;s rights under this Agreement in accordance with <U>Section&nbsp;2.8</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after the execution by the
Representative, the Buyer Entities and the Rights Agent of any amendment pursuant to the provisions of this <U>Section&nbsp;5.1</U>, the Buyer Entities shall mail (or cause the Rights Agent to mail at the Buyer Entities&#8217; sole cost and expense)
a notice thereof by first class mail to the Holders at their addresses as they appear on the CVR Register, setting forth such amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Amendments with Consent of Holders</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section&nbsp;5.1</U> (which amendments pursuant to <U>Section&nbsp;5.1</U> may be made without the consent of the Holders),
with the consent of the Acting Holders, whether evidenced in writing or taken at a meeting of the Holders, the Representative, the Buyer Entities and the Rights Agent may enter into one or more amendments hereto for the purpose of adding,
eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interests of the Holders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Promptly after the execution by the Buyer Entities, the Representative, and the Rights Agent of any amendment pursuant to the provisions of
this Section&nbsp;5.2, the Buyer Entities will mail (or cause the Rights Agent to mail at the Buyer Entities&#8217; sole cost and expense) a notice thereof by first class mail to the Holders at their addresses as they appear on the CVR Register,
setting forth such amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Execution of Amendments</U>. In executing any amendment permitted by this <U>ARTICLE
V</U>, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by the Buyer Entities stating that the execution of such amendment is authorized or permitted by this Agreement. The
Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Effect of Amendments</U>. Upon the execution of any amendment under this
<U>ARTICLE V</U>, this Agreement will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. Notwithstanding anything in this Agreement to the contrary, the
Rights Agent and the Representative shall not be required to execute any supplement or amendment to this Agreement that it has determined would adversely affect its own rights, duties, obligations or immunities under this Agreement or, with respect
to the Representative, the rights, duties, obligations or immunities of the Holders under this Agreement. No supplement or amendment to this Agreement shall be effective unless duly executed by the Buyer Entities, Rights Agent and the
Representative. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER PROVISIONS OF GENERAL APPLICATION. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Notice</U>. Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed
given when delivered in Person, or by overnight courier, or three (3)&nbsp;Business Days after being sent by registered or certified mail (postage prepaid, return receipt requested), provided, that with respect to notices delivered to the
Representative, such notices must be delivered solely by email, as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to the Rights Agent, to it at: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#149;] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: [&#149;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [&#149;] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice)
to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#149;] </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: [&#149;] </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [&#149;] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to a Holder or any or all Holders or the
Representative, to it at: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Robert Hershberg </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">650 Town Center Drive, 20th Floor
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Costa Mesa, CA 92626 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Daniel Rees; Matt Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: Daniel.Rees@lw.com; Matt.Bush@lw.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to the Buyer
Entities: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">XOMA Royalty Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2200 Powell Street,
Suite 310 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Legal Department;
Bradley Sitko </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: legalgroup@xoma.com; [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a
copy (which shall not constitute notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Embarcadero Center, Suite 2600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Ryan A. Murr; Branden C. Berns </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email:
rmurr@gibsondunn.com; bberns@gibsondunn.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any party may specify a different address by giving notice in accordance with this
<U>Section&nbsp;6.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Notice to Holders</U>. Where this Agreement provides for notice to Holders, such notice will
be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later than the
latest date, and not earlier than the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any
particular Holder will affect the sufficiency of such notice with respect to other Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Successors and
Assigns</U>. The Buyer Entities may assign any or all of its rights, interests and obligations hereunder in its sole discretion and without the consent of any other party, (i)&nbsp;to any controlled Affiliate of Parent, but only for so long as it
remains a controlled Affiliate of Parent, (ii)&nbsp;in compliance with <U>Section&nbsp;4.6(b)</U>, or (iii)&nbsp;otherwise with the prior written consent of the Acting Holders (such consent not to be unreasonably withheld, conditioned or delayed),
any other Person (any permitted assignee under <U>clauses (i)</U>, <U>(ii)</U>, or <U>(iii)</U>, an &#8220;<B><I>Assignee</I></B>&#8221;), in each case <U>provided, that</U> the Assignee agrees to assume and be bound by all of the terms of this
Agreement. Any Assignee may thereafter assign any or all of its rights, interests and obligations hereunder in the same manner as the Buyer Entities pursuant to the prior sentence. In connection with any assignment to an Assignee described in
<U>clause (i)</U>&nbsp;above in this <U>Section&nbsp;6.3</U> and clause (ii)&nbsp;above in this <U>Section&nbsp;6.3</U>, the Buyer Entities shall agree to remain liable for the performance by each Assignee of all obligations of the Buyer Entities
hereunder with such Assignee substituted for the Buyer Entities under this Agreement. This Agreement will be binding upon, inure to the benefit of and be enforceable by each of the Buyer Entities&#8217; successors and each Assignee. Subject to
compliance with the requirements set forth in this <U>Section&nbsp;6.3</U> relating to assignments, this Agreement shall not restrict the Buyer Entities&#8217; any Assignee&#8217;s or any of their respective successors&#8217; ability to merge or
consolidate with, or sell, issue or dispose of its stock or other equity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interests or assets to, any other Person. Each of the Buyer Entities&#8217; successors and Assignees shall expressly assume by an instrument supplemental hereto, executed and delivered to the
Rights Agent (with a copy to the Representative), the due and punctual payment of the aggregate CVR Proceeds and the due and punctual performance and observance of all of the covenants and obligations of this Agreement to be performed or observed by
the Buyer Entities. The Rights Agent may not assign this Agreement without the Representative&#8217;s written consent, except to an affiliate of the Rights Agent in connection with a corporate restructuring or to a successor Rights Agent in
accordance with the terms of this Agreement. Any attempted assignment of this Agreement or any such rights in violation of this <U>Section&nbsp;6.3</U> shall be void and of no effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Benefits of Agreement</U>. Nothing in this Agreement, express or implied, will give to any Person (other than the Rights
Agent, the Representative, the Buyer Entities, the Buyer Entities&#8217; successors and Assignees, the Holders and the Holders&#8217; successors and assigns pursuant to a Permitted CVR Transfer) any benefit or any legal or equitable right, remedy or
claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the foregoing. The rights of Holders and their successors and assigns pursuant to Permitted CVR Transfers
are limited to those expressly provided in this Agreement. Notwithstanding anything to the contrary herein, the Representative shall not commence any action under this Agreement on behalf of or to enforce the rights of the Holders except at the
direction of and with the prior written consent of the Acting Holders. Except for the rights of the Rights Agent and the Representative set forth herein, the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under
any provision of this Agreement, to institute any action or proceeding with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights. Reasonable expenditures incurred by such Holders in
connection with any enforcement action hereunder may be deducted from any damages or settlement obtained prior to the distribution of any remainder to Holders generally. Holders acting pursuant to this provision on behalf of all Holders shall have
no liability to the other Holders for such actions. The Representative and all Holders (including the Acting Holders) must enforce any such legal or equitable rights, remedies or claims under this Agreement against the Buyer Entities and not against
the Rights Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>Governing Law; Jurisdiction; Waiver of Jury Trial</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement, the CVRs and all actions arising under or in connection therewith shall be governed by and construed in accordance with the
laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of law thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the parties hereto (i)&nbsp;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the
Chancery Court of the State of Delaware and any state appellate court therefrom or, if (but only if) such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware and any
appellate court therefrom (collectively, the &#8220;<B><I>Delaware Courts</I></B>&#8221;); and (ii)&nbsp;consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the address at which such party is
to receive notice in accordance with <U>Section&nbsp;6.1</U>. Each of the parties irrevocably and unconditionally (A)&nbsp;agrees not to commence any such action or proceeding except in the Delaware Courts, (B)&nbsp;agrees that any claim in respect
of any such action or proceeding may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be heard and determined in the Delaware Courts, (C)&nbsp;waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the jurisdiction or
laying of venue of any such action or proceeding in the Delaware Courts and (D)&nbsp;waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in the Delaware Courts. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES (WHETHER BASED
ON CONTRACT, TORT OR OTHERWISE), INCLUDING ANY COUNTERCLAIM, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT THEREOF.
EACH PARTY HERETO (A)&nbsp;MAKES THIS WAIVER VOLUNTARILY AND (B)&nbsp;ACKNOWLEDGES THAT SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS CONTAINED IN THIS <U>SECTION&nbsp;6.5(C)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Severability</U>. If any provision of this Agreement is held invalid or unenforceable by any court of competent
jurisdiction, the other provisions of this Agreement shall remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree shall remain in full force and effect to the extent not held invalid or
unenforceable. The parties further agree to replace such invalid or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid
or unenforceable provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Counterparts and Signature</U>. This Agreement may be executed in two or more
counterparts (including by an electronic scan delivered by electronic mail), each of which shall be deemed an original but all of which together shall be considered one and the same agreement and shall become effective when counterparts have been
signed by each of the parties hereto and delivered to the other party, it being understood that the parties need not sign the same counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Termination</U>. This Agreement will be terminated and of no force or effect, the parties hereto will have no liability
hereunder (other than with respect to monies due and owing by the Buyer Entities to the Rights Agent or the Representative), and no payments will be required to be made, upon the earliest to occur of (a)&nbsp;the mailing by the Rights Agent to the
address of each Holder as reflected in the CVR Register of all CVR Payment Amounts (if any) required to be paid under the terms of this Agreement, (b)&nbsp;the delivery of a written notice of termination duly executed by the Buyer Entities and the
Acting Holders, or (c)&nbsp;subject to <U>Section&nbsp;4.4</U>, the Expiration Date (only to the extent that a Legacy Assets Transaction does not occur prior to the Expiration Date). For the avoidance of doubt and notwithstanding anything to the
contrary, nothing herein shall terminate or otherwise negatively affect any of the rights or remedies of the Representative Group with respect to the Holders pursuant to this Agreement or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Entire Agreement</U>. This Agreement, the Merger Agreement (including the schedules, annexes and exhibits thereto and the
documents and instruments referred to therein) contain the entire understanding of the parties hereto and thereto with reference to the transactions and matters contemplated hereby and thereby and supersede all prior agreements, written or oral,
among the parties with respect hereto and thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Legal Holiday</U>. In the event that the CVR Payment Date shall not be
a Business Day, then, notwithstanding any provision of this Agreement to the contrary, any payment required to be made in respect of the CVRs on such date need not be made on such date, but may be made on the next succeeding Business Day with the
same force and effect as if made on the CVR Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <U>Obligations of Parent</U>. Parent shall ensure that Merger
Sub, and Merger Sub shall ensure that Parent, duly perform, satisfy and discharge each of the covenants, obligations and liabilities applicable to such party under this Agreement, and Parent shall be jointly and severally liable with Merger Sub for
the performance and satisfaction of each of said covenants, obligations and liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of Page Left Blank Intentionally]
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XOMA ROYALTY CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XRA 4 CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Robert Hershberg, solely in his capacity as the
Representative </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[<B>RIGHTS AGENT</B>] </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT D </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TENDER AND SUPPORT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <B>TENDER AND</B> <B>SUPPORT AGREEMENT</B> (this &#8220;<B>Agreement</B>&#8221;), dated as of August&nbsp;4, 2025, is made by and among
XOMA Royalty Corporation, a Nevada corporation (&#8220;<B>Parent</B>&#8221;), XRA 4 Corp., a Delaware corporation and a wholly owned subsidiary of Parent (&#8220;<B>Merger Sub</B>&#8221;), and the undersigned holder
(&#8220;<B>Stockholder</B>&#8221;) of shares of common stock, par value $0.0001 per share (the &#8220;<B>Company Common Stock</B>&#8221;), of HilleVax, Inc., a Delaware corporation (the &#8220;<B>Company</B>&#8221;). Capitalized terms used herein
and not defined shall have the meanings ascribed to them in the Merger Agreement (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Stockholder is, as
of the date hereof, the beneficial owner (as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;), which meaning will apply for all purposes
of this Agreement) of the number of shares of Company Common Stock set forth opposite the name of Stockholder on <U>Schedule</U><U></U><U>&nbsp;1</U> attached hereto (all such Shares, together with any securities convertible into or exercisable or
exchangeable or redeemable for Shares, and any New Shares (defined in <U>Section</U><U></U><U>&nbsp;3</U> below), the &#8220;<B>Shares</B>&#8221;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Parent, Merger Sub and the Company have entered into an Agreement and Plan of Merger, dated as of August&nbsp;4, 2025, by and
among Parent, Merger Sub and the Company (as such agreement may be subsequently amended or modified, the &#8220;<B>Merger Agreement</B>&#8221;), which provides, among other things, for the Buyer Entities to commence a tender offer for all of the
issued and outstanding shares of Company Common Stock (as it may be amended from time to time in accordance with the terms of the Merger Agreement, the &#8220;<B>Offer</B>&#8221;) and, following the completion of the Offer, the merger of Merger Sub
with and into the Company, with the Company surviving that merger, on the terms and subject to the conditions set forth in the Merger Agreement (the &#8220;<B>Merger</B>&#8221;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, as an inducement and a condition to the willingness of Parent and Merger Sub to enter into the Merger Agreement, and in
consideration of the substantial expenses incurred and to be incurred by them in connection therewith, Stockholder (solely in Stockholder&#8217;s capacity as a stockholder of the Company) has agreed to enter into and perform this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW</B>, <B>THEREFORE</B>, in consideration of, and as a condition to, Parent and Merger Sub entering into the Merger Agreement and
proceeding with the transactions contemplated thereby, and in consideration of the expenses incurred and to be incurred by the Buyer Entities in connection therewith, the parties hereto agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Agreement to Tender Shares</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms of this Agreement, Stockholder hereby agrees that it shall irrevocably tender its Shares, or cause its Shares to be
validly and irrevocably tendered, into the Offer pursuant to and in accordance with the terms of the Offer, free and clear of all Liens (as defined below) (except for Permitted Liens (as defined below)). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Upon receipt of payment in full for all of its Shares pursuant to the Merger Agreement
and the full and complete satisfaction of the terms of the Offer, Stockholder agrees that any and all rights incident to its ownership of Shares (including any rights to recover amounts, if any, that may be determined to be due to any stockholder or
former stockholder of the Company), including but not limited to rights arising out of Stockholder&#8217;s ownership of Shares prior to the transfer of such Shares to the Buyer Entities pursuant to the Offer or pursuant to the Merger Agreement,
shall be transferred to the Buyer Entities upon the transfer to the Buyer Entities of Stockholder&#8217;s Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Termination
Date</U>. As used in this Agreement, the term &#8220;<B>Termination Date</B>&#8221; shall mean the earliest to occur of: (a)&nbsp;the Effective Time; (b)&nbsp;such date and time as the Merger Agreement shall be validly terminated upon the terms and
subject to the conditions set forth therein; (c)&nbsp;an amendment of the Merger Agreement, without the prior written consent of Stockholder, in a manner that negatively or adversely affects the Offer or that decreases the amount, or changes the
form, of consideration payable to any stockholder of the Company pursuant to the terms of the Merger Agreement; (d)&nbsp;the mutual written agreement of the parties hereto to terminate this Agreement; (e)&nbsp;any material breach of this Agreement
or the Merger Agreement by Parent or Merger Sub; or (f)&nbsp;the Board approves, recommends, encourages or supports an alternative transaction in compliance with Section&nbsp;6.2 of the Merger Agreement. Upon termination of this Agreement, no party
shall have any further obligations or liabilities under this Agreement; provided, however, such termination shall not relieve any party from liability for any common law fraud or willful, knowing and material breach of this Agreement prior to
termination hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Additional Purchases</U>. Stockholder agrees that any Shares of the Company (and any securities convertible into
or exercisable or exchangeable or redeemable for Shares) that Stockholder purchases or with respect to which Stockholder otherwise acquires beneficial ownership (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange
Act) after the execution of this Agreement and prior to the Termination Date, including, without limitation, by the exercise of a Company Stock Option or the vesting or settlement of a Company Restricted Stock Unit (&#8220;<B>New Shares</B>&#8221;),
shall be subject to the terms and conditions of this Agreement to the same extent as if they constituted Shares as of the date hereof and the representation and warranties in <U>Section</U><U></U><U>&nbsp;5</U> below shall be true and correct as of
the date that beneficial ownership (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) of such New Shares is acquired. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Agreement to Retain Shares and Other Covenants</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the date hereof until the Termination Date, except as otherwise provided herein (including pursuant to
<U>Section</U><U></U><U>&nbsp;1</U> or <U>Section</U><U></U><U>&nbsp;7</U>) or in the Merger Agreement, Stockholder shall not, and Stockholder shall direct its Affiliates not to: (i)&nbsp;voluntarily transfer, assign, sell, <FONT
STYLE="white-space:nowrap">gift-over,</FONT> hedge, pledge or otherwise dispose (whether by sale or merger, liquidation, dissolution, dividend or distribution, by operation of Law or otherwise) of, enter into any derivative arrangement with respect
to, create or suffer to exist any Liens (except for Permitted Liens) on or consent to any of the foregoing (&#8220;<B>Transfer</B>&#8221;), any or all of the Shares or any right or interest therein; (ii)&nbsp;enter into any contract, option or other
agreement, arrangement or understanding with respect to any Transfer; (iii)&nbsp;grant or permit the grant of any proxy, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">power-of-attorney</FONT></FONT> or other authorization or
consent with respect to any of the Shares with respect to any matter that is, or is reasonably likely to be exercised in a manner, inconsistent with the transactions contemplated by the Merger Agreement or the terms and provisions thereof;
(iv)&nbsp;deposit any of the Shares into a voting trust, or enter into a voting agreement or arrangement with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to any of the Shares; or (v)&nbsp;directly take or cause the taking of any other action that would restrict, limit or interfere with the performance of Stockholder&#8217;s obligations
hereunder or the transactions contemplated hereby, except, in each case, as would not reasonably be expected to have, individually or in the aggregate, a material adverse effect on such Stockholder&#8217;s ability to timely perform its obligations
under this Agreement; provided, that Stockholder and its Affiliates shall be permitted to Transfer Shares to Affiliates, so long as such transferees agree to remain subject to the terms of this Agreement. Without limiting the foregoing, at all times
commencing with the execution and delivery of this Agreement and continuing until the Termination Date, Stockholder shall not tender the Shares into any tender or exchange offer commenced by a Person other than the Buyer Entities or any other
subsidiary of Parent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Stockholder hereby agrees not to commence or knowingly participate in any Proceeding, derivative or otherwise,
against Parent, Merger Sub, the Company or any of their respective successors or their Affiliates and each of their successors and assigns and their respective directors and officers (i)&nbsp;challenging the validity of, or seeking to enjoin or
delay the operation of, any provision of this Agreement or the Merger Agreement (including any claim seeking to enjoin or delay the Offer Closing Time or the Merger Closing) or (ii)&nbsp;alleging a breach of any duty of the Board of Directors of the
Company (the &#8220;<B>Board</B>&#8221;) in connection with the Merger Agreement, this Agreement or the transactions contemplated thereby or hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Representations and Warranties of Stockholder</U>. Stockholder hereby represents and warrants, as of the date hereof, to Parent and
Merger Sub as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Stockholder (i)&nbsp;is the beneficial owner of the Shares set forth opposite Stockholder&#8217;s name on
<U>Schedule</U><U></U><U>&nbsp;1</U> to this Agreement and (ii)&nbsp;except as set forth in <U>Schedule</U><U></U><U>&nbsp;1</U> to this Agreement, neither holds nor has any beneficial ownership interest in any other shares of Company Common Stock
or any performance based stock units, restricted stock, restricted stock units, deferred stock units, options, warrants or other right or security convertible into or exercisable, exchangeable or redeemable for shares of Company Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Stockholder has the full power and authority to execute and deliver this Agreement and to perform Stockholder&#8217;s obligations
hereunder, subject to applicable federal securities laws and the terms of this Agreement; if Stockholder is not an individual, it is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization and has
taken all action necessary to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby, and no other proceedings on the part of Stockholder are necessary to authorize this Agreement,
the performance of Stockholder&#8217;s obligations hereunder and the consummation of the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) This
Agreement (assuming this Agreement constitutes a valid and binding agreement of Parent and Merger Sub) has been duly executed and delivered by or on behalf of Stockholder and constitutes a valid and binding agreement with respect to Stockholder,
enforceable against Stockholder in accordance with its terms, subject to (i)&nbsp;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (ii)&nbsp;rules of law governing specific performance, injunctive relief
and other equitable remedies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The shares of Company Common Stock and the certificates, if any, representing the Shares
owned by Stockholder are now held by Stockholder, by a nominee or custodian for the benefit of Stockholder or by the depository under the Offer, free and clear of any liens, claims, charges, proxies, powers of attorney, rights of first offer or
rights of first refusal, voting agreement or voting trust or any other agreement, arrangement, or restriction with respect to the voting of such Shares, or other encumbrances or restrictions of any kind whatsoever (&#8220;<B>Liens</B>&#8221;), and
has sole or shared, and otherwise unrestricted, voting power with respect to such Shares, except for (i)&nbsp;any such Liens arising hereunder (in connection therewith any restrictions on transfer or any other Liens have been waived by appropriate
consent) and (ii)&nbsp;Liens imposed by federal or state securities laws (collectively, &#8220;<B>Permitted Liens</B>&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Neither
the execution and delivery of this Agreement by such Stockholder nor the consummation of the transactions contemplated hereby nor compliance by such Stockholder with any provisions herein will: (i)&nbsp;if such Stockholder is not an individual,
violate, contravene or conflict with or result in any breach of any provision of the certificate of incorporation or bylaws (or other similar governing documents) of such Stockholder, (ii)&nbsp;violate, conflict with, or result in a breach of any
provisions of, or require any consent, waiver or approval or result in a default or loss of a benefit (or give rise to any right of termination, cancellation, modification or acceleration or any event that, with the giving of notice, the passage of
time or otherwise, would constitute a default or give rise to any such right) under any of the terms, conditions or provisions of any Contract or other legally binding instrument or obligation to which such Stockholder is a party or by which such
Stockholder or any of its assets may be bound, (iii)&nbsp;result (or, with the giving of notice, the passage of time or otherwise, would result) in the creation or imposition of any Lien on any assets (including Shares) of such Stockholder (other
than one created by Parent or Merger Sub), or (iv)&nbsp;violate any Law applicable to such Stockholder or by which any of its assets (including Shares) are bound, except, in each case, as would not reasonably be expected to have, individually or in
the aggregate, a material adverse effect on such Stockholder&#8217;s ability to timely perform its obligations under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
Stockholder has not directly engaged any broker, investment banker, financial advisor, finder, agent or other Person such that such Person is entitled to any broker&#8217;s, finder&#8217;s, financial adviser&#8217;s or other similar fee or
commission in connection with this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Stockholder understands and acknowledges that Parent and Merger Sub are entering into
the Merger Agreement in reliance upon Stockholder&#8217;s execution and delivery of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Representations and Warranties
of Parent and Merger Sub</U>. Each of Parent and Merger Sub hereby represents and warrants to Stockholder as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Parent
and Merger Sub is a corporation, both duly organized, validly existing and in good standing (with respect to jurisdictions that recognize such concept) under the laws of the jurisdiction of its organization, and each of Parent and Merger Sub has all
requisite corporate power and authority to enter into and to perform its obligations under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has been duly authorized, executed and delivered by each of Parent and
Merger Sub, and, assuming the due authorization, execution and delivery of this Agreement on behalf of Stockholder, constitutes the valid and binding obligations of each of Parent and Merger Sub, enforceable against each of them in accordance with
their terms, subject to (i)&nbsp;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (ii)&nbsp;rules of law governing specific performance, injunctive relief and other equitable remedies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except for violations and defaults that would not adversely affect Parent&#8217;s or Merger Sub&#8217;s ability to perform any of its
obligations under, or consummate any of the transactions contemplated by, this Agreement or the Merger Agreement, the execution and delivery of this Agreement or the Merger Agreement by each of Parent and Merger Sub, and the consummation by Parent
and Merger Sub of the transactions contemplated hereby or thereby will not cause a violation by Parent or Merger Sub of any legal requirement applicable to Parent or Merger Sub. Neither Parent nor Merger Sub is required to make any filing with or to
obtain any consent from any Person at or prior to the Offer Closing Time or the Effective Time in connection with the execution and delivery of this Agreement and the Merger Agreement or the consummation by Parent or Merger Sub of any of the
transactions contemplated by this Agreement or the Merger Agreement, except: (i)&nbsp;as may be required by the Exchange Act, General Corporation Law of the State of Delaware (the &#8220;<B>DGCL</B>&#8221;) or other applicable Laws; or
(ii)&nbsp;where the failure to make any such filing or obtain any such consent would not adversely affect Parent&#8217;s or Merger Sub&#8217;s ability to perform any of its obligations under, or consummate any of the transactions contemplated by,
this Agreement and the Merger Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Survival</U>. All representations, warranties, covenants and agreements of or on behalf of
Stockholder in this Agreement or in any certificate, document or instrument delivered pursuant to this Agreement will terminate upon, and not survive, the closing of the transactions contemplated by the Merger Agreement. Stockholder and its
Affiliates will not have any liability or obligation to any other party or any other person or entity for any breach or inaccuracy of any representation, warranty, covenant or agreement in this Agreement or in any such certificate, document or
instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>No Limitation on Discretion as Director or Fiduciary</U>. Notwithstanding anything herein to the contrary, the covenants
and agreements set forth herein shall not prevent Stockholder: (a)&nbsp;from exercising his, her or its duties and obligations as a director of the Company or otherwise taking any action while acting in such capacity as a director of the Company,
(b)&nbsp;if Stockholder or any of its Representatives is an officer of the Company, from exercising his or her duties and obligations as an officer of the Company or otherwise taking any action permitted by the Merger Agreement, or (c)&nbsp;if
Stockholder is serving as a trustee or fiduciary of any ERISA plan or trust, from exercising his duties and obligations as a trustee or fiduciary of such ERISA plan or trust. Stockholder is executing this Agreement solely in his, her or its capacity
as a stockholder of the Company. Notwithstanding anything to the contrary in this Agreement or any other agreement or document executed or delivered in connection with the transactions contemplated hereby, nothing in this Agreement or any such other
agreement or document shall (i)&nbsp;release, waive, discharge, compromise, settle or affect any rights or claims that Stockholder or its Affiliates may have for (A)&nbsp;indemnification, advancement of expenses, contribution or reimbursement under
any applicable law, the certificate of incorporation, bylaws or other organizational documents of any person or party, any agreement or arrangement providing for such indemnification, advancement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contribution or reimbursement, or any insurance policy covering Stockholder or any of its Affiliates, (B)&nbsp;any breach of or default under this Agreement, the Merger Agreement or any other
agreement or document executed or delivered by Parent or Merger Sub, (C)&nbsp;any rights under this Agreement or the Merger Agreement, or (D)&nbsp;any rights or claims that are expressly reserved, acknowledged or granted by this Agreement or any
other agreement or document executed or delivered in connection with the transactions contemplated hereby; or (ii)&nbsp;limit, impair or affect any rights or claims that Stockholder and/or its Affiliates may have against any other person or party
arising out of or relating to any matter, event, circumstance, action, omission, transaction or occurrence that is outside the transactions contemplated hereby or the subject matter of this Agreement or any other agreement or document executed or
delivered in connection therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Notice</U>. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given (i)&nbsp;when delivered if delivered in person, (ii)&nbsp;on the next business day if transmitted by national overnight courier, or (iii)&nbsp;on the date delivered if sent by
<FONT STYLE="white-space:nowrap">e-mail</FONT> (provided confirmation of email receipt is obtained), to Parent or Merger Sub to the address or email address set forth in <U>Section</U><U></U><U>&nbsp;10.02</U> of the Merger Agreement and to each
Stockholder at its, his or her address or email address set forth opposite such Stockholder&#8217;s name on <U>Schedule</U><U></U><U>&nbsp;1</U> attached hereto (or at such other address or email address for a party hereto as shall be specified by
like notice). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Certain Restrictions</U>. Subject to the other terms of this Agreement, Stockholder hereby (a)&nbsp;waives and agrees
not to exercise any rights (including under Section&nbsp;262 of the DGCL) to demand appraisal of any Shares or rights to dissent from the Merger which may arise with respect to the Merger and (b)&nbsp;agrees not to commence or participate in, and to
take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or other proceeding, against Parent, Merger Sub, the Company or any of their respective directors, officers or successors relating to the
negotiation, execution or delivery of this Agreement or the Merger Agreement or the making or consummation of the Offer or consummation of the Merger, including any proceeding (i)&nbsp;challenging the validity of, or seeking to enjoin the operation
of, any provision of the Merger Agreement or this Agreement or (ii)&nbsp;alleging a breach of any fiduciary duty of the Board in connection with the Merger Agreement or the transactions contemplated thereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Disclosure</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Stockholder shall permit the Company and Parent to disclose in all documents and schedules filed with the U.S.&nbsp;Securities and Exchange Commission (the &#8220;<B>SEC</B>&#8221;) that Parent determines to be necessary in connection with the
Merger and any transactions related to the Merger, Stockholder&#8217;s identity and ownership of Shares and the nature of Stockholder&#8217;s commitments, arrangements and understandings under this Agreement; <U>provided</U> that Stockholder shall
have a reasonable opportunity to review and approve such disclosure prior to any such filing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the date hereof until the
Termination Date, Stockholder shall not make any public announcement regarding this Agreement and the transactions contemplated hereby without the prior written consent of Parent, except as may be required by applicable Law (provided that reasonable
notice of any such disclosure will be provided to Parent and Stockholder shall reasonably consult with Parent and Merger Sub with respect to such disclosure). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Adjustments</U>. In the event of any stock split, stock dividend, merger,
reorganization, recapitalization, reclassification, combination, exchange of shares or the like of the capital stock of the Company affecting the Shares, the terms of this Agreement shall apply to the resulting securities and the term
&#8220;<B>Shares</B>&#8221; shall be deemed to refer to and include such securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Spousal Consent</U>. If Stockholder is married
and any of the Shares may constitute community property or otherwise need spousal or other approval for this Agreement to be legal, valid and binding, Stockholder shall deliver to Parent and Merger Sub, concurrently herewith, a duly executed consent
of Stockholder&#8217;s spouse, in the form attached hereto as <U>Exhibit A</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Binding Effect and Assignment</U>. All of the
covenants and agreements contained in this Agreement shall be binding upon, and inure to the benefit of, the respective parties and their permitted successors, assigns, heirs, executors, administrators and other legal representatives, as the case
may be. This Agreement shall not be assignable by operation of Law or otherwise; <U>provided</U> that Parent may designate, prior to the Effective Time, by written notice to Stockholder, another subsidiary to be a party to this Agreement;
<U>provided</U> that such assignment shall not relieve Parent of its obligations hereunder or otherwise enlarge, alter or change any obligation of Stockholder or due to Parent or such other subsidiary. Any assignment in contravention of the
preceding sentence shall be null and void. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>No Waivers</U>. No waivers of any breach of this Agreement extended by Parent to
Stockholder shall be construed as a waiver of any rights or remedies of Parent with respect to any other stockholder of the Company who has executed an agreement substantially in the form of this Agreement with respect to Shares held or subsequently
held by such stockholder or with respect to any subsequent breach of Stockholder or any other such stockholder of the Company. No waiver of any provisions hereof by either party shall be deemed a waiver of any other provisions hereof by any such
party, nor shall any such waiver be deemed a continuing waiver of any provision hereof by such party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Governing Law; Jurisdiction
and Venue</U>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware without regard to its rules of conflict of laws. The parties hereto hereby irrevocably and unconditionally consent to and submit
to the exclusive jurisdiction of the courts of the State of Delaware and of the United States of America located in such state (the &#8220;<B>Delaware Courts</B>&#8221;) for any litigation arising out of or relating to this Agreement and the
transactions contemplated hereby (and agree not to commence any litigation relating thereto except in such courts), waive any objection to the laying of venue of any such litigation in the Delaware Courts and agree not to plead or claim in any
Delaware Court that such litigation brought therein has been brought in any inconvenient forum. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>WAIVER OF JURY TRIAL</U>. THE
PARTIES HERETO HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY ACTION OR PROCEEDING RELATED TO OR ARISING OUT OF THIS AGREEMENT, ANY DOCUMENT EXECUTED IN CONNECTION HEREWITH AND THE MATTERS CONTEMPLATED HEREBY AND THEREBY. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>No Agreement Until Executed</U>. Irrespective of negotiations among the parties or
the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties hereto unless and until (a)&nbsp;the Board has approved, for purposes of
any applicable <FONT STYLE="white-space:nowrap">anti-takeover</FONT> laws and regulations, and any applicable provision of the Company&#8217;s amended and restated certificate of incorporation, the transactions contemplated by the Merger Agreement,
(b)&nbsp;the Merger Agreement is executed by all parties thereto, and (c)&nbsp;this Agreement is executed by all parties hereto. If the Stockholder is married, and any of the Shares may constitute community property or spousal approval is otherwise
necessary for this Agreement to be legal, valid and binding, this Agreement has been duly and validly authorized, executed and delivered by, and constitutes the legal, valid and binding obligation of, the Stockholder&#8217;s spouse, enforceable
against Stockholder&#8217;s spouse in accordance with its terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Entire Agreement; Amendment</U>. This Agreement supersedes all
prior agreements, written or oral, among the parties hereto with respect to the subject matter hereof and contains the entire agreement among the parties with respect to the subject matter hereof. This Agreement may not be amended, supplemented or
modified, and no provisions hereof may be modified or waived, except by an instrument in writing signed by each party hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.
<U>Effect of Headings</U>. The section&nbsp;headings herein are for convenience only and shall not affect the construction of interpretation of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Severability</U>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of
competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably to
effect the intent of the parties. The parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes
of such void or unenforceable provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Specific Performance</U>. The parties hereto agree that irreparable damage may occur and
that the parties hereto may not have any adequate remedy at law in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the
parties hereto shall be entitled to seek an injunction or injunctions, specific performance or other equitable relief to prevent breaches or threatened breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement
in the Delaware Courts without proof of damages and, in any action for specific performance, each party hereto waives any requirement for the securing or posting of any bond in connection with such remedy, this being in addition to any other remedy
to which they are entitled at law or in equity. Any requirements for the securing or posting of any bond with respect to any such remedy are hereby waived. The parties hereto further agree that by seeking the remedies provided for in this
<U>Section</U><U></U><U>&nbsp;22</U>, a party shall not in any respect waive its right to seek any other form of relief that may be available to such party under this Agreement (including monetary damages) for breach of any of the provisions of this
Agreement or in the event that the remedies provided for in this <U>Section</U><U></U><U>&nbsp;22</U> are not available or otherwise are not granted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Expenses</U>. All fees and expenses incurred in connection this Agreement and the transactions contemplated hereby shall be paid by the
party incurring such fees or expenses, whether or not the Offer or the Merger is consummated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Counterparts; Effectiveness; Signatures</U>. This Agreement may be executed in any
number of counterparts (including by facsimile or by attachment to electronic mail in portable document format (PDF)), each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same
agreement, and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party. This Agreement may be executed by facsimile or.pdf signature and a facsimile or.pdf signature shall
constitute an original for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Parent, Merger Sub and Stockholder have caused this Agreement to be duly
executed and delivered as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>[STOCKHOLDER]</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Tender and Support Agreement] </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Parent, Merger Sub and Stockholder have caused this Agreement to be duly executed and
delivered as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XOMA ROYALTY CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>XRA 4 CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Tender and Support Agreement] </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Stockholder Name,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Address&nbsp;&amp; Email Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Company Common Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Company Stock Options</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Company Restricted Stock Units</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF SPOUSE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
consideration of the execution of that certain Tender and Support Agreement (the &#8220;<B>Support Agreement</B>&#8221;), dated August&nbsp;4, 2025, by and among [&#149;] (&#8220;<B>Stockholder</B>&#8221;), XOMA Royalty Corporation, a Nevada
corporation (&#8220;<B>Parent</B>&#8221;) and XRA 4 Corp., a Delaware corporation and a wholly owned subsidiary of Parent, I, the undersigned, spouse of Stockholder, have been given a copy of, and have had an opportunity to review, the Support
Agreement and clearly understand the provisions contained therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I hereby approve the Support Agreement and appoint my spouse as my <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> in respect to the exercise of any rights under the Support Agreement. I agree to be bound by and accept the provisions of the Support Agreement in lieu of all
other direct or indirect legal, equitable, beneficial, representative community property or other interest I may have in the Shares (as defined in the Support Agreement) held by my spouse under the laws in effect in the state or other applicable
jurisdiction of our residence as of the date of the signing of the Support Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(Please print)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: _________________, 2025 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>3
<FILENAME>d48493dex22.htm
<DESCRIPTION>EX-2.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;2.2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONTINGENT VALUE RIGHTS AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This CONTINGENT VALUE RIGHTS AGREEMENT, dated as of September&nbsp;17, 2025 (this &#8220;<B><I>Agreement</I></B>&#8221;), is entered into by
and between XOMA Royalty Corporation, a Nevada corporation (&#8220;<B><I>Parent</I></B>&#8221;), XRA 4 Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (&#8220;<B><I>Merger Sub</I></B>&#8221; and together with Parent, the
&#8220;<B><I>Buyer Entities</I></B>&#8221;), Broadridge Corporate Issuer Solutions, LLC, a Pennsylvania limited liability company, as Rights Agent (as defined herein), and Dr.&nbsp;Robert Hershberg, solely in his capacity as the initial
representative, agent and attorney <FONT STYLE="white-space:nowrap">in-fact</FONT> of the Holders (the &#8220;<B><I>Representative</I></B>&#8221;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Parent, Merger Sub and HilleVax, Inc., a Delaware corporation (the &#8220;<B><I>Company</I></B>&#8221;), have entered into an Agreement and Plan of Merger, dated as of August 4, 2025 (the &#8220;<B><I>Merger Agreement</I></B>&#8221;), pursuant to
which Merger Sub will merge with and into the Company (the &#8220;<B><I>Merger</I></B>&#8221;), with the Company surviving the Merger as a wholly owned Subsidiary of Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Merger Agreement, and in accordance with the terms and conditions thereof, the Buyer Entities shall deliver to
holders of outstanding Company Common Stock, Company Restricted Stock Unit Awards, and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Options certain CVRs (as defined herein) of the Company
(collectively, the &#8220;<B><I>Initial Holders</I></B>&#8221;), pursuant to the terms and subject to the conditions hereinafter described; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Whereas, the Legacy Assets of the Company may require maintenance and development to allow Parent to maximize the value of the Legacy Assets
prior to disposition on behalf of the Holders, and the parties desire to preserve the ability for Parent (with the consent of the Representative) to take certain actions such as the issuance of equity to maintain the Legacy Assets intellectual
property rights, financing the development of the Legacy Assets and enlistment of services of employees or consultants in connection therewith; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Buyer Entities desire that the Rights Agent act as its agent for the purposes of effecting the distribution of the CVRs to the
Initial Holders and performing the other services described in this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Initial Holders desire that the
Representative act as their agent for the purposes of accomplishing the intent and implementing the provisions of this Agreement and facilitating the consummation of the transactions contemplated hereby and performing the other services described in
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the consummation of the transactions referred to above, the parties
agree, for the equal and proportionate benefit of all Holders (as defined herein), as follows: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS: CERTAIN RULES OF CONSTRUCTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 1.1 <U>Definitions</U>. Capitalized terms used but not otherwise defined herein have the meanings ascribed thereto in the Merger
Agreement. References to the Company and Merger Sub herein apply to the surviving corporation of the Merger with the Company from and after the Effective Time. As used in this Agreement, the following terms will have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Acting Holders</I></B>&#8221; means, at the time of determination, Holders of not less than thirty percent (30%) of outstanding
CVRs as set forth in the CVR Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Affiliate</I></B>&#8221; of any particular Person means any other Person controlling,
controlled by or under common control with such particular Person. For the purposes of this definition, &#8220;controlling,&#8221; &#8220;controlled&#8221; and &#8220;control&#8221; mean the possession, directly or indirectly, of the power to direct
the management and policies of a Person whether through the ownership of voting securities, contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Assignee</I></B>&#8221; has the meaning set forth in <U>Section&nbsp;6.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Business Day</I></B>&#8221; means a day, other than a Saturday, Sunday or public holiday (including Nasdaq or New York Stock
Exchange holidays), on which banks are not required or authorized by Law to close in New York, New York or Boston, Massachusetts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Change of Control</I></B>&#8221; means (a)&nbsp;a sale or other disposition of all or substantially all of the assets of any of
the Buyer Entities on a consolidated basis (other than to any Subsidiary (direct or indirect) of Parent), (b) a merger or consolidation involving any of the Buyer Entities in which neither the Buyer Entities is the surviving entity, and (c)&nbsp;any
other transaction involving any of the Buyer Entities in which such Buyer Entity is the surviving or continuing entity but in which the stockholders of the Buyer Entity immediately prior to such transaction own less than 50% of the Buyer
Entity&#8217;s voting power immediately after the transaction, in the case of each of the foregoing clauses (a), (b) and (c), whether effected directly or indirectly, and whether effected in a single transaction or a series of related transactions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Closing</I></B>&#8221; means the consummation of the Merger and the transactions contemplated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Closing Date</I></B>&#8221; means the date of the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Code</I></B>&#8221; means the United States Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Contract</I></B>&#8221; means any written or oral agreement, contract, subcontract, lease,
<FONT STYLE="white-space:nowrap">sub-lease,</FONT> occupancy agreement, binding understanding, obligation, promise, instrument, indenture, mortgage, note, option, warranty, purchase order, license, sublicense, commitment or undertaking of any
nature, which, in each case, is legally binding upon a party or on any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVRs</I></B>&#8221; means the
contractual contingent value rights of Holders that are granted by the Buyer Entities to Initial Holders as additional consideration for the Offer and the Merger pursuant to the terms of the Offer and the Merger Agreement. Unless otherwise specified
herein, for purposes of this Agreement all the CVRs shall be considered as part of and shall act as one class only. For the avoidance of doubt, the Buyer Entities shall grant CVRs only to the Initial Holders, and shall not grant CVRs to any other
Persons at any other time during the pendency of this Agreement, pursuant and subject to the terms hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Payment Amount</I></B>&#8221; means, for a given Holder, an amount equal to
the product of (a)&nbsp;the CVR Proceeds and (b)&nbsp;(i) the total number of CVRs entitled to receive such CVR Proceeds held by such Holder divided by (ii)&nbsp;the total number of CVRs entitled to receive such CVR Proceeds held by all Holders as
each reflected on the CVR Register as of the close of business on the date prior to the date of payment (rounded down to the nearest whole cent). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Payment Date</I></B>&#8221; means (a)&nbsp;with respect to any Net Cash Excess (if any), no later than 30 days following the
final determination of the Final Net Cash; (b)&nbsp;with respect to any Legacy Assets Transaction Proceeds described in clause (i)&nbsp;of such definition, no later than 30 days following the later of (i)&nbsp;the final determination of the Final
Net Cash and (ii)&nbsp;receipt of the corresponding portion of Gross Proceeds by Parent or any of its Affiliates, pursuant to which Legacy Assets Transaction Proceeds are payable to Holders; (c)&nbsp;with respect to any Legacy Assets Transaction
Proceeds described in clause (ii)&nbsp;of such definition, no later than 30 days following the end of the Legacy Assets Transaction Period if there are any Remaining Funds; and (d)&nbsp;with respect to Legacy Receivable Amounts, no later than 30
days following the later of (i)&nbsp;the final determination of the Final Net Cash and (ii)&nbsp;the receipt or realization, as applicable, of any amount of the Legacy Receivable Amount (e.g., the realization of Savings described in clause (c),
clause (d)&nbsp;or clause (e)&nbsp;of the definition of &#8220;<B><I>Legacy Receivable Amounts</I></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Payment
Notice</I></B>&#8221; has the meaning set forth in <U>Section&nbsp;2.4(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Proceeds</I></B>&#8221; means the amount
equal to (i)&nbsp;the Legacy Assets Transaction Proceeds, if any, <U>plus</U> (ii)&nbsp;the Legacy Receivable Amount, if any, <U>plus</U> (iii)&nbsp;Net Cash Excess, if any, and <U>minus</U> (iv)&nbsp;Net Cash Shortfall, if any. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>CVR Register</I></B>&#8221; has the meaning set forth in <U>Section&nbsp;2.3(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Delaware Courts</I></B>&#8221; has the meaning set forth in <U>Section&nbsp;6.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>DTC</I></B>&#8221; means The Depository Trust Company or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Effective Time</I></B>&#8221; means the date and time of the effectiveness of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Equity Award CVR</I></B>&#8221; means each CVR received by a Holder in respect of each share of Company Common Stock underlying
Company Restricted Stock Unit Awards and/or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">In-the-Money</FONT></FONT> Options held by such Holder, as set forth in the CVR Register. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Expiration Date</I></B>&#8221; means two years following the Closing Date, <U>provided, that</U>, to the extent a Legacy Assets
Transaction takes place during the Legacy Assets Transaction Period, the Expiration Date shall be the earliest to occur of (I)&nbsp;the date that is the fifth (5th) anniversary of the date upon which any product resulting from the Legacy Assets is
approved for marketing and sale by regulatory authorities in a country, and (II)&nbsp;the mailing by the Rights Agent to the address of each Holder as reflected in the CVR Register of all CVR Payment Amounts (if any) required to be paid for Legacy
Assets Transaction Proceeds under the terms of this Agreement, as set forth in <U>Section&nbsp;6.8(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Final Net Cash</I></B>&#8221; means the amount of Closing Net Cash,
recalculated by Parent pursuant to the procedures set forth in <U>Section&nbsp;2.5</U> herein not later than the date that is 90 days following the Merger Closing Date (such date, the &#8220;<B><I>Final Net Cash Determination Date</I></B>&#8221;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Governmental Body</I></B>&#8221; means any federal, state, provincial, local, municipal, foreign or other governmental or
quasi-governmental authority, including, any arbitrator or arbitral body, mediator and applicable securities exchanges, or any department, minister, agency, commission, commissioner, board, subdivision, bureau, agency, instrumentality, court or
other tribunal of any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Gross Proceeds</I></B>&#8221; means, without duplication, the sum of all cash
consideration and the value of any and all consideration of any kind that is paid to, or is received by, Parent or any of its Affiliates during the Legacy Assets CVR Period in respect of a Legacy Assets Transaction, solely as such consideration
relates to a Legacy Asset, as determined in good faith. The value of any securities (whether debt or equity) or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property constituting Gross Proceeds shall be determined as follows: (A)&nbsp;the
value of securities for which there is an established public market shall be equal to the volume weighted average of their closing market prices for the five (5)&nbsp;trading days ending the day prior to the date of payment to, or receipt by, Parent
or its relevant Affiliate, and (B)&nbsp;the value of securities that have no established public market and the value of consideration that consists of other <FONT STYLE="white-space:nowrap">non-cash</FONT> property, shall be the fair market value
thereof as of the date of payment to, or receipt by, Parent or its relevant Affiliate; <U>provided</U>, that Parent may elect, upon prompt notice to the Representative after receipt of consideration, to have any securities or other <FONT
STYLE="white-space:nowrap">non-cash</FONT> property specified in the foregoing clause (B)&nbsp;be deemed as Gross Proceeds only upon the earlier of (1)&nbsp;the receipt by Parent or any of its Affiliates of cash in respect of the sale or other
liquidation by Parent or its Affiliates of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property, and the value of such cash shall be Gross Proceeds upon receipt by Parent or any of its Affiliates, or (2)&nbsp;the second
(2<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP>) anniversary of receipt of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property, and the value of such consideration shall be Gross Proceeds as of such date with
a value equal to the greater of (x)&nbsp;the fair market value of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property as of the date originally received by Parent or its relevant Affiliate or (y)&nbsp;the fair market
value of such securities or other <FONT STYLE="white-space:nowrap">non-cash</FONT> property as of such date, and all other consideration, if any, paid to or received by Parent or any of its Affiliates will be deemed Gross Proceeds upon receipt by
Parent or its relevant Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Harrison Lease</I></B>&#8221; means that certain Lease, dated March&nbsp;14, 2022, between
the Company and B9 LS Harrison&nbsp;&amp; Washington LLC (&#8220;<B><I>Landlord</I></B>&#8221;) regarding the premises (the &#8220;<B><I>Premises</I></B>&#8221;) on the fifth floor of the building known as 321 Harrison Avenue, Boston, Massachusetts.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Harrison Lease Arrangement</I></B>&#8221; means that, immediately following the Effective Time, the Company shall transfer
funds allocated to all future lease payment obligations under the Harrison Lease to a bank account maintained by Parent or its Affiliate and, unless the Harrison Lease is assigned or subleased, Parent shall use such funds and fulfill lease payment
obligations under the Harrison Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Harrison Sublease</I></B>&#8221; means that certain Sublease Agreement, dated as of
July&nbsp;31, 2025, by and between the Company and Stellaromics, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Holder</I></B>&#8221; means, at the relevant time, a Person in whose name a CVR
is registered in the CVR Register at the applicable time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Kangh License Agreement</I></B>&#8221; means that certain
Exclusive License Agreement, dated as of January&nbsp;6, 2024, by and between the Company and Chengdu Kanghua Biological Products Co., Ltd. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Law</I></B>&#8221; means any foreign or U.S. federal, state or local law (including common law), treaty, statute, code, order,
ordinance, approval, authorization, certificate, registration, exemption, consent, license, order, permit and other similar authorizations, rule, regulation, or other requirement issued, enacted, adopted, promulgated, implemented or otherwise put
into effect by or under the authority of any Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets</I></B>&#8221; means all of the
Company&#8217;s and the Company&#8217;s Affiliates&#8217; right, title and interest in and to all Intellectual Property Rights and other assets and rights related to <FONT STYLE="white-space:nowrap">HIL-216,</FONT> including the Kangh License
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets and Expense Fund</I></B>&#8221; means a portion of the Closing Net Cash equal to $250,000, of which
$25,000 shall be paid at Closing to the Representative as compensation for serving as the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets CVR
Period</I></B>&#8221; means the period beginning on the Closing Date and ending on the Expiration Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets
Transaction</I></B>&#8221; means a financing arrangement for, or the sale, transfer, license or other disposition by Parent or any of its Affiliates, including the Company (after the Merger), of all or any part of any Legacy Assets, in each case
during the Legacy Assets Transaction Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets Transaction Agreement</I></B>&#8221; means a definitive
agreement, contract or other definitive arrangement entered into by Parent or any of its Affiliates, including the Company (after the Merger) or Parent NewCo, and any Person who is not an Affiliate of Parent providing for a Legacy Assets
Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets Transaction Period</I></B>&#8221; means the period beginning on the Effective Time and ending two
years following the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Assets Transaction Proceeds</I></B>&#8221; means (i) 90% of the Net Proceeds and
(ii)&nbsp;if there remain any unused funds in the Legacy Assets and Expense Fund following the end of the Legacy Assets Transaction Period (<I>&#8220;</I><B><I>Remaining Funds</I></B>&#8221;), 100% of such Remaining Funds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Legacy Receivable Amount</I></B>&#8221; means cash payments equal to (a)&nbsp;the return of the security deposit by the Landlord,
which equals $1,631,365.5 after deducting any amount used, applied or retained by the Landlord pursuant to the Harrison Lease, (b)&nbsp;any interest accrued on the bank account referenced in the definition of &#8220;Harrison Lease Arrangement&#8221;
calculated on an annual basis for each successive <FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date, (c)&nbsp;if the Harrison Lease is terminated, assigned or subleased within twelve (12)&nbsp;months of the Closing
Date (including pursuant to the Harrison Sublease), 100% of the amount equal to the lease payment obligations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
saved, or assigned to or assumed by any subtenant under the Harrison Lease (including pursuant to the Harrison Sublease) (such saved or assigned lease payment obligations, the
&#8220;<B><I>Savings</I></B>&#8221;) calculated on an annual basis for each successive <FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date (<U>provided</U>, that the Harrison Sublease shall be included for purposes of
this clause (c)), (d) if the Harrison Lease is terminated, assigned or subleased after twelve (12)&nbsp;months of the Closing Date, 90% of the applicable Savings calculated on an annual basis for each successive
<FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date, and (e)&nbsp;if any subtenant under the Harrison Lease extends the terms of such subtenant&#8217;s sublease (including pursuant to the Harrison Sublease), 100% of
the applicable Savings calculated on an annual basis for each successive <FONT STYLE="white-space:nowrap">12-month</FONT> period following the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Net Cash Excess</I></B>&#8221; means, if Final Net Cash is greater than the Signing Net Cash, then the amount equal to
(a)&nbsp;Final Net Cash, <U>minus</U> (b)&nbsp;the Signing Net Cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Net Cash Shortfall</I></B>&#8221; means, if Final Net
Cash is less than the Signing Net Cash, then the amount equal to (a)&nbsp;Signing Net Cash, <U>minus</U> (b)&nbsp;the Final Net Cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Net Proceeds</I></B>&#8221; means, for each Legacy Assets Transaction, the Gross Proceeds minus Permitted Deductions, as
calculated in a manner consistent with generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and
statements and pronouncements of the Financial Accounting Standards Board (&#8220;<B><I>GAAP</I></B>&#8221;). For clarity, (i)&nbsp;if Permitted Deductions exceed Gross Proceeds as it relates to a certain Legacy Assets Transaction, any excess
Permitted Deductions shall be applied against Gross Proceeds in a subsequent Legacy Assets Transaction, and (ii)&nbsp;if any of the Gross Proceeds or Permitted Deduction are not in U.S. dollars, currency conversion to U.S. dollars shall be made by
using the exchange rate prevailing at the JP Morgan Chase Bank or its successor entity on the date of receipt of such Gross Proceeds or date of payment of relevant Permitted Deductions, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Officer&#8217;s Certificate</I></B>&#8221; means a certificate signed by an authorized officer of the applicable Buyer Entity, in
his or her capacity as such an officer, and delivered to the Rights Agent and the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Permitted CVR
Transfer</I></B>&#8221; means: a transfer of CVRs (a)&nbsp;upon death of a Holder by will or intestacy; (b)&nbsp;pursuant to a court order; (c)&nbsp;by operation of law (including by consolidation or merger) or without consideration in connection
with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; (d)&nbsp;in the case of CVRs held in book-entry or other similar nominee form, from a nominee to a beneficial owner and, if
applicable, through an intermediary, to the extent allowable by DTC; or (e)&nbsp;as provided in <U>Section&nbsp;2.8</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Permitted Deductions</I></B>&#8221; means the sum of, without duplication, the following costs or expenses that are, in the
aggregate, in excess of the Legacy Assets Fund: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) any applicable Taxes (including any applicable value added or sales taxes) imposed on
Gross Proceeds (and which are either imposed on Parent or its Affiliates or otherwise reduce the amount of Gross Proceeds received by Parent or its Affiliates) and, without duplication, any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
income or other similar Taxes payable by Parent or any of its Affiliates that would not have been incurred by Parent or its Affiliates but for the Gross Proceeds having been received or accrued
by the Company or its Subsidiaries (in each case, regardless of the due date of such Taxes); <U>provided</U>, that for purposes of calculating income Taxes payable by Parent or its Affiliates in respect of the Gross Proceeds, such income Taxes shall
be calculated without taking into account any net operating losses or other Tax attributes generated by Parent or its Affiliates or Company or any Subsidiary of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) any reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and
expenses (excluding, for the avoidance of doubt, any Taxes) incurred by Parent or any of its Affiliates (with the Representative&#8217;s prior written consent) after the Merger in connection with the applicable Legacy Asset(s) in respect of a Legacy
Assets Transaction, including technology transfer costs, contractual expenses or any costs in respect of head licenses for sublicensed technology and the development or prosecution, maintenance or enforcement by Parent or any of its Subsidiaries of
intellectual property rights but excluding any costs related to a breach of this Agreement, including costs incurred in litigation in respect of the same; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;(i) any reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs
and expenses (excluding, for the avoidance of doubt, any Taxes) incurred by Parent or any of its Affiliates (with the Representative&#8217;s prior written consent) in connection with any Legacy Assets Transaction and business development related
efforts with respect to the relevant Legacy Asset(s) during the Legacy Assets Transaction Period, and (ii)&nbsp;maintenance costs related to the CVRs or the Legacy Assets (including fees and expenses related to the Rights Agent and the
Representative); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) any reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs (excluding, for the avoidance of doubt, any Taxes) incurred or accrued by Parent or any of its Affiliates (with the Representative&#8217;s prior
written consent) after the Merger in connection with Parent&#8217;s commercially reasonable efforts to negotiate or enter into any Legacy Assets Transaction Agreement or consummate a Legacy Assets Transaction, including any Representative&#8217;s
fee, Right&#8217;s Agent fee, any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee, service fee or other fee, commission or expense owed to any broker, finder, investment bank, auditor, accountant, counsel, advisor or
other third party in relation thereto (but excluding any costs or expenses previously deducted from Gross Proceeds and, for clarity, excluding any costs incurred or accrued and reflected in the Closing Cash Schedule, as finally determined in
accordance with the Merger Agreement as of the Cash Determination Time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Person</I></B>&#8221; means any individual, firm,
corporation, limited liability company, partnership, trust or other entity, and shall include any successor (by merger or otherwise) thereof or thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Representative Expenses</I></B>&#8221; has the meaning set forth in <U>Section&nbsp;4.6(f)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Representative Group</I></B>&#8221; has the meaning set forth in <U>Section&nbsp;4.6(f)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Rights Agent</I></B>&#8221; means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent
will have become such pursuant to the applicable provisions of this Agreement, and thereafter &#8220;<B><I>Rights Agent</I></B>&#8221; will mean such successor Rights Agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><I>Subsidiary</I></B>&#8221; means, with respect to any Person, any corporation,
partnership, association, limited liability company, unlimited liability company or other business entity of which (a)&nbsp;if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any
contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof or
(b)&nbsp;if a partnership, association, limited liability company, or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one
or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a partnership, association, limited liability company or other business entity if such
Person or Persons are allocated a majority of partnership, association, limited liability company or other business entity gains or losses or otherwise control the managing director, managing member, general partner or other managing Person of such
partnership, association, limited liability company or other business entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Rules of Construction</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As used in this Agreement, any noun or pronoun will be deemed to include the plural as well as the singular and to cover all genders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement will be construed without regard to any presumption or rule requiring construction or interpretation against the party
drafting or causing any instrument to be drafted. The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be
construed as jointly drafted by the parties hereto and no presumption of burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As used in this Agreement, the words &#8220;include,&#8221; &#8220;includes,&#8221; or &#8220;including&#8221; will be deemed to be
followed by the words &#8220;without limitation.&#8221; The words &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221; &#8220;hereto,&#8221; and &#8220;hereunder&#8221; and words of similar import when used in this Agreement will refer
to this Agreement as a whole and not to any particular provision of this Agreement. The word &#8220;or&#8221; will not be exclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
When reference is made in this Agreement to an Article or Section, such reference will refer to Articles and Sections of this Agreement, as the case may be, unless otherwise indicated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and
shall not be referred to in connection with the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) All references to $ are to United
States dollars. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTINGENT VALUE RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>CVRs; Authority; Appointment of Rights Agent</U>. The CVRs represent the contractual rights of Holders to receive
contingent cash payment of the aggregate CVR Proceeds from the Buyer Entities pursuant to this Agreement. Each of the Buyer Entities has all requisite corporate power and authority to execute and deliver this Agreement and to perform its obligations
hereunder and to consummate the transactions contemplated by this Agreement. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the
part of the Buyer Entities and no other corporate proceedings on the part of the Buyer Entities are necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by
the Buyer Entities and, assuming the due authorization, execution and delivery by the Rights Agent and the Representative, constitutes a legal, valid and binding obligation of the Buyer Entities, enforceable against the Buyer Entities in accordance
with its terms. Neither the execution and delivery of this Agreement nor the performance by the Buyer Entities of its respective obligations hereunder or the consummation of the transactions contemplated hereby will (i)&nbsp;conflict with, or result
in any violation of any provision of the certificate of incorporation, bylaws and other similar organizational documents of the Buyer Entities, or (ii)&nbsp;conflict with, or result in any violation of or default (with or without notice or lapse of
time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation under, any loan or credit agreement, note, mortgage, indenture, lease, or other agreement, obligation, instrument, permit, concession,
franchise, license, judgment, order, decree, statute, law, ordinance, rule or regulation applicable to the Buyer Entities or its respective properties or assets which violation, in the case of clause (ii), individually or in the aggregate, would
reasonably be expected to be material to the Buyer Entities. No consent, approval, order or authorization of, or registration, declaration, notice or filing with, any Governmental Body is required by or with respect to the Buyer Entities in
connection with the execution and delivery of this Agreement by the Buyer Entities or the consummation by the Buyer Entities of the transactions contemplated hereby. The Buyer Entities hereby appoint Broadridge Corporate Issuer Solutions, LLC as the
Rights Agent to act as rights agent for the Buyer Entities in accordance with the instructions hereinafter set forth in this Agreement, and Broadridge Corporate Issuer Solutions, LLC hereby accepts such appointment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Nontransferable</U>. The CVRs may not be sold, assigned, transferred, pledged, encumbered or in any other manner
transferred or disposed of, in whole or in part, other than through a Permitted CVR Transfer. Any attempted sale, assignment, transfer, pledge, encumbrance or disposition of CVRs, in whole or in part, in violation of this <U>Section&nbsp;2.2</U>
shall be void ab initio and of no effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>No Certificate; Registration; Registration of Transfer; Change of
Address</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The CVRs will be issued and distributed by the Buyer Entities to each Holder in book-entry form only and will not be
evidenced by a certificate or other instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Rights Agent will keep a register (the &#8220;<B><I>CVR Register</I></B>&#8221;)
for the purpose of (i)&nbsp;identifying the Holders of CVRs and (ii)&nbsp;registering CVRs and Permitted CVR Transfers thereof. The CVR Register will initially show one position for Cede&nbsp;&amp; Co. representing all the Company Common Stock held
by DTC on behalf of the street holders of the Company Common Stock held by such Holders as well as positions for Holders whose CVRs are held in their own name as of immediately prior to the Effective Time. The Rights Agent will have no
responsibility whatsoever directly to the street name holders with respect to transfers of CVRs unless and until </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such CVRs are transferred into the name of such street name holders in accordance with <U>Section&nbsp;2.2</U>. With respect to any payments to be made under <U>Section&nbsp;2.4</U> below, the
Rights Agent will accomplish the payment to any former street name holders of Company Common Stock by sending one lump payment to DTC. The Rights Agent will have no responsibilities whatsoever with regard to the distribution of payments by DTC to
such street name holders. Upon a written request of the Acting Holders or the Representative to the Buyer Entities, the Buyer Entities will cause the Rights Agent to make available to the Representative, as applicable, a list of the other Holders,
the number of CVRs held by each Holder, the contact information, including email address, maintained by the Rights Agent with respect to each Holder and such other information relating to this Agreement as may be reasonably requested by the
Representative and is information that is typically stored by a rights agent in accordance with general industry practices for similar types of engagements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subject to the restrictions on transferability set forth in <U>Section&nbsp;2.2</U> and subject to the Rights Agent&#8217;s bona fide
procedures to validate the identity of a Holder, every request made to transfer a CVR must be in writing and accompanied by a written instrument of transfer, in form reasonably satisfactory to the Rights Agent pursuant to its guidelines, duly
executed by the Holder thereof, the Holder&#8217;s attorney duly authorized in writing, the Holder&#8217;s personal representative duly authorized in writing, or the Holder&#8217;s survivor (with written documentation evidencing such Person&#8217;s
status as the Holder&#8217;s survivor), and setting forth in reasonable detail the circumstances relating to the transfer. Upon receipt of such written notice and proper validation of the identity of such Holder, the Rights Agent will, subject to
its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions of this Agreement (including the provisions of <U>Section&nbsp;2.2</U>), register the transfer of the
CVRs in the CVR Register. As a condition of such transfer, the Buyer Entities and the Rights Agent may require a transferring Holder or its transferee to pay to the applicable Governmental Body any transfer, stamp, documentary, registration, or
other similar Tax or governmental charge that is imposed in connection with any such registration of transfer. The Rights Agent shall have no duty or obligation to take any action under any section of this Agreement that requires the payment by a
Holder of a CVR of such applicable Taxes or charges unless and until the Rights Agent is reasonably satisfied that all such Taxes or charges have been paid or that such Taxes or charges are not applicable. All duly transferred CVRs registered in the
CVR Register will be the valid obligations of the Buyer Entities and will entitle the transferee to the same benefits and rights under this Agreement as those held immediately prior to the transfer by the transferor. No transfer of a CVR will be
valid until registered in the CVR Register in accordance with this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) A Holder may make a written request to the Rights Agent
to change such Holder&#8217;s address of record in the CVR Register. The written request must be duly executed by the Holder. Upon receipt of such written notice and proper validation of the identity of such Holder, the Rights Agent will promptly
record the change of address in the CVR Register. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Payment Procedures: Notices</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If a Legacy Assets Transaction Agreement is entered into during the Legacy Assets Transaction Period, then the Buyer Entities shall
promptly deliver to the Rights Agent (with a copy to the Representative) written notice indicating that a Legacy Assets Transaction Agreement has been entered into and a copy of the Legacy Assets Transaction Agreement and any ancillary agreements
thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) On or prior to each CVR Payment Date and subject to <U>Section&nbsp;4.2</U>, the Buyer
Entities shall deliver to the Rights Agent (with a copy to the Representative)&nbsp;(i) written notice indicating that (A)&nbsp;the Holders are entitled to receive one or more payments with respect to CVR Proceeds; (B)&nbsp;the source and trigger
event for such payment of CVR Proceeds; and (C)&nbsp;if applicable, (x)&nbsp;a detailed calculation of Gross Proceeds (including any calculations and/or supporting documentation applicable to any allocation determination for consideration related or
not related to a Legacy Asset), Net Proceeds and any Permitted Deductions used to calculate such Legacy Assets Transaction Proceeds with reasonable supporting detail for such Permitted Deductions or (y)&nbsp;a detailed calculation of any Legacy
Receivable Amount, with reasonable supporting documentation with respect to any component thereof, including but not limited to any interest accrued or Savings (each such notice, a &#8220;<B><I>CVR Payment Notice</I></B>&#8221;), (ii) a letter of
instruction setting forth, for each CVR, the CVR Payment Amount with respect thereto (including each component included in the calculation thereof) and (iii)&nbsp;any other letter of instruction reasonably required by the Rights Agent. On or prior
to any CVR Payment Date and subject to <U>Section&nbsp;4.2</U>, the Buyer Entities shall deliver to the Rights Agent the CVR Payment Amounts required by <U>Section&nbsp;4.2</U>. All amounts delivered by the Buyer Entities hereunder shall be
delivered in U.S. dollars. For the avoidance of doubt, the Buyer Entities shall have no further liability in respect of the relevant CVR Payment Amount upon delivery of such CVR Payment Amount in accordance with this <U>Section&nbsp;2.4(b)</U> and
the satisfaction of each of the Buyer Entities&#8217; obligations set forth in this <U>Section&nbsp;2.4(b)</U> and <U>Section&nbsp;2.6</U>. With respect to cash deposited by the Buyer Entities with the bank or financial institution designated by the
Rights Agent (which shall be Wells Fargo, U.S. Bank or another bank or financial institution of substantially equivalent national reputation and financial standing), the Rights Agent agrees to cause such bank or financial institution to establish
and maintain a separate demand deposit account, therefor in the name of the Rights Agent for the benefit of the Buyer Entities. The Rights Agent will only draw upon cash in such account(s) as required from time to time in order to make payments as
required under this Agreement and any applicable Tax withholding payments pursuant to <U>Section&nbsp;2.6(b)</U> herein. The Rights Agent shall have no responsibility or liability for any diminution of funds that may result from any deposit made by
the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party, in the absence of fraud, bad faith or willful misconduct by or on behalf of the Rights Agent.
The Rights Agent may from time to time receive interest in connection with such deposits. The Rights Agent shall not be obligated to pay such interest to the Buyer Entities, the Representative, any Holder or any other party. The Rights Agent is
acting as an agent hereunder and is not a debtor of the Buyer Entities in respect of cash deposited hereunder. For the avoidance of doubt, the Buyer Entities and Representative acknowledge that (i)&nbsp;the Rights Agent is not a bank or a trust
company, (ii)&nbsp;the Rights Agent is not acting in any sort of capacity as an &#8220;escrow&#8221; or similar agent hereunder, and (iii)&nbsp;nothing in this Agreement shall be construed as requiring the Rights Agent to perform any services that
would require registration with any governmental authority as a bank or a trust company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Rights Agent will promptly, and in any event within ten (10)&nbsp;Business Days
after receipt of the CVR Payment Notice as well as any letter of instruction reasonably required by the Rights Agent, send each Holder at its registered address a copy of the CVR Payment Notice (at the Buyer Entities&#8217; sole cost and expense)
and, following the applicable CVR Payment Date, promptly (or, with respect to any Equity Award CVRs, to the extent required to be exempt from Section&nbsp;409A of the Code, on or prior to the last date within the applicable &#8220;short-term
deferral&#8221; period as set forth in Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(4))</FONT> pay the CVR Payment Amount (i)&nbsp;to each of the Holders (other than Holders who received Equity Award CVRs) by check
mailed to the address of each Holder as reflected in the CVR Register as of the close of business on the CVR Payment Date and (ii)&nbsp;with respect to Holders who received Equity Award CVRs, through the payroll system, or any successor payroll
system, of Parent or any of its Affiliates, including the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Any portion of the CVR Payment Amount that remains undistributed
to a Holder six (6)&nbsp;months after the date of the delivery of the applicable CVR Payment Date will be delivered by the Rights Agent to the Buyer Entities, upon demand, and any Holder will thereafter look only to the Buyer Entities for payment of
the CVR Payment Amount, without interest, but such Holder will have no greater rights against the Buyer Entities than those accorded to general unsecured creditors of the Buyer Entities under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) None of the Buyer Entities, any of its Affiliates, or the Rights Agent will be liable to any Person in respect of the CVR Payment Amount
delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If, despite the Buyer Entities&#8217;, any of its Affiliates&#8217; or the Rights Agent&#8217;s commercially reasonable efforts to deliver the CVR
Payment Amount to the applicable Holder, the CVR Payment Amount has not been paid prior to two (2)&nbsp;years after the applicable CVR Payment Date (or immediately prior to such earlier date on which the CVR Payment Amount would otherwise escheat to
any Governmental Body), the CVR Payment Amount will become the property of the Buyer Entities, to the extent permitted by applicable Law, free and clear of all claims or interest of any Person previously entitled thereto. If the CVR Payment Amount
does not become the property of the Buyer Entities as per applicable Law upon transfer by the Rights Agent, such Holder will thereafter look only to the Buyer Entities for payment of the CVR Payment Amount, without interest, and the Buyer Entities
will be responsible for escheatment to the applicable Governmental Body. The Rights Agent will not be responsible for escheatment of abandoned property except in the case that the Buyer Entities are unable to provide the Rights Agent with the
applicable wire instructions to transfer such property to the Buyer Entities before the CVR Payment would escheat to the Governmental Body. In such case, the Rights Agent will be required to escheat the funds to the State immediately. In addition to
and not in limitation of any other indemnity obligation herein, the Buyer Entities agree to indemnify and hold harmless the Rights Agent with respect to any liability, penalty, cost or expense the Rights Agent may incur or be subject to in
connection with transferring such property to the Buyer Entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Calculation of Final Net Cash</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On the tenth (10th)&nbsp;Business Day before the Final Net Cash Determination Date, Parent shall deliver to the Representative a schedule
(the &#8220;<B><I>Final Net Cash Schedule</I></B>&#8221;) setting forth, in reasonable detail, Parent&#8217;s good faith, estimated calculation of Final Net Cash (the &#8220;<B><I>Final Net Cash Calculation</I></B>&#8221;) as of the close of
business on the Final Net Cash Determination Date (the &#8220;<B><I>Final Net Cash Determination Time</I></B>&#8221;). Parent shall make available to the Representative, as reasonably requested by the Representative, the work papers and <FONT
STYLE="white-space:nowrap">back-up</FONT> materials used or any other relevant information useful in preparing the Final Net Cash Schedule, including <FONT STYLE="white-space:nowrap">close-out</FONT>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
memos or other forms of written affirmation from vendors that either no more money is due or an amount of money is due that is reflected on the Final Net Cash Schedule. If reasonably requested by
the Representative, reasonable access to Parent&#8217;s and the Surviving Corporation&#8217;s accountants and counsel at reasonable times and upon reasonable notice will be provided by Parent in order to permit the Representative to review the Final
Net Cash Calculation. The Final Net Cash Calculations shall include Parent&#8217;s determination, as of the Final Net Cash Determination Time, of the Cash Amount and each component thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Representative shall have the right to dispute any part of the Final Net Cash Calculation by delivering a Dispute Notice to that
effect to Parent on or prior to 11:59 p.m., Eastern Time, on the fifth (5th) Business Day following the Representative&#8217;s receipt of the Final Net Cash Schedule (the &#8220;<B><I>Response Time</I></B>&#8221;), which Dispute Notice shall
identify in reasonable detail the nature and amounts of any proposed revisions to the proposed Final Net Cash Calculation and shall be accompanied by a reasonably detailed explanation for the basis for such revisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If, on or prior to the Response Time, the Representative notifies Parent in writing that it has no objections to the Final Net Cash
Calculation or if the Representative fails to deliver a Dispute Notice prior to the Response Time, then the Final Net Cash Calculation as set forth in the Final Net Cash Schedule shall be deemed to have been finally determined for purposes of this
Agreement and shall represent the Final Net Cash at the Final Net Cash Determination Time for purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the
Representative delivers a Dispute Notice on or prior to the Response Time, then Parent and the Representative shall promptly (and in no event later than one (1)&nbsp;Business Day thereafter) meet and attempt in good faith to resolve the disputed
item(s) and negotiate an agreed-upon determination of the Final Net Cash, which agreed upon Final Net Cash amount shall be deemed to have been finally determined for purposes of this Agreement and shall represent the Final Net Cash at the Final Net
Cash Determination Time for purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If Parent and the Representative are unable to negotiate an agreed-upon
determination of Final Net Cash as of the Final Net Cash Determination Time pursuant to this <U>Section&nbsp;2.5</U> within three (3)&nbsp;Business Days after delivery of the Dispute Notice (or such other period as Parent and the Representative may
mutually agree upon), then any remaining disagreements as to the calculation of Final Net Cash shall be referred to for resolution to the Accounting Firm. Parent and the Representative shall promptly deliver to the Accounting Firm the work papers
and <FONT STYLE="white-space:nowrap">back-up</FONT> materials used in preparing the Final Net Cash Schedule and the Dispute Notice, and Parent and the Representative shall use commercially reasonable efforts to cause the Accounting Firm to make its
determination within three (3)&nbsp;Business Days of accepting its selection. Parent and the Representative shall be afforded the opportunity to present to the Accounting Firm any materials related to the unresolved disputes and to discuss the
issues with the Accounting Firm; provided that no such presentation or discussion shall occur without the presence of each of Parent and the Representative. The determination of the Accounting Firm shall be limited to the disagreements submitted to
the Accounting Firm. The determination of the amount of Final Net Cash made by the Accounting Firm shall be made in writing delivered to each of Parent and the Representative, shall be final and binding on Parent and the Representative and shall
(absent manifest error) be deemed to have been finally determined for purposes of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement and to represent the Final Net Cash at the Final Net Cash Determination Time for purposes of this Agreement. The fees and expenses of the Accounting Firm shall be allocated between
Parent and the Representative in the same proportion that the disputed amount of the Final Net Cash that was unsuccessfully disputed by such party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Final Net
Cash amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except to the extent any portion of the CVR Payment Amount is required to be treated as interest pursuant to applicable Law, the Buyer
Entities and the Representative intend that, for all U.S. federal and applicable state and local income tax purposes, (i)&nbsp;the CVRs received in respect of Company Common Stock (which for avoidance of doubt does not include the Equity Award CVRs)
will be treated as additional consideration paid with respect to such Company Common Stock in connection with the Offer or the Merger, as the case may be and (ii)&nbsp;any CVR Payment Amount paid in respect of any Equity Award CVR will be treated as
compensation in the year in which the CVR Payment Amount is made (and not upon the receipt of such CVR). The Buyer Entities and its Affiliates (including the Company after the Merger) shall (and the Buyer Entities shall instruct the Rights Agent to)
report for all Tax purposes in a manner consistent with the foregoing (including as relates to any interest), and none of the parties will take any position to the contrary on any U.S. federal, state and local Tax Returns or for other U.S. federal
and applicable state and local income tax purposes, unless otherwise required by applicable Law or a &#8220;determination&#8221; within the meaning of Section&nbsp;1313(a) of the Code (or a similar determination under applicable state or local Law).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to any Permitted Deductions, the Buyer Entities and its Affiliates (including the Company after the Merger) and the
Rights Agent shall be entitled to, and the Buyer Entities will instruct the Rights Agent or its applicable Affiliate to, deduct and withhold, or cause to be deducted or withheld, from each CVR Payment Amount or any other amounts otherwise payable
pursuant to this Agreement such amounts as may be required to be deducted and withheld therefrom under applicable Law. With respect to Holders who received Equity Award CVRs, any such withholding may be made, or caused to be made, by the Buyer
Entities through the payroll system or any successor payroll system of the Buyer Entities or any of its Affiliates, including the Company. Prior to making (or causing to be made) any Tax deduction or withholding pursuant to this
<U>Section&nbsp;2.6(b)</U>, the Rights Agent will (and the Buyer Entities shall instruct the Rights Agent to) provide the opportunity for the Holders to provide properly completed and duly executed Internal Revenue Service Forms <FONT
STYLE="white-space:nowrap">W-9</FONT> or applicable Form <FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable, or any other reasonably appropriate forms or information from Holders in order to eliminate or reduce withholding. The Rights Agent
shall and the Buyer Entities shall (or shall cause its applicable Affiliate to), as applicable, promptly and timely remit, or cause to be promptly and timely remitted, any amounts withheld in respect of Taxes to the appropriate Governmental Body. To
the extent any amounts are so deducted and withheld and properly remitted, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made. Promptly
following such withholding, the Buyer Entities will (or will instruct its applicable Affiliate or the Rights Agent to) deliver to the Person to whom such amounts would otherwise have been paid reasonably acceptable evidence of such withholding. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Buyer Entities and the Representative intend that each payment provided under this
Agreement with respect to an Equity Award CVR (the &#8220;<B><I>Payments</I></B>&#8221;) is a separate &#8220;payment&#8221; for purposes <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(i)</FONT> of the U.S. Treasury Regulations. For
the avoidance of doubt, the Buyer Entities and the Representative intend that the Payments satisfy, to the greatest extent possible, the exemption from the application of Section&nbsp;409A of the Code and the Treasury Regulations and other guidance
issued thereunder and any state law of similar effect (collectively &#8220;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#8221;) provided under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(4)</FONT>
and, to the extent not so exempt, that the Payments comply, and this Agreement be interpreted to the greatest extent possible, as consistent with Treasury Regulations
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)(iv)(A)&#8212;that</FONT> is, as &#8220;transaction-based compensation.&#8221; To the extent this Agreement (and any definitions hereunder), or any payments hereunder, are not exempt, they
shall be construed in a manner that complies with Section&nbsp;409A, including by reason of satisfying the &#8220;transaction-based compensation&#8221; provisions thereunder, including the five-year post-Closing payment limitation therein, and shall
incorporate by reference all required definitions and payment terms. Notwithstanding the foregoing, none of the Buyer Entities, the Company or their respective board, or any of their respective representatives make any representation or warranty and
will have no liability to a Holder or transferee or any other Person if any payments under any provisions of this Agreement are determined to constitute deferred compensation under Section&nbsp;409A of the Code (or any similar U.S. state tax law)
that are subject to certain additional federal, state or other taxes. The Buyer Entities may provide each recipient of an Equity Award CVR with a notice or award agreement setting forth the terms and condition of the Holder&#8217;s entitlement to
payments under such Equity Award CVR in accordance with the terms of this Agreement. The Rights Agent makes no representations or warranties with respect to tax treatment of the CVRs. None of the Rights Agent, its Affiliates or the services provided
by the Rights Agent hereunder are intended to provide legal, tax or financial advice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7 <U>No Voting, Dividends or
Interest; No Equity or Ownership Interest in Parent or any of its Affiliates</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The CVRs will not have any voting or dividend
rights, and interest will not accrue on any amounts payable on the CVRs to any Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The CVRs will not represent any equity or
ownership interest in Parent, any constituent corporation party to the Merger or any of their respective Affiliates. It is hereby acknowledged and agreed that a CVR shall not constitute a security of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Holder, by virtue of the approval of the Merger and this Agreement by the Initial Holders or the receipt of any consideration in
connection with the Merger, and without any further action of any of the Holders or the Company, acknowledges and agrees to the appointment and authority of the Representative, as of the Offer Closing Time, to act as the exclusive representative,
agent and true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> of such Holder and all Holders as set forth in this Agreement, which shall include the power and authority of the
Representative to (i)&nbsp;incur and pay expenses on behalf of the Holders as required hereunder, (ii)&nbsp;exercise the audit rights under <U>Section&nbsp;4.4</U>, and (iii)&nbsp;take or refrain from taking the actions specified herein and any
other actions relating to the subject matter of this Agreement reasonably deemed necessary or appropriate by the Representative. Notwithstanding the foregoing, the Representative shall have no obligation to act on behalf of the Holders, except as
expressly provided herein and in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representative Engagement Agreement, and for the avoidance of doubt, the Representative shall have no obligations of the Representative under the Merger Agreement or any ancillary agreement,
schedule or exhibit thereto other than this Agreement. All actions taken by the Representative in accordance with the terms of this Agreement and the Representative Engagement Agreement shall be binding upon each Holder and such Holder&#8217;s
successors as if expressly confirmed and ratified in writing by such Holder, and all defenses which may be available to any Holder to contest, negate or disaffirm any such action of the Representative taken in good faith under this Agreement or the
Representative Engagement Agreement are waived. Each Holder agrees that such Holder will not threaten, bring, commence, institute, maintain, prosecute or voluntarily aid any action, which challenges the validity of or seeks to enjoin the operation
of any provision of this Agreement, including the provisions relating to the authority of the Representative to act on behalf of such Holder and all Holders as set forth in this Agreement. The Representative shall be entitled to: (A)&nbsp;rely upon
the CVR Register and associated list of Holders, (B)&nbsp;rely upon any signature reasonably believed by it to be genuine, and (C)&nbsp;reasonably assume that a signatory has proper authorization to sign on behalf of the applicable Holder or other
party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent, its board of directors and its officers and Affiliates will not be deemed to have any fiduciary or similar duties to
any Holder by virtue of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) It is hereby acknowledged and agreed that the CVRs and the possibility of any payment
hereunder with respect thereto are highly speculative and subject to numerous factors outside of Parent&#8217;s control, and there is no assurance that Holders will receive any payments under this Agreement or in connection with the CVRs. The
Parties acknowledge that it is possible that no Legacy Assets Transaction will occur during the Legacy Assets Transaction Period and that there will not be any Gross Proceeds that may be the subject of a CVR Payment Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Ability to Renounce or Abandon CVR</U>. Notwithstanding anything to the contrary contained herein, any Holder or
Holder&#8217;s successor or assign pursuant to a Permitted CVR Transfer may, at any time, at such Holder&#8217;s option, agree to renounce, in whole or in part, its rights under this Agreement and abandon all of such Holder&#8217;s remaining rights
in a CVR by transferring such CVR to the Buyer Entities without consideration therefor, effected by written notice to the Rights Agent, the Representative and the Buyer Entities, which renouncement and abandonment notice, if given, shall be
irrevocable. Nothing in this Agreement shall prohibit the Buyer Entities or any of its Affiliates from offering to acquire or acquiring any CVRs for consideration from the Holders, in private transactions or otherwise, in its sole discretion. Any
CVRs acquired by the Buyer Entities or any of its Affiliates shall be automatically deemed extinguished and no longer outstanding for purposes of the definition of Acting Holders and <U>ARTICLE VI</U> and <U>Section&nbsp;6.3</U> hereunder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE RIGHTS
AGENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Certain Duties and Responsibilities.</U> The provisions of this Section&nbsp;3 below shall survive the
termination of this Agreement, the exercise or expiration of the Rights, and the resignation, replacement or removal of the Rights Agent, and the exercise, termination and expiration of the CVRs. The Rights Agent will not have any liability for any
actions taken or not taken in connection with this Agreement, except to the extent of its bad faith, gross negligence, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fraud or willful misconduct (in each case as determined by a court of competent jurisdiction). IN NO EVENT WILL THE RIGHTS AGENT BE LIABLE FOR ANY SPECIAL, INDIRECT, INCIDENTAL, PUNITIVE OR
CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATED TO THIS AGREEMENT (INCLUDING LOST PROFITS, DAMAGE TO REPUTATION OR LOST SAVINGS), EVEN IF FORESEEABLE AND EVEN IF RIGHTS AGENT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Certain Rights of Rights Agent</U>. The Rights Agent undertakes to perform only the duties and obligations as are
specifically set forth in this Agreement, and no implied covenants or obligations will be read into this Agreement against the Rights Agent. In addition, the Buyer Entities and the Representative (on behalf of the Holders) each agree that the Rights
Agent shall have the following rights: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Rights Agent may rely on and will be protected and held harmless by Parent in acting or
refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, power of attorney, endorsement, direction, consent, order or other paper or document believed by it in good faith to be genuine and to
have been signed, executed and, where necessary, verified or acknowledged or presented by the proper party or parties; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Rights
Agent may rely on and shall be held harmless by Parent in acting upon written (including electronically transmitted) or oral instructions from the Buyer Entities, the Representative or any Holder with respect to any matter relating to its acting as
Rights Agent; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) whenever the Rights Agent deems it desirable that a matter be proved or established prior to taking or omitting any
action hereunder, the Rights Agent may (i)&nbsp;rely upon an Officer&#8217;s Certificate, which certificate shall be full authorization and protection to the Rights Agent, and (ii)&nbsp;the Rights Agent shall, in the absence of bad faith, gross
negligence, fraud or willful misconduct on its part (in each case as determined by a court of competent jurisdiction), incur no liability and be held harmless by Parent for or in respect of any action taken or omitted to be taken by it under the
provisions of this Agreement in reliance upon such Officer&#8217;s Certificate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the Rights Agent may engage and consult with counsel
of its selection and the written advice of such counsel or any opinion of counsel will, in the absence of bad faith, gross negligence, fraud or willful misconduct (in each case as determined by a court of competent jurisdiction), provide full and
complete authorization and protection to the Rights Agent and the Rights Agent shall be held harmless by Parent in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the permissive rights of the Rights Agent to do things enumerated in this Agreement will not be construed as a duty; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the Rights Agent will not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the
CVR Proceeds; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to, any of
the statements of fact or recitals contained in this Agreement or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) the Rights Agent will have no liability and shall be held harmless by Parent in respect
of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof
by Parent), nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Rights
Agent shall not be required to perform any action if such action would cause the Rights Agent to violate any applicable law, regulation or court order; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) the Rights Agent shall not be deemed to have any knowledge of any event of which it was to receive notice thereof hereunder, and the
Rights Agent shall be fully protected and shall incur no liability for failing to take any action in connection therewith, unless and until it has received such notice in writing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) the Rights Agent shall not assume any obligations or relationship of agency or trust with the Representative or any Holder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Parent agrees to indemnify the Rights Agent and its affiliates, and its and their respective employees, officers, directors,
representatives and advisors for, and hold such Persons harmless against, any loss, liability, damage, judgment, fine, penalty, cost or expense (each, a &#8220;<B><I>Loss</I></B>&#8221;) arising out of or in connection with the Rights Agent&#8217;s
duties under this Agreement, including the reasonable, documented and necessary <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses of defending the Rights Agent against any claims,
charges, demands, actions or suits arising out of or in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement or enforcing its rights hereunder, unless such Loss has been determined by
a court of competent jurisdiction to be a result of Rights Agent&#8217;s gross negligence, bad faith, fraud or willful misconduct; <U>provided, that</U> this <U>Section&nbsp;3.2(l)</U> shall not apply with respect to income, receipt, franchise or
similar Taxes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Parent agrees (i)&nbsp;to pay the fees and expenses of the Rights Agent in connection with this Agreement as agreed
upon in writing by the Rights Agent and Parent on or prior to the date hereof and (ii)&nbsp;to reimburse the Rights Agent for all reasonable, documented and necessary
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses paid or incurred by the Rights Agent in connection with the administration by the Rights Agent of its duties hereunder, including all stamp and
transfer Taxes (and excluding for the avoidance of doubt any income, receipt, franchise or similar) and governmental charges, except that Parent will have no obligation to pay the fees of the Rights Agent or reimburse the Rights Agent for the fees
of counsel in connection with any lawsuit initiated by the Rights Agent on behalf of itself, except in the case of any suit enforcing the provisions of <U>Section&nbsp;2.4(a)</U>, <U>Section&nbsp;2.4(b)</U>, <U>Section&nbsp;2.4(c)</U>,
<U>Section&nbsp;2.4(d)</U> or <U>Section&nbsp;3.2</U>, if Parent is found by a court of competent jurisdiction to be liable to the Rights Agent or the Holders, as applicable in such suit; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) no provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability
in the performance of any of its duties hereunder or in the exercise of its rights if there shall be reasonable grounds for believing that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured
to it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Resignation and Removal; Appointment of Successor</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Rights Agent may resign at any time by giving written notice thereof to Parent (with a copy to the Representative) specifying a date
when such resignation will take effect, which notice will be sent at least sixty (60)&nbsp;days prior to the date so specified but in no event will such resignation become effective until a successor Rights Agent has been appointed. The
Representative shall have the right to remove the Rights Agent at any time by specifying a date when such removal will take effect but no such removal will become effective until a successor Rights Agent has been appointed. Notice of such removal
will be given by the Representative to Rights Agent (with a copy to Parent), which notice will be sent at least sixty (60)&nbsp;days prior to the date so specified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Rights Agent provides notice of its intent to resign, is removed pursuant to <U>Section&nbsp;3.3(a)</U> or becomes incapable of
acting, Parent and the Representative, acting in concert, will, as soon as is reasonably possible, appoint a qualified successor Rights Agent who, unless otherwise consented to in writing by the Acting Holders, shall be a stock transfer agent of
national reputation or the corporate trust department of a commercial bank. The successor Rights Agent so appointed will, forthwith upon its acceptance of such appointment in accordance with <U>Section&nbsp;3.4</U>, become the successor Rights
Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent will give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights
Agent by mailing written notice of such event by first-class mail to the Holders as their names and addresses appear in the CVR Register. Each notice will include the name and address of the successor Rights Agent. If Parent fails to send such
notice within ten (10)&nbsp;Business Days after acceptance of appointment by a successor Rights Agent in accordance with <U>Section&nbsp;3.4</U>, the successor Rights Agent will cause the notice to be mailed at the expense of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Transition Support</U>. As long as all fees and charges that are due and payable to the Rights Agent for the Rights
Agent&#8217;s services performed under this Agreement have been paid, the Rights Agent will cooperate with Parent, the Representative and any successor Rights Agent as reasonably requested in connection with the transition of the duties and
responsibilities of the Rights Agent to the successor Rights Agent, including the transfer of all relevant data, including transferring the CVR Register to the successor Rights Agent. The Rights Agent shall be entitled to reimbursement by Parent for
costs and expenses related to such transition services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Acceptance of Appointment by Successor</U>. Every successor
Rights Agent appointed pursuant to <U>Section&nbsp;3.3(b)</U> hereunder will execute, acknowledge and deliver to Parent and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such
successor Rights Agent, without any further act, deed or conveyance, will become vested with all the rights, powers, trusts and duties of the retiring Rights Agent. On request of Parent or the successor Rights Agent, the retiring Rights Agent will
execute and deliver an instrument transferring to the successor Rights Agent all the rights, powers, trusts and duties of the retiring Rights Agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>List of Holders</U>. Parent will furnish or cause to be furnished to the Rights Agent (with a copy to the
Representative)&nbsp;(a) in such form as Parent receives from the Company&#8217;s transfer agent (or other agent performing similar services for Parent), the names, email addresses and addresses of the Holders of such securities and (b)&nbsp;in the
case of Holders of Equity Award CVRs, the names and addresses of the Holders of such securities set forth in the books and records of the Company, in each case, within thirty (30)&nbsp;days of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Payment of CVR Payment Amounts</U>. The Buyer Entities shall, promptly following receipt of a payment of CVR Proceeds,
deposit with the Rights Agent, for payment to the Holders in accordance with <U>Section&nbsp;2.4</U>, the aggregate amount necessary to pay the CVR Payment Amount to each Holder; <U>provided</U>, that the Buyer Entities shall aggregate multiple
payments of CVR Proceeds until the aggregate amount reaches $500,000 and that such exception does not apply to the final payment of CVR Proceeds which shall occur no later than 30 days following the applicable CVR Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Discretion and Decision-Making Authority</U>. Notwithstanding anything herein to the contrary, but subject to
Parent&#8217;s obligations as set forth herein, (a)&nbsp;Parent and its Affiliates shall have the power and right to control all aspects of their businesses and operations (and all of their assets and products), and subject to its compliance with
the terms of this Agreement, Parent and its Affiliates may exercise or refrain from exercising such power and right as it may deem appropriate and in the best overall interests of Parent and its Affiliates and its and their stockholders, rather than
the interest of the Holders, and (b)&nbsp;following the Legacy Assets Transaction Period, the Company shall be permitted to take any action in respect of the Legacy Assets; provided, that, during the Legacy Assets Transaction period: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Solely if requested in writing by the Representative, Parent shall (or shall cause its Affiliates to) enter into one or more Legacy Assets
Transaction Agreements; provided, however, that Parent shall not be required to enter into a Legacy Assets Transaction Agreement if such arrangement would result in the Legacy Assets being required by GAAP to be consolidated in the financial
statements of Parent following the consummation of the transactions contemplated by such Legacy Assets Transaction Agreement. For the avoidance of doubt, neither Parent nor any of its Affiliates may enter into a Legacy Assets Transaction Agreement
without the prior written consent of the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent shall (or shall cause its Affiliates to) utilize the Legacy Assets
and Expense Fund to take all actions reasonably necessary or advisable (subject to the prior written consent of the Representative) to maintain, advance and maximize the value of the Legacy Assets and pursue one or more Legacy Assets Transactions
(collectively, the &#8220;<B><I>Purpose</I></B>&#8221;), including but not limited to (i)&nbsp;the transfer of the Legacy Assets out of the Company and into a newly formed special purpose vehicle or other similar structure (&#8220;<B><I>Parent
NewCo</I></B>&#8221;), (ii) the issuance of any amount of new equity interests in Parent NewCo to bona fide third party investors and financing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sources (iii)&nbsp;the issuance of any amount of new incentive awards to Parent NewCo employees and/or consultants for services to Parent NewCo for the advancement of the Legacy Assets and
pursuit of Legacy Assets Transactions, and (iii)&nbsp;any amount of new equity interests in Parent NewCo to maintain, retain or improve the intellectual property, including the license, with respect to the Legacy Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent shall not, before the expiration of the Legacy Assets Transaction Period, terminate or negatively impact the required maintenance
of Legacy Assets, including by failing to preserve and maintain the Legacy Assets. Solely if requested in writing by the Representative, Parent shall terminate the Legacy Assets and wind down prosecution and maintenance costs relating to the Legacy
Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent shall comply with all prosecution, maintenance and other obligations relating to the Intellectual Property Rights
within the Legacy Assets required by any license or related term set forth in any Legacy Assets Transaction Agreement, to the extent such Intellectual Property Rights are contemplated by said Legacy Assets Transaction Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Audit Right</U>. Parent agrees to maintain, for at least six months after the applicable CVR Payment Date, all books and
records relevant to the calculation of a CVR Payment Amount and the amount of Gross Proceeds, Net Proceeds and Permitted Deductions. Subject to reasonable advance written notice from the Representative and prior execution and delivery by it and an
independent accounting firm of national reputation chosen by the Representative (the &#8220;<B><I>Accountant</I></B>&#8221;) of a reasonable and customary confidentiality/nonuse agreement, Parent shall permit the Representative and the Accountant,
acting as agent of the Representative (on behalf of the Holders), to have access during normal business hours to the books and records of Parent as may be reasonably necessary to audit the calculation of such CVR Payment Amount, the calculation of
the amount of Gross Proceeds, Net Proceeds and Permitted Deductions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Assignments</U>. The Buyer Entities shall not,
in whole or in part, assign any of its obligations under this Agreement other than in accordance with the terms of <U>Section&nbsp;6.3</U>. At any time, the Representative may resign (in which case the Acting Holders shall promptly appoint a
successor Representative (reasonably acceptable to the Buyer Entities)) and may assign any of its rights or obligations under this Agreement (or this Agreement in its entirety) to any third party (reasonably acceptable to the Buyer Entities) to
serve as a successor Representative, provided, that such assignee executes a written joinder to this Agreement assuming the rights and duties of the Representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Additional Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the Legacy Assets Transaction Period, Parent shall, and shall cause its Subsidiaries, licensees and rights transferees to, use
commercially reasonable efforts to enter into one or more Legacy Assets Transaction Agreements as promptly as practicable following the Effective Time. During the Legacy Assets Transaction Period, Parent shall, and shall cause its Affiliates to, use
commercially reasonable efforts to (i)&nbsp;preserve and maintain the Legacy Assets (including with respect to its obligations in <U>Section&nbsp;4.3</U>), (ii) pursue any Legacy Assets Transaction required to advance the Legacy Assets and
(iii)&nbsp;take all other actions reasonably necessary and advisable to advance and maximize the value of the Legacy Assets in connection with achieving one or more Legacy Assets Transactions. Parent shall consult with the Representative on all
efforts taken by Parent and its Affiliates in compliance with Parent&#8217;s obligations under this <U>Section&nbsp;4.6(a)</U> and <U>Section&nbsp;4.3</U> herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any of the Buyer Entities desires to consummate a Change of Control
prior to the final CVR Payment Date, such Buyer Entity or its successor, as applicable depending upon the structure of the Change of Control, will cause the Person acquiring the Buyer Entity to assume the Buyer Entity&#8217;s or its
successor&#8217;s (as applicable depending upon the structure of the Change of Control) obligations, duties and covenants under this Agreement. No later than five (5)&nbsp;Business Days after the consummation of any Change of Control, the Buyer
Entity will deliver to the Rights Agent an Officer&#8217;s Certificate, stating that such Change of Control complies with this <U>Section&nbsp;4.6(b)</U> and that all conditions precedent herein relating to such transaction have been complied with.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Until such time as the Expiration Date occurs, (i)&nbsp;Parent shall, and shall cause its Subsidiaries to, maintain records in the
ordinary course of business pursuant to record-keeping procedures normally used by Parent and its Subsidiaries regarding its activities (including its resources and efforts) with respect to entering into Legacy Assets Transaction Agreements and
(ii)&nbsp;to the extent Parent licenses, sells, assigns or otherwise transfers intellectual property and other rights (including, without limitation, all data, marketing authorizations and applications for marketing authorization), assets, rights,
powers, privileges and Contracts, Parent will require the licensee, purchaser, assignee, or transferee, as applicable to provide the information necessary for Parent to comply with its obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Upon the reasonable written request from the Representative, and subject to the Representative executing a customary confidentiality
agreement in the event the information provided would constitute material <FONT STYLE="white-space:nowrap">non-public</FONT> information of Parent, Parent will provide (i)&nbsp;during the Legacy Assets Transaction Period, the Representative with a
written update in reasonable detail describing the progress, status and anticipated trajectory of efforts in respect of Legacy Assets Transactions and (ii)&nbsp;the anticipated timing of receiving payments in respect of such Legacy Assets
Transactions, in each case up to one time in a fiscal quarter of each calendar year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Parent shall, and shall cause its Affiliates,
including the Company, to, until such time as this Agreement is terminated pursuant to <U>Section&nbsp;6.8</U>, (i) comply in all material respects with their respective covenants and obligations under each Legacy Assets Transaction Agreement, and
(ii)&nbsp;consider the interests of the Holders under this Agreement in good faith, and not take any action, or fail to take any action, the primary purpose of which is to circumvent the purpose of this Agreement and the intent of the parties,
including by reducing the amount of Legacy Assets Transaction Proceeds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the Representative nor (if applicable) its members,
managers, directors, officers, contractors, agents and employees (collectively, the &#8220;<B><I>Representative Group</I></B>&#8221;), shall be liable to any Holder for any action or failure to act in connection with the acceptance or administration
of the Representative&#8217;s responsibilities hereunder unless and only to the extent such action or failure to act constitutes gross negligence, fraud or willful misconduct. The Holders shall indemnify, defend and hold harmless the Representative
Group from and against any and all losses, claims, damages, liabilities, fees, costs, expenses (including fees, disbursements and costs of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
counsel and other skilled professionals and in connection with seeking recovery from insurers), judgments, fines, amounts paid in settlement (collectively, the &#8220;<B><I>Representative
Expenses</I></B>&#8221;) incurred without gross negligence, fraud or willful misconduct on the part of the Representative and arising out of or in connection with the acceptance or administration of its duties hereunder. Such Representative Expenses
may be recovered first, from the Legacy Assets and Expense Fund, second, from any distribution of CVR Payment Amounts otherwise distributable to the Holders at the time of distribution, and third, directly from the Holders. The immunities and rights
to indemnification shall survive the resignation or removal of the Representative or any termination of this Agreement. The Holders acknowledge that the Representative shall not be required to expend or risk its own funds or otherwise incur any
financial liability in the exercise or performance of any of its powers, rights, duties or privileges or pursuant to this Agreement or the transactions contemplated hereby or thereby. Furthermore, the Representative shall not be required to take any
action unless the Representative has been provided with funds, security or indemnities which, in its reasonable determination, are sufficient to protect the Representative against the costs, expenses and liabilities which may be incurred by the
Representative in performing such actions. The powers, immunities and rights to indemnification granted to the Representative Group hereunder: (i)&nbsp;are coupled with an interest and shall be irrevocable and survive the death, incompetence,
bankruptcy or liquidation of any Holder and shall be binding on any successor thereto, and (ii)&nbsp;shall survive the delivery of an assignment by any Holder of the whole or any fraction of his, her or its interest in the CVR Proceeds. The Legacy
Assets and Expense Fund Amount shall be held by Parent in a segregated client account and shall be used only with the consent of the Representative (A)&nbsp;for the Purpose and (B)&nbsp;for the purposes of paying directly or reimbursing the
Representative for any Representative Expenses incurred pursuant to this Agreement. The Representative is not acting as a withholding agent or in any similar capacity in connection with the Legacy Assets and Expense Fund and has no tax reporting or
income distribution obligations with respect to the Legacy Assets and Expense Fund. The Holders will not receive any interest on the Legacy Assets and Expense Fund and assign to the Representative any such interest. The Representative may instruct
the Rights Agent to contribute funds to the Legacy Assets and Expense Fund from the CVR Payment Amounts otherwise distributable to any Holders, on a pro rata basis. As soon as reasonably determined by the Representative that the Legacy Assets and
Expense Fund is no longer required to be withheld, Parent shall distribute the remaining Legacy Assets and Expense Fund, if any, to the Rights Agent for further distribution to the Holders in such proportions as though the amount of the remaining
Legacy Assets and Expense Fund constituted CVR Proceeds hereunder (provided, that, any amounts remaining from the amounts contributed to the Legacy Assets and Expense Fund from the CVR Payment Amounts otherwise distributable to any Holders pursuant
to the previous sentence shall first be distributed to such Holders in proportion to such Holders&#8217; respective contributions). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Amendments without Consent of Holders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Without the consent of any Holders, the Representative, the Buyer Entities and the Rights Agent, at any time and from time to time, may
enter into one or more amendments hereto, for any of the following purposes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) to evidence the succession of another
Person to the Buyer Entities and the assumption by any such successor of the covenants of the Buyer Entities herein as provided in Section&nbsp;6.3; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) to add to the covenants of the Buyer Entities such further covenants,
restrictions, conditions or provisions as the Representative, the Buyer Entities and the Rights Agent will consider to be for the protection of the Holders; <U>provided, that</U>, in each case, such provisions do not adversely affect the interests
of the Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to cure any ambiguity, to correct or supplement any provision herein that may be defective or
inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; <U>provided, that</U>, in each case, such provisions do not adversely affect the interests of the
Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) as may be necessary or appropriate to ensure that the CVRs are not subject to registration under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, and to ensure that the CVRs are not subject to any similar registration or prospectus requirement under
applicable securities laws outside of the United States; <U>provided, that</U>, in each case, such provisions do not adversely affect the interests of the Holders; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) as may be necessary or appropriate to ensure that the Company complies with applicable Law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) to evidence the succession of another Person as a successor Rights Agent or the Representative and the assumption by any
such successor of the covenants and obligations of the Rights Agent or the Representative, as applicable, herein in accordance with <U>Section&nbsp;3.3</U> and <U>Section&nbsp;3.4</U>; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, unless
such addition, elimination or change is adverse to the interests of the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without the consent of any Holders and the Buyer
Entities, the Rights Agent, in its sole and absolute discretion, at any time and from time to time, may enter into one or more amendments hereto, to reduce the number of CVRs, in the event any Holder agrees to renounce and abandon such
Holder&#8217;s rights under this Agreement in accordance with <U>Section&nbsp;2.8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after the execution by the
Representative, the Buyer Entities and the Rights Agent of any amendment pursuant to the provisions of this <U>Section&nbsp;5.1</U>, the Buyer Entities shall mail (or cause the Rights Agent to mail at the Buyer Entities&#8217; sole cost and expense)
a notice thereof by first class mail to the Holders at their addresses as they appear on the CVR Register, setting forth such amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Amendments with Consent of Holders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section&nbsp;5.1</U> (which amendments pursuant to <U>Section&nbsp;5.1</U> may be made without the consent of the Holders),
with the consent of the Acting Holders, whether evidenced in writing or taken at a meeting of the Holders, the Representative, the Buyer Entities and the Rights Agent may enter into one or more amendments hereto for the purpose of adding,
eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is materially adverse to the interests of the Holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Promptly after the execution by the Buyer Entities, the Representative, and the Rights
Agent of any amendment pursuant to the provisions of this <U>Section&nbsp;5.2</U>, the Buyer Entities will mail (or cause the Rights Agent to mail at the Buyer Entities&#8217; sole cost and expense) a notice thereof by first class mail to the
Holders at their addresses as they appear on the CVR Register, setting forth such amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Execution of
Amendments</U>. In executing any amendment permitted by this <U>ARTICLE V</U>, the Rights Agent will be entitled to receive, and will be fully protected in relying upon, an opinion of counsel selected by the Buyer Entities stating that the execution
of such amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent&#8217;s own rights, privileges, covenants or duties under this Agreement or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Effect of Amendments</U>. Upon the execution of any amendment under this <U>ARTICLE V</U>, this Agreement
will be modified in accordance therewith, such amendment will form a part of this Agreement for all purposes and every Holder will be bound thereby. Notwithstanding anything in this Agreement to the contrary, the Rights Agent and the Representative
shall not be required to execute any supplement or amendment to this Agreement that it has determined would adversely affect its own rights, duties, obligations or immunities under this Agreement or, with respect to the Representative, the rights,
duties, obligations or immunities of the Holders under this Agreement. No supplement or amendment to this Agreement shall be effective unless duly executed by the Buyer Entities, Rights Agent and the Representative. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER
PROVISIONS OF GENERAL APPLICATION. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Notice</U>. Any notice or other communication required or permitted hereunder
shall be in writing and shall be deemed given when delivered in Person, or by overnight courier, or three (3)&nbsp;Business Days after being sent by registered or certified mail (postage prepaid, return receipt requested), provided, that with
respect to notices delivered to the Representative, such notices must be delivered solely by email, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to the Rights Agent, to it at: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Broadridge Corporate Issuer Solutions, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: BCIS IWS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">51 Mercedes Way </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edgewood, NY 11717 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Broadridge Financial Solutions, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2 Gateway Center </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Newark, New Jersey 07102 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: General Counsel. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to a Holder or any or all Holders or the
Representative, to it at: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Robert Hershberg </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[***]
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute
notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">650 Town Center
Drive, 20th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Costa Mesa, CA 92626 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Daniel
Rees; Matt Bush </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If to the Buyer Entities:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">XOMA Royalty Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2200 Powell Street, Suite 310 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Legal Department; Bradley Sitko
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute
notice) to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gibson, Dunn&nbsp;&amp; Crutcher LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One
Embarcadero Center, Suite 2600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Ryan A. Murr; Branden C. Berns </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: [***] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any party may specify a different address by giving notice in accordance with this <U>Section&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Notice to Holders</U>. Where this Agreement provides for notice to Holders, such notice will be sufficiently given (unless
otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid, to each Holder affected by such event, at the Holder&#8217;s address as it appears in the CVR Register, not later than the latest date, and not earlier than
the earliest date, if any, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed, to any particular Holder will affect the
sufficiency of such notice with respect to other Holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Successors and Assigns</U>. The Buyer Entities may assign any or all of
its rights, interests and obligations hereunder in its sole discretion and without the consent of any other party, (i)&nbsp;to any controlled Affiliate of Parent, but only for so long as it remains a controlled Affiliate of Parent, (ii)&nbsp;in
compliance with <U>Section&nbsp;4.6(b)</U>, or (iii)&nbsp;otherwise with the prior written consent of the Acting Holders (such consent not to be unreasonably withheld, conditioned or delayed), any other Person (any permitted assignee under
<U>clauses (i)</U>, <U>(ii)</U>, or <U>(iii)</U>, an &#8220;<B><I>Assignee</I></B>&#8221;), in each case <U>provided, that</U> the Assignee agrees to assume and be bound by all of the terms of this Agreement. Any Assignee may thereafter assign any
or all of its rights, interests and obligations hereunder in the same manner as the Buyer Entities pursuant to the prior sentence. In connection with any assignment to an Assignee described in <U>clause (i)</U>&nbsp;above in this
<U>Section&nbsp;6.3</U> and clause (ii)&nbsp;above in this <U>Section&nbsp;6.3</U>, the Buyer Entities shall agree to remain liable for the performance by each Assignee of all obligations of the Buyer Entities hereunder with such Assignee
substituted for the Buyer Entities under this Agreement. This Agreement will be binding upon, inure to the benefit of and be enforceable by each of the Buyer Entities&#8217; successors and each Assignee. Subject to compliance with the requirements
set forth in this <U>Section&nbsp;6.3</U> relating to assignments, this Agreement shall not restrict the Buyer Entities&#8217; any Assignee&#8217;s or any of their respective successors&#8217; ability to merge or consolidate with, or sell, issue or
dispose of its stock or other equity interests or assets to, any other Person. Each of the Buyer Entities&#8217; successors and Assignees shall expressly assume by an instrument supplemental hereto, executed and delivered to the Rights Agent (with a
copy to the Representative), the due and punctual payment of the aggregate CVR Proceeds and the due and punctual performance and observance of all of the covenants and obligations of this Agreement to be performed or observed by the Buyer Entities.
The Rights Agent may not assign this Agreement without the Representative&#8217;s written consent, except to an affiliate of the Rights Agent in connection with a corporate restructuring or to a successor Rights Agent in accordance with the terms of
this Agreement. Any attempted assignment of this Agreement or any such rights in violation of this <U>Section&nbsp;6.3</U> shall be void and of no effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Benefits of Agreement</U>. Nothing in this Agreement, express or implied, will give to any Person (other than the Rights
Agent, the Representative, the Buyer Entities, the Buyer Entities&#8217; successors and Assignees, the Holders and the Holders&#8217; successors and assigns pursuant to a Permitted CVR Transfer) any benefit or any legal or equitable right, remedy or
claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the foregoing. The rights of Holders and their successors and assigns pursuant to Permitted CVR Transfers
are limited to those expressly provided in this Agreement. Notwithstanding anything to the contrary herein, the Representative shall not commence any action under this Agreement on behalf of or to enforce the rights of the Holders except at the
direction of and with the prior written consent of the Acting Holders. Except for the rights of the Rights Agent and the Representative set forth herein, the Acting Holders will have the sole right, on behalf of all Holders, by virtue of or under
any provision of this Agreement, to institute any action or proceeding with respect to this Agreement, and no individual Holder or other group of Holders will be entitled to exercise such rights. Reasonable expenditures incurred by such Holders in
connection with any enforcement action hereunder may be deducted from any damages or settlement obtained prior to the distribution of any remainder to Holders generally. Holders acting pursuant to this provision on behalf of all Holders shall have
no liability to the other Holders for such actions. The Representative and all Holders (including the Acting Holders) must enforce any such legal or equitable rights, remedies or claims under this Agreement against the Buyer Entities and not against
the Rights Agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>Governing Law; Jurisdiction; Waiver of Jury Trial</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement, the CVRs and all actions arising under or in connection therewith shall be governed by and construed in accordance with
the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of law thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the parties hereto (i)&nbsp;irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the
Chancery Court of the State of Delaware and any state appellate court therefrom or, if (but only if) such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware and any
appellate court therefrom (collectively, the &#8220;<B><I>Delaware Courts</I></B>&#8221;); and (ii)&nbsp;consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the address at which such party is
to receive notice in accordance with <U>Section&nbsp;6.1</U>. Each of the parties irrevocably and unconditionally (A)&nbsp;agrees not to commence any such action or proceeding except in the Delaware Courts, (B)&nbsp;agrees that any claim in respect
of any such action or proceeding may be heard and determined in the Delaware Courts, (C)&nbsp;waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the jurisdiction or laying of venue
of any such action or proceeding in the Delaware Courts and (D)&nbsp;waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in the Delaware Courts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN THE PARTIES (WHETHER
BASED ON CONTRACT, TORT OR OTHERWISE), INCLUDING ANY COUNTERCLAIM, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT
THEREOF. EACH PARTY HERETO (A)&nbsp;MAKES THIS WAIVER VOLUNTARILY AND (B)&nbsp;ACKNOWLEDGES THAT SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS CONTAINED IN THIS <U>SECTION&nbsp;6.5(C)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Severability</U>. If any provision of this Agreement is held invalid or unenforceable by any court of competent
jurisdiction, the other provisions of this Agreement shall remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree shall remain in full force and effect to the extent not held invalid or
unenforceable. The parties further agree to replace such invalid or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid
or unenforceable provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Counterparts and Signature</U>. This Agreement may be executed in two or more
counterparts (including by an electronic scan delivered by electronic mail), each of which shall be deemed an original but all of which together shall be considered one and the same agreement and shall become effective when counterparts have been
signed by each of the parties hereto and delivered to the other party, it being understood that the parties need not sign the same counterpart. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Termination</U>. This Agreement will be terminated and of no force or
effect, the parties hereto will have no liability hereunder (other than with respect to monies due and owing by the Buyer Entities to the Rights Agent or the Representative), and no payments will be required to be made, upon the earliest to occur of
(a)&nbsp;the mailing by the Rights Agent to the address of each Holder as reflected in the CVR Register of all CVR Payment Amounts (if any) required to be paid under the terms of this Agreement, (b)&nbsp;the delivery of a written notice of
termination duly executed by the Buyer Entities and the Acting Holders, or (c)&nbsp;subject to <U>Section&nbsp;4.4</U>, the Expiration Date (only to the extent that a Legacy Assets Transaction does not occur prior to the Expiration Date). For the
avoidance of doubt and notwithstanding anything to the contrary, nothing herein shall terminate or otherwise negatively affect any of the rights or remedies of the Representative Group with respect to the Holders pursuant to this Agreement or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Entire Agreement</U>. This Agreement, the Merger Agreement (including the schedules, annexes and exhibits
thereto and the documents and instruments referred to therein) contain the entire understanding of the parties hereto and thereto with reference to the transactions and matters contemplated hereby and thereby and supersede all prior agreements,
written or oral, among the parties with respect hereto and thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Legal Holiday</U>. In the event that the CVR
Payment Date shall not be a Business Day, then, notwithstanding any provision of this Agreement to the contrary, any payment required to be made in respect of the CVRs on such date need not be made on such date, but may be made on the next
succeeding Business Day with the same force and effect as if made on the CVR Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <U>Obligations of
Parent</U>. Parent shall ensure that Merger Sub, and Merger Sub shall ensure that Parent, duly perform, satisfy and discharge each of the covenants, obligations and liabilities applicable to such party under this Agreement, and Parent shall be
jointly and severally liable with Merger Sub for the performance and satisfaction of each of said covenants, obligations and liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of Page Left Blank Intentionally] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>XOMA ROYALTY CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Owen Hughes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Owen Hughes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>XRA 4 CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Owen Hughes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Owen Hughes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President, Treasurer and Secretary</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">Dr.&nbsp;Robert Hershberg, solely in his capacity as the Representative</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Hershberg</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Robert Hershberg, M.D., Ph.D.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its
behalf by its duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>BROADRIDGE CORPORATE ISSUER SOLUTIONS, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John P. Dunn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">John P. Dunn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> C<SMALL>ONTINGENT</SMALL> V<SMALL>ALUE</SMALL>
R<SMALL>IGHTS</SMALL> A<SMALL>GREEMENT</SMALL>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>xoma-20250917.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 9/24/2025 12:55:09 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:xoma="http://www.xoma.com/20250917"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.xoma.com/20250917"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" namespace="http://fasb.org/us-types/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xoma-20250917_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xoma-20250917_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xoma-20250917_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="xoma_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="xoma_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" name="M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" name="DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>xoma-20250917_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 9/24/2025 12:55:13 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="xoma-20250917.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:type="locator" xlink:label="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:type="locator" xlink:label="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="xoma_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>xoma-20250917_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 9/24/2025 12:55:09 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="xoma_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="xoma_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="xoma_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="xoma-20250917.xsd#xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:type="locator" xlink:label="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:to="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 8.625 Series A Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 8.625 Series A Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]</link:label>
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:type="locator" xlink:label="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:to="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depositary Shares Each Representing 11000th Interest In A Share Of 8.375 Series B Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depositary Shares Each Representing 11000th Interest In A Share Of 8.375 Series B Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>xoma-20250917_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 9/24/2025 12:55:10 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="xoma-20250917.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="xoma_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="xoma_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="xoma_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:type="locator" xlink:label="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="xoma-20250917.xsd#xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" xlink:type="locator" xlink:label="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="xoma_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XOMA Royalty Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000791908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 17,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2154066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2200 Powell Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">204-7200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0075 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XOMA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember', window );">M 8.625 Series A Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XOMAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember', window );">Depositary Shares Each Representing 11000th Interest In A Share Of 8.375 Series B Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_xoma_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XOMAO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_xoma_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">xoma_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>xoma_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d48493d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d48493d8k.htm">d48493d8k.htm</File>
    <File>xoma-20250917.xsd</File>
    <File>xoma-20250917_def.xml</File>
    <File>xoma-20250917_lab.xml</File>
    <File>xoma-20250917_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d48493d8k.htm": {
   "nsprefix": "xoma",
   "nsuri": "http://www.xoma.com/20250917",
   "dts": {
    "inline": {
     "local": [
      "d48493d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "xoma-20250917.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "xoma-20250917_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "xoma-20250917_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xoma-20250917_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 29
   },
   "report": {
    "R1": {
     "role": "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-09-17_to_2025-09-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d48493d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-09-17_to_2025-09-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d48493d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "xoma_DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.xoma.com/20250917",
     "localname": "DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depositary Shares Each Representing 11000th Interest In A Share Of 8.375 Series B Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]",
        "terseLabel": "Depositary Shares Each Representing 11000th Interest In A Share Of 8.375 Series B Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "xoma_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.xoma.com/20250917",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "xoma_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.xoma.com/20250917",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "xoma_M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.xoma.com/20250917",
     "localname": "M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 8.625 Series A Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]",
        "terseLabel": "M 8.625 Series A Cumulative Perpetual Preferred Stock Par Value 0.05 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.xoma.com//20250917/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-213583-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-213583-xbrl.zip
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MOO[8:5;#/[Z%O69-VW&S>?/!GCOP,K#&.:]=%[)X;'"W0T<OONF[*9NL1D?
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M#< $TTPX\XF>YT><*5: %77H#T.3:X1O)=:U .<6XPKTSG"ZZH0HWNAFHTA
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M]2:KY\B*+K4]J; : REZ2[\([:Q*%"P&%#>YKFW,X// &YJU_P=02P,$%
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MY>E@=4;5A0*E9VUJW+_<)/PM3PRKLZ@.\AKQ-Y.H6 >TQ888'D ,*P0C@J(
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MUE8/S&/K5[/(\KEJ%D:SXWJ2XA$CR6ZT>084C.>% DU,G/Y :@"QI,2?T>W
M_#XK-J(<D<PXJ61,RE>%*)4[(T:.1[T%V/&^WS\+42JFB2"V$+S%2AS\4W'8
MR$=.F"G0;4/1^M'O@&/+VF<+CP.UA"&G(]/\MS3-?]&-["ERUC(#@5L,DU()
MJ U>@F:2+.N=G8COO. 8R.I:;7\ %7<JO8IUR^)3EO-;80!$X<##D!X<LXE9
M#Z/WE4'O%PWT?BSH_09!=#LV+@CK"&\Q207TJD]O,+?@TYMY8]"#T"\F !FI
M\6 A4!4R))R$#:TX? @)&3/:N&IAEV^1)'&O<O:SWQ"4Q;?:S/8??>%FT,'A
M?T?CR>O3;N=,*ZGP*(2PE!8!"),']J#=H4A]&%#'HFIH'>-]4Y@;ZEUZ38"\
MO46YN><1=(FR!!9<;9/9@:]-\^R*/VEU%Z$OKC%-5SE+[-#O,3"A 3P49=@6
MGKFB)DZ/FC3O@UA&Z(568/6/9L)#R^]2ZU*X*^'XG$V22<-:KS,BXM6\'8[T
MC7M$C@P2]"#'B-@9_'=;HXCX88*G(K<#L.6,["N?$;D'A Z&>#PU0A%XEX$\
M('X*3/Z:M9L;PE#!(42]($NGCRYE\KC=@*=%_K1SL0.$!"28 >&=JQN5U4@?
M,7' O5]^_HG.LF"?'WTNIV_/^_,G<^">M--QE@QJ[.8=7RE4/]$-1/X,I,P^
M=RF ";[@D(>+FO!B@<]_^7GWK1R<;H=6!L\D5E,+?J),QJ1"(L$_C\Z/+_J/
MK!W!V1Z0''X/YO=DG@?T"G^DV!9Y0\2)J5!EHM,*ZBEBXB^C+[!R55UDW0X"
M1T#3I"_%MV;U2[C%M=/I_M)[0,#WE_H!2%5P +6/*>8AA3Z[--_)G.1SG245
M>F]E%DT?&W\ML$8YB2.M1R#'!^7WT4E96'"_+/-ABY,-KJ)@@C5$Q(>)T\4@
M)<Q72=OA4 R10GM\V*@ 54#14(UPP972B\4:2[>S0&?)\FQ;OT,K*Z4J;@CT
MS_YGB@V:^#[#SI&I Q69C!;KE'CLQ7X;I:B4PJ2OE9H3'2"M$ 0LF;9\/4AM
MN+QTIXK$A5=.5524 8=1#T$5&P]4P7SCV1XE.#V3G,J6GY[#X'9P &M"B@?1
M)$%/4EO&AT^.K8X!G*?^X:Q0(+R1,=!OZW+83)_N,]C7^2:_=QESQKM)W FP
M3)"%%>C>&T<)!Y P:(XF?5D1\B8O^$R"A*I(/:*OK*XOIPL#&5BNL]*N[=RX
M5?4-^@Y*=<*1>2$2^Q+AT/+@.Y][LT5I3X6*0#H07'R@R.H@R P\BZ&5V=0H
MIU,O'M#MZ#EIW;"NX*K_L"XX,XJF^"!%/Q 2\_EDT,L-KF62UV0$&4['2SMP
M:YQN/5V'Z+.-0_3;LP108##H=AL5\1RGJ&LQB:WN,CL$R(+JG]#)8%;X"?03
M>>2:2+ZCB[.SNV<'0FG?<C^>RYG.#$%FN"Z,'"T6\N^AN7Q68 DQV$2&(<_A
MZV#5+[I+TG!]ST)X'RUIF&_3O5I#:CX"&)+Z C9[R0E?$N*)FU" ^9*%',1D
ML:*'..2GB0=@P83FO4CG\8&I'GU6<12<\(7K$WC6(_T08=H"3*T?@SB $7)[
MN?F"&P@UN\(5NN$T"0VL0@D!BY]/)'TB*8;U&(/U0[B8O(.X[B/0D%%H*VEB
M!P)IR$KW4-)Q2,@&8SVL2(:E;\A\M^Q X@NAXXITAA258'1B=(_W36*A(#_K
ME'5-4QAO)B#CZ0JDL(H(;ES'&H! 4V<0@:]M+A?.#F;>-)F&*86#859AD%%P
M?M0  QD(; 6TE#%^ KV_E**;>:$,&Q=6A3(H#5C/.[;[U<JV-FC?V9S#.N*<
MX@W  1.Z X]ED9 +"IWPF,7<EX6_DE1$![^'N@F/M.1Y)MF6=E9C*A#*"?9&
MLAO)VU3:;CSNO;>--Z#O(A\G0R:0JSJ-P)0#UI)B3"UEIQ-N78Y.PN'=0PK)
M12A,A%/0V/%8.%FU)9QV5!DPK:^N8N!QN-:C"%;'Q>30AC26-*)UYO@5M^_B
MAX]43/.Y,H%K8H\V]  ;"$9#@GG%4?:97'7V[!C3=2B&"D<O/ "EXQ[5DY9%
MI(0EQ&VIFXAB;P8U'\BRR_"GR&#I7O,#C<F\#ADZ:PT<*DB1 .EK,++IU3=Y
M6@.#VVIR;J$$5 ](5^#'D]>R1BX U@;\QFW-X)'JEHZ*W'6;%VD,Q'&@,?OF
M5) GT_-NX ,PZ ([4?&1ZW8HD,CQ$WC*H2&QO(UL>%1 \:0OTGA*N,( ]*]S
MA#G)G@D%E6)&J(CY%^@_04^?>O@) Y(:L0Q+4T8@/8"^Z"XP%G,X9F.3N^Z^
MKL"YEXJX"#IRLJEE1' <<J*3WI&S+FH"; T.#! ZG"WZTR6-.Z,U!Z>_'Q]N
M[_VR%6JI'H-90O%99TF8&B<UF%Q#6-DHK:ZW"\5)(7PL>HV%:YD)8V=N&-/A
MGB*2^S+B)B'AW-'20C!($PG2[9R.R/I)RP?-6<_X \RWAI=LP5Y=PYB 0C)\
M=5YD40S&W2C-\QC/)U:5 (J'GW/TK!?5];]K!%B;%0(64!=\@.\<!6@#V^,H
M5LZZ1V@T&_U(/U$S%<$-F6]PL<<$1!HBWZ9%U0\!*GGG2,T1,(*ZX'.)"CWK
M7BH=S53)0,RX4E4@&$'VEI-B)W\#(:*ZOPUK@FP+)>N_E ;U(Y7"OI$$DNA$
MR<:XDB+I)!(TE$X(PV=\K L0_!9MC1(S?_"YE)2/:Z,/N@.[/*0B.0[_%T["
MC$P'.IML:W$5#WZ'<$094C-/"W[AL@:D:H(<R9W<&?HNG9* ):9QQ;GP!=K]
MKE]$PGZ,W..=HNT6GB=56;Z=WA$D(_UR'*:&5%@G!>OA?F6,V*"NX=3TWF^Q
M.S'+8&!#08^RJV)(6IR;<.)SMD;VDQ^U9K@HZ7N&88XT!W95(/30IY$L96N2
MA'&F"/6A*F& G\+;W500:M"I:"0]"QN$7Y(;TD.V&I3<0 );*V<V/P63)-"A
ME'.4UMEK>B3S4 02AGZTU'$<A;J(P[0%'#<-*=\Y39 1 ,.-T4W>]&<S<@1$
MDR"5,.$APZ_9G,K-7TKY+&E"[76N(R)FK?K#PD2,\VG"&YJ(4@T_"&G>,!JS
M&_87RER;RIN$7 HV]B1XCF1)V<*15@VH.!"!1K="WBF\O2X,O6D'/TL?CB.4
MLV6"FI#SI^I3>[[QJ7U-J523C(C@';$.WWN)!<@C41F=:K]#T=+0TJ98^9%7
M#+LK:1M"J!3Y1T*QU"8+B$]+(5-JP7N(L5I-;:41K*&I1M#VY#ZG47@H!8=S
MLAQ8/!'D][]MS4& P!E+_+)"-K&LD?CA9^:@I7_L*+8"K&"IUTA>,"D0^L7=
MCOJ"0RX)1@.3HG@M6CRHB-HZ#V:@S<L%;&S*OS2 BGJA^UMDLY)M0J8%#?MH
M*VS+TO#2+4I4S= ! GN'ZANA0"*=F4L2>T P%5Q"RG2D85N.FR 04_+QR,JY
MKY6-_%=^INFPA0YZC4B,YKB"!.YG8<=_E=]> ]E:%T?<J5-T;A%\F%(C<ER^
MK,9P)^4&W DI=NP<<M/R'=V.HRG>X8(/%GG@'609%AZ3?&"WCMX#@$A<[J6L
MQTWYK8&#]T0,+O0LWXT9;)D&>1/8_P+* XYV![O\?3V"\<X+@$JV\]&\(3=&
MWNT8UR'OODU\6YZ"O&5H.C'=D^C1T0Q1K\UQF[3EE_@A^'QB,H9-[2Z[4*V+
M=$5=-2C&,1,+0&23B0'MZ:C8<89J$](11<)%['K1(GL)G38G2O3H,2_.."#
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M&8DQ6!9EQ=F68M::+ M8S*(*F[);O(XY*\1L+[8]&Q49CJ)54I-9!R&X]+>
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M%?'IR>)QU0<[-$DJI@(066,U@Q.IM,3:'OB31,VK]SJA(U":BFOTER(OG:Z
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M1423<<$L+/1&H4-.I+ ^&VJ@Q;TNT \F:5]T<FB:#(\TM>@3ZF2/JBLFSLJ
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M(7L8F,(TZ[273<MV?[.I#]G4-<RMV^SL5^[LDX' [/Z\$:C+[NY%/5BO/=U
MB)?<1^Y%$%PJJHMWH+O\K->N'GVY3@:)M)GI;_;V?GM+Q1S7:R,W.N\#MM"K
MQ[E>^SD;KMOX&I;<6]-7;;.S?ZZ=-=77UWUC-]&;Y3;VK%@[V,1&KBZYD=(?
M=,W]#;_P\>QMX"_WW5@NX+Y>6[JQ21^RA\&A:; 9G*BJ6C=3IH_U0%,5_/Z
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MZV2B524K1EJ\$*(8FU-JZ1;.:]\1[Q&3B&C-L>QN%7V&.0QH>7'QX#A,>7)
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MT$6LW^?LMG5UPX5 ,:)&MY%1'S\%/7R "*+%Q45$-&WQ0I+7"EBS^C))&$#
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M>40@:I:]#,'&(6OG'K%9G01BC#!92,YTQT25DR]<APUFN8IBNSI<2Y"W8'Q
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MA$Y/D,7*[O;#E001&4=O"B=5+49P+3XS;]?<5YE0I9C<M,DA0"JPBU$)M0+
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M>40B(?^AOXN\R\%=AX>@ *S;X%Y#W>ANHN4"_6I3'2?NT-PI<4G183U0@2P
MZ])GP\.GC$?>6P\U2U*XNDT"IPTLIF9R5=:KW!KF?2\@DE/">A*]_0M,_".L
MD1*7X,7DEY(LM3=J2IF0ZR$[*-NE#UT;=<%23@[%*C=H]VVH)>=>DS]&\U>$
M]( <X_;R4O+('TT*D?8*1<G%!U-.X2A,E2@7P(+FUMV<\H,<4K4/(.]&!Y"D
MG@D[CCPYA=K7VG=X(KM([\$)U,[(HN=>0.07Q1*E,B2[02*X9QV$9J;;BC9Y
MMC"A3+)3<K;T-$!BL7D M1@9CX'D_[9R9^VRWK:3JWK3P8%0DAHS+VC ^TRR
M.KW2YB68=,SO9!3H-YUVX2L2F9U5P48MO+786I]1WM6;>K%O%00.3<6;]9<Q
ML7XEW8@60-Y$^?/%%:.)#3Y!;JI;,//[#Z.(M.%QL^S;C]XR#C9+8G=DUI/&
M.;XRD]D]1'Z\BJ4ZQR)>WDZ0:F9^[V2SG\Z>GFCGM=2][7D!?Z.6+F.>J"Y(
MRX]'W>P>QPNN]"4)Q;$(-DVR>)&(O$W2$,=:B$-;-D-06F'!E=RI/[Y-V_Z]
MC#*)J\K83C*'(L.N.SR0D#@M$S CEX.[7\U!EKO3>%DOR&GE\A%HXE2)KG-6
M*)SR8!,H2VN7V+LWJA\+1V@$7J@<X@*X?LDK]?V^"S)Y$AC+<Z^-P3D2*:SY
MO#[HE. 5%79J),01<]?8L2:$,F@8Y /KU$J_DILA*P'[Q:1,#M'3(8#_2+(%
MJA?691/,AI>0D;!E9(DMNS)@H*1\=ALBH]W#L!:W(EX^B[!722^Y]$BB&TD)
M@7(Y&0#IJ:E6T([)+03PYE&W4#&$Z=K"]QG!4/LY;EM)*TC7$P@E%7G%-8GO
M(2=U^GCQX/3D:#$].IV:F%60T42K,?<IU?4JKQ":=-[DEW  _1.UEE$#9VC"
M"-V@)4WN'ACO-L#>XQ+\()!'06/3$L?F9'#7PKPX\Z!PDG0IH0J^(=)/H*JB
MZ$%-U (R@:W-,B/22LCP?(1G N7*" .RU>@3P53AFIO/GSDKU;.:FH"R<^:H
MSR6MH<< :E L2%D3!1Z3*UL",=Z:55T]P$1,"VG]-E\"$48ST[I27.F]H'3=
M"H(_3V^';ODB9]^E]=5!^T$YQ^ Q\Z;\$XRK]PRKE"8O1AK?TDH=CX:H]$#>
MDU,W5_O4\E-(.S1.C<'N#I+)N\.*3V0?0HBP]<H;+<J6(W*<?P-H0U$LF(Q%
M03[=*N@E_RPRG,:CT&'X;D%ISW]$L.[SW#V!/;M7RKQQLHJ"7Q!ZA30KBQLH
MAJ<MZ]WU;YE08F_]KJ[PHN8XV@X/Q!@@WOO!WJA)%TTB066*I%65GK0/= ]<
MKLKYQJ,:F*:5S5H;\\F(%G"9P_='HC@%0R%U[0WW 8?18U@0=*\;*!L*^#>V
MJ6S*ECN2:(/0C>> RVP7'61R P=C57CC#&?4&*\-M44B*+1$GL2^\<_V[X<3
M#BP'YH:_ET70VH')K)@1";]%7C83/^#D+$.T.#L;F7_,VQ&8)<J-'=$W^"RU
M:8ZCR)>^F%O@2MLDF,:,@Q8\)LZ7&AN(?\F1$#)([AU9]< ] CTY?76_F_H-
ME>3[-F][-1,( F>5B]ES,Q[]UW9QSBHF\H>^OC[$U]U DP4Z/0W3>\)^0-:K
M:E*4^'+SO"T8S%VV-I^;)O8+S5#ZC(]ZV20W3B; '=A]F>[2G [4? 6%.&VP
MU)S>-U1@3GQ>4GLVDSWMY5@8@L_\RR98G2/G;+:7VN643[C'8&8<25(901O6
MBSNB.T.FB*R?9JT,2VV@?;94K]4-D;O. '/5I-'*WE]V\K9B.U]%\Y @5E=U
MJ/NY+V9EI)D5+78F/'IM:<J(X#-VC ?4MYX^_M63K@1(-\8%KY$1I<=;9"80
MV^,C.5MV"K)^]=@3P SP.7X*1%C;/B)"QL:.RX9 O$VQ8=+/#YO<1V'UCU^=
MPKI&X0E6O2\5,IPG>KO&:;,KB'5)\-XD;6CH(9ZBK-+RNQ^7$HAMZ-<GPKH[
MV7Y9&K?<C)YT!VF[TJ3;Y$W>+O+_%K?TRMZ9*:]8\'C$!Y+]X)B5) ;/RZ?B
M+R2:OHV#^12K+X+^ X?-,)G<1@SQ"+88%H*W9-, K\:3DY/LA/YG0KIS"N.V
MU(3660Y<'_&WDV-WX:FGA!B/CI*AW+ 901S"U8WTY"0[?7R:G3Q]+ _WC$VE
M,Q,XOII'U/<^W(MP9OA#$1ONJ?^U7=UPG<QI-GEX\O!)(NC\#[=/MXT/%>\I
MX'T23Q,6NZW5+MH_59/T3+W36^R;+'#SO]XDD8@-YR#,;"FD" G6N"9#WAQ)
M=X.-YDXSQHL;O.G-\>0WH62+'R.:-([5;Q!CYE\.Z!M;R"#,J0%)Y'V9[1KN
M>(F+7M746BZHNH@J#%/&?;UF_2*8Y0SSI]#4J)Q1*W1A;*?B#GT MSEY,$/8
MIE7YVZJT" @N-#+5C_?W-L$#P8X\%[+)B", 86#N1>M+8.IURI(?&>"^!/6%
MC<P, :!A'.M+" 76"UPDJ[N[#EY:$B@MC2$U(WX,G(HK[B1HOMU1*M_V]#\I
M 0$)WO7W&^1Z=/(CR/75.4<\2#K=;RFY=;THB_$':)$)MIZ$>*92'#A#;I@)
M$%EL*W G6\J;ZT5-H;R#$,EH[>&B#SJ52;T0'T\_:4K6O*"ADC1A';_E)-@N
M8M3*+BAU7(,.6&\HAN1D5.8#2 K?)'=*/P>&_TU121(,-1,#-^D:GK4[CC:N
MQ93'+LNF!?MVN6VQ7L;9Q5=US Q];##"MC1_/ (A6U99;/!C;CH)"VPP7N8E
M+$OCNM.)2")A*.ND!HFY.I$T<;UMG+IJD4Z@+58KXA5P"W+.-_0@OD79K@E
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M'16DS9;:A-;'OI1Z@"II";Y2, \"IH),>;$:&].?(2A)0!W8IX"DD;I]S[O
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M7(Y'7-1X%$94#FG!7H%5!:(+X'J(U-W%[UD'K0AL7.=G_,+33<)F8#NJGN0
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MN>O@05,"2*$0LZ.S^>RP3*P_A>.NTEX5XY%M?+B_DN @Y7,!-$RH5-P$N8F
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MPX<\I-M[D#E>B;'H"V9*Z?9%+![NCK@<TR'"-F*=Q%M=XS7:4IMR2Y-+@E+
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MR:2AXK>OBV+: 6\E"KO2=HT%B[^]QPA>#"AP*4NU@L+H..(QVYZ#]=,TH)&
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M& D"!X54*\!KVNY,JN'4X)== :_U\_<;L'O^(V!W;];9D^,3A(:]-=W$,J
MYCI"MZO>U=<%^^%2Y9B61:6SQA9;C%'@S2 AC?6;JQOR#^2.[N2>@SW>RF,\
M&2-E^T@4!ES%RO-<,N<Y/P*U.[ISW TJN'-,]DM^7X4B&>4!-FS\=Z$]'X.'
M2HJ]%1)L@0ZM84K("I4FY@CV9I0Q"A2/-453G8ZI12(?V"YW*X]X$;^ ARLT
M,YL(F.RYMI/]8+'IL5\=K3&>+=@X3BC6/;9EMRLQ58":S$;@SG.)S'A$9:QJ
MH_G:<UTY,GM-Q7F3YAP5>)FRCK:6@IVVI;"K)3C2\*4)/8\8&WX%>SNP J4L
M&3Q49*2:@*^\6F$8FAI>'::Y'GAQ!@0]S]?E!ON(80QG:2<?0";8/P\P@"<G
M)KXQI[@&_@A0=@V(E&TQ^=L)2"[ 7U'T&L/P&L%0O-)X)!*(*I(9V;^%D 8U
M\<8"YBI'FBSTRXF-0&(_A*.4J@W]RWO]B2H!@)65Q>$#K.Z((T;A3(34B\FK
M@,[O5Z;S<Y]7R'+ ./(ATA[Y8+"@@Z+E12P?H8+1"$B*$F%KVXFA$HQ#/\JM
M\,_W\:>U9PLL$H>>?<DL;@]HXV926K^HU^E39V-]&&E9%4&"*=RV@;F-5*<
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M.Z"034-7*3F@31M H]+!$[?1Q6D]N-UUBDSMH(L*!#/^HAB_,(2TQSN9H+5
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M\$H%RQ>[R&H/M#AOZBTRO])'V$4>AHCS-63(F2^L%!_#*K)=O>7YSSL/!K)
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M$^$4EEW9(7-MD.GH%HA/-RG=NDG7DQ05]"(,T902SS/$I+8>2&-GK3X;W2[
MX8(;F#F%FXDKN%S9KK(%;QOS.-*Q>:Y3M]>1W0V?7<.%U!E-7+=MYX*P-)+.
M(N@YDIW#F6W;^[SD[#0O((/1>3' 1("S5>LKB=Q&W3Z93<V(5V(T!4/F\GDG
M^ZVD.5#!8#[R[QJOY8HG=#N<;I=VMRW-CDEK1>KFF=8TP:L"/VC5J%T-%S@)
M<%@@S(&7XKIT7_-4V[9(%6[QQD:"Q@9H&F8TAY%H-$HBND&IZ[XQN[DTPNCO
M,*),:JUMDS5HA(U?.LN4( 3,\B;!(CU"$=[H+GR+Y0G&-5T+8UA =WAE+CP\
MOW^%7[ZE[=\(!M]I+)A;6%<-+:*=U$R[G3[E7.Y5H*;NBCV@^6GA,D(I2(8F
M-C^V6YK)[0Q-*W(H\I3IM34'(L..N<C#<?DFF.$8(\:$61,,_!1J ^E-7VN5
M=3NW-<N2[](JBU[QU>988^C?GS5&ML9FYEBROC6V0L8D#R%BHC:;HUK0T$Z2
M:$Z3<DCN$ &MT7W3H<?X3+YU.\S<[W4,L>2?S Y3J%LK#+%-JG5&CV2'?9<!
MNA^> G1W#<UKSM(%=5Z&Q)AKQJ^Q-K#.KXDW<\:5V:IL!Z^/.7L7Q:#PBR0P
M@+ZEL"$%TWE$%$HL)4%&USJSA96&190";_T\XVO5\+7NM_)GE&A9DITT!J]*
M3S9Z]?W*<X3:<Q/S\/BFLAP6]L=\%,![RY*HK2<HX*4BHO%@6.@ZR&\&;1L>
M'(^\;.3HJV)K'RM'@?3B/=:C:./7 M8J/?]U2KX,-7Q+54^0(%.Y0L8=0M@P
MU0^UTF6RCCT&:[%*")M#S#$NOB+GEZ[ST<'Z'[61@=$Z#1:BP+8*X.B"0\1Y
M6C@"L%8_*2Z.-<_RQ-*FQ:^-X%?S*=?%<9Z-LX$P4$4'.'ZJ$_"NLD=?$=P4
M3%J[42Q+RWNFF%?*:-$E+?OO>&E.4N+X'D56@P-4FQ0@H^=DV[&\!V'J\,!@
M;'Z%!-YOPL2TER5%.FM(A)()GX\V./- 34-;QZQNJ[ZZG(WSWA##^VRL>GZD
M7ADRJ%"IF?F@*F-7F@UT[=L-!,)[9;Y'L8"/L*6-*K6H!'7DB)<;-N=FS(5?
M*1'6MV@C3DS*^.M4GIO56H8SM@O*8@*O) R_]2IV6<G(O9G+FF'UN77LE:>+
M,(3J*B]M2UW1\M126N^[YP/CO^40W%BGJ!T!PU?=?*>\F[F\I"65MW2:2Z:X
MI9@ H2A-B8)A>6FQ"V]LA(Q;L.(=Q![J,)6CC'#<$+K/<Z:$=Y1YRF4F 99R
MT\$-@H3 J\SNVA5P9!>VQI 51RT/V+:RLR65JNRAVRS<#O*7Y$2D;ME+O'@R
M1A%82C2*KW);D)T@I>L,O#Y]U*1D.@RAD;A%G$A[^$$] 8#>S \6<H<<X2YE
MMO?'+B=3E=."QI"3;K- W<[6;;=2QZK8>G/Q/@B,P1&]:239' 5I1;&E$:WN
MR'*KE)4^@QR H<TIJP9?514/97+#HT7A=/R-:FZBE\L ;<LE M&8-_/P<$@<
ME8ZZZE+9NP5--^:N@I9U8W<B,$6NDND4\7G&;B/;UMX?4_W8'-F/1)+=.SP\
M L2)WGOCXOYRTN]_,*[^-T"(_0,38O=L_]Z1,T??A)6'!(EQ:-OAU@#[7M(/
M)V _8VT/L<$3IFF:<36&#O!Z3-Q/UB0.+E:J,PO<M,A1O!E,>^(0ABX ="C9
M<N7#-=2SD #&C"G6:%]66/=,#>8S;FO3A>EDMC/;O4]%C)CX8PA_V&@@#R*P
MS'.%>^2YT=OL:6N@! )(@&$P0D*J@,$1E%#&BA(P];(AL5R";2M76 '-M RW
M_:QIJZ5JXQANV7E!T)F55QC7UOS<&@_"GPB\QQ6D+S\!V&&C!B5-WT%[+!9"
M?+?QSA^?XIVW*TC$:C/RF0"U;28!1KC#S9-"(HN=40>F*[BR@WQ^G>=LEV46
M\9]ZU6SO1+TZCH3BRGK$) '1B1[93T'RV-TD^UG7E)?-PPN""--UWNRP1CM7
M84%<@I]$'7%1H](C7=<Y#Q_F!3):D5Y3WV-V- NA=(#>%5<J:5.M))*7>,IL
MU!F'L!HQ#8)7/K^<[(" -E5*':="445C:$\$ TD#50>!T] &#H?*9K$>8*D9
M!JA,/.7J$^/?$DH3OSWU0HG00I-!K3D#QL$$D.+2>SS& H0%TX.L\TB5U*0T
M -T<NDHH^ "/=K!SR\DG/&[E<',#]&5E!C GGJQJMV,&2PW?M,K3')G8&ZM.
M3C5E&2(E,-1["H0X8(G7WF#<TEM.P-(UO.'3/'CH(&2O*U:+V54YL<CW0!W2
MP/A'L$MK+BL*0$W0CG F\#7+S3)N^58L/L@<(PR1-$1&ZRSR!68R=)5,0BO@
MA3&70W(=J$]&,M6E1TNMW]U6E60\'YT1$,)%BR= PA(E37A-G<2Q?_$:HU>$
M5OZ>EY?0/_R_W(^'31QHX_F P0*\^VPX*4!T&(ER54SR<T18K/X \V4$2&W&
M59Q7S"7.#4;JG,N7U"^)>#08=NKD3H/H0XT1HA35PA@X55'_8747+_8:#<G7
M11Q32%?DV"!['M[:0,"[@!JLW8W*B:#:4(+40\9&%T##7"J!5#)L,V^X6[\=
MFZ)<+S'Y P-Y1A.329B7''#J!E@&J/*'V#P"WQ[^$\'MT?6YMG80*HW-)R\S
M)@4Q_X05AGN836YJ!$$S+D=60%3,W*#+8B9BATZ16NR=I#?Q,8FD&W$DXAVE
MGD]FN?X:V44(5'&HTS@CX[3P".7H1R,O@&"'GKJW9X3:_N[^<\]2TJ$J6UU4
M)P(5OP6?";HX6MKDPH:.9;UJ#^-S[V.&[,3=IK?@@O3I2KW!.@T)6+U)F,(,
MF*3>&5/1Z#CRPS]+7-"%;IN[(>$=+\H?UJ*Z]C-GH')HJ06-C&Q7-F;@]FD@
M4E0PZ\"0.<@-)", G41/QWPL,D&DB+1E>2/8R1^5C4^/REEN_PY43_6<H]GD
M3"LGFZMS_8D"$$5)\:T)*!.T)68YW)-,0I"46\3D@/!FH39" F5\&]:^6IO(
M<X81ZWIIYD)!C7C&Z#%GO FL%W\S1KXJ^"?WN-N<'L[MS.,N=E%SA^:6+;!*
M0N\\/A3$K)P9Y"U3']#1PE*_/$PA]0#?PTSKMZ.C(SBKJ+] 6" )2)&/?(S#
M==,[+7!(:9#2<*C@C--F=]'?/66VK86L(NMINZI1^=N<28TA3\CGT<90*H#<
M$F\01MZ;PUE9_+P<0 (SM^1CNN36"*.-G3O4D<E$WZIZGE_6CN-1O0@NPE59
MC'R6G,$-67:_('D)K**QV/J4S&A"Q'BJCXT'_W0%9IQQ/ C*#QN*L<RFEM09
M-X'Q2!2K]M_-\1PR 7DV(@KR*J,K- 2QD\_.R7B.C<?>067)MMV .L__X/(@
M+%!%@WU.'+M0$%16M$7P?CY$%00 Q56T"=E%Y9B#O+7L=G@QK[)AQLQ#B%-2
MLZON>'_)W\V'"UO7S1'W&Q=4L$5\!/1+@75OCY4(:K@D+ _'"P ?'V85/'DQ
MU^&+2(TREJS:G#$\0@#WL8!"M0Z1Y9*20V8]F;9"9%O/00WD5J[[T\EG5$,$
MIN&L]/L@S6=M)%2Y+]:FLJX(V\'BBD&E D,.5XX0M&!J7_.D7-<IB"=^YK/$
MAY@&B&DD#E$A)?CW-MJO'&>K)M86_-H;@AOMG3"6.NX0CD)QKF6X9[&$-7C-
M!=:\HV4"<F$*7AC>&TL:AX9_?,WX=<TK$9SW[S;0^_HIT'N?=OISL&:.S,.F
M,VN0/QXN/+ATCC^R\(>5,,OL8G))/V-ED>;10P:W(9-13@M!7,-6 XQOSPF=
M2%F>?1O=@P$!,@P 1CL*2R)?%"83#B37VT9N7SO2"0#\,7:(#9.HKO.B7O5*
MEGIH[D/U&/!3>."<2\*VD*IV+/0,E^S3T6?G%&RV]@%B(;F:3VT0477-S'V?
M2>$Q0[ =*9.ES%P^0F$*J,U;%, -H7#L <O1TX4\:X! D-6.,:_PW>.#"_,-
M<0:LUKV99-<V(-DX*7:5Q-_F?I)@&&)[6M6>"+]9K.HL")G3=[.YV[56TF$7
MZ[>IC=HH$T=V>[JHKJA$[J"LP$2S!UX" V*@C(U9YO#>$<:U>:B\"#2!). +
M<N73I!Z[L72D0 9@@4$AL*C@1@UIIKP:<;C'HF*%U\H?5CO0*<GV1':C*M!G
M0^:CL:TM#NZS;V'BG;>$?&-$@K[)LPJD@6XKLYO7[=#-\7(Y''.!Y/EEGDW(
MIG6JF>IK<NO"ZLPW!?<X-P;V@'2NWDCF ?SO!2-G+9E^JO;;.D7Q@V&/T:!<
MT >K?& !2V'GT/RA1),]D-*=!)\Y_.7@?30Z"Y;:DC4%D1L[;Y*A([(XO @Z
M\D;(\216N601?[72+36O?@:OMIT%-*C@N++SK6-#JT'P0?MQH;A=;AZB%46R
M8.O$#>W#@/UQ0O>'O%UP;A1YNCW;N%@[MDK CSZU;#T$E?(*00T0$51EX]Q@
M-YCZHP R_AYZ6^LO+DM\WBB^4.HN=3LD2T) F785X6([Y:KR8!S(@ ?B:\-#
M5_+^'D/"*:-@P<6P<1V.0'$'#UV=(H)XH0B#R:9AWG0.++BXPA!R 4:4#ZMB
MBN<L$E\89 P(:@P2HK@T_X;@8 (*!+[ <C?Z$93%!.N85Q)W,HNZI6,B8V'C
M M7?%.P%<X77=VNO8$)A77LEE9P$]KQ Q6?EQW0%V6#<C/UZ-H[7'M2,UZC,
MAQ^BD2UC'<)Q04?>++M ?@G^QIZ;0-SB(7<R SSK=86'W .R?:#UPM@OU72"
MY4>9C:=$](C/)Q?DKC#4V:;6E>8'KD,P=H4&FPFB/3YL2/1CA;28V^HX>!5:
MDHZTZ=]QSH53]IO8&X VO(:+:8AC/VZ',8$L.I>-EX:*FW7?BGD52FJ.=]HR
MDL97MU,(&YX3W31"Q_/LA$WZ,BOP7CM::GA!V4H<2"">RT6+KXZB>9'6PY6&
MN8BX,"!YAV%45UPTS3"/!J8'HS@P;D#X=6H3@"AG0Z9;0ZN1]>4>NLV,*ZQ_
MG^22;UEP][,,''?B\K(L9G-"P)0\/<P!EYH_:0M!_0(@9UYJSR=#:O#5NBIP
MDAKJ9V>3R8(5'&>V5V3"./39W(5NO]>8TJO=IYC2[8H'12R)+ELA4]2M#H_V
M4+I6:VC*9Q*RB-"P5SLUPG."58(8%+62K^W@,@Q,C1=K,;,9/N2C)!I2,<>;
M;R4+;J+9O6,^JIJI7/WFL_R.6$QR*.6D.K#$75HYM_8K#O$,>\>M=HS["AN8
MO.L&"6S]*#EK@]P<MYG7Z-.T@^G[5):YTM]L*R2=3'3P+CQK#);"0?5 Y6M+
M#-U7[:;&O4[R\UIMBN!H/)J?-W@D/V^XG?16!5Q3%:51/8'-GG@)@WG!.K9^
M!]Q#-.(LX&5&035CM4^+Q12/(X<C ?U)>JDMUYQ 66G*.?F=N_@! 7A!QJ4^
M4+>+/#N/)QK&[G;<TR+F'5>EF2L!/F"CV5DDQ*I$\O;]W]U(7=/AOV73RS?'
MR9G9'>/:\/(VR8:0X]P6=<2CN8HNN0$'V:Q/)LYT;51ORU.D$&3)]XWP ;X\
M8ZZ+UX%TB;B.))"DOLZ\XOP<2%H@\CB#7E:CP3!GH-*<,6N76<NY"C]6\GHG
MQUARC5%NPN:&]27S(3O7MF=+RB^GV9=BNI@"'CVOC!GY# P'?6]1B$8N;V0:
MSI0%<]NLX/[+W3_)JK6^Q @+2AC[78MC5+-\/'0L"80QPOF"2X=X^;/\VCQ/
MDS"T+ XN9+?CK>0'6H6DAZ>OF1;A>XMZ%KQBJU@V61."_@ S"%/7.IO>9T=Y
M)SG:Z,&62IW%KTMEV'"+5G?=#NF[#=Y ,=VI>;9#WXF:&ZG(K**B#\"])\>5
M7DI*PNE/%9"GEUR4LY(]\&*%PQ2 G7EEW=("QPJ)'-BU)HMZ;9;>O_#U=R5A
M7AQSOH<7V6;;8]O0^%&R48A/P.)D^6UX2.V9/(CR?(/V6%/<S7B=><%FO,LK
MP@^ZOPA,&H"U6RDJ6\3[EZ%JK?1E3B168G[!:485.^'ZG^#%%CC;O=B*31+#
M[*GY+[7G<+VEX-O++>9TO90.<=#.2J7;-*Q<JG $@P7ZKY2)P=-/G?)R&=RC
M E6-4CQ4U=BR66,7T(HWP\>$KH\<O<6 VIH0ID>DB.MP.,\N\31/S'^IFLT.
M+;1(*(JVT=UY'/#A0(IF*D>^SLD0\+!8L-ZLJ0K50Z'TN;F;KJL)KK&Y&U"G
M7Q.G%_I\D!2O$\NYX[$#8O4R;0L+ O  K;\O(QRJ$995XO SF(-)WLM_)T(>
MS"=(D1UV5(WS2K +KO*;.N$0?T8')2,VYJ!]2C4.NZRN-$/IHA1HJ'/I"TUR
M99,CT05$=B6@SJG;MT74&!=[NYP \;Q'_%^N.7>X'Z+U@:NA=,:B"HRKT:'9
MSL,KN1T-NLU#ZFB\L"TC#O";\B_0RE)C79^-^&KCH=EFL-H%5_[W]Q@NW7L*
ME]XUMN2[]5+#X>%SIWIYR&^S\)Z*[>DRH9BYHWHQO/H9VUH[<G T9+)STYJ0
M&$I57;-8)IIKN[Y ,W:]2!=5<L!ESFM;+P6C=H@V%!.VM44"TM9X]TYR=J'@
MB-;%K76CJ/(-\O]S:O@BV2=& ^>RH;U"9^$P+X4N$+NM:4LT)&7-"/\C-<&D
M*0.\$!PA!2H4C!K]'K87-U%9*..RTIVS+MY*$?Z6V(Q9.\FGN52X=JS#%DB%
M(?GPL<OQMJ^MT/[VNU*PF8$AD7*7<=:M&)%4M8W(0*J:+6LN,"^(K7G4[7 +
M1C1URNJ/(IUT$BR2 7V> V&T.UIZ^ 66&VJN%@/Q8;H)7\!0WTER7V(6-#B&
M(\PVPOFS%W5+5Z=*^?,1L@6N?,(K^X0SMCR2L^P+!<$H=+/\$:_U(,Y8@L(-
M,S.E0>"9BQ4UT$F)^[)-%HY-FNF$)&:04WD!1W4N^?R)6X'R$T<&AJX]^W*Q
MS2_%6#X6;E#U^J+6[12/WZWZ$G?[$S)!)KW9S+AI5/3-9TPI78_&EYP8 %^\
MR&8CU\KF( ]F:IGI,S:)A.X=[AFU(.)GN/C'V-H+:M4$%"#&;E,?PX=>@@^P
MF#&R!L#AF1E2]'J*@0N(&I&H1J/6)3PKRPU)4[8XI\T*WDW/3QH8!S 3Q:79
M&,C4H]H,Q^,<5^M"25[(5E6XQL#V4IJ4^]DN(1U7U]BY-_"Q3,*"P0G'K4)\
M%?,GNJ94; ?;92Q)(WS,U: V!&E$7Q+\]KJHOL*E>*EL-EAEF*W%5^'5A9UP
M)QDUJL+E)81ER]4\TIY7$ MO%'4O(\I:PGX9!\E8CHXK]?@B33@JXH."6'K1
M=6"9Z4:?730:P9D06[:H,!>KH$B7.K$,I V'>A2]*UXGE@J_4Q@?TKGT.KSF
M^$I:>B=F]9"DQ8#3F6T#$6QBOIUB7[)-/Y?&R8.LOE!!*,Q:3VX""I/-&';W
M=W;W& 7W&[ 37L%HC0Y./E <[/$ZF9Q5HJVNY6OY?&?WM04?IITKAW_8L 8B
M^TV2G/?3_E:,4&SB-W^<7J8,C <:I-LQXJC@<C42U]*%B<:*#ITC7)]Y?IH8
M?9Y-+ R=N 4VEH3"&+^^G113DA^Q3L0M+]?5M)*\7%?#[HC1W#/3]R)O*%O^
MOFNM!^H=KQI1/45U6D"A,V*2H+[E9F4&0Z-&=6YE_6)$U'Q1S9HZDI;#F]U.
M\+/6B$),14\E$PI-J?9";<S_ 'P_.(SF1!G'D#K&H+3V.PXM[3^%ENZZMX(C
MZ\/,U=;.LR^$O$1I1=*I4A>W!7D0FW5 ]JW9=M+4)M0WU6 6/C6":#2:Y QZ
MVBS:V"KH:2Y'0P8IQJO)516!E(V2JVQBMFTJ%\/OL:"^I."-''8@ #/1PE^#
MV@HW_),N]+*8_(+NX4]#A*"-V$!\ ]K(_=6> I07Q*3(+$W&E:7+R).9D=P5
M(-_  [E"LI:_#*AC;&0.L!@0P;,Y[0L)$8JYLR2/[9]N6H2)S4KT-Y>]VAB,
MZMW!NJ=)$VO=WV-V#MIV\F[WR9HP)$0Q:4,*K9@F0IDC6+,$(&M'!7_&RR)@
M!L8_F+4MX4[RKJP";(D\BAQI=,GTDIVBH7%+4&9G4.X&UA6*?:X@HJH$+A@:
M9I/A@B #:!:<<B4<<J6N1Q#)&Q:N5]0LOS$?_U?X/NRCH7ITP;@%Q;CU;%QG
M-4/O ??C*+-]+,'.*U4-LR$,$ \"U ?I"R^L.[6K3NF*!V$A!P5748N7\GF6
M LT[Y%)2_-%OP&C] <U"1X22O#?&UKGJQ'=PU%]U7^2ZJO9("\DBF*(+8VHB
MX/G?L9W!MC@T:B P=EQ=>4F!$!4PUE:JD +-/LTY8N6*ICSX0/L BR/(81#Y
M'J; '1::!P/'A7@,O*V%#B&U7&"\8)1CY]A2YS.&_1K@Z -T:&L8AO"_$$&7
M(S)D0&.U#+NN H545I;(L5[BBK<T]BC((<LJ.$+[D&_"'^9\3/+1.:$^>R$J
M5;NO,? 'A,T*J"QFXF-L+") QREXKDOXLU+;\*5'+GP,MES1HWL,0%[:C'M$
M> UB\$'9L*7UMNWGO/0 /<BA#NM;8#77K.0R!'J'?BL:>E@3D$IX +D(*$PU
ML41'',%R;5A1#T'ODJ2G J1BSE"E+MQ%!4-S/A,>NCH\XR*? ,"Y6<H;RKW9
MRM7< M!#PE^4M->!%+09@/YG'*7R2K"@U'+844:*C+8D+IE11XBZ^JY*=MOO
MG0Q?+]"XM7%^)K;5SN<$<6A1*I8E!LKPPKS*$EMU.TNIK0Z?O;9 9\8$]@';
M4B8?&S?6R&%YN@(=#!=-PWY"%>,37>= [BN'@!_CGX.;XG"S*5S5 *&&)DZ6
M0Q:-2+"#10I(5ZJD0.FV1Z#*E!5(B!;8LGCE&$XMD%2271. I]A?FDS%P2+-
M/,!92[("]6N5\(TW[L4WH(Y_!'6\/C_:WJX<(B_F]$D77-5\,#&%4_B\!RZV
M[OH:MD *HL8GJM*F$G,EB5-(O4@O%9$7AZ7B]!VQVA:U)T+CY-,D;<B 92V]
MR9(@T]42*DB//H[IK+"'&X^KGI21A( LES%1,$F91K]W5E7P-,O49B%94K^-
M.BAL1^3? 5CJ&B8]%OTFLN(YX2S/0>98/6;[V"D5QD,++_4W<+!?;W"P7PV>
M/5]]KI?5%EL5[H[U- -S0X#8"-71(PZF:NW9C>ZDHDHXV/_))+._8*Z\%9\;
M.T5NWC*_T4D:SX\RQFE&M8/J QE0&XTE+ X+MP8;S-ZK[!D%Q!5E8N/(;V^O
M3MW&L"CA;**.,F?"V-,C< L99<H!*^ ]H2/90#V7SXJ"YZ+ <>#1<I":P8M?
M6:.QP?J(*9F%]+\X7+I(D?W7"!-]#.,K^1W'/I\_Q3[O4=SM[8*X"T+^\6+B
M \LOZV7[59UJMZ,>M*PPN5%/.O?YT+&4=\Q@E;9BN:4QU^] 4"-0G4ZS<R@#
MYS9LD!)7)+W8P)MEJ*SR:#:JK%8 5.XP0=#C*:V]/1L<<==^I=PXS)]Q]OZ-
M2 _S7,$6?V/^,3.[#>[WJ2U\>+Q4X=F*_@?7*1SZ84I;D8Q=N3(C6ADH1Z!U
MP1K%CUD]ROX!=MAHK4<0OC,HD.7">1E.JH_.%K3S--#"C8^.80=JAS1^S-;>
M+GN1&-IS)EXT8OO@VSK83C[;[O#03&K&-;8<V[AT41D)(14HYB30#DEQSR7Q
M8GN!)!8GM=?19-DUPDI6<^*R:I 97_39\9=)?N,I=/PB;I*8O;86!N,M@ 2-
M!GE<\YL7T' U"J%Q97.NH$3.!Z]\TK/&.+4AGX-R.*B:6&TL[#[[+T5<OTX,
M8/?9_V<--;ML("F0"13 -X$JA>@_9UQMYU.1^^OLTP[S0NL+D2Y;>ER=Z(IJ
M'TH (\THYPKOAK":'9ZCIMD86W&GZKPTPA;5#.'CC5*!I#Z7(A<3J7+!G!WN
M3#&T>^,OR.H3B6$SY.AJ/3DR-XT!3<4PC^]![>V#,OI84I5RB9K\>,Z-?<0=
M";4<))WYISH1-F92,,+8PFWJJAC7:7N$'W4UX1#TM(!?7C%$RC;_A&)&,_F)
MCIGEO1K*<"O^?%29J'C4TFZQI1Y@4[09L[^"^A-B[T(R^[D[$6V<S%3RK\I8
M\9SE\]Q.ALA +%]E@F5HB)1AY^&E/+Q08KVZ&.<5$\%\ \<.,9I[1IT\T_5V
M/!,N@F82BZ [1 ??FT$D2S#L D? #W M7+[@JG<[@L**UJU'<;U- 11798.O
M\8'6/:X+#QJWRM%F:,#$&V'EX;\O*6BFTN)#T2)>A:J/Q#?73O0*HU?N*/2T
M2M4>$QBI>CYS<HV,G;=S(_$:8\G": &S7\PORLJ<@9%:\#F1$F\[C'JVXS%B
M;.%EVZF[J'$@N%H(<6@A$T<+-!')1FM2:3E+#""2EF;$S-IXK<RI]DJDK=F_
M_TLF)89M<W\9H=CMM3A=G&58?S=CT+"!GN8"-MMVP74=[D@:CT'<IC2Y,/?C
MBL:&] V*@.MK3TJP;IL?G"H? Y<'-_T[@O9USY'4MS0/$DXJ/$A1_L&VT^4*
M07@T^K@MS[]^ Z*7&D^.3CZ=]9(#Z*_%)A&.$_3F$8\CI@.9\T0!@F?)T#W-
M*ST_@RU:5#?=SHFRC%A1U6N8P6;0+UX^VU<Q2!#+>SL_OO[!_/9B&V(2Y]2E
MP82A6)5<CB71PW?DZ.2T!>V[8>;*F!,UY#5BI7Z4T0U0QNTGY(H9#904/S9"
M#W-/NPPAR.$CKW_'X<$73^'!^[S9+^%F]R61]/CUXM:0=F5I4($59R>6OR+)
MA!#1!C$4A("H8^+(\>"*;0B_?;&[M_7'=K<#V,GUHZ"">W'7A53-5."Y3FYT
MSM(GV,-Z'(9DD$0HPV.XL-1Y52XNDXL\FQ@9AE/4T$*#&^M@:5E\</SVI"<E
M.VV9/;5A;:5LC#;=^@1*M6/T#]\8G\SR]T *)P>/+\?HV(\24#*/N@BY$&*%
MO7$8&+9V?!@87BE%8^LYC+'1<41+[2&4;QBKR-HG!?J]BYG(;]G892LRMYRQ
MD@VK Y0)>8J4/T@M@T.M$5RT]5_9GHV/EXJAYYG=D+;T>KV.C.&:O&@DW,#U
MA [D=H1Y6^G"P[&-[-Y*^-2GXFR;$70[- 2T(6W_P,-"0[IXAE_KH@-3:O;;
MVIW *3>:YQB]7Y8&9#QW)MFJF&5+&6OF:@M/8#2LK.=2:JDIFU4M@@I]N;LO
M9(K0Q\@5@>O6"=P;&L_9Q5>!'>R]%+ #6] -M5NV+&-Y0&)6^K5=0<PG#(T/
ML4R1^AF X?T9M233N\@_L04BC$G *01!OG$5:FI4MFA1M>W;;P=PL3POKM7F
MIE/G&K8%XQ8VT"'3MW;'ITDV8R^IVXG2&/A(-O!E>U>PN,7!+P@N[4C7T@ ^
M$<3(M/FN_$[A)PH?;=U+BN'[9-#($D"4.>2R"TEXE> FJ1JXZ(13F8E,V+C>
MZ\X80]R-P)[GD!BO%HH282,V[ZRE(YWBHN7$/8$D)1[;GNB,L.Y5C=KYP6I-
M2UHT7C!D[<B)BVAASMD,ZS=]XVR]]=OHP#CJ))S8+2?DANNDG! 1Z"%^ [X\
M-H<>$(>)F=G-(Z=]>6V9NBD;VA)M%B_ZIH*H@;Y/3)\ $-AECOD<8U94)81@
M;X9(19\0E:LKXU//8!1!_)48?A^R6<9E<V_+V:*VRR(G'4#2UO R'M]=N"2"
MVY:,N9J\<7!DCB27,<00%\RGZS,#O3#G2V#2MQ2).V2]-3F(LRH:.)/;J4N6
M8[^G:E:A(5,!+B9)&;76.3CJH5Y*DF?6[31T#KX#[VA630KHMC";O55O^R95
MBP4J)!/?;7CEY5-XY3Z%+38U\0W5O4T'U-) 8O=(!3=\#]7CC.YV-&ET$-^7
MBDCIP_, % )O$*/I]&C&;^+ ;-: "&.'=9A=9D-$5*J=>:MZ7^"U*@5"X?I1
M><GEVU$8V?;L!>L"0-"-A5V1L\]6?JOX,524S88!<>2 &3+U !\=:6?O1U>5
M1V?@G=[W;B<&D)9[R<TT[.-ORSEYE/1,UE.5EQ6:+K+^GJKD!V,R!#L=<AV5
MJTM86;^*:3FRFS3Y9,DTSX4B7@VWVU%7 Y'#&N%V+S"P_W)OZ\+&!>QQL.#0
MSET-[.-F<CW@0F>XWPS[5N$!43[T<V-F5IFV%!5#>@3D."Q95-A W0Z4+Y)J
M5*TD=B]\2-<3'[..&Z+2>')QR)DN5(VKUJ^9;99CL-0JW']Q#SKISV]_[IV<
M'1V\[R>_'1T=)=!'_[!:T8S@X/CCX1%<V=-NY]-)_Z!_:#10<G:<G/W:3S[T
M3W[IGZP8V ,(DA]W=K$P],"=:[-W6 2QK!3GV-;9.A"@:!DNML6BV+FT[$-P
M.,I$(9L[++/@MD'G2CUV=/7B'L]6H9C;2R4BT=W;U(O5VUXMCD'@&^+((4:?
M3!?(QZ30+]LEJ8V1I:+R$$B"WI,&#&9+:.]^>G"/P+A45)WU/C\WLSV![CN(
M\-O"J^0OEK4*49-2%R^:P%> 6I"_P\!8%\6 .OJX1"#L$>2"@5^P(A(A>"9)
MWX(^8QL3KM/?%U51CPJNH2G#-'GXV*VA.0!T+B!\Y,%M-"<7H.@800D5LXQ-
M;2?!$CR"Z6IKVS58%1WS1W'KZ%HWD&=1O])6-BKAD8RBJ,S,RZ%*!><C:FQA
MYPF;CB[,R:\;\6#SWZEY%=697QD--X+^4]0@^2@1(%3"+.%2_E&57<\:(7:R
M J+E^CA(A7KH/O^HFN;HKX^C9XQ7\^'H8P]D>MKM]#[T/QY^ $W3^WB8_-X[
M^NU;4#.O6<TH;$Y1')YESU)8@2!GA&D,)<2^Q/?,Q&Z'[$1SN.!(04D#%>2B
M!^&BXKZ[(\'K>H4W\B@BV*F;".@RJQVOFR:PX-]\OQ&%5T\1A;O6!>#<>UZ%
M7RKWTVT#MWO/-QY5L0TI\*V>0CV*</*X#BT4^T3'08 ^I05YW=O[Z>5K+M??
MF>ZDQH"%KIH9B@W$CGV7#ZJ%<5\YQI@F^[O[KV(T4L>+.2!?8+*]81)X!!-V
MO$HK85<ZP4<@I9,69$ 2#9\AH/=\1K:?D-4&WBKFQJP3&JT>\Z29>)E*'IB7
MH0B,:G!PF3T5GD0UN-7<A2)-6H;&*I7R.IOA#=37\ROS2* XS/DUAR7 :1WD
M?A$T)I*UB\&0-6/S&0BS:N/'F"OZB $2"1PK_TSAI]5A@'2Z,^-#KQUHN(W#
M;;E1MN6"J?>KO8$!X[Z$NY)\[::L-;QNQQS?;7"TC"HU-[H X)4%K5\$!#:B
M,CF(;M;Y#?8&W4HO?HW0(*D!:Q(8\.A#93/S7"KP<K8[-FVM,MZCZ-I-0UY%
M6)BX#<-;1%NZ5M??K)P],UY+GN'1M6V5=WBE5F'WVCOU59<*3T"X]K$3Y8Z*
M8Y7GR^!Z>9>W.D7Y6M? DT=HXDC906SL;QZC9L<:GVD(K467CZ%,S7+5BK^6
M\#ULU[.+Y&%8XQKK982X".JL9E@6LZ1!*N7@A]SX2N^0)<VUE5!2D$&9,<N@
M9ONQ<7D9?3V8QJ+*]4Q<,8I4TVL$("4SLYD5V1+!"= 2AX#-C4>WK!"MQ.I7
M(]+SD>\T2(+./'GKRW;R?#<)FE[/J7H0PD)^H5M0KB:HE4M7#@=ZH^T%I4]:
MM&@#(!_XE@98&<3(W4B_O%)8/_RQ'JEC33)Z!2(Y;);8<V\>OG(@#\<;V@HV
M9NA7OY J3;:NY 2:CT,%]!=4,3&)U,/M?>3ICK<;O*)@?LLDE'%BQ8Y 7RG]
M:.9_5903JSE78YI3(M^5C($V;K<]W,,#\""6>DV AY4C0&4@Y5?Q8)(RT]U4
MK> HJ!1*X*9&!-[+E(/A'SB"H6S[9@IR#2#X;)M'K6KM5GH!7-35V% U4]A;
MZI^B$:KY(AZX1A$:E< <U]*Y8JLDH*.R,B+26 Q'1U3R1<QX4AS%87;EW[E<
M@R._I5!_0;X31^$U%!XQ-ZOT&TI+.B1%)? <626(6^YY;$=A!$DMB@L@UFYL
MQ&6ILA""'BAO'>3H4[%]Y+T'9DT#W^8*<[_E0*NA.'B9#>%LX ?#AA2$1F=.
MY7-><VF5-IKF)JQ9;WGY(XBD\^4BR6CHD%M1[9^U,-IM(CI*UBI:9@B9K=.6
MT$5&YW!YRVAZ.]LH569/)HKH@TA"T9U])A2OG"FQ?#TBAJ->(VL8 K3ADM9Y
MJF@*#?,H5K7+P2PUAVYAJ<G+"O!%MI[O;F]BMX7+11;5/5AP8?JI47WHZ%?6
M->+$Q_X>P[@_/(5Q[U1<7BP7E_J@<3>-M#O780FG'TO0O0)@&5BL7NB;!N"^
M C/K<K,"'B>/SV@):9$O-$(HZ:N<$5 X'KH4_Z2H-C8$@;!(RDI=8 #+$U ,
MM Y<!%YL\"#$@&,%4]%U,<5.E+Q<U()2)I:2\-$U8VJ7Y@3[K84!?]VM:ZHW
MSMR=7>1^U&>4UT7%^-)W&=@-70/]C+6"6&PE:TSK>'^:MPEPQ!T!G#=3C.Y!
M2?CX)BS_51TVE6[QH?8.;_ID2C3>6XCYF'.3V<-O;9B411P>L3#&22,]ZY&+
MP^%=>I9=DLGSW"J5:%6H>>OLL+1+>J^AW49_'"\9QV"ORL++LO RJ^)!Y**S
M'1I:ADA]-A;Z>&T?2UD*_21:E*00?D86"&&S2%:3J_W@SWSE,NW;+M-U.#*9
M3E.<MK\R2Q8CV(B\EY+:-ON0$*>,W\#.(OA-8-MXWY&8JX9-DYBCND)40.S>
MZS,HA_=H)_E]XY+**.VD;A6A^3O>.D3[<N&@J,4-[B%Z?S>-T 3(KV89C9?L
MH7^Z=K_5>1_GQOEU<7'?VFUI<QZMM;JJ3M=W&F-O5&ZQ#I#AZ9;3!>67=, 8
M(EH AZG-CKB0S>J;/9U,QHM)\M::PIEU56*EM@+_18VWEK+,V ]7N<I;E%6C
MD#W %65NZ4 TC+(I-"F3@P;OL1\;5]D"G</&B '9UT?,@9-$?3T!_::6HUMT
M'R*OKZU,0OZXZ&GUDC=X(00>IY@.S(MSZ2%;F9A:^0%SY9Z5XV>7YBSF<\Y;
M\7^Z'6)A'I;UW".R7<&PN[J&GRN=;2[)"]OI]%B=YW_8=;/419.RMI?*J F@
M:AKJKMKE0XB"(.G[B3T5^A>Z#'T[3H[9*G3"HM"HT"E\I&\0(3+IMA5>JK/Q
MC *J;3[RO 2;L[,[N1X4Y&U.$1^?]4F9U^X$T4W) HN^@,B?H#7.13IP4'=(
M#*$<3JH1T,MQ<LF*2_.8GVF$,P?D&PN0R WN#VXIX5[J&I'$(6P9.T$>A(G?
M/QCB'*H0MC\:^UQ2,-]M-.''IVC"?7H"SX/R3' ]'QG*.0 !R6X\V*\Q@"S^
M ^HCS6__=3]]\</+='=W%VNZ_$KO%L>Z4=U5C!^I#,X+SL@]KI<YV&OXQA?<
M0@O,DFVQ#5B"[5L'_K^RC$=LT;N:\,A->&G>^1$G;3,;O>U6+A5C\"1F"H-R
ME@%@( ZWG28<*V^$0\O2<B%< 3&6CUPSMRI8$KYZ\R6P1F:V@>.Z8+2HQ:P@
M.D*S^%/7W-XD6&H$\Y3%MG38V @@HW"- &6%84WOK]&)I8UQ-N.*YO-N\.:Y
M-77+N;<UBN;\@ :&:P CST@:JBQ3>G;#\^FJ&+<B=:;;UI;Y8/S@Z6)JQ-5L
MI#TZ/V7B\HZMGD6W R]R"8JCGU5*8N@U?*EBUEBI@ZITL"@_>VBUQ-.LD:@;
M]N2K_,Z(0HC$23^_+I.M_6CNTOL2E=F%*7>/_PE+'&VZJ-U(6E$0?=>;B]S
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MY$XIKJ4._4XMG>+1[W8L+/1R[!3GU)V.@L0%QYK#V2 &$F2Z;RU@C:(>5L7
M94[7,2:H-H4J2I0@B13@KF^8E&MMVX M0M]I;TY\^:1#2PLSBMW.I##::X1W
M7N+F8\93%!0.CIA_M['IUT^QZ5LLIWFX2GG:M F6TSI-%,V&"00PRQ@J#<-F
M?M)HPXFQXI#IWAS(FP!&5S_GW#@>M7_QL?$6"F:)NBT5\/'2,A<KP(":./]"
M>"4YZ)B&M#-#,%2N_95:!;_UQ*.JI<R\<C53!M*8-?BI-QLS_#H<L?+J,-M-
M<%9M=3. ]#+A2 /Z%EE58,TZE&<T!7?9).)M:8.:K<'NU9;S9XL;8R%NW+(5
MS4*#!HJ7OZ:NF#JC?D7C*!"AG3F\LZ#8Z>NTQ2+?S,KX*O&>8#V2AC8M!XC@
MJH$Q;:G,U+CGR&\\R8HI[@FB^I@C2VC0R=\% VA<WGX)8N0*OCD=@-X'1C(E
MCCTK5J&?MW\O,Q*KFN4W-:>[F];P-E:TA*8M+EF]*.8A!PR2% $1? #X^57G
M8LLK5=D6APGZIXQ(0_"]6E$!FFT!I^1W6+S3N3G.\^0OY:*"D*GK7]9PM!XB
MZG7F5Q: ZIYFB+I?E8OSBR5?,U=YP<P20+\@L; ';C[LMX)7MF "VTB@7^G&
M93SK5M,A-23N^WF%0,+5/"K%R;O)5#VB^4BM1Y'&ANY"O:HL.Y18CXL(;=8"
MV9UZ@F/^QISKN3G79MYOS'$LK@1OZG$RR3&$(4$5YJA[>%[:0(=\F#G-9H:G
MRJ^9BR(4S9O#D<[[J4,#F2GE D",$+*J=;4> 'N9%U>VHIF"(IP L"__5!7#
M_%' Q\Z"OH+(1#EVB]AO28&8^-)Z!%7<&$LV)B@5<KD01#M(+45R78 _*.K-
M&AB$F"B0HZH !IL,%A'#8\!NJ\W4^$60&\W)U;=1\-#K@+]ICMNX2]7<ZWPC
M\H(HY[F7VW7U@E[YI2 K\E#H<=^ 8$%R*>.J#_/1@LDQSG2RR,J<U,D<+,Y4
M4J>WJ@5CLZX#,;PT<T/<ULUF7W.Z-K($7[A@BV_;Z5K>5!1[&J8@K5.ED<12
M 8$=4&$SI]+'R2$2<905UQ9' &<<Y*5]0C0IC[9$P,A(R8V\X=/@EW8\"VKI
M'J[;>*+0<S67)&(;7V6V9]EWF!KE#^MBR"T3PO>-3.B "5ON\CTA$_[2_]@_
MZ;U//IT<_W9T"DBXJP;R $)E;Y>Q"#^"0PTM!K37)T'O,)SPWVWSL$"?.I<[
M[#5&K&?7;-QT5S&>01 N2C$P<'I03A)5.-(0T31$&$=Q1<YTUSOYJ .(N(0R
M[5)K7VD-&C6GI?7>@92IR'XMS;,8KK1YLVZG.62X2#.H<3)+1IT;K9Q%=NY+
MI<!*(#75@^C881S!?##"[S4>^</N4SSR7N4'T]=#AR%+!C \J>60E&U>S[$]
M;)1/J;NI%ES T,>&KL49WBPRWJ1/1EF,!"-/OZ:/F\MWB?7CF>7$-4K7O*O0
M/X/A!X#*V"(Q+!=5D5L2*[]7/<E&(R/-:@I..B1OC_EID!OG)E&U9LQ&3%\E
M,JO 5L518S 1$-D*+#@ $@I=QL )=%H]$@NN"TF2_MGR]975T74"D05J%M+3
MDD%9#P9<;'NB#1+45(4GAC$O<<G0^1SP4+07,$@DDV ))2_O=MBFWZ:<:N[*
M-H!_E.0D43<ZE8")3Z-H%D3&NV0S8Q#CW@9;R&5OIU4[9BP;:]$KAA?F2B$]
M90[9J<?QY $IK8GF0!8KF'T//*2_'G_HF7_?9),YU(TYSI#-A?VMQK&_O[O;
M[7PJKW,;]TO-HA3FF#_?VWWHT?2GYK!?F>MH#N!!+WG]XM7NC\NVYEX&T8.K
M"'OQ$Z/]'>8@ELA/?%MEHTE^DYP6\S^6GII[6A\C!GY*_OO?__W?_^>AXS+,
M4CXL+V^XZQ!!8)OQ )*TV^96/3CT]2_%H ;'_G Q8ZZ1?\NFEV^2@VHQ'X*Z
M>?_^TX-OVK$1U_WI(*N&F5$&94*F"E^R_5>[NP\^HM-LEKP#EIFB'I9\T_;V
M]A[SIIW< .+?3O)A455OX);!(Y.#G>2MT5KU8UVT:FJ&\Y_G>*I&YDSM#$MC
MT0X&,*;@UX]21D9*S8N=/((N^Q4$]F_9ES0YF@V7A2KN9:N>[^\EOQK7N0!R
MV1[R>;XTDNK=I%P*,7PO8WE;UG.0/T:W[^[O[3VJ[CHI!\FOQHJ],*?U_.$5
M.=R?;N?D0D;PGQ=P2JZR+_:R/*KNBH>R0]7UD+?H?6;<AJG66K]G\S\*(_P>
M0VF]>KF;G$%O%VNKPPI#P?N[WM5ZR!$=F+N5&;.]SDAC[;_:?_70Q]I=KV[G
M,)L5.4!!Y_4; -Z;)V\7]<7C7+2$!K,#@_G/R36I*1C3#HR)?_/]1J3VGB)2
M]QJ1>D[!WZN\XGHGQF]RY;2.HVM933XD;4<Y!4>9C0R##?-V'B[.-A4SS(:F
M"2B)<VK(*F9 ^XFAB[%@7\W,=@WYT69HU8)8UB; WH4-3=#SF5R6YG\ACP3@
ML3AJU; (H0D%']2<!6L&6 [SW0EA.4RAUJD AD9"CQIRD2 1='4[GX'\$8,\
ML@"<7!<\H+95+.I-)Q^M])!!GQL-!C$J,]3SLAQ!+AB*Z<MD6HX(E\R?:XG!
M'X]0KZR*\X+J?N;M8?P,($ G90U1/H@%E75=,)H%]1Q!O3;\0DH1N!V("UF"
M\A;(SBXF8U@ VXPK[';\Y$<F385[\@(SO ?03957L![U,AXJ9KC%\!BF?KB]
M9:B^G_H\@K8V8,@5&ICJSVUS W:[9%Z43;X2$*4B'G/;6S5R,M43+*7O333Y
MK]L?AX"GBR@.%4<PIK!Y$=3[J9R"HKB0EP=Y' >$&V?#NC";D[N;DP,E7U7.
MS#4O$&6I'@+ ,YRF:5'CE=K*=\YWTN2P'"Y.S4O@N[U1:585?MIVB^S1RFIN
M8^@7F6%16K?3-H%8%=6C'DXL=N@;ZZ12H !OX&Q6HV=(QVE\:8 N&A9958#1
M\K%,CG%-P^PE9/3#[.4CD)@%UTK59,(&,F2^N4(](V"^<.6E=)C7&K1'9]T;
MY.DIU'$"^/$(2S@:9/#-IJ*5 S$'SHXC87 @?M+IXO*R-">HY\H'O^YQBK&M
M+0MJ\Y]^D3O4 L(AL7(DI0M>0Y-+G8^(LYDJUU25(U(<0SI#^/',",UV7SAD
MUQFDJ "L-9N6O.I-0<)E]J[YBY@X9P*\-TTC)2ZY156?9K!G+5V;RY?#3^%R
M_=BX7(<2YCG#'#*/!BK&D<6A@UHY)'_&SB!,'"4>^'QD'6ZDZ J3>H#T#BO1
M@(1N@$#' ,Q2OQQ,?]S#@]H2$7]] 7!T58ZGO1IQUFV@I4,,[,M3RS83217<
M16WA +A^B*P5K#W&J!16*.0,D I&FD[T^R" :]0B_.B*V!'Q(_I8Q@FIH0(9
MDS[G(-(P>=7M9-S7D6H(M!5$:5N.[I<N+>U"  DW,+(0S$4C9ASM513C3:J@
M+$1J9C'D"1BVK74ETC)=".((WEFVLAK=P51"TCHBVCDC*X3G82:VKMQ/8 3'
MDZOO+8W1HKYY8W6_=1"7:;S6L+$:,E1:%.)7J+)Y"!(;7(IF"T^W8Y'^D)>"
M<!S/<VY :%T.1(KT.$%5 [I%-8%W^FP-N3'3"<V 8%O3H+@W()R>7^2!2^+Q
M8ASY* 'J9L'Y4-5E!\9CH?PQ:<-N1_WQ;5G^\<S8!Y5%<X-UFMP$]WJ6 WI=
M5MT0#B1EJ)?5#BN\8@L\5_FG:&X+%%(KIQOS77+AG^_L[:Z[!MEU5HW,]98#
M%LC"Y-/$6(J/4M3<MQIGG1*P$,_"'H??2#.(+&^C?&HT+<PBZ,HSOL*BM-K4
M"/;S<..8#WPSBP!,3FZPB6M&9.ELMG^YQ#H/<&T9J-U? $6W<1.U %399 1[
MI=NA]Q0SE/[X1&Q \2CIXJ"8\>9SST%5-EIL;!E #&3#&^).,_.#0 =,=TYR
MG%J$8V^![JV1L83.$9^@F%WEQE([5R5J"LOAIF6SVQ"*42!*5PW^$107'*QB
M1MQ)<K]MX;^%SC&2!%08C&9*5IJYL'^GT=?8&9@/,VF;HJ4WOX.[]^R[#3/N
M/X49;]>(.S$J!JZ(NH2H:;&XQ/Q73M5 T%$N01AS'VX]?R9XJO!K_R% B%.%
MOIRU+.SS\#!>LG(R4K[E7B"JJP>J0BV*>%M1>P%&'(Z5RW$O<MM-/X=:56E:
M!<'(M5U?<5.BZX6B@91J2[LQ!,M@#XRESAY"^P?- 'G5@/;BVMSHJVRRT/+%
M6(0C0!,9<D>]%65C] /O;%[J')!-M\8A@/<LJAEU*)*LG6I9//? 3QAAB"1R
M72^FEXKA@Y02X<FOG%.Z?"K!T%'HAR/?%E-'J=ZXSKS HDE4B>A%!LH.:I!U
M&X'Q5UPG16G<Z"'^$@JHRQO$T=:^=38"G\Q\P&SS.?KQ-I(6-&\[>Y[&BB9!
MZ(S;5BGTD\S"3&Z6F"++;ENK/7)'\TWL=,4T:,QW%ITP; =:#C"66BX0>NSM
M!@MS4OEHF3XN_)9@([67ZE.'#82'=-?5=L/D6$_@F"V_]2F^]65;8YBK08J"
M:0CXT)+9("A$]%)RW">KQ23UJI1CMO;#.PO#VS@+/H." ^NS* ]-SX ;4P02
M+H#("*](&Z:3^IKR%_2K"ZE[OG,/P4$"^6&2J*^0K.,J>.-^$ _A\3N;7L'A
M_X4*Q<T\WF?7T?R6]<+/\:.8/DH=FDJUX#YD/Y8F;#;75FR<SJG8OMLY-)?4
M;&TNAMY$"1?\!I[3*<9P7#<JO9Y#21[9DMF+XG)"44P(T)J_S/$'?A@N^3>0
ML_F!+FL-N3""&,-&,:L9O66?E3I.;J-P AI1^^ J+>V\=N^RFE)_J'.N+TK*
ML9E_0S X1?0V,:1YX?Q68,[ QQ.&"J2 $PF2)( 30M$]HKZ()1%;4%T\^7+#
M$\#AH\D ,Q@5]= \H;"298Q&C9FQ:W/6*X:FZZHE\^(&+$'()*$5XW_#&@*/
MYS5<"#/(NA@5676C!2O1'$&F!9I6[*X'6#2^_')09ZIA>]68(^22YA<,QZ,R
M"S; VA@,HC>"<V/TIN[$L[3.NL//\<^Z+[N3(DQ\D$TUDCTGTVIDKOP-/]''
MQ&R(5N_<N:<E_#!W&99F/V+K1*U7"(-;45[ +H,<8>'PK;W; W1A.[!%?U<R
MOAGWK0FR04,92+/1H*" ,IC\<"29.]1/)Y!4;<0[HQ4@+K?F.K!@]!#.+:N:
M,5IA?O5WW)SX_"E&<Z\:Z4<,Q4LRK4_'CD3*7U39UN-R>VR CEM!SUF%]X99
MN0@3!T%A_823E8BBTY85B5WGD#Y%G@%*.$9M'M),LIK,>E[AE[4J)?+ED8H8
M3(U)/@?MP;G)%,>(B.YBI*8>D#L676$<9VX!Z]#.,6/;28ZP-3!S3KN7)&PM
M)PN2@4!C5,S^OI@-Q1QW/X7A P1",*H?AH-DR("]\H]%035AJ.K&E!:N:/4=
M W4\M>]RD;*>J -P["KE*ZQ<MFE[Z2XR6@[5*&I"PM4$DY2$%NQ+T1;F;>58
MDSQYNFL+DY*992/CQ>8("0)\U!QIP.2ZAY!6Y^;$HMM404W<G!FK,3-0SJ)\
M5X3&@H=AF\&#*$4,\QXYG&Z[;8#21D>GM%Q1^8V?SS,'AHU!R _ EC+LC"-3
MDP.?._'!)TIGS>GS@<KVR 7?+F[,48*:)CR;WM^(L$%G)BW>,Q[ Y2"(@NYC
MSPD899XR;^$G;!@0$7DDL(<DA]"2LJ@[)&04I&1TL0HP5Y3.3UV-*+CZ%:=G
MW\L^N)LE0(44J*$85_O;NYU0T+!08=LQ(E5VUH9*LZ)8H:;9/6^;]MIH:)Y]
MQF4P&M0RBH0&8;EN![4QRNL(&MK16.'=KT83YLNIZ2S29B?[ "XN76V$(T(K
M,21\WQBJUQ=!2R1DM[.NB'1E)TZ4ZYFDC=GRQ<X61L6;1:)W#KB<@$'2/)9Q
M1X2'"&DC$FJJBL"M$.(9YS-:K,O) KA><HC^;.WO1H'VS6ZXR@R*]7,A%H*Q
M 8;S""*2F: >#L0% 04 P:8"WXO4$L%@8FWRCU-'T'[_2)/X[+%&KDT1QT3*
M/ 36UBO#+\=N(1H!FD3B,Z**X8^QKW^>(9$,?J^&4LMY93Y@A#LLKRBRQE-3
M^R<F)!&]IDY"  V+57,..S9TLOAQUH&,QC8#Y%&V!:6$GF(((W/U81;\LU>S
M!KI<"2^.*I$1MZ28FK6]1_"KI"0")@!L:AT/^ZLUH3/8[5SD (Q%2"&V^<+N
M\\1.S>[B@?1D *?9$(N>C2KE<J!BO.K#%L "LQQ!9:;?W.'6Y,9V8BR<5&\>
M,%9?XQQ*C";\Z;J8S]ELB<<-ERHEKPP6<T*XEG KP#[/)[:)UH)^Q,YV^X)L
M,#W+JKS._-S7/#\%JUV"JP&69@PT.6VQE?Q08M-B2I4<U:>SX  &[#YGPK&H
M+J=<Y<B8T$(Y%5],<_*GI;@/]%Y&9$$A,,DS*4>QL2E<(Z#F<A1X^O+H724[
M&5%-$,0%%JFNQ<S?2)S<Q1IZB1(^:ISA)$25^0U&6C_OG.Y Y-M(&C1,$":&
M+[S1W:!_;:V#"NX(=LZ&I;/[3&NP##E;#-WU#1"Q UP?D;7U8B"4L$MY0NU.
MP3:Q)\)]0Y<@T.:,]F,,WFVNX[Y:<3K1Y JW_>XWV7<A@ZKO)3)TJUWB=CO-
MCUM_?#%3 8![D:KV6RT,U(KFGBGUYA"/Y8=:8&]>EU!GZ0XG,42D,FV MCEW
M^!520Z_%1TWEU(5%9[6O(W?4+8B<'H$HHL.S B^>5P+B@.>E&RWD"M".L0?9
MW4:*.\^901P_ %EG.RZ*=+CZ)1LFR2XO<[-J(.I2S@BTK^9W'+!]\12PO=>
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MY/3A7B$JQSJ'SASLV;?22,Y<XA^Y9 MUH*I]E6Y;$?BU6<-ZG*FNT:+6]HU
M%E SD. +_,,,RI*^$UXI;9>5_H3LB*H)>IQPD=A.$C2L@GJ2P)8T@^0_KIB0
M6$\IM!#<4F+?1OXBAOEW(X!7/R&4OR1US2S;Y:X1T?<G>CW]&?:4KS4;?#JV
M70ZW-Y6ZW<Y#B5V%-\K"[R"K+RQUT@JA##?+_%DNE*Q1O9FT)NG;[?SS2.NM
M@S5E U3"?XUP" ]8ZS%>OG_JC,-;CWXVJPVR>5K@<5/[.0_G//_J54?G]AZ6
MG=;B4%J<[U$T+S.ZDHC-)=U)*ZY1<'OL,K]YBFG?I<=%'FN,!PD,*C* I&6D
M5<"AWZFJSR$F.\@5KAV@E<S#G8Q6GNO8K%@[$W,%YT*&VN1N:'9W+#^SKQC
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M?4C0CR\Q@E]AJ7Z[6?E7CUGYK^;@1&UZ/>EYM]LBW*Y;MH)P$+CP]M:9>Z4
MP0P?S]*MBN(3A=?-H]; H?&<XJL_L$,OC^%>6[H5[S)ZELVT^VZ;C%SW-_UC
M%][_H;UJ&\2L(-E F[@"7 HO%D$U\/4A'&'YQ@-RCM&Q #2F,<38[,*2:PP$
M!"<)$3T7Y0PJ!H!<=19YCH45\F[Q1&@ U#V?EAI1A51=G;ZL>N[<7_2ZB-=[
MYJXT*BE*X&-WSU_^O;_\6T!2ZU>NG(D?N05SQ"A4:F>C*H.[^WO"/_*54%H
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MG'XVY!IP;:7RKFB6+<4I(8*G9HF.E]X3P>,0WW_0Z85Q_\1V.R(,Z/!I2BP
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M/.GI0V%SBM4]6?3V<I".%\'888F9&Q+(C"! )FY;):BM7!/N.,4#>>.WQ<=
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M!0H*U,"GZPP>@V@PE[I(O6H#M%)Y?'5/[^@'VJT3>5Q^2:EO1Z\)3SZKPRD
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MY[O/P/>%RNJ;;$\(CMQ_SN=P\ NT/<SE@4M\+O781K*WLF@5AI%0L5:U51+
M9M%KVU:NA[U@.$-)5I6%B02;PPQFN"T.%171^1FDE0M<PLY/;-UZU219R2DP
M)+!0XB<@A_H#4!^EA:4GMCM\<UXV@!O&HJ?I "8!;&KG5,=;JX:8CO%U.;)8
MY=5<)3)2!Q8]D[J0]%0)"6D%L^@-#9M0_UWIL#<@RC'P)QK8/VOD.A/F+#^
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M_GC$1.Z4N*\;?D.OG.(&CKW/LATU]8WI*)?Z1#2P>28*NW)W.&OX-CW\ %E
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M5H]AAKRNPG&-;=(<6ABD5$Q09YY.@Q,3&7G<@POPFE'%N,IB":K:#<L?I74
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M++JI%':>(+<EJ6&",ZE2-"-;3"\&,Q_J&1V%(3O:&T7_YI,;C0A7ZO14AS-
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MIO"WX\.?3LZ/L,/-/<3!+T?'1V?NNO3O]X>G/YZ<_K)WO'^( W=X[/ZY3\\
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M<N_G2;PW! YM(,5B)V7JT1K@&8DCP#S;0;OE^VF!(&.ZR@;'"QTKTCZRP4/
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M,76\*!%'W0<$ ] SYN.@G<(K%!414P ?%0A63WD4^!Z(+20\#<)8HB2 .U1
M)/>/RVKHO+V]+^&!WGW"B9[X+6-$#R6W.L[VD$+K2J=_SVC=]:)-X+PMA-0Y
MN:N@"8MOYF$@U8S!1HN@=3J7K2<AHB@1>%HO7R[V<:*0[V+1M&I:"0WI3V/G
M@P#G;>$9P'R+6@#/0#T!9GJ!KJ7M+?(!=F/<L'==0,,/[XU.P3HVW1ZOD5<F
MW&Q<XL7 5PK0=2&&#AO2Q8EA5R.BF' ORMTUGI6.MH_DECJHG3?(J=1]/))L
MU-61$!>0;& 7LA5P/_JM7\ZF5)1%708,K\GJHU'QB)QN-SW+Y?C\HTFI^5=U
MJY=:[.29*2RAGE@3P4/KJ M=2+@1CFE(O.BZG8GD$&C*W_].?268FM^P;[45
MI SWL6KAME>' 5GDQT%5"K)'72LY)-0DT+NS)IVTRDZBLHN H@VR-LGW2_/1
M+U]R<UDC^M[@[$V-PD@33F\#D]I]R0[/"IU%2.-0-X&R*! J$;D#';OARDJ]
MA_^U&>5409+77WS5#C@C&MBH^=M]"LCER@#08D<BGAK-S'6O(Y&'6^14T =(
M,+LZ$I3PQ>SU___VKO2G;2V+?T?B?[BB>D]%2AG(T%<*?4@F,<1O((X<TQ95
MU<@DYC6C$#-9VLE_/_<L=[-- H2U#1]:\')]U[.?W[&0-Z_IK/4-; 2;?_SS
M0<EE1SK87U+;/?&7E:1$<LK'=#!A:T\I&9=CIX0!#E37,#]X&HI9#\2D[,2H
M8H"N4CE)>575Q'22@DYNIX2%T0:"G>3*[K#V:E?9(^.$SL;&T^& HV,=5<D?
M 7Z=HZJEG#D"OI'/WJ)@H,EP/&,8!)=)IJ1!CTIBH#]57O2DS"]%>-'/.JAL
MJ\@U0I#(1RBK%FOX1<>PI((HH>@-D_W9+MAR.\"L(&[M35#"2\'8GNN ^1PO
M!IL%='@>#F.=PXR8:_U'.4PSWB%3#FS]#CO0L058GV+JEILA4>CJ53]-NMKS
MS?;\U17W/8MA6Y\X'V83\"J..1A2ISVI&^P<0/ATV=D>>C>RX>3R\0\U!4-_
M\H*/?B3"0_'7:70FXBCPCOD(-_S5E987Q8'?%E!E-0[QOX,S@2\)KWDFHN"H
M$0MY!U\4\AXV\RF(&R+RVRV_AG?A4:\6!V%3A)%H16'-]^M!\T@^<^S%?AV>
MD3>\*&C#U? TAA[%C: MO*/(]T^DFE_!5NIA[13^$OYGOW8*KP9-40N;39^:
MAQ[BU[UF'88@3KPX]J,V/!/[)RWZ'(^#GX'?7ZZEYMW24G.OYT('6!O"=XJ6
M5I\E*-;9AY;V!' 6QF$VXCKH8XO59!HJ!^5OIE?=87(Q+G71EFIXF.-DU/YL
MZ-H]4C0283UU4S/CIB4RSM/Q#Z!4XR)_G SZX"XGG@@SX=0R)+\5IAN34;U+
M-=^O)D/ /:*Z1;G RKG!$R"2O@'G*\@+*H9" VY*9C_IJUP-92&QFB^X[E@N
M-)DPER2N4V/(2+MS@CSOE#-AQXV7NO%ZEF .@B2XJ'CRF2%R_F5'M^+LBQGO
MT^MH7"*9H\S 9*;O#@8F95'2AJ2>5: (7,C*574' U/N\5S^,&B*JC[R37*)
M+5G32N2][NNN7ES)3U_!$F4E]!J(]NM?F DY^?AR ,5^^?+ 2=G&<KMYEUSV
MLURBGT D5MI-&66 ;"C&7E715A/,0H%Y+A)%IB]EX1NYH#NKY!H;PF@)4^JV
M46B+'[EQZX4QPB%0IB<B&!4L=4G%[#B8CR"GU$F"(I0%#9']6^I)5($11TX[
MP5"'M'._K# ZL*Q8"?%VN-+C%]3=W$#3%1LSY=@:4E8&WZW:) AI9R* OO%M
ME1T$\O,%Q7B0^ NNNP$?:</D.!"5TRA@5@P6!@@.5W+TUQ0"??R ARH%/+0!
M)9'3W4J<.[K4Y8R*!17E@;&3]\<*BOX<ZJ^2EP8R9\"[H[REI"8AIX7DBQ3+
M,CEZ*-';7E_1O*S7)1G (E[** S52K11I9AMR&:+U"XXWB$5-C5&[OPP5.*.
M&?XX<Y"0*-C8BO =:>^M7G,P1J-UWW+3@J$M-?L%GAWD"^RZ:K\J"&L5:)%L
MO,,^HM*IF5EG@A &+3Y2_B*A"/0PF.P;6',K0ML.L,]27!KU]#K(U08<U$[%
M1+4:D[H2KM!+<I-N/SZIJ+*_BW$A6@87PM"*'"/@!<%8;2E>R[LXB&YR">!P
M0$:IGC9"@>!C)=Q$46V=A)ITT_].0*A#D^H4HD,!NZ)7>CK5OG&0]_+KG0[)
M6,!9U*7&*_:B:%P,]H@.Z6UCH"=K)Y3/#,943A.:H3HQ.!\<\T V='>HVJR6
M6EAA$.!&W(2P-Q@B3_\%^"$E8!W&+V@#<R!F!]A$.)>3>\NN8D3&0^:D+Y>#
M"&3J2.A/HT7->(H3M_1;H1E(N2VUWBC[GWPY(]@2W"S88D696S@*$_.G2G%*
M"IQ5Z##8J0,/H4"(R9%,P8SR("JT77029(/2,#Z"?\0MR.+M><HI>0G73':-
M^O0L&A@IX'4,Y6D9SHR6F[<RY2WCNK%#QNKSZ,:=+K?+ZU[CIU6D#\HOI8<X
M1UVQ3NW4A%U^,W@O)BKG(M/I\O,JEE8Q6+VBG6M&:.#%5@,@@R%:@S'2WQP-
M-<'*SZ&V.7259;7D>]+K.Z"-]+721"(K"%I*GU(R@<A.VH9D='7#/Z\E,39&
M?S8L(5!S)V].K#_-'0-PCZU!.BY#=9L3EYY H*)0"9]S-XV3_")5%:KX%BCI
MDV%9)LW= MA,#;BDIY1Z=NKPIU BQ[C E*B@R3!5!6.S(5F2[9AF2_GOC2Q0
MC>[+M3ON+.V.][KI*5Q$LC44=N66&^V98 00__9$&R,6)L-T5*J3,^W25A#E
MN1A,+L])G.]8K=MD"Z#)DP["@Y)9<<HA-<I6DP(H^3 ;2,:)*320B94-24K0
M26[(3R4Y;-4/U]>9J2HGCOHL,SUCM 1B"Q)*3\XFF)"T#LRF*7D>\VVH')UQ
M]C>=.,M2A7Q.:NMN;6 K$PUT*-93@#]@NEE&Z-V7<M>YWS&I:CDMW%4O<O8F
M)PF'7;9SEBJW !M7W0LQ4JM-$S'K 8Z MJ&HK3E%OQ]8!EEIF*4+;%4?@%1\
M^1#LZ[TK6B#,'Q(XZ(=_!/M?7RP)?+\D@?=) H,F. Z;?KLM/H%7+CRLE&0]
M%0*W\9 B]%NWW,H,-N/5E6N,P[FZ?U2Q0]DND_/L>UHX+M:@JF9S7KM7G;TI
M%R#V#HY]4?./C]LMKQ8TC_Y<VUS#OUM>O:[^YH7<AG4\"*.Z'^%E[@)=>2,7
M_]AKM?U=]<O,&<XO!RPO[=(XVN=?ZGH'_?.W-;F?X[JY\Y'W$PW-[#7UH-O
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MPE"1PGZ(/, '(  78&ID]2??*I^X2/,Y7*R@RL/U08T.4D,7PG15I& :PTJ
MF-'"T6=\=\J?\;ZM001@YJ/A0/^%YVB-EN4*!HOV)3F&\BG+*%G*G=?L):\B
M5@5)Y<P<X)$Z8N[+=0+!1]G,C?OY'[HRP>^LP'1N&GK%#,RA:5O0+&#)Y5\C
M/6[+ZCH3EP0_0:,!_9\2KB5CO2RK(I_F8ACI@EU?<N2QO:RKU06?58PVU& R
M+?&;5Q7);Y--5S49NR->.+3 8"Q&+VT,E'T-$8*%NBBSC@1=BOLCZL _!J"(
M12]SX/+IWB/6QMN=RXM5 RH>3OG+-(R6J> GLQ1W7_8.!"9-SM)V5=.?ST#.
M4Q*5Y6H"FYY<PM;C7W;R<EJL*$IRG#:S]'_P.SB*?U;U!XZ'# >'?T_A@1>9
M_JH!JXDD!:-BD[3\ *\'VQQ5D7C:,WQ,NFHOJYKN+SAL1^DUBN.T@$.#*ZTO
M&=G7P6]>5$V+TOTV;< FO 2UW[;-ME?_@&</LG_ !S.^!3OI+@M-FC1ID9G#
MX$<%V"*%SYK5!'4R>CEPBNF/?'13$\<@;3;GLQLXF)AX('.:M@2=B4G:@!;:
M<22 PJ9K-TJXP]K U1F[-G0(V[HSV87G+OBN%L^;WX"#S\NKJKAB@WZMPPT&
MEJM@E%DN0^E^IPGL!?2YVC5'1G:FNHP8Y9+I6!_A;H,@+>Y\N.Z^FV<).FUE
M1T)6EGD(?1^/@A-?#%X*SUTLLAG>6+"9)AY$KW<'#YK4N:Z?W/]7[UEPU.AA
M*%</_O&\45W+RMQ]@S66G*>/]"*?I@U'=> (=9VQ:9&N\.(">94-YU4?&=W/
ML0>0J;Y+!G_1^3*:@PGHJ8LB\^=<X]^S6FZ:.F/GU_7[]M#IVJ*Y<0!:"08>
M/]=]CJN&Y<6W[7?S6_;SMZ[&>))PAW3-*CM35"8FPL2_V/K J]F& 6.XGF+W
M,/ F&:/_5Z8%&+)76;E"/V-&\WGPZR]/R=E/P?Z99;/M3XIMII[K'%3;-9A7
M;4;G!WRI(DFMVZ,&UPAO$?N/(H.##V;NC?D(^-4]_K+)BDZG*_#'IFOW-9.<
M$RAD):L# 7<_F! 7XHHLP7T#8P]53]/6*_X=+]"JAC\OP+*Z *-SA.8!_.]J
MR;^[3FLX+ZCSP9 &\P(55CW#1!Z8)UF)3VS(5.'_1@L]ET"Q6.UM^H'4-UV3
MPT&9\@M)99,F).V'JI#  T5V01>MF=.2KE"T\$F]42:?[A.,RQK_H]FR(X3.
M6J_LBT.34D1>;C$*?7*R@@/S."5U&"E\BK;:!2X^&V:1ZQ-NKDX\&?YGQED@
M?I43[M-HW G<!%8?BGJ,9YE$P41_X80CWI=T6=I81[/,IOD\SV;# 4<@.!;8
M<<:<,"T85B9:SBG#268FP"EC% (6I)E\1<+)59GA=8E#*(NU=?[2JRJ?:>YD
M5JTF[88,):TUOQ^?H@L1K/#(>3M:TLZOQ(ZC51@.V$]K,$1@O5T*%,S (=/(
M->HX/,V=!7'R?I%4'^\.)UU%\C%LN.P)VW5$/W%E_9=E"]),MES_&?H2T;^'
M.O(?L=POH9# 75C3V=I?5*L.>$)#6'.R^RYRN(9%QE'$X?K%WTCD'I/VDFB9
MK:9T!HT7I1&I=W4US;(9I[3 7.5/=_)=%MBJA>>4*\27D8>&!X:,^(*S"&"R
M9AA*)%/<>]YE5I "I$]XA&#P7H%:H#_OY+DSDL_P'C<3D3;# =U/=38OV'RN
MND$X@;.0 4I^,_QCHJ$ ^3[9:\;A<"VXI>S23EWAA0G6/'H?\J4R@VN@:0E/
M@FEB\/ZV;A$YDM5OHQKYH"@=S&$IZ@N5X7$&*C-M+I/#OZ>X1CLY60>[:'TD
M:(R+9_SH/H9+-/$C2G,XP QVX0=;=?U?T4?Z_.=6$&/#\!/=YXXO9(3"R[ZR
M1P:CE6=B+AS%R TIWF("\@4\1*[HWC2KX< L&QTQ(_<DTDN3OI]6-<ZS8OM)
MLFWXX>NZ@K4V4P-1%[@":H"83>5C3]C)OL6:H>$"0IU."@)+R%EZ;B,&=]H+
MN$DW;\:G[@9<P7'D@S<Y\(LK>.^<O42:(Z.2$(B!CWH%A[?A\/#.K&>B\OQ3
MTD&T/JR:F^Y(AX//)CA)C]S@%XSLU/"?F,52,&Y#.:-\BJ,<:9!++@5_M3JS
M27:RO8L]MK2<AQ+&.+VB5%=T)Z>[&/J7?^@28MA'_I39C6;DBNXS/ME34;WK
M'$>);M-K4%4*I[MJP8WZI##XP[W'H/!L)'R[$Y-CVQ\28'&"&U:,#%^L;]8T
MHX3OC1$NQ+)8448V$/ ^4>C]K?XXN*/L]PES\_YW.&KF1U?A;\XN88OF8$GH
MS[Z%2UO-E4\4L4>>B&UO2@:\?%"MZL[1OFO^Z,FW,JOS@_B!.8>YO,PH05'5
M:S@/")W6[+S<X'#_H:RR]XL0@FW/QH<(W!#-I/B"9-+I8M8?LQWM1G.W/B_&
M81+Z&%V!^,S(<\"3)TX'NQ?JPX 8JFF@.8#F$N69$EA=*#2'TXHU@P-N@8K&
M!?T99.&KX*(C7MKHENB%+6[CW\M<@F,;HNW75;(&-RPTQMPX/=\B"$,$!VY$
M\3M4)B-UXV#$%.0*$<GNK89 X"99%K#P;HCH)IN4[:Q@)C:"1F]/ZR)'+Q)&
M@P%D-B''SBU)YX^BCI)WF^=SV+*=)^TEYIU*A.XW4K]@OD^A6?8*".LAP0$0
MZE5!^3#"#'7GD"- <(FK!5*+X0?8XP]9JP!$2LI.$ U^L0*#%Y6=I*@U9X@9
M5;C":\U$CMVI@#V.0 X-F7J(7MF-=#:K1:70L9,#F3:.FQ^15DT*=T,KUH.U
MF76L?4,_*.<Y\A(,!YL<)T:Y!-%7/R@8GJCN1?8+>-Z.!?@=A@4?_0@+?C&-
MYSN$-YGF=!6)FM/?C+#:;YH6"+>2U(2$$<(4PA+E&C19=H/,/MQ[0G:T8!4)
M*F==X8YZ^C7JQ4M2PE7*R0[' T@_XW<VK 285J[['+D-=K>=_'X-^K(N40W
MN%]4LSZ$$8(U,TSZ@//1M#1YNIG*:8Y_*JHI_I_%JLRG^1+_$\\$"*<%PERX
M;ZKJX0#\LR:_Y_U95?(:<WB"31IQD*">Y&V-BIO,4OX7W$4P8G@M02,J3B;9
M"(,#4X.[DF%,X'*)63O+,//#"A"VB)0QUYA.UY)S%+2=_6_\QJ0",X@2E!@O
MYF],0![3E?VUS8>F!<UFBMX$S5HQ+?EDA:)B@#X^3F/+GK8?U.N)\6,<JEJU
M8%;0@G.(A^$U"[W5IG **%'I9 PUXV>*JA1A3#\(:PGPPP\Y_81/*EU^;47[
MF#>N%3RZ*?38;P'1[2O1.,^"3OM-)5/'G$IIE3=V5&@%O11CD=Y3Z,+5R!I;
M!1=5A04EL*)[Y)-Y:^.(\8X";V;9A.;)M5N[]IC=:':757EO2FJ:;6U3RH7#
M;_-V1393$-8UEI\S;+=V8F??&DO#@1F],W(T5PRBJL8"-$P(@?T()S5O+N%Y
M@DYDN\V^T<1Q2&:J HY5<DUL%S@&4![IA3IW>4VI$L)[\U.6-970:))ZCD[C
MSA,=:YU2-)L4?\:1;;X8UIN3*B)]&N:TD@?'NR:9@[W/KO#6,L(G5N4+QZB,
M+1-).>'7RVK#ZG3.D']NZ"GTIX8Q )\H&R/?] =!5?N:1T")/$P;.TFK6R]:
MTKMFSUT'2%P?G)G\#JL[,[2L1^PU(!QE2042L.FZ=V&I&&'GG.2&MW#D6M'J
M!^<N.%[#P<<<,(-?4#\@A.59\:"3!M8YG;+@+!*.@"9LW3!VOAY$8O W)V1H
M%=!:\34?:7(7RCH<%#EH&X&#>L_M/I 48O\"?I0,=H2>M2X.W8AGL%:T3+=?
M"I+0G8?.,L(4JG(V'.P\_.WLO;F-[<WZCR=PT8(2 I%+BWMDCS^#2QJF 0(+
MO_B]X^DZLO<5%\E3#WVKE=JMH].+-SQXU?(L3Q&#\VC21G^[::-0-7R9>7;T
M3)U?H.E=K+VPV$T*AK9['1^^>XU]J?$[KH0:0/S@0"MIED!L'Z-'.].,'W J
MBK(J9?,94::/_E7;LG'Z)JWK'*M5CA#$V.=MX@4H]>_T/24)>9O6TTLA(V*.
MD(<CY1%B/(I;]/;BU^3H+-$W\L_^+5TLGR=_IE1&W.(XC@X"@I\C^&U1U;/0
MV\/P$W@/ML0X0_QDC(?FG7S4>8*H?0ZES8NJJO4@3%9Y08_^4"+6 R3LT<,'
M9NS)/D%B1SU5%EMV0_T]3?81'WH18V=Q]G?D@>)]Q]U/$;!;8OA52/L18GN.
MM]H<<^S$_S!EQ#:1023S%6)*&59KC!B+?G4#:\'HR>#'TABJ.%^1I<*\"C&M
M9)41" U8,J64"'0>BQ8SES7-I(2$QC8S=A1/#.T(TBLR+ZQ47Q5S5 '>7,!6
MO<5DOI6S?B:SO<5QUZ^Z$4Z'(&@X^,]5L>:C_.@!LP2-$JG$5T*Q4 ^<(?E%
MBG#G:<-,1]]M(/3QCT#HEQ-7BOEO+NLU]VE+FLG47E+%$>+\RA0\W!1#$L,!
M!3@X4="3/I"G.E&OENJFMWIL_PNT]V5RQ #^7J:MR.&E>L-BU:#F[OS<Y_GZ
MS[1<@4DM&0HZQX]O/,<'EUEY,5LE-,!5FKS(JZ*Z0-L=[2',-#7P_;U1<M1N
MO4CD*+W>$(RUX=7W>V=[07 6_TPAV:1(K]TZ3REVAK_NPJ6(-OR:?[)JJ=!B
MAK L*L7 4,:,2'U02"FQAH_7NDXQ3'';P*6=D@G+DJHV:_9WMI!Z#^$K<LH[
MI-QCB;$DCF8(Z4D."Y/6_FO@[-2K@E^ ^0%ZIK'!)3=&US.R&N&%F)4IYMM@
MN+-J2?^!L8%5<9'2/PS7"]^DML)@N8)KD;C<&";@%8K3,=, M<;F.O'S+9\\
M+UK9(SZFVM1D_$W-H7J/X=^M,R%_XOH2D"'$0"L%7D:HXEQ"O&Q&C1W>*#QC
M[/Y( M5N?&IYH:1RQ90*5C>[66_&1_<>/GAJ"IJLP.-D/&WD,5Y\.UM%,S_\
M>TD:#U&??97>#O36Q0N8E)/QTO_EX9/[H_OW[Q/.DB*OPP'\#?]D P#D4(+Z
MU<?T!,T:XO^$L=F:'Z(GPN1Z$_G%-[6R=)%R<+\_-;GDX/\$5%A)R"Y%Y+NI
M/V8MFSD?!PB);VG>'@ZD3YHL;5MJ72[<7U*P&@(<&6_)J/!X@?MM(FS^V31\
MF;:HF9.NNR.G7%Y9/U3K>A/UZ_V&@SO 7+ZE_?*&=X/)E!J<\E4FO%A^;:BS
M/>:+WA9G/IWRY]NVQ!(6PK0/*HELP7<-QTB%KBPFY)'7U8;B#%DR1_P)ZT-E
M1/UB_<WNW\>J&S]NX2J<]KH:#FY"C'V[Z[$1MHWU7+]:.@2\R]S"K^' HJ]-
MK41--1(D6*N2&*(XWA$EKPPOUT\HUMB!>>JD<3+"&NT5;'3I5M&U-0'?X-M;
M]S-ZP.SQO:)TBX20&FMM>)5[==:N:F.B2."<$!=X42B(3H.D(^58IH<UR;\\
M&#U]]&#TZ.F3O2>)LLVB:Z:T'P(C6E'LBQQ?MN/AM2;&YKZ@@R'R0UPC6\^%
M3S=V;#J=UBM;F^<%]&JE2C-.>;1PI#^L*8LZ'#B@)\)&8+H(UY0975 !,HB7
M0=BH&6ZTAA\\O =.7FN3#BRYFX"FIHHJG_>$'A7(1&L>"T-2M@@7XSHK,,O^
M0--H-)8F,%B' P93V6NE=Y,TGN<<(P=,YF6E^H.UWVNT[LF/:-TGK"8\O$FO
M4&2KVDHM)]#@GZN%H.>IRF%"[-!M?US_3L(J.$%ZO??V7AF-]7B0TK9.%NA;
MT!IP%4;1&='UL"XG+Z* M!WN!J&VM75[2% TVTT^02.)<7HKA22*T#%#G)"J
M5AC>>=EO0<?R$=J:D$29U=BWE%^J%Y@U/A:<I51_; (^NH@?J:$YD_HY5O +
M".ZV#:Z@"+ G70#[&J")88$4=F% S&<@]AZ0&O]:QBY(L*+51O.?.PH*#R>.
M)1<^?LL.1K<4\A:+-QSHZKE<J7=9.FO==G_3OW;^*G\+0G<#H-><O@V05YQ8
M@!^AZ:-[M$#*JEGRDHUUNM&0ZL(Y\E1F V,K%>+24 435;1?9"5F,!!/"V=_
M28D>MK9)]]0(-5\6F?'P?.JO3D58M01SG*ARF""\A"=-,_9:1,'OV\>_LX]_
M@?AN\Y4%*),I",Q8L+%<2,=9#WC[.T9ERI.H1P$YK)2%X9?UO_\5!]] 2)R1
MG"'3%A7:\4!\8,GK_?UWW7+S5US/SL#Y'<=5CFT*0N&S+@J(>A(D'F;9XF=Z
MQ0%OGHRT&(58NR\SU[[Z:>E%BNCX\/7,'[B:-'#F4"0VOM/E&\@] 'T(E:QC
M2V (2^&EE#R;59C<1R[;55T3<Q((YY6T@X.E<+]D9[1(9QGAI5:-"20H66K-
MQ"S9E=2-B5GTG^^2MU5] ?)T0*QG+]"G%!R(+;,5&DJ7XR6"&^Q.-43<,M\B
M)YO[CJ=S1V];0YW,YSF(G#%!#FQNL2\*ZJ0?$S$ R9QWZ6<K?FS$JG,I/$?4
M7 $-4%A(0N Y7<FX<4JICV(1E-Y#[$^T85&@)M*^J;R(%0+*B9Q+4#^ZNL]@
M>37J;SB/S#U(F,$9V"*77"0AQ8ZP^(0U),;0%N'KT[5#E^,:D*FIB8$?.C0N
MF'%=.O4?00)[L@YH:;'2TT:>M2;%Q[MZ;6.& T-#/\OAO'$C/$QL6' SYCY\
MWA/4,5.WL>"&%GF8J3"<V1J'YT/]W'*0!'2MM+Y4[PP?3*KJP[T,BU'M S0U
M7E98?D'@\<5(&/3-'QEZ1@TPZ&(A\FX&EN5S*I U["O*\9V6'/(B*!U6OP;5
MQ6A%TW&!I7]Y?O"<,+/J?"!_GGB \2*\7[X%^H.8\NN/S7/YTH;Z)NM93"NJ
MKX#=Y>"R)5E4.E[,SEP@ZK/E/_%E&8\V8S3XV08-\47:$\"1YJ"JU8OGZ=^(
M2;6'+OB<<='I;";^=HIF4XL_VD5H1=60<S<<!#?4#A,'4V4W7,#"$&U_L*&>
MP,5HU+B%F6NF=UFH^C'@]JF[?"RBNXP3_EXCAD]_1 P_+6((<E\MLJ[BY6.A
M'&2W@-V3+KBN5J#3T=JDNJ()HM+@#2MJ=+2IB 99R+5N+1#O2PJF\+.,J.,P
M.&,Q'$@"Q"%RP8<;+OB<C[=+DLO ],+13;.5M3W) *+Y[_;59(5,K.KUX4!E
M13<L8##W;B62OP(C'I'W7+++8>J9&V/2TRU\P=Q-5'(XN#(EN(UB;L#'!;78
ML#L/#\96L]1[#?[.'FI[P[[!7P("';]3I[,QG]ZW[N[J?L+J'ALH5B5M!!FS
MU70E@+A/)W:!!;]7S>\MJ^F'K V87?C&)!_9W)D[V=^FUELE/D:RB^,^EVLF
M>H+BQ]#V3?2-<>-H<*VG,FX+6'$W":$-0?=!\U3G9G3O\QT:9JR6.,;7X0$L
MLNEEB;C4M;7 :=TLO@/C4F;]9.:\M/XK+[-TII =#J]:8NV9^R+U5[S.C34:
M=XWT1Q]Y'33)387G<4BC=QL\E8-A8;>-I*V&$L@?JCPC"\Z<'"@@6+>U[6S@
MTYBX,%=>"A$26!.PT"7/$BUS7&3;.(OJ\R#^8>N'DCNJ?^N',G(&-Y.N$AI<
M:7-=Z1:A CTTQ\!ADX2\FAY8/SS9=^)2\B-6[C'JR+?@^QN%W_D/=VSR.;9'
M]78L>$HL'!%VSMS]+,T^[R[XLQOD_19IL\]P"WV*B%MKZ_-)^W#P47<0O]P\
M"B'^63W-I1C6K+"*.8A'F5U4K=:_DN6M?=8WG21+JR^]@:@G2K:9(L-W(N.S
M'P[FV->3!-8BSKF-:Y;Q^D_JZ@-3/="?YBAZ-E1(?Y.(/_]#HJG\#[<A#7_*
MO57Q'];:HT\LUXOCUB?5M=P^9B0Z!)SA529MC!$BA"42,V13'*FAF3(P<P4/
MP@**V57>$(N-X8*YS!&C1+THZ&XJE,2!&S;N]%V+;MP!8\UYM6J*M8"E,,&.
ML:$PS(\^[]S-%\2>'!-S@N9WF,PDK<I)N>DEO!IC2T@-(N78'L\)W#&1YN]A
MZP>GN#O"HH3:9-L4NPQE[:_.P38CX""MB @IKQ?4??#.P4,47.3C#&*(;K,(
M 5,$/)T[H))L&R\3.MEED4(ZD&^&RS.H-!"0YJ?QKC[>>[HS_R9X5X/9P5E<
M+?]OF9IC7O3'4CTC! L;+?=)7H-H@[2G%W!=1^UYS(@6E!94P78?AW%\[?4Z
MR2@0P&T[ Y2*XYYM:NEMF#/@RJ1+]]:SI6%0FT[!TL1&^_W6"__C1SSQBQTB
M&QG:P+$6-C7@RV?424D-!][=D8(,@A5XXX6S*GL_M#>/\: T-RTE938CB'EX
M/T.&2(^_3+$D@<ZHCXK7UQ"#B\A/S%@T(AO.M+'*CD;O.#BI!YK(9@E\+8DY
M[H1%W:^FZUW\&KPB4T5##%&2Q>,FAA6F^KD=;LV.%EZS&45L^7[,&[\)\[5
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M8.^L&K2]EACL-XU6-2X%#V='-2LQV$(2N27PQ-EJ\I=7U8?G13/-96+=+;Y
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M:$XJN )&CJ?7^8;?<: 1W#_!$\(,+5PGL.[MFCG&O.)>2VWD%DKCB"PQMN>
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MW#[O]PBFW=JX&I75&)?]I?8S1RU@+60']:WF;@#0,6'["/* ;>N>"G"F36&
M F+89QG"X25;BS.@"A/LP(%W4 01-KV$P]:'6^QV>M[GIZ9(+AC4*-**NE-%
M$,BJ04[C6AJ1X,# LH5+\.>R*M%[23MA)"&'IC7M6Q*&Q.E(1@KQXYJH7L]C
M ^W?R%9%4X)5 R<EE@(4)LB6@,]8F_9DT<R!"GFCW/!19PJ-?CH>$;$T[."^
M9(XBWY4.UI\JJEL%4#P6  51P4L7\4W)"#(7J%RC2^4N?/).H,"]*.)UER;4
M=V-SGQYB[+UDWV6EC\B=@T#?H7'G2O#4Q79:<G1.N!ADJ8>5".3:+>M@((H#
ML/(7<7=7S(1U9+64R:B^>=UVJLZ?A"(=SSAR_^PJ[9[K&MYIJ!1R%YNK\2%Z
M@?'DQSTEBD;3R[1Z%[T$HW:QI<Y,04U!6:5#O2'KT<5/Q*)"V[QPG](1LOV"
M#Y1K=8N%&"]OWWK#5_XN79*-<<%]VN2S/*V)_U&L,PGFRS[9]M -\2?!3XG\
M3+#,Q=J]GK(Y6G%-$*B]53S)B0XGW.)'SBK^-WYE*DQ0;ASUT!0?X&KM?>[E
M\4* MY^ZB6#=TKMQV3P[U=F!OH7?=_LYDLK4()0$\39;T6Y(7<VG'D<][!!)
MV2_%CO6'-@T1A&EL]A%!R5B!Z_12ROIN%Z;<"_TBA\0P<JUP/Y+AP&RG\CWV
M9[YHD%YN+^P$U*/XNQOY5.LN8CTC'CL](_+R^P66/7SP(_+WV<N"I&:6:A$8
M'6X[!0<6'U'=LK-H\E!8]')PB0DR0CEP<AQI39T2* 9#=!U%,@R<=U!:@SA!
MU;0(ZZ39H3*DQ@3"-&%W#>B'HQF%>'^FDG$ZU 1S98] V\CY']FC24-U[$#S
MR<YG&/.N>_1'+@N\)6Z/68*(JG"1)'.R2)]L*,2(916I8T]W&<U:# >R3K2P
M#I2Y@Z>[B9$84YZFTII]K?"]HB.E%5._ IQ8!<ARS$J;K3"T!>"&(5]<X"5N
MI,K"V95\V10MR-L9Q+R'BN?K%S.])YP2#Q)+,J5I]J$-S;ZD8"M"B;#'8N[C
M7&YIQY&I8HP-]:(5"@C_@&-,L0,BFT"Z/14G%QO/O[OW(<N6N+A+='C!?R>0
M%+KOR%7=< @MN!F]L2 :JYXI_0[NRA4K(<?D(2<ITVP&E2KPY;O;L89(!W-!
M8;NI69UK2XH-8ZE7G)BA#%T,7ZP!S(JB49\WX#I02[B)YPN<2*J8SG:.%GM/
MB4ZA-J*.L%0O M+V(>-HB\LF+$A,5D)"WHX63_S;NR,!(XT4LPX*7$#KV(PK
M+S)M"4]G$M:J,5:P-!^TG!#J#(Q0+*:7X%C7(^/^C9@:33V#4+^WE2%,YO0*
ML3_0SE@#T2)@^2:R\>K;Q!BVX7_-X BK[G<L?_5_M9RA)^[8 85%K$\)2%*!
M=F^8;SA(W?" >^_[:VV:D0L=8Z4-=I'<'LX1".^-Y$!E5=Y;KF SIDH)Y+[!
MQ.9\.=+--QKL#ATCH\$>MOR' UWJU7+&?!WN/LPPMX?W6#.M\XE#4G.!0&:^
MI%9RI& MI_F2$Q!U^A?1V9&]I':_CPKK=R]"9B<,';H/SRGN4<T%34ZZ5'&L
M_CNZ$!\//=7XF&E8@D1<:[I+J"_B/&^FL*G_LTKKEC$3\OT"3)>T3M996F^G
MI>M=?&T*1+J95P,:)R<\=HGZ(;/&IOHV%WP]W?N%P<A(@"H:*.>&E.:$R X9
MLR4@2+1V7!KT]F&M11MPJVQ6<%%IAT63H#883!?/'0TC>C3OVC*H#8&/I,/G
M6J<<?B8 )-(_BIFQ#*;L/.3U=+4PFL?Y5D_'=B$DD"E(9Q9OMXG@&QL7*U;:
M1.$WJ V)Q6]!L.>[\,]<@MT=I87PNIU\[ER,NR3IBVPQR8@\$YX"OJM/J>GP
M;$[EEJ8_4PY&S",#T;@)@16,Z'5=K99=[)+!R5KB*Z?IB_(;:Y-Y%AKT>J2%
M>1_KFU.]60<<<(98VA^@T_<U*-BU]9@.&RUWU^HF@7M':F_ & WC!NY%SISX
MV01#LSH2&LW$,)T:<M/N%(<#V@1I^H0_<G@V%5R.-*AHC0KOIK"@.LRH%*Z=
M$RTKX1%&MKK7,:SY"[.\,=7!ZGN*)OEN(T@/?T20/@T[I@R"UF=I/H#44U^C
M:@ZB2RF/1HL"PO,-?L$'J5>J*&5.X@QR#(>-,K_*U]LP82_J+RZ*8B))K+C+
MVK:0M->=M-AP(%C;+J.O(:=4;^MN?6+$M+>EUG'2@ML2W&Y2@'W\=PAQ  T6
MO%8GC#>&Y+]IW;,9DXZ,K,_1A36YR&1T<'&V(]4_:U0/+9C+IGM(I)#-\8'-
MM]T,HR$X84. S#($G3M/UD+UO)[I95>L.WVC6<WFB\6JM-6,VOG;8;96?KY.
M/UV/#R;2\#;*WKVQ!:^O^=WR?]O),$;2%2M=N#NKXG 0H57L$B36&Q@6-0*@
M9>R:<ZW=F$!5>W9RO,5#?X$"BN]D+=_#_]P#:2-^ 4S.1#VZWE522]0T4),+
M/_(,PRAF'5T\>[2@(ZU/Y6@T"PYW@D<3UO0>]_U'*PDC0HMA4R7PY21&(3S[
M4<7@=)T(;V048N?B%AM:3G+ I]NA?,M+KXS8FC=R6'1[HX<FB9R9"]C%UBF;
MCEB(5AT]LRX\@^=6R\(0092VA,OK*^(TK)>0ASV?LRQM:?&5@!5T\G" ?%CU
M:MDRY7Z1@S3,O"BVF*+>:\##GW$:,."1(1GD5C^N:]Y5%@;P16^1X)8A+[*O
M%>UAH#'$GU&KE3E/X+2,DDLA+Q7B-5H6A\W)>BGG';AH1TTK;LYOU>(WA03Y
MEEI7,.B*W$&G^<M$45JRE,W%M+&4)-G9-Z5W?.ZEC(.7\T7PH7A]9$XN4^(6
M-.K=8346AZXCWNI<]%QX]GCTJR>AR0F.C13S6@@;31^M<_J#DOD*W%2+/Y#A
M;BHJ-G:E;[Y=V0%(\=6@QOZ65JS:\94YIX/[UNO8>P.LO/,^_VXR7<2TJP@3
M76N190QW$)V ()CB^D%.VJ5Y<'3U4;=IRU&&TX5,2^3:XBID<O_=:L(.$\/=
MK!1[F-'!QM,#NAQ+4M-DDC9Y0XQ;RD?HP!G\1H&1]3!&0 0XX8V<!))(O:A9
MJKWO)AS=Q!,>P#7-+-2T64C#X)MLO)R4YBB:R:,F,,+]XXEBERB "XCKBH18
MJK'1K+ZX#&(SWNB&@QOVT#KA,[^<WOKX.V')K2W[:)QU,-*@'UFIFGT]@3*J
MB4Q4CIME5WFU:HADE+I7\H:2K4Y-@\S.6A8N9^'MFH>?2H#$#T"69A.;W8UI
MD8>/ORROC:6U^;JT.F\/CU]B@_LSC 9L&L!7@ T^85J;?1"D&4=<U!<]L+>N
M1W:S%1SAGTZIKF,.>'HREL**P$D,]:O?4=BA'D[-0<-_X2$A4"_<$L-!#TPP
MM>NGUIR:"J)P+!!039"/:1(O?\*8"VW\I[=10V9H3-9-/3958\N23AD.!+L2
MA>C:<@G$KC ]B1BDTEU +5U9"IN#B -^!"G!J$IVE."?(>SZ^^TH^?#1CW#@
MEY5K%NQT9J[5FT1.&BRPG6&^3/W"\.K3C*8#[*& A.DGDL8<_ENK'^4BU0P:
M,X:IQV*[,_O)M)X&2R%7E9I%.M19Q:[&#%S)!FL44R9.]_)V)N%AW[5M726;
M.EW5DOE;3/*+%75=(P.]KC/NA]NLELM",WEKI[6($OR@#2SA#,R$3"6XQBX/
M[$'3\IY(>QJ.-X>/84@)UJ]))C+X6M=!6J1M*SV."7C!@B/1V5AB]$MNL,C2
M</#M;/#5KE,QY7-..+0_A*IJ*$FFO@S2P5'X"Z?=N"5W%S: K0L,4SZS3'#[
MC&5X\.NC1PP*PGL<%UL.G_/5P[^GC!&TOWGL_T:/=KTJ-*QE>H-RA<"JX !(
M&[;,O/VD7/??FR K))*VE:EDI5- +QH.',"3PX6'S9<P-X"J1Q7,^Y+(+<Z0
M&.:+JIFN1KL[_=#GE<*/%T(A]/!AH\Z:'Z77W\+\;FOS&;ART\^+7D5Q!+WF
M(*&6-]J#(28EQGL=?6F Z!NIKK\5<_NCWA(&875_3LV[MK]U^:YSTW1<CB2(
M<=)FSAC.F2&.LTPEN)>0)A/RNZ M6DCLQND,V;I4JLN<!TK;8U:-\%,Y\&IX
M]1WU[9 HW>Q&&NEU$><$7^CZC)*2:2I)'*03^$\,?\T,(>%M'<N^\K.(7TD7
MVVPE9[=<(3A'$J&,N6L-P-)-19B"^SHKJY46-J43^-^&B)N_:U$M/-L^S-;-
MQ)R_V(C!5V_$8>KQ3+F!K9Z/YZYN;ZX;IAK9G"#:'W8:C-8./-E[8&E+HS7.
MQ*R[8WF$(V%I)M^-\9)JY(V$DYH..YSZN]@>-NATI0U!D@T-0>A%R"%IZ7[)
M[UEK.Y"JVPYD1,@)Z7'97DI*4%=NVU6S3Y@8-PA_?5NQ+X=$HD>(DAW.T3K:
M8A.,5'\E5LXBG64FZA?)MQE^!"9.B7TE;$UT?9G1':5FAL=]@[<452FB:DP6
M&9<&A*R:G^).WT6A;K@UAX./OS91 5LNQYNO3<7OHL:ZTPWZ/<:_'O^(?WUV
M>LB;[[O@Z,2/F'^>M*O4Y[GP'O9>>!3_^H+W77*'Z\Z$1+[<?;?%; \19A\:
MR4#Z&'OY\24W+MVZ'G_;#74,B13OLDFGV>WM!C<[/8 HY\_RIE^8KU#]2;R3
M[XPZ*]9:PXI?3JIE7HJCJIA0^/_\_:B8^[6>WKF@(*>_/^3!2)$:]YCI3CE$
M<@0W#Q.&"Z!#G%F:],BCJ-7LB'TUEX]2E*3IK*(M +XN;8L7@X@;N1'N6D%S
M<;(;\&I,IGCK\D@L84R+@7L:RJ*I7\L<D0V$TF<HZ$BC.WG;J7-1S;A#H^_(
MD'JXIC*48'>XN0=UW' 0M][*4L:O*"S&B%00(;;$"].W3ZC%=ZO@PUY*>NXQ
MX;ZCPT[?.6Y&@P<HY TX3^U"M'9CYU7MRF8'9$G2FG.;5 =VPJ5[G:B?@D=]
M5.?(#_;4+BJP1W;C=)8Q0]'4E-[\KEL4*5&%^^U7QS8^<]K-%DPJ5JQUR7M4
MUN@V&[I=Y,1X.]")D_,WAZ?#P;O3DS_&9^.3X[/DY%7R^O#X\'3_*-E_]^YH
M?+!_#G_?NV%X7T&U/65@!7<,%HHP.&#:C%-IG)&>!\10P*[F6'H7CTD6Z"$F
M'*[QISSX)+9)@)]P(V)JERRH459U'-2E] 8"H.'O)?59P.KZ'(T7<H9 BI.=
M1QO8&YANGCQ *H%CTT>:LC'1 G.L@D$'JK % QU11MR)$;RN55V:WC&&'W6W
M0^'%?2><L\ZKUSASZE$ I+SUVXN5P)C,KQIF9X6Q4_\BBAXS0..C4!EWDI+Q
M/ 9T&S%Y$MB<']6#X4XC>%%7Z:S.L2C@P#0!'C?-"G;V#".8G.P^.CK8L!:?
MI;!GOVW+9\F+@_%9,O[S;-/$/\OKGCQ(WF8U\G$TR9_I^DO/[A!6^+K"$O'C
M?R8/'OSCP3^^^ P/49R?)?_[W__]W_^_[S<^\.1'?.!3A.!/IYG<CMOT"8T_
MAU6!]2/F [^JSGEE2H0<93,NIYM\D<^R+@^3UZ#I8.<3WJLO?AKA/]/ZPXC^
M])]H$*^3^_]X</_A5U"KZ&Q7H%M?9R6V10)%3\[R1JOQ"VF@NUE@'W&7IJ;P
M11"7[(:9!H!U3[;'NW"_X(W_LMYC-7I:3< X2M[ J"[AORZ^M!S0)FSBCOK^
M=OSZ=KI-.\-;Y?8%]_<H!6MUP5O\;^EB^1R,B_9##F[FT=&[+[W'3Y_<3\[1
MM6:=-AR\K$FZ']Z'A7I55()<^((C.$ #'PRK)ATE!_O)KP^?/GSZ%37<R[3,
MLP*/-V*5WJ9M"^YT<_G%C;NOK^>ZD8)GFP[W9Y'M_SYYNP__O4Z+=FV\!715
MO_1=_?#^_>1==9W!T3YKP2$%#^ELE8/5\NC!_:]PB67U^@H)!EBD'S^]_\M7
M%&DL BJ2EQG&&1D(^J).9P68#V=Y^Z'ZOTNCW]):_:H:_74^H3#)RU59NGK]
MH%ZU4PS;? 7%?E(B=<1BDM;3%.R82A2\'H.'3^_?_])#.$O+Y%6-QGHSK>0D
M/'CPX(L?/^<HG*YA#/M[R=M57=,QP-A<<K"7O,AJN&"_]D'XJD@5C!<R8SX"
M&J@CW'P-1V66SY'&$$/#G)C$0-8%D[5)?#':QB"2E'W*4)!MPW">,@SG6'*T
ME8^Z^1,#H&&$74*%S#!9AC_T(H F[6+I$8JUA$AW%-]HBR<%.IK]C>Y"4ZQ-
M5'(7 1U!X!4%!..5E$R^Q\GD3L2S]9I+2T[$:91):+V1)K8#%)[N,;?"Y<2S
M\J,&F6?J3&A9>/$+^,^F1=K.S#*KP1.*W&MNRW\Q7]2*7%P!)"=$XA:!R8B<
M:>:45YB2QH1^1JJ_:]JOSIY@3I07?;)...Q:.FQD#O<5!8Z=QX],ZT^NU] R
M>'E%4YEMD,PJ<;5ACY3:R[Q9"#KB6446INM@,IT,$T?JOW_8S=,?8;4OJ,$(
M67&FV'9._G)#F_YF-F$'EEIZ=0\'MA/+R$& A?AX6X+N8I%G?C_T'FB?4[.4
M4OO '8=SF"L9B @;$1N&[-)E4$68 Q%U4)=%)@L0+<4U[PV9=9L?8OE.\I*:
M57A]"?H)MRE3Y;1ZL.K;8!0W]J,-&N[LT/G7[Q#[)!7AK4J'7<'R'I@Z0$YY
MS;(B75,"RRZJE$_LD#HRJ3S3CT;R>3!!N#-63(0G$X._X:J86?*_]0^@U_UF
M7/+$6-=:AWXU6L/#*Z%#LA!Q(:%'X3%@!2SA,'WD^_K <X[3/!'%FT .G#6T
MDHZ\WOJXCY!T*EI)%_B"LJ0'QX _78Q:3NU F>. KJQ.LXYR[=+JT$&PTYF9
MRY"[FO#.Z<8)[="D8A8D7!C:WUB[**8UU)\;RB+WMWV=IC8 QFD#&5V%QT_I
M,0W U>'<PLPGRH:9&RH$W(]N\4VD.)LW@IGU5LY3\%:=&+(,?6_P@#BZXMRW
M[@Q0)K<]#% \Q$# QTZR,IOGHLIF##"#5TXSFK1.,#H) Q;TM;6W(E[SOE O
M$;[$5MAA>8S;$7+3_GD- *RL-2%4R7&"M09YPTQ2Y]BYO2(L 8%/ VQG;IX@
M9&UH?F7U!4$4G,;Q"8.BZ  A)3)V[>6B6;AM%#=--U!;33]8?$.GW6U5"^M[
MPI17OK[<2P[ONFLZ;3T%UFX7-4;%9\+OPRMK8#QI8<IJ#"3'::WHX M<0,Z.
MTGM3S"**0-CE8SI;2?O&52GD^T+9(A-,+X03RV>64<1/]^?.$68-B?V:#(N>
MU<\WE-2%D+*)T0Y\H?%S^_!)>\-!#/C(]9["QA0>9VN"]%#H!O<T;@C248H.
M3EW;H;,AL;9+6!$NT 8Z/]3Y1,L/JOZ:QAL: **[U+WQL+)[L;07O-WCD)C0
MX#ZEN I>=Y57MO'C1M5A4#Y75<Z"B@T]*P&9;=^))S#G"];+)&EFZFP!@W\?
MAS6.]-1*IVOL?"+]<RZ(MHHM4K6IG'Z-':SZ;2M'8G^[2<.,_'(H.:4!UU'P
M8VW-X5HCJ=.#$P_^N72FX/).<[&QM!04#*Y$E=+E1K*#0"HXKFM2PL2\W(>9
ME+^S3<]ZP:.OT(@'VNHIHCBYU8>8Q*XB<6#^# '3.Y[\#N=&)H<>7,*+"K[%
MKH_VE9R'"YC7MUFS^(K!KF.-/'4I46V-EU$W>-,5N@VXVP!E:R@?NJ+EQ:H7
MBXPULV$?C^^(VX&6U9&8+@YP-02EBCI,)7S!I(4&#SW[*+=G#TD-\*FZC?ZK
M;X%"=3IANVL4>%=TD*FWD9$5$6%O*9RD_0AOGJN\;KG3GLHP[+;'Z!$IO"(*
M446X^#SP2[Y?8VT+PZ=PI S)2'.0'KQZ+<2 M<\%,8\ZTAPK<S"4MX[*WX,E
MM%T8B6,W;ZE3D<NM&G"LH:W1=55$:ICJ1#I(&?/<,)P@5W0V<QB4F9V=;3E#
M:EU-^.PG7@^UD&T9?\_>A1#5Z! O&&=2K/<<\N%6Z*Y\)DQG^WIV7PX52@RF
M?1PJ81F6%Y'C^$.':39&A>V\8L?OV>%+["YC1O54FDN[3Q<WHHR%J9AY\..'
MWV7>C=0RD@W%7^DR47['L<=__(@]?D'#B[IGOV8X-Q)N(M7(?X*YV\R8N@H1
M*=0L#\X9_'T-]V>>%ENL:3X/M;9AO)%C:MH5>?Q('?)Z4Z]C;>,+6@;6HJGR
M=]:K3JD/@\LY1W)M[CSBO,%_O 0W_3I%-G#N"4?%&_(E^@'32!%ZW@8?^>5J
M<%GR%U"JY31?%EQL@@VRX!.^:>%AB50E;F,S)KN>RRU=;K0XVL2$+4DVK^JJ
M-#%0*EH6.X,WL%E-%GEK2'+!="E6#2KAOQR9I&^"<6EZZ0X'V(1QBN52!]7*
M]C3H; D+">ID^@138@7FN:B*H>7%I-L.RX7R>;)C(M7Y?%?-6OQFD4X_-(9<
MB?FYO#&R8'IT2,G+7*(Q/,@FYVI/$"Y<UH.T@1N5X):6^;YW!D3*U#/XF[I,
MF&?1.#K-)9XG/IVXV2"D: 7G/N>8 =E$G$%VZV'](H[^FHU1--E)H0U-6[9"
M(,\$493.SKD]@A(_]^>L>]/5,9&]240-4;@$NB7*[YGM03\>QV(4^UMV-%C\
MD24:URBZ]K1ES\RV3J.BT\VO$LOM,@.U(^$H4U_7^_X#>?\U*OK&; /6U&)>
M5_H-Y1RI(3M&ELE4J"%_-,B&1N7H4+".3<T/R^H:!VMC^FS5\[N\TXW$^,RO
M#O.E8WZ+F<=GQY+\\E83],IUX2D2A\.&1\+M4!*;?PE#RJ5H<[70AU$;4O1W
M^7#<=:#;T-]3T-_[!V^P$.[\S6'R#DOT#L^2-X>GA^<GR?CT]/"/DX/]%T?_
M3/[<'_\!G^P?_Q/^_TNP>(Z2T_'K-^<)?._\=+Q_E+SX9_*?[T__F8R/Z5M'
MAZ_AC^].3PX.#U^.CU\G+P[/_SP\//9>M//GFT.NRGNQ?W;X,CDY3@Y.CL]/
M]P_.1_#DT_/DY#2ANKT_QV>'NR-X^,'1>WH<ON/@Y#U:7 ='^^.WHV3_='R&
MGYR\/\<)P2]/#X_VS_%/.,@W8QC^Z]/#0V1/QD]Q(/"JXS-X&Y4#XJL/W[Z#
MW\!0< U@2O(]_0H\%U^,XZ>9XF?'AZ]/SL=4.@B#>/EV?#P^@^?RO]\=GKXZ
M.7V[?WQP2 MW> S_/* Q# <XL<.35WN\"?Q067NC;][N_Q<L%(V>]N T^>/D
M"*8-LSWBO3#:8__@OXY/_CPZ?/F:?K%_GIR]M\_=/X,M@/4?'[]\?P 3A)>0
MO0I_Z"[/BW_"5-Z>X&KB(/'CX]=G(YKOV_?G[V%K>32\:OOC8W@BK0<\!A7O
M(2V8,3%!PWP;4*&G?"V H25>H= 6S),;@@,(0*'.%'EY!:;[C,,*0=:(HV1B
M?FC7#]#:7;.@0_C9?2$;I9*.RTM25HGZE#,3M]V_8=R;!\V632E5Z9B-ICS@
MK=X=M*/#*S%XV7#@O4VZN,B5JXRY3N9Q"495ICT7>D:\::X2O>=?TD"C/Y3Z
M4/(4+O-,ZCF<J8!=TN1$!4A_!(U?+?+IR':/MJW$W)X@[L I2]TS\BT3)SS=
M^P>> C(SLQJW@R=T1MVD5G6FD!-O;<6P,*DNO,6N*^5&XBYKYG$[7IM+N#:)
M9J.NRGR:--/4+2S&9*O]$"U&T/.:?G4AO;9 &:D\ZAP6*"T(2"*Y*_YR6UTP
M?Y3YE7(C4V\82S%)( #;7=BMA*;F);;ZGDJAO?F97NO# 87W9V'..'"%HGE!
M#T"3MQ(5)_>O:;&GJ6$=T:>58$$PIROGR602SM"^XRC/+S^B/%_PR/^"1_[<
M]OR*GG$-0SLMA6VBD-4_*G4^&:.8H-MHO1=Z==J=./FW#LDUJ  LT)?,-7<\
MB!/SQ%+K47+771./-ZVH=99!9QJDLAL16"3Q4*T(XIQBCSI,X.ZD3O-K5%;.
M$$/"*=>3K>8^BA=)EN>%H2H*X;@:TXYU:MEA@.UN.'YJ-FF8JOM05N#M39PI
M>&W!3.)'B28P8^TT#+P%_8C1KB&K'R+NIMJ=K)^4\#&3YK)L'?Z]S*5BZ"5&
M.78B37#95][0,GE6B;O.F^AE*((7[.XEK[3@,\4TN?IRLVHU:37$?JNL'^&I
MZ0/)C_+58@Z6WP.Q1!P'>]$",W::?VA>K7;2!-%F9MS/+D9Q$W;OB?8]_':8
MG9[N_4K,3B!3X!X'.(!8]/<M@HYJ9S9!@J:97F8S)%9'95""! MFZ^_+?))3
MOTWGGJ9C44U7MH>PA?_0L<UJ>XGCWNYJ\IOEDD<MU[B(2;]5T!K%2=M&M1E3
M$Q7QVE!RR0#W 8BUI#2/D_]N5DNL&Y]E3"Q%@F_L'20WTN..LEBG!?6ME173
MD7K2U!WVU@4%Z_G>_\XU;V\(;K8V1'2T&U=&28B.'0Y4H9).\9BMTL0EK"'9
M*D>Q,[_1"^FH JXJX)=&+ATGP*>"0ND,H5:FL@IK^NF/W$\93^U2LLHE!K+>
M$OVVQI[<^=FT/UF1'?<.X=AS[W'N=82KM_WM)YZD$P^BAAM<&W7A=9ES>?=%
M9YRM)FPAV']'OJR(<[H!!>TV@F5K\V;.APUQ\Y<I8A]=-\!V@_%P=&&75"?9
MHTW0.-@=RP+S<+UY3>#"^JO*J32)3CX%.#!(*S!>VFEGAC%8+_V09F2[?>I<
M&K0M;C>9CXOQ?!*WU_CW_WUJ< 54'W"!S?#F;?*B2,L/H ND)!"7!&OQQK]_
MMU[2KS^\I,^I3\;',/SSX\.SL^1/CL:.XGX\*$.BEIU%M+T;%JFHEF8X^/_;
MN[[>M&$@_CYIW\%BVEL'':I6#75(!EO 9'#D&*1J3ZS-!B]T2E=M?/O=^5\<
MVDQKJVI-91Y(<G;B._O.]TMLG]W<%'#%=NMSM,PH-BBN'S/S7 *8NUQ;V]UC
M;%@[G&;G]#LO?:NOC>3L5PK;J+\U?84VT70D.!ES(?*,CF>+R:?.<<=<9Y0Q
M?^W:]@2;=B05X\J0'0N6\@[T0= LYP-_\M=*/VPA;'&KN%H-W0GS!9^^!?ON
M:58EK)R&6<DJ[?,9Z_=_['LZ_*FH)"]"9 !;\YEH8) _N:<(#<Q!A4#M+M!X
M, 2A#8@@SZG0.'JA,FG'"6S 0<]DG<&HI*B@*<?1%Q#[0UWLB%X5WN\T/OU)
MQ1^.]H.8N<-DKY#-.?ZY)WB/I*]7)7B BO2;F!4(Y,VQ^=VS:^A=]XC\!?!X
M>O-]4URCW?R?6GQ<%=9$:!_[X\VV^$9<T&GH#:7M.6.3A@/V94\9:.+0#7_)
MS_(Y%6((5*J7BI_U[#7)7 *=5#1'TC)0QHXD%S@^";XRI*S\_6(9'O#ZE0K%
M374>\E)']<-V/B&$&T@ (0&$!!#:!! 4)2<&&703)DB8(&&".W-D98$<X:<0
MC4OL;TJS0ND2=]PLBY_K<I_@08('"1XD>/"2X$%C)-@C'Y)^NR.H6Q?K'^L+
M''6_<V/QA"F>(:8X;-*V HO;JCGOLNX1R39P2$XY.>7DE)-3?DE.&=[91TI2
MIF9LPL,G?4YF>;[DP(\42[-RP.R(DE[IGZG[_7RUV9&L:T+VMM7UUF5H'_]Y
ML<,)2BN<>!A>\!-D>"!D@*Y&LG,@3O5<#/\ 4$L#!!0    ( +&)-UL^WT+R
M6 0  !02   1    >&]M82TR,#(U,#DQ-RYX<V3-5]]/XS@0?E]I_P=?GNZD
M2]*$Z[*-*"MV"Z=*P*+27=T;<I-I:ZUCYVP'Z']_8R<I:2G=4KCC>,'US#?S
MS0]/[*-/]SDGMZ TDZ+O14''(R!2F3$QZWNE]JE.&?,^';]_=_2+[Y/!V?"2
M^&1N3*&3,+R[NPNR*1-:\M*@!1VD,@^)[S?Z7\;?R/?*>D)&P(%J('$WBLGG
MDO$LB3MQMW,8QT'4!BF@UAK)J(&$],+XC] JDBA.NMVDTR,G%^24:@-*D#'+
MH8V5Q4*QV=R07]/?B$,-I!# .2S(&1-4I(QR<MT0_IT,11J0$\[)R,(TLM2@
M;B$+:JOW.DMT.H><OG]'"*9+Z$2@R3+O>S8/=1KN)XH'4LW"S*C0+ H(4<E'
M+5 L]5K0G^,>8; .5J*7P"G5$P=J)"X_+<2]S.FJ&]QPQ7$9[T6'+>4,V%+7
MT=&0!C-Y&Z+@D6&4L\T!Q)W.08B]8##'T()P)GYL05CQ!-NB[>01Y.[  :)>
MKQ<ZZ1JES*Q&4%OOAI5P-9<S2HN-J;2"AX"I,8I-2@-G4N4#F-*2HY=2_%U2
MSJ8,,J>%/9V#,"LZJQJ&JAF82YJ#+F@*.Y<%&V]3#C"L*/SKXOS:]:1W; &$
MN#9E>2&5(56WGLO4G:(MJ;>__*9BOMWRH]@_B (TYA&QF?'F<I/PQ42:1MB+
MR+*+=B:BG^IVN_#MXBGOF\_(WAE8/_@V_IZ-/_JP4_R/!L<K,)'B\J5D6M-O
M_YH(RM)JN%7+W>OR@'Q1;S83Q.9AN^/UD?/\H#>.HA"XT<W.UO W3[+7IN$^
M-SOS:'V<:B*.!A5"&N>[38X6!1-366_AICW427.R1S E;O0G5*5*<MC^@0@+
M)0M0AJ'_A^%0&9@KF/8].WO]9N[><#H)<.XV*H\<K(X;*PX1 OS\@5Z#-<Q8
M\+D5$RO'6P;E2],V)WU/8REX:US]Q^$6"IX;+D(T?NE<V9Z.^JJE]7\-/H/I
M<X-'"!-L>^B#I<ZS [<^QJA![.+;:+CYDK"\)82&WDLA\T5%;B#3TEY"FO\G
M(CL52&HQQ..D<E<+CS"\3HQ0_68G]27!AN)#!HZCCOW#=T!CH;VD(B.5.=*R
M=Q2N&UFW7VK(OHICMTXI3TN^[+0:7&ML Z[WZ.[(U0)OQM6[3;&:V16N#Z]Z
M9W7(N1%7WQ9=+6Q9;[;58$PGME?LA,7F^KEBU6+NAIYHO+N*V=! ;IEZ1)<3
MC2CWZ/E3R;*H%#.3S%&NTG("5AF[U<%QB\EL[ QFI:H[2##.K:N^9U2)1BG:
M5#0US>]PST QX\Z[WB78EO(> ;.$_:MA7GP,/L3=:[0+^N1+F;LNOH4K4 48
M?!;@>)R"4I!=&YG^N*+J.^4E=().%U6NYU3!!>034$TF7L]>E:SJY9IDR)6)
M-\_6  JI&3Z0%HZJ/J7I? 3U(<9R1G;2F/E0X%,?M!F*$Z?W=?HQ.#BLL_+Y
M%;+\]CS>LCK5N*KNA/CS'U!+ P04    " "QB3=;$H8P\#0&  "^.   %0
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MK%@FE=T/M&0KF4'M:2M:SKE3J'/S<=G6QR#Z<[RGC\[4S?]02P,$%     @
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MGN62M(8^XOQQ/HZH]\=@0XRZS "DAN8RET8-@L]M)4-@1QVDP('.0<'#-UG
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M/YEW<)=[S#_S1JG>\B]02P$"% ,4    " "QB3=;FK"?HK,:   >I   #0
M            @ $     9#0X-#DS9#AK+FAT;5!+ 0(4 Q0    ( +&)-UML
M6&&X O4! )O1"@ /              "  =X:  !D-#@T.3-D97@R,2YH=&U0
M2P$"% ,4    " "QB3=;9PL$C+!X   F2P( #P              @ $-$ (
M9#0X-#DS9&5X,C(N:'1M4$L! A0#%     @ L8DW6S[?0O)8!   %!(  !$
M             ( !ZH@" 'AO;6$M,C R-3 Y,3<N>'-D4$L! A0#%     @
ML8DW6Q*&,/ T!@  OC@  !4              ( !<8T" 'AO;6$M,C R-3 Y
M,3=?9&5F+GAM;%!+ 0(4 Q0    ( +&)-ULIE#!JCP@  *-@   5
M      "  =B3 @!X;VUA+3(P,C4P.3$W7VQA8BYX;6Q02P$"% ,4    " "Q
MB3=;D:->(N<%  #)/   %0              @ &:G ( >&]M82TR,#(U,#DQ
?-U]P<F4N>&UL4$L%!@     '  < O0$  +2B @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d48493d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xoma="http://www.xoma.com/20250917">
    <link:schemaRef xlink:href="xoma-20250917.xsd" xlink:type="simple"/>
    <context id="duration_2025-09-17_to_2025-09-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xoma:M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000791908</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">xoma:DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2025-09-17_to_2025-09-17"
      id="Hidden_dei_EntityRegistrantName">XOMA Royalty Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-332">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-09-17_to_2025-09-17"
      id="Hidden_dei_EntityCentralIndexKey">0000791908</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-367">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-368">2025-09-17</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-369">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-370">001-39801</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-371">52-2154066</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-372">2200 Powell Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-373">Suite 310</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-374">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-375">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-376">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-377">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-378">204-7200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-379">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-380">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-381">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-382">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-383">Common Stock, $0.0075 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-384">XOMA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-385">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember"
      id="ixv-386">8.625% Series A Cumulative Perpetual Preferred Stock, par value $0.05 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember"
      id="ixv-387">XOMAP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-M8.625SeriesACumulativePerpetualPreferredStockParValue0.05PerShareMember"
      id="ixv-388">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember"
      id="ixv-389">Depositary Shares (each representing 1/1000th interest in a share of 8.375% Series B Cumulative Perpetual Preferred Stock, par value $0.05 per share)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember"
      id="ixv-390">XOMAO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2025-09-17_to_2025-09-17_us-gaap-StatementClassOfStockAxis_xoma-DepositarySharesEachRepresenting11000thInterestInAShareOf8.375SeriesBCumulativePerpetualPreferredStockParValue0.05PerShareMember"
      id="ixv-391">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-09-17_to_2025-09-17" id="ixv-392">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
